第三部分 2021年欧洲专利统计分析报告

28 各领域的欧洲专利布局和竞争

28.13 有机化学领域的欧洲专利竞争态势

第13个技术领域是有机化学。2021年，欧洲专利局在该领域共授权专利3547项（增长率为-17%），占总授权量的3.3%，是专利数量第17多的领域。

2021年，美国在该领域获得专利权1189项，占该领域专利授权总量的33.5%。中国在该领域做出专利发明155项，获得专利权143项。日本和韩国获得的专利权数量分别为324和213项。

表28.13-1 2021年各国有机化学领域的在欧专利发明和专利权数量

	国家和地区	发明数量	专利权数量	净流失数量	专利流失率	发明份额	专利权份额	份额流失量
1	美国	1271	1189	82	6.5%	35.8%	33.5%	2.3%
2	德国	469	446	23	4.9%	13.2%	12.6%	0.6%
3	日本	328	324	4	1.2%	9.2%	9.1%	0.1%
4	法国	181	168	13	7.2%	5.1%	4.7%	0.4%
5	中国	155	143	12	7.7%	4.4%	4.0%	0.3%
6	韩国	202	213	-11	-5.4%	5.7%	6.0%	-0.3%
7	英国	171	145	26	15.2%	4.8%	4.1%	0.7%
8	意大利	73	58	15	20.5%	2.1%	1.6%	0.4%
9	荷兰	68	118	-50	-73.5%	1.9%	3.3%	-1.4%
10	瑞士	152	244	-92	-60.5%	4.3%	6.9%	-2.6%
11	瑞典	43	33	10	23.3%	1.2%	0.9%	0.3%
12	加拿大	33	27	6	18.2%	0.9%	0.8%	0.2%
13	以色列	19	17	2	10.5%	0.5%	0.5%	0.1%
14	印度	66	51	15	22.7%	1.9%	1.4%	0.4%
15	其他	316	371	-55	-17.4%	8.9%	10.5%	-1.6%
	小计	3547	3547	0	0%	100%	100%	0%

注：本表分别按照专利第一发明人和第一权利人进行统计（中国的数据暂未包含香港、澳门、台湾地区的专利）。

图28.13-1 2021年各国有机化学领域的在欧专利发明和专利权数量对比

2021年，在有机化学领域上获得欧洲专利授权最多的机构是巴斯夫公司、罗氏制药有限公司、LG化学公司。

表28.13-2 2021年有机化学领域在欧专利授权前10机构

	机构名称	国家	机构英文名称	2021
1	巴斯夫公司	德国	BASF SE	76
2	罗氏制药有限公司	瑞士	HOFFMANN LA ROCHE	69
3	LG化学公司	韩国	LG CHEMICAL LTD	67
4	默克专利有限公司	德国	MERCK PATENT GMBH	50
5	默沙东公司	美国	MERCK SHARP & DOHME	40
6	先正达参股股份有限公司	瑞士	SYNGENTA PARTICIPATIONS AG	38
7	百时美施贵宝公司	美国	SQUIBB BRISTOL MYERS CO	33
8	诺华公司	瑞士	NOVARTIS AG	33
9	再生元制药公司	美国	REGENERON PHARMA	30
10	科思创聚合物有限公司	德国	COVESTRO DEUTSCHLAND AG	21

注：本表数据按照第一权利人进行统计。

图28.13-2 2021年有机化学领域在欧专利授权前10机构

致谢

感谢大连理工大学刘则渊教授、河南师范大学梁立明教授、科技部中国科学技术发展战略研究院武夷山研究员、大连理工大学丁堃教授、大连理工大学杨中楷教授对本报告的大力支持与帮助。同时，向以不同形式对本报告提出意见和建议的专家学者们表示诚挚的感谢。

如需要中美欧日韩五局及PCT专利数据、专利报告，以及咨询相关专利问题请添加微信号。

微信号：chenlixinip5

附表 2021年该领域欧洲授权专利

PATENT NO.	TITLE	ASSIGNEE
EP1587540	IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME	MACROGENICS INC
EP1613613	CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS	ANORMED INC
EP1915394	HIGH-LEVEL EXPRESSION OF RECOMBINANT ANTIBODY IN A MAMMALIAN HOST CELL	LONZA BIOLOGICS PLC
EP1951885	IN SITU FRUCTOOLIGOSACCHARIDE PRODUCTION AND SUCROSE REDUCTION	GENENCOR INT
EP2019815	INTEGRATED SYSTEM AND METHOD FOR PRODUCTION AND VAPORIZATION OF LIQUID HYDROCARBON FUELS FOR COMBUSTION	LPP COMB LLC
EP2035526	USE IN OLEDS OF TRANSITION METAL CARBENE COMPLEXES THAT CONTAIN NO CYCLOMETALLATION VIA NON-CARBENES	BASF SE
EP2080749	METHOD FOR SYNTHESIS OF CHEMICAL INDUSTRIAL RAW MATERIAL OR FUEL COMPOSITION	SANGI KK
EP2141152	COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE	NIPPON STEEL CHEMICAL CO
EP2155351	PRESSURE-ENHANCED EXTRACTION AND PARTITIONING OF MOLECULES	PRESSURE BIOSCIENCES INC
EP2165377	ORGANIC LIGHT-EMITTING DIODES CONTAINING CARBENE TRANSITION METAL COMPLEX EMITTERS AND AT LEAST ONE COMPOUND SELECTED FROM DISILYLCARBAZOLES, DISILYLDIBENZOFURANS, DISILYLDIBENZOTHIOPHENES, DISILYLDIBENZOPHOSPHOLES, DISILYLDIBENZOTHIOPHENE S-OXIDES AND DISILYLDIBENZOTHIOPHENE S,S-DIOXIDES	BASF SE
EP2217625	RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS	NEOGENIX ONCOLOGY INC
EP2257612	CATALYTIC PYROLYSIS OF SOLID BIOMASS AND RELATED BIOFUELS, AROMATIC, AND OLEFIN COMPOUNDS	UNIV MASSACHUSETTS
EP2259360	Organic light emitting devices having carrier transporting layers comprising metal complexes	UNIV PRINCETON
EP2294043	METHOD OF PREPARING GLYCEROL ALKYL ETHERS	GTBE COMPANY NV
EP2307381	NEW DRUGS FOR INHIBITING AGGREGATION OF PROTEINS INVOLVED IN DISEASES LINKED TO PROTEIN AGGREGATION AND/OR NEURODEGENERATIVE DISEASES	UNIV MUENCHEN L MAXIMILIANS
EP2314692	Methods and compositions for enhancing the efficacy and specificity of RNAi	UNIV MASSACHUSETTS
EP2318336	HIGH ENERGY REDUCTION IN A PROPANE DEHYDROGENATION UNIT BY UTILIZING A HIGH PRESSURE PRODUCT SPLITTER COLUMN	LUMMUS TECHNOLOGY INC
EP2322930	Sequences for detection and identification of methicillin-resistant Staphylococcus Aureus (MRSA) of MREJ type xiv	GENEOHM SCIENCES INC
EP2325643	Sequences for detection and identification of methicillin-resistant staphylococcus aureus (MRSA) of MREJ type XV	GENEOHM SCIENCES INC
EP2325647	SEQUENCES FOR DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) OF MREJ TYPE XX	GENEOHM SCIENCES INC
EP2331257	CATALYST AND PROCESS USING THE CATALYST	MEXICHEM AMANCO HOLDING SA
EP2334427	FLUORINATION CATALYST AND PROCESS TO PRODUCE FLUORINATED HYDROCARBONS	MEXICHEM AMANCO HOLDING SA
EP2344433	AZEOTROPE-LIKE COMPOSITIONS OF 1,1,1,2,3-PENTACHLOROPROPANE AND HYDROGEN FLUORIDE	HONEYWELL INT INC
EP2345668	Sclerostin epitopes	UCB PHARMA SA
EP2357250	Production of polypeptides	WYETH RES IRELAND LTD
EP2394732	METHOD FOR REGENERATING FILTER	NIPPON CATALYTIC CHEM IND
EP2403964	METHODS AND PRODUCTS FOR IN VIVO ENZYME PROFILING	MASSACHUSETTS INST TECHNOLOGY
EP2405940	ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS	HEALTH PROT AGENCY
EP2407784	METHOD FOR DETECTING MUSCLE DEGENERATIVE DISEASES, AND METHOD FOR DETERMINING THERAPEUTIC EFFICACY ON THE DISEASES	OSAKA BIOSCIENCE INST
EP2408807	METHOD FOR THERAPEUTIC USE	AC IMMUNE SA
EP2414328	DIHYDROOROTATE DEHYDROGENASE INHIBITORS	MERCK SERONO SA
EP2423188	Agricultural/horticultural insecticide and method for using the same	MITSUI CHEMICALS AGRO INC
EP2427775	PEPTIDE LIGANDS OF SOMATOSTATIN RECEPTORS	BCN PEPTIDES SA
EP2445343	PRODRUGS OF NH-ACIDIC COMPOUNDS	ALKERMES INC
EP2445924	CAPTURE PURIFICATION PROCESSES FOR PROTEINS EXPRESSED IN A NON-MAMMALIAN SYSTEM	AMGEN INC
EP2448968	N-TERMINAL TRUNCATED AMYLOID BETA PROTOFIBRILS/ OLIGOMERS FOR USE IN THERAPEUTIC AND DIAGNOSTIC METHODS FOR ALZHEIMER'S DISEASE	BIOARCTIC NEUROSCIENCE AB
EP2449057	METHOD FOR CONVERTING LIGNOCELLULOSIC MATERIALS INTO USEFUL CHEMICALS	CIRCA GROUP PTY LTD
EP2450341	DEVICE FOR CRYSTALLIZING ACRYLIC ACID AND METHOD FOR CRYSTALLIZING ACRYLIC ACID USING SAME	NIPPON CATALYTIC CHEM IND
EP2459555	PROCESSES FOR CRYSTALLIZATION OF RIVAROXABAN	KRKA D D NOVO MESTO
EP2491056	VHH FOR APPLICATION IN TISSUE REPAIR, ORGAN REGENERATION, ORGAN REPLACEMENT AND TISSUE ENGINEERING	UNIV TWENTE
EP2493849	SWITCHABLE HYDROPHILICITY SOLVENTS AND METHODS OF USE THEREOF	UNIV KINGSTON
EP2494008	SYSTEMS AND PROCESSES FOR CATALYTIC PYROLYSIS OF BIOMASS AND HYDROCARBONACEOUS MATERIALS FOR PRODUCTION OF AROMATICS WITH OPTIONAL OLEFIN RECYCLE, AND CATALYSTS HAVING SELECTED PARTICLE SIZE FOR CATALYTIC PYROLYSIS	UNIV MASSACHUSETTS
EP2496726	METHOD FOR HANDLING AQUEOUS METHANESULFONIC ACID SOLUTIONS	BASF SE
EP2504308	METHOD FOR PRODUCING (METH)ACRYLATES FROM C17 ALCOHOL MIXTURES	BASF SE
EP2506877	THERAPIES FOR PREVENTING OR SUPPRESSING CLOSTRIDIUM DIFFICILE INFECTION	HEALTH PROT AGENCY
EP2513022	AZEOTROPE-LIKE COMPOSITIONS OF CIS-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE	HONEYWELL INT INC
EP2516557	FIRE RESISTANT GLAZINGS	PILKINGTON GROUP LTD
EP2531586	LUBRICATING OIL ADDITIVE AND LUBRICATING OIL COMPOSITION CONTAINING SAME	CHEVRON ORONITE CO
EP2538222	Biochemical markers for CVD risk assessment	NORDIC BIOSCIENCE IMAGING AS
EP2539707	ARTIFICIAL MYCOLIC ACID MEMBRANES	UNIV WASHINGTON
EP2539715	METHODS FOR PREPARING PEG-HEMOGLOBIN CONJUGATES USING REDUCED REACTANT RATIOS	SANGART INC
EP2542580	ANTIBODIES AGAINST PHOSPHORYLCHOLINE IN COMBINATION THERAPY WITH BIOLOGIC AGENTS	MEDIRISTA BIOTECHNOLOGIES AB
EP2552878	SEPARATION OF CLOSE BOILING COMPOUNDS BY ADDITION OF A THIRD COMPOUND	HONEYWELL INT INC
EP2556081	A CYTOSINE ANALOGUE, A METHOD OF PREPARATION OF A CYTOSINE ANALOGUE, A DNA METHYLTRANSFERASE 1 INHIBITOR, A METHOD FOR DNA METHYLATION INHIBITION, THE USE OF THE ANALOGUE IN THE TREATMENT OF DISEASES ASSOCIATED WITH DEVIATIONS FROM NORMAL DNA METHYLATION	INST CHEMII BIOORG PAN
EP2560986	GENETICALLY MODIFIED SENDAI VIRUS FOR TREATMENT OF TUMOURS	UNIV EBERHARD KARLS
EP2563817	FLUORESCENT FUSION POLYPEPTIDES AND METHODS OF USE	STC UNM
EP2563911	INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ALANYL TRNA SYNTHETASES	ATYR PHARMA INC
EP2564245	INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES	NOVARTIS AG
EP2565175	Catalytic process for the production of 1,2-propanediol from crude glycerol stream	ARISTOTLE UNIVERSITY OF THESSALONIKI RES COMMITTEE
EP2566965	ANTAGONISTS OF SEMA3E/PLEXIND1 INTERACTION AS ANTI-CANCER AGENTS	NETRIS PHARMA
EP2570471	Preparation and use of aminoalkylphosphonic acid dialkyl ester compounds in a lubricant for antiwear and/or friction reduction	AFTON CHEMICAL CORP
EP2571898	HIGH-AFFINITY FULLY FUNCTIONAL SOLUBLE SINGLE-DOMAIN HUMAN CD4, ANTIBODIES, AND RELATED FUSION PROTEINS	US HEALTH
EP2584409	RESIST COMPOSITION, RESIST PATTERN FORMATION METHOD, POLYMERIC COMPOUND, AND COMPOUND	TOKYO OHKA KOGYO CO LTD
EP2588502	POLYMERIZATION PROCESS WITH IN-SITU INITIATOR FORMATION	AKZO NOBEL CHEMICALS INT BV
EP2591001	AGONISTIC ANTIBODY TO CD27	BIONOVION HOLDING B V
EP2591778	Polyunsaturated fatty acid compositions obtainable by a simulated moving bed chromatographic separation process	BASF PHARMA CALLANISH LTD
EP2592062	Production of paraffin fuels using renewable materials by a continuous hydrogen-treatment method including a step of pre-treatment with hydrogen	IFP ENERGIES NOUVELLES
EP2598470	FORMULATIONS	SYNGENTA LTD
EP2613375	ORGANIC SEMICONDUCTOR PARTICULATE MATERIAL, ORGANIC SEMICONDUCTOR THIN-FILM, DISPERSION LIQUID FOR FORMING ORGANIC SEMICONDUCTOR FILM, METHOD FOR PRODUCING ORGANIC SEMICONDUCTOR THIN-FILM, AND ORGANIC THIN-FILM TRANSISTOR	UNIV SHINSHU
EP2621957	CHIMERIC SPIDER SILK AND USES THEREOF	UNIV NOTRE DAME DU LAC
EP2626370	Immunogenic compositions containing Escherichia coli H7 flagella and methods of use thereof	UNIV EDINBURGH
EP2627168	ALS INHIBITOR HERBICIDE TOLERANT BETA VULGARIS MUTANTS	BAYER IP GMBH
EP2627629	METHOD FOR PRODUCING ISOCYANATES	BASF SE
EP2627639	N-OPTIONALLY SUBSTITUTED ARYL-2-OLIGOMER-3-ALKOXYPROPIONAMIDES	NEKTAR THERAPEUTICS
EP2633018	SULFONATES FROM NATURAL OIL METATHESIS	STEPAN CO
EP2636661	Method for converting a heavy load using a catalytic cracking unit and a step for selective hydrogenation of gasoline from catalytic cracking	IFP ENERGIES NOUVELLES
EP2637687	VACCINES COMPRISING NON-SPECIFIC NUCLEOSIDE HYDROLASE AND STEROL 24-C-METHYLTRANSFERASE (SMT) POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS	INFECTIOUS DISEASE RES INST
EP2638064	CELL CULTURE MEDIUM AND PROCESS FOR PROTEIN EXPRESSION, SAID MEDIUM AND PROCESS COMPRISING A PAM INHIBITOR	SANDOZ AG
EP2640732	AGENTS AND METHODS FOR VISUALISING ANALYTES	BIOPERCEPT AB
EP2643345	IMMUNOGENIC PEPTIDES FOR USE IN THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, IMMUNE RESPONSES TO ALLOFACTORS, ALLERGIC DISEASES, TUMORS, GRAFT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENE THERAPY OR GENE VACCINATION	IMNATE SARL
EP2649095	MIMETIC PEPTIDES DERIVED FROM COLLAGEN TYPE IV AND THEIR USE FOR TREATING ANGIOGENESIS- AND LYMPHANGIOGENESIS- DEPENDENT DISEASES	POPEL ALEKSANDER S
EP2653506	METHOD FOR STORING LEUCO CHROMOGEN-CONTAINING AQUEOUS SOLUTION	KYOWA MEDEX CO LTD
EP2654803	RADIOLABLED HER2 BINDING PEPTIDES	GEN ELECTRIC
EP2658837	GLYCERIDES AND FATTY ACID MIXTURES AND METHODS OF USING SAME	NALCO CO
EP2670432	IMMUNOGENIC BORDETELLA BRONCHISEPTICA COMPOSITIONS	ZOETIS LLC
EP2670525	DEVICE AND METHOD FOR THE GENERATION OF MOLECULAR MICROARRAYS	UNIV ALBERT LUDWIGS FREIBURG
EP2670909	METHOD FOR PRODUCTION OF DIMETHYL SULFONE BY OXIDATION OF A METHANOL BASED MEDIUM OBTAINED FROM A SULFATE CELLULOSE PROCESS	STORA ENSO OYJ
EP2673262	PROCESSES FOR PREPARING QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS	EXELIXIS INC
EP2674418	BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME	IDEMITSU KOSAN CO
EP2686000	MULTIPLEXED DETECTION WITH ISOTOPE-CODED REPORTERS	MASSACHUSETTS INST TECHNOLOGY
EP2694532	AUREOBASIDIUM DERIVATIVES AND METHODS OF SYNTHESIS	AUREOGEN BIOSCIENCES INC
EP2697385	FERMENTATION PROCESS	GLAXOSMITHKLINE BIOLOG SA
EP2698835	Compound with branching alkyl-chains, method for preparing the same, and use thereof in photoelectric device	UNIV BEIJING
EP2702122	GREASE COMPOSITIONS COMPRISING ESTOLIDE BASE OILS	BIOSYNTHETIC TECHNOLOGIES LLC
EP2707353	CATALYTIC CARBONYLATION CATALYSTS AND METHODS	NOVOMER INC
EP2710033	HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES AND METHODS OF USE THEREOF	UNIV ROCKEFELLER
EP2710114	HIGH-PURITY PRODUCTION OF MULTI-SUBUNIT PROTEINS SUCH AS ANTIBODIES IN TRANSFORMED MICROBES SUCH AS PICHIA PASTORIS	ALDERBIO HOLDINGS LLC
EP2714625	PRODUCTION OF CHEMICALS AND FUELS FROM BIOMASS	VIRENT INC
EP2714735	ANTIBODIES SPECIFIC FOR TGF-BETA	XOMA TECHNOLOGY LTD
EP2719451	FLUIDIZED BED REACTOR AND METHOD FOR CONVERTING OXYGENATES TO OLEFINS	FUDE BEIJING CHEMICAL & INDUSTRY CO LTD
EP2725011	NOVEL COMPOUND	TOKYO OHKA KOGYO CO LTD
EP2727982	High- and low- viscosity estolide base oils and lubricants	BIOSYNTHETIC TECHNOLOGIES LLC
EP2729170	ANTIBODY VARIANTS AND USES THEREOF	GENMAB BV
EP2739591	PROCESSES FOR MAKING CX-CY OLEFINS FROM C5 AND C6 PARAFFINS	UOP LLC
EP2742019	N1-CYCLIC AMINE-N5-SUBSTITUTED PHENYL BIGUANIDE DERIVATIVES, METHODS OF PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME	HANALL BIOPHARMA CO LTD
EP2742047	ANTIBACTERIAL PIPERIDINYL SUBSTITUTED 3,4-DIHYDRO-1H-[1,8]NAPHTHYRIDINONES	JANSSEN R & D IRELAND
EP2748179	PROTEIN PURIFICATION BY ANION EXCHANGE CHROMATOGRAPHY	BAXTER INT
EP2751057	PROCESS FOR PREPARING 2-CHLORO-3,3,3-TRIFLUOROPROPENE	HONEYWELL INT INC
EP2751095	NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF	SANFORD BURNHAM MED RES INST
EP2751128	CELL-PENETRATING PEPTIDES HAVING A CENTRAL HYDROPHOBIC DOMAIN	MEDICAL RES COUNCIL
EP2752240	CATALYST FOR OXYGENATE SYNTHESIS AND METHOD FOR MANUFACTURING SAME, DEVICE FOR MANUFACTURING OXYGENATE, AND METHOD FOR MANUFACTURING OXYGENATE	SEKISUI CHEMICAL CO LTD
EP2753356	ANTI-SIGLEC-15 ANTIBODIES AND USES THEREOF	MEDIMMUNE LTD
EP2756883	METHOD FOR PREPARING 2,3,3,3-TETRAFLUOROPROPENE	SINOCHEM LANTIAN CO LTD
EP2757883	TRIAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS	MERCK SHARP & DOHME
EP2763958	PHOTOALIGNING MATERIALS	ROLIC AG
EP2763963	ENANTIONSELECTIVE PROCESSES TO INSECTICIDAL 3-ARYL-3-TRIFLUOROMETHYL-SUBSTITUTED PYRROLIDINES	SYNGENTA PARTICIPATIONS AG
EP2764011	ADENOVIRAL VECTOR-BASED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE	GENVEC INC
EP2766329	PROCESS FOR PRODUCING 2,3,3,3-TETRAFLUOROPROPENE	HONEYWELL INT INC
EP2766331	PROCESS FOR PRODUCING 2,3,3,3-TETRAFLUOROPROPENE	BEKTESEVIC SELMA
EP2771359	TDP-43 SPECIFIC BINDING MOLECULES	BIOGEN IDEC INTERNAT NEUROSCIENCE GMBH
EP2771737	OPTICAL MEMBER, DISPLAY DEVICE HAVING THE SAME AND METHOD OF FABRICATING THE SAME	LG INNOTEK CO LTD
EP2773672	METHOD FOR PREPARING PHYSIOLOGICALLY ACTIVE POLYPEPTIDE COMPLEX	HANMI SCIENCE CO LTD
EP2774969	Process for converting bio-oil	UPM KYMMENE CORP
EP2780312	PROCESS SCHEME TO IMPROVE DIVALENT METAL SALTS REMOVAL FROM MONO ETHYLENE GLYCOL (MEG)	CAMERON INT CORP
EP2780434	DEVICE AND METHOD FOR UPGRADING PETROLEUM FEEDSTOCKS USING AN ALKALI METAL CONDUCTIVE MEMBRANE	CERAMATEC INC
EP2791094	A PROCESS FOR MANUFACTURING HALOARYL COMPOUNDS FROM MIXTURES OF ISOMERS OF DIHALODIARYLSULFONES	SOLVAY SPECIALTY POLYMERS USA
EP2794858	COMPOSITIONS AND METHODS INCLUDING B LYMPHOCYTE CELL LINE EXPRESSING MEMBRANE IMMUNOGLOBULIN DIFFERENT FROM SECRETED IMMUNOGLOBULIN	ELWHA LLC
EP2797862	OLEFIN OLIGOMERIZATION METHODS	CHEVRON PHILLIPS CHEMICAL CO
EP2798059	PROCESSES USING VLPS WITH CAPSIDS RESISTANT TO HYDROLASES	APSE LLC
EP2799088	Factor VIII polymer conjugates	BAXTER INT
EP2808321	METHOD FOR PRODUCING POLYTHIOL COMPOUND FOR OPTICAL MATERIALS AND COMPOSITION COMPRISING SAME FOR OPTICAL MATERIALS	KOC SOLUTION CO LTD
EP2809146	PLANT TRANSACTIVATION INTERACTION MOTIFS AND USES THEREOF	DOW AGROSCIENCES LLC
EP2810662	Factor VIII polymer conjugates	BAXTER INT
EP2812309	AN APPARATUS FOR CONTINUOUS SEPARATION OF VALINE AND A METHOD FOR CONTINUOUS SEPARATION OF VALINE USING THE SAME	CJ CHEILJEDANG CORP
EP2812324	HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF	SUNOVION PHARMACEUTICALS INC
EP2812349	METHODS FOR THE CHARACTERISATION OF INTERACTION SITES ON TARGET PROTEINS	PHYLOGICA LTD
EP2813512	PEPTIDE-COMPOUND CYCLIZATION METHOD	CHUGAI PHARMACEUTICAL CO LTD
EP2814795	PROCESS FOR THE PRODUCTION OF HCFC-1233zd	HONEYWELL INT INC
EP2816053	BASE-PROTECTED OLIGONUCLEOTIDE	AJINOMOTO KK
EP2821415	ANTI-LIPOARABINOMANNAN ANTIBODY AND IMMUNOASSAY FOR MYCOBACTERIOSIS USING SAID ANTIBODY	OTSUKA PHARMA CO LTD
EP2821505	Nucleotide-specific recognition sequences for designer tal effectors	BROAD INST INC
EP2824105	Indolopyridines as Eg5 kinesin modulators	4SC AG
EP2825041	SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR	CELGENE AVILOMICS RES INC
EP2826079	ELECTRONIC DEVICES	MERCK PATENT GMBH
EP2829543	Silated core polysulfides, their preparation and use in filled elastomer compositions	MOMENTIVE PERFORMANCE MAT INC
EP2831104	BIOMARKERS FOR USE IN INTEGRIN THERAPY APPLICATIONS	BIOGEN IDEC INC
EP2834375	SEQUENCES FOR DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) OF MREJ TYPE XXI	GENEOHM SCIENCES CANADA INC
EP2836475	PURIFICATION OF BIO-BASED ACRYLIC ACID TO CRUDE AND GLACIAL ACRYLIC ACID	PROCTER & GAMBLE
EP2839005	MIRNA MODULATORS OF THERMOGENESIS	APTAMIR THERAPEUTICS INC
EP2841484	CONJUGATED POLYMERS	MERCK PATENT GMBH
EP2841584	A METHOD OF PRODUCTION OF 2,4-DIHYDROXYBUTYRIC ACID	ADISSEO FRANCE SAS
EP2844288	BINDING PROTEINS HAVING TETHERED LIGHT CHAINS	JANSSEN BIOTECH INC
EP2844303	LIPIDS THAT INCREASE INSULIN SENSITIVITY AND METHODS OF USING THE SAME	BETH ISRAEL HOSPITAL
EP2844634	NEW INTERMEDIATE COMPOUND FOR PREPARING VITAMIN B6	DSM IP ASSETS BV
EP2844654	IMPROVED PROCESS FOR PREPARING RIVAROXABAN USING NOVEL INTERMEDIATES	SYMED LABS LTD
EP2845905	Production of oligosaccharides	JENNEWEIN BIOTECHNOLOGIE GMBH
EP2847166	PHENACENE COMPOUNDS FOR ORGANIC ELECTRONICS	BASF SE
EP2852296	HIGH-PURITY STEVIOL GLYCOSIDES	PURECIRCLE SDN BHD
EP2852565	PROCESS FOR PRODUCING CUMENE	BADGER LICENSING LLC
EP2852589	TRIAZOLES AS KV3 INHIBITORS	AUTIFONY THERAPEUTICS LTD
EP2852603	D-AMINO ACID COMPOUNDS FOR LIVER DISEASE	IDENIX PHARMACEUTICALS INC
EP2855676	COMPOSITIONS AND METHODS FOR PEPTIDE EXPRESSION AND PURIFICATION USING A TYPE lll SECRETION SYSTEM	UNIV UTAH RES FOUND
EP2857419	ANTIGEN-BINDING MOLECULE FOR ELIMINATING AGGREGATED ANTIGENS	CHUGAI PHARMACEUTICAL CO LTD
EP2857830	FLUORESCENT PROBE FOR HIGH-SENSITIVITY PANCREATIC FLUID DETECTION, AND METHOD FOR DETECTING PANCREATIC FLUID	UNIV TOKYO
EP2858136	ORGANIC ELECTROLUMINESCENCE ELEMENT AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT	IDEMITSU KOSAN CO
EP2859018	CANINIZED ANTI-NGF ANTIBODIES AND METHODS THEREOF	ZOETIS LLC
EP2860173	METHOD FOR PRODUCING AZIDE COMPOUND, AND METHOD FOR PRODUCING 1H-TETRAZOLE DERIVATIVE	NIPPON SODA CO
EP2860178	P2X3 receptor antagonists for treatment of pain	MERCK SHARP & DOHME
EP2861241	IMPROVED CD31 PEPTIDES	INST NAT SANTé ET DE LA RECH MéDICALE INSERM
EP2861246	COMPOSITIONS AND METHODS OF INHIBITING MASP-1 AND/OR MASP-2 AND/OR MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS	OMEROS CORP
EP2861742	PLANTS HAVING INCREASED TOLERANCE TO HERBICIDES	BASF SE
EP2864280	SUPPORTED CATALYSTS FOR PRODUCING ALDOL CONDENSATION PRODUCTS	SYMRISE AG
EP2864283	PROCESS FOR THE PRODUCTION OF ACETIC ACID	LYONDELLBASELL ACETYLS LLC
EP2864312	NOVEL ANTI-CANCER THIOPHENE COMPOUNDS	UNIV LEUVEN KATH
EP2864342	1,1 '-[[(SUBSTITUTED ALKYL)IMINO]BIS(ALKYLENE)]BIS-FERROCENES AND THEIR USE IN I ELECTROCHEMICAL ASSAYS BY LABELLING SUBSTRATES OF INTEREST	ATLAS GENETICS LTD
EP2865446	Process for producing optically active secondary alcohol	KANTO KAGAKU
EP2865669	NOVEL REBAMIPIDE PRODRUG, METHOD FOR PRODUCING SAME, AND USAGE THEREOF	SAMJIN PHARM CO LTD
EP2867359	METHODS FOR INACTIVATING VIRUSES DURING A PROTEIN PURIFICATION PROCESS	EMD MILLIPORE CORP
EP2869841	NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES	GLAXOSMITHKLINE BIOLOG SA
EP2870167	STABLE LIGAND MIXTURES AND PROCESSES FOR MAKING SAME	INVISTA TECHNOLOGIES SRL
EP2877189	ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT	TAIGA BIOTECHNOLOGIES INC
EP2877488	NEW MODULAR BASE-SPECIFIC NUCLEIC ACID BINDING DOMAINS FROM BURKHOLDERIA RHIZOXINICA PROTEINS	CELLECTIS SA
EP2880012	COMPOUNDS	PHOTOCURE ASA
EP2882727	IMMUNOMODULATORY COMPOUNDS	UNIV STRATHCLYDE
EP2882765	LIGHT EMITTING COMPOUNDS	UNIV NORTHUMBRIA NEWCASTLE
EP2885288	1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS	NOVARTIS AG
EP2887804	CYCLOALKANYL[B]INDOLES USEFUL AS GLP-1 MODULATORS	DARTMOUTH COLLEGE
EP2889319	Bio-polyol composition and bio-polyurethane foam material
EP2892916	METHODS FOR PRODUCING HIGH TOUGHNESS SILK FIBRES	AMSILK GMBH
EP2899799	PHOTOELECTRIC CONVERSION ELEMENT AND METHOD FOR MANUFACTURING SAME	KONICA MINOLTA INC
EP2900822	OLIGOMERS WITH IMPROVED OFF-TARGET PROFILE	MIRRX THERAPEUTICS
EP2901157	METHOD OF DETECTION OF SCHMALLENBERG VIRUS (SBV) AND KIT	IDEXX LAB INC
EP2903614	NOVEL COMPOUNDS, THEIR SYNTHESIS AND THEIR USES	SPHAERA PHARMA PTE LTD
EP2903953	PROCESS FOR THE PRODUCTION OF HIGH-PURITY ISOBUTENE THROUGH THE CRACKING OF MTBE OR ETBE AND INTEGRATED PROCESS FOR THE PRODUCTION OF THE RELATIVE ETHER	SAIPEM SPA
EP2906601	THE DETECTION OF FREE AND PROTEIN-BOUND NON-HUMAN GAL-ALPHA-(1-3)-GAL EPITOPE	NAT UNIV IRELAND
EP2907803	FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT	TORAY INDUSTRIES
EP2909222	2',4'-BRIDGED NUCLEOSIDES FOR HCV INFECTION	IDENIX PHARMACEUTICALS INC
EP2909307	COMPOSITIONS AND METHODS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN	PFIZER
EP2910540	NOVEL RUTHENIUM COMPLEX AND METHOD FOR PREPARING METHANOL AND DIOL	SHANGHAI INST ORGANIC CHEM
EP2912018	PROCESS AND CATALYST FOR THE PRODUCTION OF PYRIDINE AND ALKYL DERIVATIVES THEREOF	GRACE W R & CO
EP2912019	HETEROARYL INHIBITORS OF PDE4	TETRA DISCOVERY PARTNERS LLC
EP2912186	PLATELET TARGETED TREATMENT	PLATELET TARGETED THERAPEUTICS LLC
EP2913104	Catalyst for oxidation or ammoxidation, and process for producing the same	ASAHI KASEI CHEMICALS CORP
EP2913106	CATALYST FOR DEHYDRATION OF GLYCERIN, METHOD FOR PREPARING SAME, AND METHOD FOR PREPARING ACROLEIN	LG CHEMICAL LTD
EP2913321	Novel cannabigerol derivatives	VIVACELL BIOTECHNOLOGY ESPANA S L
EP2914570	REMOVAL OF ALDEHYDES IN ACETIC ACID PRODUCTION	LYONDELLBASELL ACETYLS LLC
EP2914616	PEPTIDES THAT BIND TO AMINO-TERMINAL TRUNCATED AMYLOID-BETA-PEPTIDE AND USE OF SAID PEPTIDES	FORSCHUNGSZENTRUM JüLICH GMBH
EP2914627	ANTI-CD40 ANTIBODIES AND METHODS OF USE	APEXIGEN INC
EP2914630	NOVEL ANTIGEN BINDING PROTEINS AND THEIR USE AS ADDRESSING PRODUCT FOR THE TREATMENT OF CANCER	PIERRE FABRE MéDICAMENT
EP2918422	Reducing agent, ink-jet recording apparatus, discharge printing method, image forming method, reducing agent stabilizing method, and reducing agent enhancing method	BROTHER IND LTD
EP2919779	CANNABINOID RECEPTOR MEDIATING COMPOUNDS	US HEALTH
EP2920188	PROCESS FOR THE PREPARATION OF LIQUID TIN(II) ALKOXIDES	CHIANG MAI UNIVERSITY
EP2920196	TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES	UNIV BRANDEIS
EP2920197	PROLINE-LOCKED STAPLED PEPTIDES AND USES THEREOF	HARVARD COLLEGE
EP2922812	PROCESS FOR PREPARING A SALT OF A SULFURIZED ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOSITION	CHEVRON ORONITE CO
EP2922816	DTPA DI-ETHYL ESTERS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME	UNIV NORTH CAROLINA
EP2922859	PHOSPHONUCLEOSIDES USEFUL IN THE TREATMENT OF VIRAL DISORDERS	UNIV CORK
EP2925755	NEUROPROTECTIVE AGENTS FOR TREATMENT OF NEURODEGENERATIVE DISEASES	UNIV WAYNE STATE
EP2925771	A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES	COUNCIL SCIENT IND RES
EP2925784	BINDING PROTEINS COMPRISING AT LEAST TWO REPEAT DOMAINS AGAINST HER2	MOLECULAR PARTNERS AG
EP2927321	CH3 DOMAIN VARIANT PAIR INDUCING FORMATION OF HETERODIMER OF HEAVY CHAIN CONSTANT REGION OF ANTIBODY AT HIGH EFFICIENCY, METHOD FOR PREPARING SAME, AND USE THEREOF	AJOU UNIV IND ACAD COOP FOUND
EP2927981	Organic photoelectronic device and image sensor	SAMSUNG ELECTRONICS CO LTD
EP2928484	COMPOUNDS USEFUL IN THE TREATMENT AND/OR CARE OF THE SKIN, HAIR AND/OR MUCOUS MEMBRANES AND THEIR COSMETIC OR PHARMACEUTICAL COMPOSITIONS	LUBRIZOL ADVANCED MAT INC
EP2928898	BETA-LACTAMASE INHIBITORS	VENATORX PHARMACEUTICALS INC
EP2928921	COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO	NOVARTIS AG
EP2928935	BINDERS	KNAUF INSULATION SPRL
EP2928940	FUNCTIONNALIZED BENZODITHIOPHENE POLYMERS FOR ELECTRONIC APPLICATION	BASF SE
EP2929335	DEVICE AND METHODS FOR ANALYSIS OF BIOMOLECULE STRUCTURE, DYNAMICS AND ACTIVITY	NYMIRUM INC
EP2931304	WT1 VACCINE	UNIV PENNSYLVANIA
EP2931398	METHOD FOR ISOLATING DIAMONDOIDS	TOTAL SA
EP2931400	METHOD FOR CLEANING OF PACKED BED CHROMATOGRAPHY COLUMNS	GE HEALTHCARE BIO SCIENCES AB
EP2931417	ZEOLITIC ADSORBENTS, PROCESS FOR PREPARING SAME AND USES THEREOF	CECA SA
EP2931744	POLYPEPTIDES HAVING PHOSPHOLIPASE C ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME	NOVOZYMES AS
EP2931750	ANTIBODIES AGAINST IL-1 BETA	DELENEX THERAPEUTICS AG
EP2932981	Albumin-binding derivatives of GLP-1	NOVO NORDISK AS
EP2933254	NOVEL COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT OR OPTICAL ISOMER THEREOF, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF VIRAL DISEASES CONTAINING SAME AS ACTIVE INGREDIENT	KOREA RES INST CHEM TECH
EP2933874	PHOTOELECTRIC CONVERSION ELEMENT	SHARP KK
EP2934512	USE OF CANNABINOIDS AND TERPENES FOR TREATMENT OF ORGANOPHOSPHATE AND CARBAMATE TOXICITY	KOTZKER CONSULTING LLC
EP2934538	FACTOR IXA INHIBITORS	MERCK SHARP & DOHME
EP2934589	GLYCAN-MODIFIED ANTI-CD4 ANTIBODIES FOR HIV PREVENTION AND THERAPY	UNIV ROCKEFELLER
EP2935311	APJ RECEPTOR AGONISTS AND USES THEREOF	AMGEN INC
EP2935332	ANTI-H7CR ANTIBODIES	AMPLIMMUNE INC
EP2937325	METHOD OF UPGRADING LOW-VALUE LINEAR ALPHA-OLEFINS OF C18 OR MORE	SK INNOVATION CO LTD
EP2938608	SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1	SANFORD BURNHAM MED RES INST
EP2940103	A METHOD FOR OBTAINING BIOFUELS USING ETHANOL, OR MIXTURES OF ALCOHOL AS BIOFUEL OR BIOCOMPONENT AND BIOFUEL OR BIOCOMPONENT FOR THE PREPARATION OF MOTOR FUELS	EKOBENZ SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA
EP2941423	DEOXYURIDINE TRIPHOSPHATASE INHIBITORS	UNIV SOUTHERN CALIFORNIA
EP2941434	MANGANESE-BASED MAGNETIC RESONANCE CONTRAST AGENTS	GEN HOSPITAL CORP
EP2941435	MANNOSE-RECEPTOR SELECTIVE LYSINYLATED CATIONIC AMPHIPHILES AND A PROCESS FOR PREPARATION THEREOF	COUNCIL SCIENT IND RES
EP2943219	VACCINE TO PREVENT MYCOPLASMAL INFECTION IN WATERFOWL	SZATHMARY DR SUSAN
EP2943454	TAPENTADOL MALEATE AND CRYSTALLINE FORMS THEREOF	FARMA GRS D O O
EP2946001	FORMULATION, PREPARATION AND USE OF A GLYCEROL-BASED BIOFUEL	INST UNIV DE CIèNCIA I TECNOLOGIA S A
EP2946791	Anti-CD277 antibodies and uses thereof	INSERM INST NAT DE LA SANTé ET DE LA RECH MéDICALE
EP2948437	NOVEL APPROACH FOR SYNTHESIS OF CATECHINS	SPHAERA PHARMA PRIVATE LTD
EP2949789	PROTEIN COMBINATION-BASED FV LIBRARY, AND PREPARATION METHOD THEREFOR	SCRIPPS KOREA ANTIBODY INST
EP2951138	METHOD FOR PRODUCING AN OLEFIN BY CATALYTIC CONVERSION OF AT LEAST ONE ALCOHOL	ADISSEO FRANCE SAS
EP2951284	RECOMBINANT YEAST TRANSFORMANT AND PROCESS FOR PREPARING IMMUNOGLOBULIN FC FRAGMENT EMPLOYING THE SAME	HANMI PHARM IND CO LTD
EP2952511	ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE	CHEIL IND INC
EP2953718	METHOD FOR PURIFYING A CRUDE PNPNH COMPOUND	SAUDI BASIC IND CORP
EP2953926	POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS	IMPHAR AG
EP2953929	PREPARATION OF FLUOROSULFONATE ESTERS AND ONIUM SALTS DERIVED THEREFROM	TRINAPCO INC
EP2953976	SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES	IRM LLC
EP2958158	ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO
EP2958904	UNSATURATED FATTY ACID ESTER-BASED PLASTIC ADDITIVES	ARKEMA INC
EP2961733	DISULFIDE COMPOUNDS FOR DELIVERY OF PHARMACEUTICAL AGENTS	UNIV TUFTS
EP2961760	SELECTIVE REMOVAL OF A PROTEIN FROM A MIXTURE OF PROTEINS USING ACTIVATED CARBON BY ADJUSTING SOLUTION CONDITIONS	EMD MILLIPORE CORP
EP2961774	ALPHA-SYNUCLEIN ANTIBODIES AND USES THEREOF	UNIV UNITED ARAB EMIRATES
EP2962992	FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND MANUFACTURING METHOD THEREOF	LG CHEMICAL LTD
EP2963035	COMPOUND, LIGHT-EMITTING MATERIAL, AND ORGANIC LIGHT-EMITTING ELEMENT	UNIV KYUSHU NAT UNIV CORP
EP2964603	USE OF SULPHONIC ACID FOR RECOVERING GLYCEROL FROM A TRIGLYCERIDE TRANSESTERIFICATION REACTION	ARKEMA FRANCE
EP2968299	COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN	GLOBAL BLOOD THERAPEUTICS INC
EP2968337	HETEROARYL COMPOUNDS AND USES THEREOF	CELGENE AVILOMICS RES INC
EP2968597	POLYALKYLENE OXIDE VALERATE HEMOGLOBIN CONJUGATES	SANGART INC
EP2969140	ONE-STEP PROCEDURE FOR THE PURIFICATION OF NUCLEIC ACIDS	ABBOTT MOLECULAR INC
EP2970068	PROCESS AND SYSTEMS FOR OBTAINING 1,4-BUTANEDIOL FROM FERMENTATION BROTHS	GENOMATICA INC
EP2970083	PROCESS TO PREPARE LEVULINIC ACID	SEGETIS INC
EP2970095	METHODS OF REFINING AND PRODUCING ISOMERIZED FATTY ACIDS ESTERS AND FATTY ACIDS FROM NATURAL OIL FEEDSTOCKS	ELEVANCE RENEWABLE SCIENCES
EP2970154	TETRAHYDROXAMATE CHELATORS OF ZIRCONIUM89 AND NIOBIUM90 FOR USE IN DIAGNOSTIC APPLICATIONS	US HEALTH
EP2970277	IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS	KNOPP BIOSCIENCES LLC
EP2970308	COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN	GLOBAL BLOOD THERAPEUTICS INC
EP2970315	COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN	GLOBAL BLOOD THERAPEUTICS INC
EP2970378	HYDROPHOBIC INTERACTION PROTEIN CHROMATOGRAPHY UNDER NO-SALT CONDITIONS	BIOGEN MA INC
EP2970399	PROTEIN PARTICLES COMPRISING DISULFIDE CROSSLINKERS AND USES RELATED THERETO	UNIV EMORY
EP2970448	HUMAN ANTIBODIES TO GREM 1	REGENERON PHARMA
EP2970456	METHODS AND COMPOSITIONS FOR DELIVERING MRNA CODED ANTIBODIES	SHIRE HUMAN GENETIC THERAPIES
EP2970468	NOTCH2 BINDING MOLECULES FOR TREATING RESPIRATORY DISEASES	NOVARTIS AG
EP2970916	ADAPTED LEPIDOPTERAN INSECT CELLS FOR THE PRODUCTION OF RECOMBINANT PROTEINS	MERCK SHARP & DOHME
EP2971123	NUCLEIC ACID AMPLIFICATION	THERANOS INC
EP2972258	PURIFICATION OF RAPAMYCIN DERIVATIVES	BIOSENSORS INT GROUP LTD
EP2975051	READILY ISOLATED BISPECIFIC ANTIBODIES WITH NATIVE IMMUNOGLOBULIN FORMAT	REGENERON PHARMA
EP2976317	COMPOSITION COMPRISING HF AND 2,3,3,3-TETRAFLUOROPROPENE	ARKEMA FRANCE
EP2976352	PURIFICATION OF TRIPLE HELICAL PROTEINS	COMMW SCIENT IND RES ORG
EP2978456	RADIOLABELLING PROCESS	GE HEALTHCARE LTD
EP2978855	MICROFLUIDIC DEVICES AND METHODS FOR USE THEREOF IN MULTICELLULAR ASSAYS OF SECRETION	UNIV BRITISH COLUMBIA
EP2980066	METHOD FOR PRODUCING ISOCYANATE	ASAHI KASEI CHEMICALS CORP
EP2981518	AN IMPROVED PROCESS FOR THE PREPARATION OF FLUVOXAMINE MALEATE"	ZCL CHEMICALS LTD
EP2981523	INSECTICIDAL COMPOUNDS	SYNGENTA PARTICIPATIONS AG
EP2981526	NAPHTHYLUREA DERIVATIVES USEFUL AS KINASE INHIBITORS	RESPIVERT LTD
EP2981529	ORIDONIN ANALOGS, COMPOSITIONS, AND METHODS RELATED THERETO	UNIV TEXAS
EP2982380	ANTIBODIES REACTIVE WITH B7-H3, IMMUNOLOGICALLY ACTIVE FRAGMENTS THEREOF AND USES THEREOF	MACROGENICS INC
EP2982690	METHOD FOR THE PRODUCTION OF DOMAIN ANTIBODIES	ABLYNX NV
EP2985347	METHOD FOR DETECTING PROTEIN STABILITY AND USES THEREOF	SHANGHAI INST BIOL SCIENCES
EP2986595	EPOXIDATION PROCESS	SCIENT DESIGN CO
EP2986618	ORGANIC ANION LITHIUM IONIC COCRYSTAL COMPOUNDS AND COMPOSITIONS	UNIV SOUTH FLORIDA
EP2986639	COMPOSITION WITH REDUCED IMMUNOGENICITY	INST NAT SANTé ET DE LA RECH MéDICALE INSERM
EP2989112	MODIFIED G-QUADRUPLEX NANOPARTICLES	UNIV NANYANG TECH
EP2990397	PROCESS FOR THE PREPARATION OF 2,3,3,3 TETRAHYDROFLUOROPROPENE	MEXICHEM FLUOR SA DE CV
EP2992010	FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE	HOFFMANN LA ROCHE
EP2994169	LABELLED CARBOXYLIC ACIDS AND THEIR USES IN MOLECULAR IMAGING	IMP INNOVATIONS LTD
EP2994457	RADIOMITIGATING PHARMACEUTICAL FORMULATIONS	UNIV CALIFORNIA
EP2997007	METHODS OF DIRECT ADDITION OF (METH) ACRYLIC ACID TO BIO-BASED OILS	3M INNOVATIVE PROPERTIES CO
EP2997036	PURIFICATION OF RECOMBINANTLY PRODUCED POLYPEPTIDES	MEDIMMUNE LTD
EP2997043	ANTAGONIST OF THE BTLA/HVEM INTERACTION FOR USE IN THERAPY	INSERM INST NAT DE LA SANTé ET DE LA RECH MéDICALE
EP2998285	EXTRACTION OF CARBOXYLIC ACIDS FROM A DILUTE AQUEOUS STREAM	PURAC BIOCHEM BV
EP2999358	SYNTHETIC MIXTURE OF OLIGOSACCHARIDES FOR T TREATING A MICROBIOTA OF A MAMMAL	GLYCOM AS
EP3000482	DOUBLE-ACYLATED GLP-1 DERIVATIVES	NOVO NORDISK AS
EP3000819	METHOD FOR PRODUCING GALACTOSE CONSTITUTING A RAW MATERIAL FOR PRODUCING TAGATOSE FROM WHEY PERMEATE LIQUID OR WHEY PERMEATE POWDER	CJ CHEILJEDANG CORP
EP3002275	PROCESS FOR PREPARING A CONCENTRATED, NON-GELLING, AQUEOUS SOLUTION OF BETAINE	HAYAT KIMYA SANAYI ANONIM SIRKETI
EP3003299	NOVEL N-3 IMMUNORESOLVENTS: STRUCTURES AND ACTIONS	BRIGHAM & WOMENS HOSPITAL
EP3003390	ANTI-C10ORF54 ANTIBODIES AND USES THEREOF	IGENICA BIOTHERAPEUTICS INC
EP3004053	A PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES	CADILA HEALTHCARE LTD
EP3004137	IMPROVED METHOD FOR THE DETECTION, PREPARATION AND DEPLETION OF CD4+ T LYMPHOCYTES	IMCYSE SA
EP3004155	PEPTIDE COMPOUND	TAKEDA PHARMACEUTICAL
EP3004171	METHODS FOR INHIBITING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF PCSK9	REGENERON PHARMA
EP3006459	METHOD AND COMPOSITIONS FOR ENHANCED ANTI-TUMOR EFFECTOR FUNCTIONING OF T CELLS	HOPE CITY
EP3007709	LIPID-BASED PLATINUM COMPOUNDS AND NANOPARTICLES	INVICTUS ONCOLOGY PVT LTD
EP3008083	METHOD FOR DETERMINING MUTATEABLE LIGAND-GPCR BINDING AT SINGLE AMINO ACID RESOLUTION AND PAIRS OF MUTATED LIGAND AND GPCR	SCHERRER INST PAUL
EP3010055	MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO
EP3010509	FREE BASE CRYSTALS	INTRA CELLULAR THERAPIES INC
EP3010550	CYCLIC PEPTIDES AS PROTEIN TARGETING AGENTS	CALIFORNIA INST OF TECHN
EP3010936	LECTIN-LIKE OXIDIZED LDL RECEPTOR1 ANTIBODIES AND METHODS OF USE	NOVARTIS AG
EP3011971	ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF	AMGEN FREMONT INC
EP3013818	(S)-ENANTIOMER OF MEPAZINE AS PARACASPASE (MALT1) INHIBITOR FOR TREATING CANCER	HELMHOLTZ ZENTRUM MüNCHEN DEUTSCHES FORSCHUNGSZENTRUM FüR GESUNDHEIT UND UMWELT GMBH
EP3013839	MACROCYCLIC COMPOUNDS AND THEIR USES AS ANION QUENCHERS	UNIVERSITé D AIX MARSEILLE
EP3013840	ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, DISPLAY ELEMENT, AND DIMMING ELEMENT	RICOH CO LTD
EP3013854	CD86 VARIANTS WITH IMPROVED AFFINITY FOR CTLA-4	ALLIGATOR BIOSCIENCE AB
EP3016671	ACTIVELY TRANSPORTED AND PROTEASE-RESISTANT PEPTIDES AS BBB SHUTTLES AND SHUTTLE-CARGO CONSTRUCTS	UNIV BARCELONA
EP3016931	A NOVEL PROCESS FOR THE PREPARATION OF TETRALIN AND NAPHTHALENE DERIVATIVES	PHARMATHEN SA
EP3016966	CONCENTRATION AND PURIFICATION OF HYDROPHOBINS AND ANTIBODIES WITH A PHASE SEPARATION METHOD	TEKNOLOGIAN TUTKIMUSKESKUS VTT OY
EP3019190	CATIONIC NEUROTOXINS	IPSEN BIOINNOVATION LTD
EP3019272	NOVEL CATALYSTS WITH A SILYLENE LIGAND	BLUESTAR SILICONES FRANCE
EP3019273	NOVEL CATALYSTS HAVING A SILENE LIGAND	BLUESTAR SILICONES FRANCE
EP3019484	THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE	AGIOS PHARMACEUTICALS INC
EP3019615	CYSTOBACTAMIDES	HELMHOLTZ ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
EP3020708	ORGANIC COMPOSITION, AND ORGANIC OPTOELECTRONIC ELEMENT AND DISPLAY DEVICE	SAMSUNG SDI CO LTD
EP3020715	TETRAZOLINONE COMPOUND AND USE THEREOF	SUMITOMO CHEMICAL CO
EP3021852	NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF	SAGE THERAPEUTICS INC
EP3022217	COMPOSITIONS FOR MODULATING TAU EXPRESSION	IONIS PHARMACEUTICALS INC
EP3022221	HUMANIZED ANTIBODIES WITH ULTRALONG COMPLEMENTARITY DETERMINING REGIONS	FABRUS INC
EP3022225	TRANSTHYRETIN AMYLOID-SELECTIVE AND POLYREACTIVE CATABODIES	UNIV TEXAS
EP3022250	METAL-ORGANIC MATERIALS AND METHOD FOR PREPARATION	YEDA RES & DEV
EP3022321	MIRROR BISULFITE ANALYSIS	ZYMO RES CORP
EP3024049	Fluorinated aromatic small molecules as functional additives for dispersion of conductive polymers	HERAEUS DEUTSCHLAND GMBH & CO KG
EP3024862	THE USE OF SUCCINONITRILE IN THE PRODUCTION OF POLYISOCYANATES WHICH CONTAIN IMINOOXADIAZINE DIONE GROUPS	COVESTRO DEUTSCHLAND AG
EP3026049	METHOD FOR PREPARING BENZAMIDE DERIVATIVE, NOVEL INTERMEDIATE USED IN PREPARATION OF BENZAMIDE, AND METHOD FOR PREPARING NOVEL INTERMEDIATE	DONG A ST CO LTD
EP3026722	COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME	SAMSUNG ELECTRONICS CO LTD
EP3027615	ANTI-INFECTIVE COMPOUNDS	PASTEUR INSTITUT KOREA
EP3027650	ANTI-GARP PROTEIN AND USES THEREOF	UNIVERSITé CATHOLIQUE DE LOUVAIN
EP3027666	POLYMER CONTAINING SILANE GROUPS	SIKA TECHNOLOGY AG
EP3029033	COMPOUND, LIGHT-EMITTING MATERIAL, AND ORGANIC LIGHT-EMITTING DEVICE	UNIV KYUSHU NAT UNIV CORP
EP3029034	BENZOTRIAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT	HODOGAYA CHEMICAL CO LTD
EP3030581	ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII	AFFIMED GMBH
EP3031805	ORGANIC METAL COMPLEX, LUMINESCENT MATERIAL, DELAYED PHOSPHOR AND ORGANIC LIGHT EMITTING ELEMENT	UNIV KYUSHU NAT UNIV CORP
EP3031907	MATERIALS AND METHODS TO ENHANCE HEMATOPOIETIC STEM CELLS ENGRAFTMENT PROCEDURES	UNIV INDIANA RES & TECH CORP
EP3033081	COMPOSITIONS AND METHODS FOR TREATING CHRONIC URTICARIA	KNOPP BIOSCIENCES LLC
EP3033097	FACTOR VIII-XTEN FUSIONS AND USES THEREOF	BIOGEN MA INC
EP3033347	COMPOSITIONS AND METHODS FOR MAKING NOSCAPINE AND SYNTHESIS INTERMEDIATES THEREOF	EPIMERON INC
EP3033350	PROGESTERONE PHOSPHATE ANALOGS AND USES RELATED THERETO	UNIV EMORY
EP3036328	RUST RESISTANCE GENE	COMMW SCIENT IND RES ORG
EP3037105	ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF	AMGEN FREMONT INC
EP3037398	METHOD FOR MANUFACTURING CHEMICAL COMPOUND	SUMITOMO CHEMICAL CO
EP3037426	PHOSPHORUS-CONTAINING COMPOUND, AND CURABLE EPOXY RESIN COMPOSITION CONTAINING SAME	ADEKA CORP
EP3037534	POLYPEPTIDE EXHIBITING FLUORESCENT PROPERTIES, AND UTILIZATION OF SAME	RIKEN
EP3038644	SITE-SPECIFIC ANTIBODY CONJUGATION METHODS AND COMPOSITIONS	STEMCENTRX INC
EP3038650	ANTIBODIES AND ASSAYS FOR DETECTION OF FOLATE RECEPTOR 1	IMMUNOGEN INC
EP3039039	ANTIBODIES NEUTRALIZING GM-CSF FOR USE IN THE TREATMENT OF RHEUMATOID ARTHRITIS OR AS ANALGESICS	TAKEDA GMBH
EP3039040	ANTI CD30 CHIMERIC ANTIGEN RECEPTOR AND ITS USE	UNIVERSITÄT ZU KÖLN
EP3039047	REDUCTION OF ALDEHYDES IN AMINE CATALYSTS	HUNTSMAN PETROCHEMICAL LLC
EP3039064	EXTRACTION METHOD OF A POLYESTER POLYMER OR CUTIN FROM THE WASTED TOMATO PEELS AND POLYESTER POLIMER SO EXTRACTED	CHIESA VIRGINIO
EP3040344	Fab REGION-BINDING PEPTIDE	KANEKA CORP
EP3041507	NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A	MABVAX THERAPEUTICS INC
EP3041603	METHOD FOR PRODUCING ACRYLIC ACID	EVONIK DEGUSSA GMBH
EP3041837	CRYSTAL HAVING SPECIFIC CRYSTAL HABIT AND PHARMACEUTICAL COMPOSITION CONTAINING THE CRYSTAL AS ACTIVE INGREDIENT	POLA PHARMA INC
EP3041853	METALLACROWN COMPLEXES AND METHODS OF MAKING THE SAME	UNIV MICHIGAN
EP3041864	IL-18 BINDING PROTEIN (IL-18BP) IN INFLAMMATORY DISEASES	AB2 BIO SA
EP3041946	FERMENTATIVE PRODUCTION OF OLIGOSACCHARIDES	GLYCOM AS
EP3043790	NOVEL ANTHRANILIC AMIDES AND THE USE THEREOF	UNIV TULANE
EP3044195	COLLAGEN AND ELASTIN STIMULATING COMPOUND AND TOPICAL COMPOSITIONS COMPRISING SUCH COMPOUND	JOVENTIS S A
EP3044199	METHOD FOR THE DEHYDRATION OF 3-HYDROXYPROPANOIC ACID TO FORM ACRYLIC ACID	BASF SE
EP3044208	OXIME ESTER PHOTOINITIATORS	BASF SE
EP3044228	HIGHLY EFFICIENT SYNTHESIS OF LONG RNA USING REVERSE DIRECTION APPROACH	CHEMGENES CORP
EP3044230	CASPOFUNGIN DERIVATIVE	DSM SINOCHEM PHARM NL BV
EP3045444	METHOD OF PREPARING VANILLIN	JIAXING ZHONGHUA CHEMICAL CO LTD
EP3045474	THERAPEUTIC AGENTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH UNDESIRED CELL PROLIFERATION	FUNDACIó PRIVADA INSTITUCIó CATALANA DE RECERCA I ESTUDIS AVANÇATS
EP3046903	PROCESS FOR OBTAINING METHIONINE	EVONIK DEGUSSA GMBH
EP3046920	GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES	BIOMARIN PHARM INC
EP3046931	CELL-PENETRATING BACTERIAL E3-UBIQITIN-LIGASES FOR USE IN IMMUNOTHERAPY	WESTFÄLISCHE WILHELMS UNIVERSITÄT MüNSTER
EP3048107	BENZOBIS (THIADIAZOLE) DERIVATIVE, INK CONTAINING SAME, AND ORGANIC ELECTRONIC DEVICE USING SAME	FUTURE INK CORP
EP3048899	ON-COLUMN VIRAL INACTIVATION METHODS	BIOGEN MA INC
EP3049183	METHANATION REACTOR FOR REACTING DIHYDROGEN WITH AT LEAST ONE CARBON-BASED COMPOUND AND PRODUCING METHANE	GDF SUEZ
EP3049380	APPARATUSES AND METHODS FOR FORMING C8 AROMATIC STREAMS WITH SELECTED AMOUNTS OF C9 AROMATICS	UOP LLC
EP3049473	DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO	ENGENE INC
EP3050865	PROCESS FOR THE REDUCTION OF CARBON DIOXIDE TO METHANE BY DBD PLASMA-ACTIVATED CATALYST	FUNDACIO INST RECERCA EN EN DE CATALUNYA
EP3050896	METHOD FOR PRODUCING POLYPEPTIDE HETEROMULTIMER	CHUGAI PHARMACEUTICAL CO LTD
EP3052505	BORON-CONTAINING COMPOUNDS	MERCK PATENT GMBH
EP3052523	METHODS OF TREATING AND DIAGNOSING ALPHA-V-BETA-6 OVEREXPRESSING CANCER	MEDIMMUNE LTD
EP3052556	LIGAND-FUNCTIONALIZED SUBSTRATES WITH ENHANCED BINDING CAPACITY	3M INNOVATIVE PROPERTIES CO
EP3053910	ANILINE DERIVATIVES AND USES THEREOF	NISSAN CHEMICAL IND LTD
EP3053944	METHOD FOR PRODUCING POLYALKYLENE GLYCOL DERIVATIVE HAVING AMINO GROUP AT END, POLYMERIZATION INITIATOR FOR USE IN THE SAME, AND ALCOHOL COMPOUND AS RAW MATERIAL FOR THE POLYMERIZATION INITIATOR	SHINETSU CHEMICAL CO
EP3055299	PYRIMIDINE HYDROXY AMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS	ACETYLON PHARMACEUTICALS INC
EP3055331	CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER	OXFORD BIO THERAPEUTICS LTD
EP3056217	OSTEOARTHRITIS TREATMENT	UNIV MELBOURNE
EP3056492	MEGUMINE SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG (DELAFLOXACIN)	ABBVIE INC
EP3056568	METHODS FOR CONTROLLING BLOOD PHARMACOKINETICS OF ANTIBODIES	CHUGAI PHARMACEUTICAL CO LTD
EP3057610	DRUG-CONJUGATES WITH A TARGETING MOLECULE AND TWO DIFFERENT DRUGS	SORRENTO THERAPEUTICS INC
EP3057615	ANTI-RSPO ANTIBODIES AND METHODS OF USE	HOFFMANN LA ROCHE
EP3057933	UNIT AND PROCESS FOR PURIFICATION OF CRUDE METHYL METHACRYLATE	ARKEMA FRANCE
EP3057956	POLYCYCLIC INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)	DANA FARBER CANCER INST INC
EP3059249	ANTIBODIES BINDING TO PIVKA-II AMINO ACIDS 13-27	ABBOTT LAB
EP3060562	SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AS SYK INHIBITORS	GENOSCO
EP3060577	PRODUCTION OF RECOMBINANT LUBRICIN	LUBRIS LLC
EP3062151	RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM	MITSUBISHI GAS CHEMICAL CO
EP3063159	PROCESS FOR PURIFICATION OF A NEUTRAL HUMAN MILK OLIGOSACCHARIDE USING SIMULATED MOVING BED CHROMATOGRAPHY	JENNEWEIN BIOTECHNOLOGIE GMBH
EP3063195	ADDITIVES MADE FROM FATTY DIAMIDES FOR NUCLEOPHILE-SENSITIVE CROSS-LINKABLE COMPOSITIONS	ARKEMA FRANCE
EP3063592	DIRECT PHOTOPATTERNING OF ROBUST AND DIVERSE MATERIALS	CALIFORNIA INST OF TECHN
EP3064486	PHENYL(META)ACRYLATE PRODUCTION METHOD AND PHENYL(META)ACRYLATE COMPOSITION	MITSUBISHI RAYON CO
EP3064500	SINGLE MOLECULE AND ORGANIC SOLAR CELL COMPRISING SAME	LG CHEMICAL LTD
EP3066054	BISMUTH-BASED ENERGETIC MATERIALS	SELLIER & BELLOT AS
EP3066068	HYDROXYTYROSOL DERIVATIVES THEIR METHOD OF PREPARATION AND USE IN PERSONAL CARE	EASTMAN CHEM CO
EP3066110	OPTIMAL MAIZE LOCI	DOW AGROSCIENCES LLC
EP3066116	TREATMENT OF DAMAGED NERVE WITH PTEN INHIBITOR	TISSUEGENE INC
EP3066122	PRE-HAPTOGLOBIN-2 MONOCLONAL ANTIBODIES AND USES THEREOF	BIO RAD LABORATORIES
EP3066124	ANTICORPS ALLOSTERIQUES DE LA NEUREGULINE, DIRIG脡S CONTRE HER3	INSERM INST NAT DE LA SANTé ET DE LA RECH MéDICALE
EP3068758	EBNA1 INHIBITORS AND THEIR METHOD OF USE	WISTAR INST
EP3068789	METHOD FOR PREPARING A HALOSILANE	DOW CORNING
EP3068793	ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS	CODEXIS INC
EP3068803	DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS	SANOFI SA
EP3070095	ADENO-ASSOCIATED VIRUS WITH SITE-DIRECTED MUTAGENESIS AND SITE-DIRECTED MODIFICATION, AND PREPARATION METHOD AND APPLICATION THEREFOR	UNIV BEIJING
EP3070163	METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELL, COMPOSITION USED IN METHOD, AND USES THEREOF	GUANGZHOU INST BIOMED & HEALTH
EP3071223	CELL	UCL BUSINESS PLC
EP3071538	OLEFIN DOUBLE BOND ISOMERIZATION CATALYST WITH HIGH POISON RESISTANCE	LUMMUS TECHNOLOGY INC
EP3071551	FUSED RING INDENO COMPOUNDS FOR PREPARATION OF PHOTOCHROMIC COMPOUNDS	TRANSITIONS OPTICAL INC
EP3071576	PHOTOCHROMIC INDENO-FUSED RING PYRAN COMPOUNDS	TRANSITIONS OPTICAL INC
EP3071592	ARTIFICIAL DNA-BINDING PROTEINS AND USES THEREOF	FOND TELETHON
EP3071598	SINGLE CHAIN INTRABODIES THAT ALTER HUNTINGTIN MUTANT DEGRADATION	VYBION INC
EP3072906	ANTIBODY FORMULATION	NOVARTIS AG
EP3074398	A3 ADENOSINE RECEPTOR AGONISTS	US HEALTH
EP3077396	SYNTHESIS OF TRANS-8-CHLORO-5-METHYL-1 -[4-(PYRIDIN-2-YLOXY)-CYCLOHEXYL]-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENE AND CRYTALLINE FORMS THEREOF	HOFFMANN LA ROCHE
EP3078654	MONOMER AND BLOCK COPOLYMER	LG CHEMICAL LTD
EP3079697	PROLYLHYDROXYLASE/ATF4 INHIBITORS FOR TREATING NEURAL CELL INJURY	UNIV CORNELL
EP3079701	SOLUBLE GUANYLATE CYCLASE ACTIVATORS	MERCK SHARP & DOHME
EP3079722	METHOD FOR THIOETHER CONJUGATION OF PROTEINS	NOVO NORDISK HEALTHCARE AG
EP3080144	STABILIZATION OF GLUTAMATE DEHYDROGENASE IN AN AQUEOUS SOLUTION	BIOMERIEUX
EP3080161	COMPOSITIONS AND METHODS FOR PHAGOCYTE DELIVERY OF ANTI-STAPHYLOCOCCAL AGENTS	UNIV NEW YORK
EP3080277	AXMI477, AXMI482, AXMI486 AND AXMI525 TOXIN GENES AND METHODS FOR THEIR USE	ATHENIX CORP
EP3081549	FLUOROPOLYETHER COMPOUND, AND LUBRICANT AND MAGNETIC DISC COMPRISING SAME	MORESCO CORP
EP3081571	IRIDIUM COMPLEX COMPOUND, METHOD FOR PRODUCING SAID COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE	MITSUBISHI CHEM CORP
EP3082855	COMPOSITION	UNIV EXETER
EP3082858	ADRENOMEDULLIN BINDER FOR USE IN THERAPY OF CANCER	ANGIOBIOMED GMBH
EP3083038	HETEROGENEOUS ALKANE DEHYDROGENATION CATALYST	DOW GLOBAL TECHNOLOGIES LLC
EP3083048	METAL-LIGAND COMPLEX, OLEFIN POLYMERIZATION CATALYST DERIVED THEREFROM, AND OLEFIN POLYMERIZATION METHOD UTILIZING THE CATALYST	DOW GLOBAL TECHNOLOGIES LLC
EP3083527	METHOD FOR MAKING POLYOLEFINS USING ALUMINUM HALIDE CATALYZED OLIGOMERIZATION OF OLEFINS	CHEVRON PHILLIPS CHEMICAL CO
EP3083543	IMPROVED PROCESS AND APPARATUS FOR MANUFACTURING AROMATIC CARBOXYLIC ACIDS	BP CORP NORTH AMERICA INC
EP3083559	THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS	MERCK SHARP & DOHME
EP3083560	THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS	MERCK SHARP & DOHME
EP3083575	C-6 SPIROCARBOCYCLIC IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE	MERCK SHARP & DOHME
EP3083616	BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY	ASTEX THERAPEUTICS LTD
EP3083619	P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS	ASANA BIOSCIENCES LLC
EP3083629	THE METHOD FOR MANUFACTURING OF VARDENAFIL AND ITS SALTS	ZAKLADY FARM POLPHARMA SA
EP3083652	COMPOSITION COMPRISING ESTERS OF LIGNIN AND OIL OR FATTY ACIDS	REN FUEL K2B AB
EP3083659	VIRAL PEPTIDES	EQUIGERMINAL SA
EP3085385	PHARMACEUTICAL COMPOSITION COMPRISING ADALIMUMAB	ZHEJIANG HISUN PHARM CO LTD
EP3085388	HYPERBRANCHED POLYMER CONJUGATES VIA NON-ENZYMATIC CLEAVABLE LINKER	ASCENDIS PHARMA GROWTH DISORDERS DIVISION AS
EP3087064	PRODRUGS OF UROLITIHNS AND USES THEREOF	AMAZENTIS SA
EP3087087	BETA-HAIRPIN PEPTIDOMIMETICS AS SELECTIVE ELASTASE INHIBITORS	POLYPHOR AG
EP3087091	VAR2CSA-DRUG CONJUGATES	ZYMEWORKS INC
EP3087093	PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES	STEALTH BIOTHERAPEUTICS CORP
EP3088386	METHOD FOR PRODUCING INTERNAL OLEFIN SULFONATE	KAO CORP
EP3088412	PROTEIN PURIFICATION METHOD	CHUGAI PHARMACEUTICAL CO LTD
EP3088487	SURFACE TREATING AGENT INCLUDING PERFLUORO(POLY)ETHER-GROUP-CONTAINING SILANE COMPOUND	DAIKIN IND LTD
EP3089758	COVALENTLY LINKED HELICAR-ANTI-HELICAR ANTIBODY CONJUGATES AND USES THEREOF	HOFFMANN LA ROCHE
EP3089804	SOLID-LIQUID SEPARATIONS WITH A NO-DRY ROTARY PRESSURE FILTER	BP CORP NORTH AMERICA INC
EP3089958	HIGH-PRESSURE CONDENSATE GENERATION IN THE MANUFACTURE OF PURIFIED AROMATIC CARBOXYLIC ACIDS	BP CORP NORTH AMERICA INC
EP3089964	HETEROATOM-CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS	UNIV SOUTHERN CALIFORNIA
EP3089996	BISPECIFIC ANTI-HAPTEN/ANTI-BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES, COMPLEXES THEREOF AND THEIR USE AS BLOOD BRAIN BARRIER SHUTTLES	HOFFMANN LA ROCHE
EP3092220	VITAMIN C PRODRUGS AND USES THEREOF	UNIV FLORIDA
EP3092248	FUSION POLYPEPTIDES AND METHODS OF USE	PROSIT SOLE BIOTECHNOLOGY BEIJING CO LTD
EP3092251	MONOVALENT BLOOD BRAIN BARRIER SHUTTLE MODULES	HOFFMANN LA ROCHE
EP3092253	ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)	ANAPTYSBIO INC
EP3092309	CPMV ENHANCER ELEMENTS	MEDICAGO INC
EP3093011	METHOD FOR THE PREPARATION OF DIRECTLY TABLETTABLE MANNITOL	MERCK PATENT GMBH
EP3093292	METAL COMPLEX AND LIGHT EMITTING ELEMENT USING SAME	SUMITOMO CHEMICAL CO
EP3093338	RECOMBINANT ANAEROBIC GRAM-POSITIVE BACTERIA	TEIKYO HEISEI UNIVERSITY
EP3094325	HETEROARYLS AND USES THEREOF	MILLENNIUM PHARM INC
EP3094351	IMMUNOMODULATORY AGENTS	KADMON CORP LLC
EP3094397	METHANE-RICH NATURAL GAS SUPPLY FOR STATIONARY COMBUSTION SYSTEMS	DOW GLOBAL TECHNOLOGIES LLC
EP3094612	METHOD FOR PRODUCING E-1-CHLORO-3,3,3-TRIFLUOROPROPENE FROM 1,1,3,3-TETRACHLOROPROPENE	ARKEMA FRANCE
EP3094630	READ-THROUGH COMPOUND PRODRUGS SUPPRESSING PREMATURE NONSENSE MUTATIONS	UNIV CALIFORNIA
EP3094652	NOVEL VACCINES AGAINST HPV AND HPV-RELATED DISEASES	BAYLOR RES INST
EP3096609	HIGH-THROUGHPUT MOUSE MODEL FOR OPTIMIZING ANTIBODY AFFINITIES	CHILDRENS MEDICAL CENTER
EP3096774	CELLULAR PLATFORM FOR RAPID AND COMPREHENSIVE T-CELL IMMUNOMONITORING	EINSTEIN COLL MED
EP3097071	SYSTEM AND METHOD FOR UTILIZING HYDROGEN	HYDROGENIOUS TECHNOLOGIES GMBH
EP3097079	PROCESS FOR THE CYCLOADDITION OF A HETERO(ARYL) 1,3-DIPOLE COMPOUND WITH A (HETERO)CYCLOALKYNE	SYNAFFIX BV
EP3097089	ARYL AND ARYLALKYL SUBSTITUTED PYRAZOLYL AND PYRIMIDINYL TRICYCLIC ENONES AS ANTIOXIDANT INFLAMMATION MODULATORS	ABBVIE INC
EP3097119	HUMAN ANTIBODIES TO PD-1	REGENERON PHARMA
EP3098229	ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES	UNIVERSAL DISPLAY CORP
EP3098232	MOLECULAR GELATORS FOR CONTAINING OIL SPILLAGE	HINDUSTAN PETROLEUM CORP LTD
EP3099186	NOVEL TRITERPENE-GLYCOSIDES AS SWEETENERS OR SWEETENER ENHANCERS	ANALYTICON DISCOVERY GMBH
EP3099704	MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES	MOLECULAR TEMPLATES INC
EP3099707	OPIOID RECEPTOR BINDING AGENTS AND USES THEREOF	VIB VZW
EP3099714	HYBRIDOMA CELL LINES (MY-C-CC0C2-259-1 A4) AND USE THEREOF FOR PRODUCING A MONOCLONAL ANTIBODY AGAINST HUMAN CARDIAC MYOSIN BINDING PROTEIN C (C-PROTEIN, MYBPC3, CMYBP-C OR MY-C)	MARTIN-LUTHER-UNIVERSITÄT HALLE-WITTENBERG
EP3099821	CIRCULATING TUMOR CELL DIAGNOSTICS FOR DETECTION OF NEUROENDOCRINE PROSTATE CANCER (NEPC)	EPIC SCIENCES INC
EP3101132	ANTI-TRANSTHYRETIN HUMAN ANTIBODY	THE CHEMO-SERO-THERAPEUTIC RES INST
EP3102215	4'-DIFLUOROMETHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF INFLUENZA RNA REPLICATION	RIBOSCIENCE LLC
EP3102230	METHODS OF TREATING ALZHEIMER'S DISEASE	HOFFMANN LA ROCHE
EP3102234	AIPA, OMPA, AND ASP14 IN VACCINE COMPOSITIONS AND DIAGNOSTIC TARGETS FOR ANAPLASMA PHAGOCYTOPHILUM INFECTION	UNIV VIRGINIA COMMONWEALTH
EP3102555	COMPOSITIONS OF COMPOUNDS AND USES THEREOF	VM ONCOLOGY LLC
EP3102575	NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS	GALAPAGOS NV
EP3102583	2,7-DISUBSTITUTED CEPHALOSPORIN DERIVATIVES AS BETA-LACTAMASE SUBSTRATES AND METHODS FOR THEIR USE FOR THE DIAGNOSIS OF TUBERCULOSIS	TEXAS A & M UNIV SYS
EP3102585	BORONIC ACID ESTERS AND PHARMACEUTICAL FORMULATIONS THEREOF	OHIO STATE INNOVATION FOUNDATION
EP3103796	NOVEL COMPOUND AND EPOXY RESIN COMPOSITION CONTAINING SAME	ADEKA CORP
EP3103809	IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS	BIOGEN HEMOPHILIA INC
EP3103812	ELISA FOR VEGF	GENENTECH INC
EP3105230	PYRIDOPYRAZINES MODULATORS OF GPR6	TAKEDA PHARMACEUTICALS CO
EP3105246	TARGETED TGF BETA INHIBITION	MERCK PATENT GMBH
EP3105249	ANTIBODY MOLEULES TO DENGUE VIRUS AND USES THEREOF	VISTERRA INC
EP3107395	BIOACTIVE PROTEIN, USE THEREOF AND METHOD FOR ITS PRODUCTION	KOPPERT BV
EP3107902	COMPOUNDS AND METHODS FOR INHIBITING FASCIN	CORNELL UNIV CORNELL CENTER FOR TECH ENTPR & COMMERCIALIZATION ( CCTEC )
EP3107923	WATER-SOLUBLE O-CARBONYL PHOSPHORAMIDATE PRODRUGS FOR THERAPEUTIC ADMINISTRATION	MICURX PHARMACEUTICALS INC
EP3107931	MEANS AND METHODS FOR REGULATING SECONDARY METABOLITE PRODUCTION IN PLANTS	VIB VZW
EP3109246	THIOPYRANOSE COMPOUND AND METHOD FOR PRODUCING SAME	FUJIFILM CORP
EP3109257	DIAGNOSIS AND THERAPY OF MULTIPLE SCLEROSIS	PATERNO' ROBERTO
EP3110786	PROCESS AND SYSTEM FOR PRODUCING ACRYLIC ACID	ARKEMA INC
EP3110841	PEPTIDES AND METHODS OF USE	BAXALTA INC
EP3110945	COMPOSITIONS AND METHODS FOR SITE DIRECTED GENOMIC MODIFICATION	MONSANTO TECHNOLOGY LLC
EP3112000	NOVEL FIRE RETARDANT COMPOUNDS	BOEING CO
EP3112338	CYCLOHEXENE DERIVATIVES AND THEIR USE AS ODORANTS	GIVAUDAN SA
EP3112439	LUMINESCENT MATERIAL, ORGANIC LUMINESCENT ELEMENT, AND COMPOUND	KYULUX INC
EP3112873	METHOXETAMINE ASSAY	RANDOX LABORATORIES LTD
EP3113790	PEPTIDES HORMONE ANALOGUES DERIVABLE FROM PREPROGLUCAGON	IMP INNOVATIONS LTD
EP3114112	CRYSTALLINE DERIVATIVES OF (S)-1-((2R,3R,4S,5S)-5-ALLYL-3-METHOXY-4-(TOSYLMETHYL)TETRAHYDROFURAN-2-YL)-3-AMINOPROPAN-2-OL	ALPHORA RES INC
EP3114138	IMPROVED MUTEINS OF CLOTTING FACTOR VIII	PFIZER
EP3115064	RNA-CODED ANTIBODY	CUREVAC AG
EP3116491	PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS	AGIOS PHARMACEUTICALS INC
EP3116507	TREATMENT OF BRAIN AND CENTRAL NERVOUS SYSTEM TUMORS	KADMON CORP LLC
EP3116525	TCO CONJUGATES AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS	UNIV CALIFORNIA
EP3116531	PURIFYING INSULIN USING CATION EXCHANGE AND REVERSE PHASE CHROMATOGRAPHY IN THE PRESENCE OF AN ORGANIC MODIFIER AND ELEVATED TEMPERATURE	MERCK SHARP & DOHME
EP3116887	CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN	UNIVERSITÄT BASEL
EP3116999	METHODS AND COMPOSITIONS FOR SECRETION OF HETEROLOGOUS POLYPEPTIDES	HOFFMANN LA ROCHE
EP3118183	COMPOUND, RESIN, BASE LAYER FILM-FORMING MATERIAL FOR LITHOGRAPHY, BASE LAYER FILM FOR LITHOGRAPHY, PATTERN-FORMING METHOD, AND METHOD FOR REFINING COMPOUND OR RESIN	MITSUBISHI GAS CHEMICAL CO
EP3119194	NON-HUMAN ANIMALS THAT MAKE SINGLE DOMAIN BINDING PROTEINS	REGENERON PHARMA
EP3119489	METHOD AND DEVICE FOR SEPARATING A SUBSTANCE OUT OF A SOLUTION	BASF SE
EP3119490	IN VITRO PREDICTION OF IN VIVO HALF-LIFE OF ANTIBODIES	HOFFMANN LA ROCHE
EP3119756	2-(2,4-DIFLUOROPHENYL)-1,1-DIFLUORO-1-(5-SUBSTITUTED-PYRIDIN-2-YL)-3-(1H-TETRAZOL-1-YL)PROPAN-2-OLS AND PROCESSES FOR THEIR PREPARATION	VIAMET PHARMACEUTICALS INC
EP3119762	BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER	CAPELLA THERAPEUTICS INC
EP3119885	ANTIBODY-FYNOMER CONJUGATES	MITSUBISHI TANABE PHARMA CORP
EP3121162	NITRATED HYDROCARBONS AND DERIVATIVES	ANGUS CHEMICAL
EP3121188	CRYSTALLINE 3',5'-CYCLIC DIGUANYLIC ACID	YAMASA CORP
EP3121193	PLANT CYTOCHROME P450	SUN PHARMACEUTICAL IND (AUSTRALIA) PTY LTD
EP3121211	POLYMER AND ORGANIC SOLAR CELL COMPRISING SAME	LG CHEMICAL LTD
EP3122363	TREATMENT OF AUTISM	SYNAPTEC DEV LLC
EP3122766	IMPROVED ANTI-NUCLEAR ANTIBODY DETECTION AND DIAGNOSTICS FOR SYSTEMIC AND NON-SYSTEMIC AUTOIMMUNE DISORDERS	IMMCO DIAGNOSTICS INC
EP3122776	FGF21 RECEPTOR AGONISTS AND USES THEREOF	REGENERON PHARMA
EP3124519	COPOLYMER AND ORGANIC SOLAR CELL COMPRISING SAME	LG CHEMICAL LTD
EP3126323	MINIMIZING WATER CONTENT IN ETHANOLAMINE PRODUCT STREAMS	SABIC GLOBAL TECHNOLOGIES BV
EP3126371	METAL COMPLEXES, COMPRISING CARBENE LIGANDS HAVING AN O-SUBSTITUTED NON-CYCLOMETALATED ARYL GROUP AND THEIR USE IN ORGANIC LIGHT EMITTING DIODES	UDC IRELAND LTD
EP3126380	CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALLING SYSTEM	UCL BUSINESS PLC
EP3127894	COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE	IDEMITSU KOSAN CO
EP3127898	OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING SAID COMPOUND	ADEKA CORP
EP3127905	HIGH-PURITY MAGNESIUM LITHOSPERMATE B AND PREPARATION METHOD THEREFOR	SHANGHAI INST MATERIA MEDICA CAS
EP3127917	METHOD FOR PREPARING ANTIBODY THROUGH REGULATION OF SUGAR CONTENT OF ANTIBODY	PRESTIGE BIOPHARMA PTE LTD
EP3127923	METHOD FOR IMPROVING SOLUBILITY OF PROTEIN AND PEPTIDE BY USING IMMUNOGLOBULIN FC FRAGMENT LINKAGE	HANMI PHARM IND CO LTD
EP3129023	POTENT SOLUBLE EPOXIDE HYDROLASE INHIBITORS	EICOSIS LLC
EP3129347	REACTIONS IN THE PRESENCE OF RUTHENIUM COMPLEXES	CALIFORNIA INST OF TECHN
EP3129350	MACROCYCLES	LUMIPHORE INC
EP3129359	DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES	BASF SE
EP3129368	CYTOTOXIC COMPOUNDS WHICH ARE INHIBITORS OF THE POLYMERISATION OF TUBULIN	CENTRE NAT DE LA RECH SCIENT (C N R S )
EP3129373	HISTONE DEACETYLASE INHIBITORS
EP3129393	CRISPR ENZYME MUTATIONS REDUCING OFF-TARGET EFFECTS	BROAD INST INC
EP3129399	DRUG RELATED TRANSGENE EXPRESSION	SEATTLE CHILDREN'S HOSPITAL DBA SEATTLE CHILDREN'S RES INST
EP3129405	TRANSGENE GENETIC TAGS AND METHODS OF USE	SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RES INSTITUTE)
EP3129493	IMPORT OF UNNATURAL OR MODIFIED NUCLEOSIDE TRIPHOSPHATES INTO CELLS VIA NUCLEIC ACID TRIPHOSPHATE TRANSPORTERS	SCRIPPS RESEARCH INST
EP3129767	REACTIVE LABELLING COMPOUNDS AND USES THEREOF
EP3130587	HYDROPHILIC POLYMER DERIVATIVE HAVING CYCLIC BENZYLIDENE ACETAL LINKER	NOF CORP
EP3130596	NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE	UNIV HIROSAKI
EP3131131	LIGHT-EMISSION ELEMENT, AND COMPOSITION USED THEREIN	SUMITOMO CHEMICAL CO
EP3131550	METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY	SIGNAL PHARM LLC
EP3131908	METHODS AND DEVICES FOR ISOLATING LEAD 203	LANTHEUS MEDICAL IMAGING INC
EP3131920	MSP NANOPORES AND USES THEREOF	UAB RES FOUND
EP3131994	RAPID-CURING, MIGRATION-FREE COMPOSITION BASED ON ORGANIC POLYMERS CONTAINING SILANE GROUPS	SIKA TECH AG
EP3132005	METHOD FOR THERMAL CONVERSION OF KETOACIDS AND HYDROTREATMENT TO HYDROCARBONS	NESTE OIL OYJ
EP3133932	EGG WHITE PROCESSING	ALEXION PHARMA INC
EP3134389	QUINAZOLINE SCAFFOLD BASED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF	TECHNION RES & DEV FOUNDATION
EP3134410	INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL	HYDRA BIOSCIENCES INC
EP3134431	LDLR VARIANTS AND THEIR USE IN COMPOSITIONS FOR REDUCING CHOLESTEROL LEVELS	UNIV PENNSYLVANIA
EP3134522	RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS	UNIV MASSACHUSETTS
EP3135666	(S)-OXIRACETAM CRYSTAL FORM III, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	CHONGQING RUNZE PHARMACEUTICAL
EP3135744	MONOAMINE MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME	SAMSUNG DISPLAY CO LTD
EP3137169	INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1	CELGENE QUANTICEL RES INC
EP3137186	METHODS FOR THE PURIFICATION OF PROTEINS USING CAPRYLIC ACID	NOVO NORDISK AS
EP3137447	INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF	RGENIX INC
EP3137451	ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME	ROHM & HAAS ELECT MATERIALS KOREA LTD
EP3137456	PYRIDAZINONE HERBICIDES	DU PONT
EP3137461	OPTICALLY ACTIVE PDE10 INHIBITOR	OMEROS CORP
EP3137478	PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF	AGILENT TECHNOLOGIES INC
EP3137487	POLYPEPTIDES FOR GENERATING ANTI-INFLUENZA ANTIBODIES AND USES THEREOF	INDIAN INST SCIENT
EP3137490	MUTANT PORES	OXFORD NANOPORE TECH LTD
EP3137494	ISLET AMYLOID POLYPEPTIDES WITH IMPROVED SOLUBILITY	UNIV NEW YORK STATE RES FOUND
EP3137497	AAV VECTORS FOR RETINAL AND CNS GENE THERAPY	GENZYME CORP
EP3137501	ION CHANNEL MODULATORS AND USES THEREOF	MEDIMMUNE LTD
EP3138580	COVALENTLY LINKED ANTIGEN-ANTIBODY CONJUGATES	HOFFMANN LA ROCHE
EP3138853	FC VARIANTS WITH ALTERED BINDING TO FCRN	XENCOR INC
EP3139947	CONJUGATES OF AN IL-15 MOIETY AND A POLYMER	NEKTAR THERAPEUTICS
EP3140292	CATALYST RECYCLE METHODS	NOVOMER INC
EP3140306	PHOTO-STABLE AND THERMALLY-STABLE DYE COMPOUNDS FOR SELECTIVE BLUE LIGHT FILTERED OPTIC	FRONTIER SCIENT INC
EP3140322	MODIFIED FC GAMMA RECEPTOR TYPE III (FC III, HNA-1) POLYPEPTIDES AND THE USES THEREOF	ONE LAMBDA INC
EP3141540	CRYSTALLINE FORM OF CHLOROGENIC ACID AND PREPARATION METHOD THEREFOR	SICHUAN JIUZHANG BIOLOGICAL SCIENCE & TECH CO LTD
EP3141565	SPHERICAL PARTICLES	EVONIK DEGUSSA GMBH
EP3142700	MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES	MEDIMMUNE LLC
EP3143022	CARBOPYRONONE COMPOUNDS USEFUL AS DIAGNOSTIC ADJUVANTS	LIFE TECHNOLOGIES CORP
EP3143037	ALPHA4BETA7 INTEGRIN THIOETHER PEPTIDE ANTAGONISTS	PROTAGONIST THERAPEUTICS INC
EP3143403	METHODS FOR DETECTING AND/OR MEASURING ANTI-DRUG ANTIBODIES, IN PARTICULAR TREATMENT-EMERGENT ANTI-DRUG ANTIBODIES	ABLYNX NV
EP3144015	NOVEL LOW MOLECULAR WEIGHT CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY	SIRNA THERAPEUTICS INC
EP3144302	HETEROCYCLIC COMPOUND CONTAINING AROMATIC AMINE GROUP, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	SFC CO LTD
EP3144371	HYDROXYALKYL SUBSTITUTED SUCCINIMIDES AND FUELS CONTAINING THEM	AFTON CHEMICAL CORP
EP3145901	PROCESS FOR GENERATING A MIXED MULTICOMPONENT VAPOR FOR PREPARATION OF MONOALKYL ETHERS OF DIPHENOLS	CAMLIN FINE SCIENCES LTD
EP3145931	TREATMENT OF AUTOIMMUNE DISEASE	MINGSIGHT PHARMACEUTICALS INC
EP3145944	MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS	RQX PHARMACEUTICALS INC
EP3146080	ALLELE-SPECIFIC AMPLIFICATION USING A COMPOSITION OF OVERLAPPING NON-ALLELE-SPECIFIC PRIMER AND ALLELE-SPECIFIC BLOCKER OLIGONUCLEOTIDES	UNIV RICE WILLIAM M
EP3147282	OPTICAL RESOLUTION METHOD OF LENALIDOMIDE	SHISEIDO CO LTD
EP3148577	NOVEL SEMI-SYNTHETIC MENINGOCOCCAL CONJUGATE VACCINE	BIOLOGICAL E LTD
EP3148580	TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS AND METHODS OF USE THEREOF	MACROGENICS INC
EP3148996	C2-CARBOCYCLIC IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE	MERCK SHARP & DOHME
EP3149000	IMPROVED FORMS OF A PI3K DELTA SELECTIVE INHIBITOR FOR USE IN PHARMACEUTICAL FORMULATIONS	RHIZEN PHARMACEUTICALS S A
EP3149015	MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF	MEMORIAL SLOAN-KETTERING CANCER CENTER
EP3149024	DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDES	AGENSYS INC
EP3149028	VARIANTS OF GH FAMILY 11 XYLANASE AND POLYNUCLEOTIDES ENCODING SAME	NOVOZYMES AS
EP3149032	NEW BISPECIFIC FORMAT SUITABLE FOR USE IN HIGH-THROUGH-PUT SCREENING	UCB BIOPHARMA SPRL
EP3150218	TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES	UNIV CALIFORNIA
EP3150579	FLUORANTHENE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT-EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT	TORAY INDUSTRIES
EP3150604	BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLYL GROUPS, CARBAZOLYL GROUPS, BENZOFURANE GROUPS OR BENZOTHIOPHENE GROUPS FOR ORGANIC LIGHT EMITTING DIODES	IDEMITSU KOSAN CO
EP3150625	A FAMILY OF PESTICIDAL PROTEINS AND METHODS FOR THEIR USE	ATHENIX CORP
EP3151940	PROCESS FOR OPERATING A SIMULATED MOVING BED REACTOR	DOW GLOBAL TECHNOLOGIES LLC
EP3152231	PEPTIDES, AND METHODS AND APPARATUS UTILISING SAME	UNIV MANCHESTER
EP3152235	TRI-SPECIFIC BINDING MOLECULES AND METHODS OF USE THEREOF	MACROGENICS INC
EP3153583	EXPRESS HUMANIZATION OF ANTIBODIES	BIOATLA LLC
EP3154583	HUMAN MONOCLONAL ANTIBODIES TO GANGLIOSIDE GD2	MABVAX THERAPEUTICS INC
EP3154584	COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS	XBIOTECH INC
EP3154669	COMPOSITIONS OF MONO-ALKYL ETHERS OF MONOANHYDRO-HEXITOLS, PRODUCTION METHODS THEREOF AND USE OF SAME	SYRAL BELGIUM NV
EP3154941	SMALL MOLECULE LFA-1 INHIBITORS	ALLOCYTE PHARMACEUTICALS AG
EP3154945	COMPLEXES	JOHNSON MATTHEY PLC
EP3155004	VACCINE FOR IMMUNOCOMPROMISED HOSTS	UNIV DO PORTO - REITORIA
EP3155011	GLYCOPROTEIN HORMONE RECEPTOR MUTATIONS	RSR LTD
EP3156396	N-SUBSTITUTED SULFONAMIDE COMPOUND AND METHOD FOR PRODUCING SAME	UBE INDUSTRIES
EP3156402	PYRIMIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT	HODOGAYA CHEMICAL CO LTD
EP3156413	GANIRELIX PRECURSOR AND METHOD FOR PREPARING GANIRELIX ACETATE BY USING ANIRELIX PRECURSOR	HYBIO PHARMACEUTICAL CO LTD
EP3157571	FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES	NOVARTIS AG
EP3157674	CATALYST COMPOSITIONS, METHODS OF PREPARATION THEREOF, AND PROCESSES FOR ALKOXYLATING ALCOHOLS USING SUCH CATALYSTS	SASOL (USA) CORP
EP3157892	SALT REMOVAL AND TRANSPORT SYSTEM FOR USE IN A MONOETHYLENEGLYCOL (MEG) RECLAMATION PROCESS	CAMERON SOLUTIONS INC
EP3157895	FULLERENE DERIVATIVES	MERCK PATENT GMBH
EP3157937	GREEN METHODS FOR PREPARING HIGHLY CO2 SELECTIVE AND H2S TOLERANT METAL ORGANIC FRAMEWORKS	UNIV KING ABDULLAH SCI & TECH
EP3157952	TREATMENT OF CONGESTIVE HEART FAILURE AND OTHER CARDIAC DYSFUNCTION USING A GDF15 MODULATOR	AVEO PHARMACEUTICALS INC
EP3157953	TREATMENT OF CHRONIC KIDNEY DISEASE AND OTHER RENAL DYSFUNCTION USING A GDF15 MODULATOR	AVEO PHARMACEUTICALS INC
EP3159417	METHODS OF NONSPECIFIC TARGET CAPTURE OF NUCLEIC ACIDS	GEN-PROBE INCORPORATED
EP3160501	INFLUENZA VIRUS HEMAGGLUTININ PROTEIN AS A VACCINE ANTIGEN	INST BIOTECHNOLOGII I ANTYBIOTYKOW
EP3160935	PROCESS FOR PREPARATION OF DI- AND POLYAMINES OF THE DIPHENYLMETHANE SERIES	COVESTRO DEUTSCHLAND AG
EP3160936	PROCESS FOR PREPARATION OF DI- AND POLYAMINES OF THE DIPHENYLMETHANE SERIES	COVESTRO DEUTSCHLAND AG
EP3160958	CRYSTALLINE SALTS OF (S)-6-((1-ACETYLPIPERIDIN-4-YL)AMINO)-N-(3-(3,4-DIHYDROISOQUINOLIN-2(1H)-YL)-2-HYDROXYPROPYL)PYRIMIDINE-4-CARBOXAMIDE	GLAXOSMITHKLINE IP DEV LTD
EP3160984	PROCESS FOR PREPARING D-ARGINYL-2,6-DIMETHYL-L-TYROSYL-L-LYSYL-L-PHENYLALANINAMIDE	FLAMMA SPA
EP3160985	PROCESS FOR THE PRODUCTION OF D-ARGINYL-2,6-DIMETHYL-L-TYROSYL-L-LYSYL-L-PHENYLALANINAMIDE	FLAMMA SPA
EP3161051	COMPOSITION FOR PREPARING AN AMORPHOUS POLYMERIC FOAM USING A BENZYLIDENE SORBITOL NUCLEATING AGENT	CLARIANT INT LTD
EP3162796	METHOD FOR PRODUCING 2-AMINO-6-METHYLNICOTINIC ACID	AGRO-KANESHO CO LTD
EP3162797	POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME	HEESUNG MAT LTD
EP3162799	FLUOROALKYLATING AGENT	IHARA CHEMICAL IND CO
EP3162809	CARRIER FOR AFFINITY CHROMATOGRAPHY	JSR CORP
EP3163644	ORGANIC ELECTROLUMINESCENT ELEMENT	HODOGAYA CHEMICAL CO LTD
EP3164194	Dickkopf2 (Dkk2) Inhibition Suppresses Tumor Formation	UNIV YALE
EP3164204	SELECTIVE NUCLEIC ACID SEPARATION	SIEMENS HEALTHCARE DIAGNOSTICS INC
EP3164385	NOVEL POLYMORPHIC FORM OF N-[2-(6-FLUORO-LH-INDOL-3-YL)ETHYL]-3-(2,2,3,3-TETRAFLUOROPROPOXY)BENZYLAMINE HYDROCHLORIDE FOR THE TREATMENT OF ALZHEIMER'S	H LUNDBECK AS
EP3164409	GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION	GUANG MING INNOVATION COMPANY (WUHAN)
EP3164410	PROTEIN RECOVERY	HERIOT-WATT UNIV
EP3165528	IONIC COMPLEX, ELECTROLYTE FOR NONAQUEOUS ELECTROLYTE BATTERY, NONAQUEOUS ELECTROLYTE BATTERY AND IONIC COMPLEX SYNTHESIS METHOD	CENTRAL GLASS CO LTD
EP3165539	IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS	KIRIN-AMGEN INC
EP3166634	NOVEL VACCINE COMPOSITIONS FOR PORCINE EPIDEMIC DIARRHEA VIRUS AND PORCINE DELTACORONAVIRUS	ZOETIS SERVICES LLC
EP3166636	PSGL-1 MODULATORS AND USES THEREOF	SANFORD-BURNHAM MEDICAL RES INST
EP3166916	METHOD OF DEPOLYMERIZING LIGNIN	COMMISSARIAT à L'éNERGIE ATOMIQUE ET AUX éNERGIES ALTERNATIVES
EP3166917	METHOD OF PREPARING AROMATIC COMPOUNDS FROM LIGNIN	COMMISSARIAT à L'éNERGIE ATOMIQUE ET AUX éNERGIES ALTERNATIVES
EP3166944	ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME	ROHM & HAAS ELECT MATERIALS KOREA LTD
EP3166949	THIENOTHIOPHENE-ISOINDIGO	BASF SE
EP3166968	COMPOSITIONS AND METHODS OF CHIMERIC AUTOANTIBODY RECEPTOR T CELLS	UNIV PENNSYLVANIA
EP3166970	IMPROVED A脽 PROTOFIBRIL BINDING ANTIBODIES	BIOARCTIC NEUROSCIENCE AB
EP3167283	DEVICE, USE OF SAID DEVICE, AND METHOD FOR SEPARATING SUBSTANCES WITH AN IMPROVED UTILIZATION OF THE CAPACITY OF CHROMATOGRAPHIC MEDIA	SARTORIUS STEDIM BIOTECH GMBH
EP3167899	ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C.DIFFICILE AND USES THEREOF	VALNEVA AUSTRIA GMBH
EP3168232	COMPOSITIONS, KITS, AND METHODS FOR THE DIAGNOSIS, PROGNOSIS, MONITORING, TREATMENT AND MODULATION OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND HYPOXIA ASSOCIATED ANGIOGENESIS DISORDERS USING GALECTIN-1	DANA FARBER CANCER INST INC
EP3169670	QUINOXALINE COMPOUNDS, METHOD FOR PREPARING THE SAME AND USE THEREOF
EP3169674	ARYL-TRIAZOLYL-PYRIDINES AS PESTICIDES	BAYER ANIMAL HEALTH GMBH
EP3169709	CRYSTALLINE ANTIBODY FORMULATIONS	AMGEN INC
EP3170901	METHOD FOR IDENTIFYING EPITOPE OF PROTEIN	CHUGAI PHARMACEUTICAL CO LTD
EP3171706	NUTRITIONAL COMPOSITIONS CONTAINING PHOSPHATIDYLSERINE POWDER	ENZYMOTEC LTD
EP3171870	PROTEIN PHOSPHATASE 2A INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROMES	H LEE MOFFITT CANCER CT & RES
EP3171892	ANTI-PD-1 ANTIBODIES	CB THERAPEUTICS INC
EP3172213	MACROCYCLIC KINASE INHIBITORS AND USES THEREOF	DANA FARBER CANCER INST INC
EP3172217	PHOSPHORUS CONTAINING FLAME RETARDANTS	CHEMTURA CORP
EP3172221	PURIFICATION PLATFORM FOR BISPECIFIC ANTIBODIES	REGENERON PHARMA
EP3172225	COMPOSITIONS AND METHODS FOR INCREASING PLANT GROWTH AND YIELD USING RICE PROMOTERS	BENSON HILL BIOSYSTEMS INC
EP3172230	COMPOSITIONS AND METHODS FOR TARGETING OF THE SURFACTANT PROTEIN A RECEPTOR	PENN STATE RES FOUND
EP3172231	BCMA CHIMERIC ANTIGEN RECEPTORS	BLUEBIRD BIO INC
EP3172296	SELECTIVE ALKYLATION METHOD FOR PRODUCING P, P'-DI-ALKYLATED DIPHENYLAMINE ANTIOXIDANTS	CHEMTURA CORP
EP3173485	PLANT WITH TOLERANCE OF THE COLD	KWS SAAT SE & CO KGAA
EP3174537	MONOCYCLIC ISOXAZOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN	MERCK SHARP & DOHME
EP3174868	COMPOUNDS ACTIVE TOWARDS BROMODOMAINS	NUEVOLUTION AS
EP3174894	COMPOSITIONS AND METHODS OF USE FOR TREATING METABOLIC DISORDERS	NGM BIOPHARMACEUTICALS INC
EP3174932	CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS	HENKEL IP & HOLDING GMBH
EP3177282	ANTIDIABETIC BICYCLIC COMPOUNDS	MERCK SHARP & DOHME
EP3177616	NOVEL ROUTES OF SYNTHESIS FOR THE PREPARATION OF SUVOREXANT	SANDOZ AG
EP3177642	ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE	NOVARTIS AG
EP3177645	SUBCUTANEOUSLY ADMINISTERED BISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF CANCER	LINDHOFER HORST DR
EP3177932	BIOMARKERS OF POLYCYSTIC KIDNEY DISEASE AND USES THEREOF	GENZYME CORP
EP3178472	ORAL FORMULATIONS OF METHYLNALTREXONE	WYETH LLC
EP3178850	COMPOSITIONS COMPRISING CROSS-SPECIES-SPECIFIC ANTIBODIES AND USES THEREOF	AMGEN RES (MUNICH) GMBH
EP3178929	NEW ANTI-HUMAN IG(BETA) ANTIBODY	ASTELLAS PHARMA INC
EP3179308	UNDERLAYER FILM-FORMING COMPOSITION FOR LITHOGRAPHY, UNDERLAYER FILM FOR LITHOGRAPHY, AND PATTERN FORMING METHOD	MITSUBISHI GAS CHEMICAL CO
EP3180004	CANCER THERAPEUTICS	UNIV VIRGINIA PATENT FOUNDATION
EP3180313	2-OXO-3,4-DIHYDROQUINOLIN-6-YL SULPHONAMIDES AND THEIR USE AS PLANT GROWTH REGULATORS.	UNIV CALIFORNIA
EP3180320	PROCESS FOR PREPARING FURFURAL FROM BIOMASS	SHELL INT RESEARCH
EP3180330	2,2,2-TRIFLUOROETHYL-THIADIAZINES	HOFFMANN LA ROCHE
EP3180332	DIFLUOROPYRROLIDINES AS OREXIN RECEPTOR MODULATORS	EOLAS THERAPEUTICS INC
EP3180352	ADVANCED MACROMOLECULE TRANSDUCTION DOMAIN (AMTD) SEQUENCES FOR IMPROVEMENT OF CELL-PERMEABILITY, POLYNUCLEOTIDES ENCODING THE SAME, METHOD TO IDENTIFY THE UNIQUE FEATURES OF AMTDS COMPRISING THE SAME, METHOD TO DEVELOP THE AMTD SEQUENCES COMPRISING THE SAME	CELLIVERY THERAPEUTICS INC
EP3180353	MYCOBACTERIUM TUBERCULOSIS PROTEINS	OXFORD IMMUNOTEC LTD
EP3180619	SIGNAL AMPLIFICATION IN PLASMONIC SPECIFIC-BINDING PARTNER ASSAYS	ABAY SA
EP3181575	CELLULAR LIBRARIES OF PEPTIDE SEQUENCES (CLIPS) AND METHODS OF USING THE SAME	UNIV CALIFORNIA
EP3183100	PROCESS FOR THE RECOVERY OF CARBOXYLIC ACID AND WOOD TREATMENT PROCESS	SOLVAY ACETOW GMBH
EP3183252	OXALATE SALT OF RUXOLITINIB	RATIOPHARM GMBH
EP3183260	MODIFIED OLIGONUCLEOTIDES AND METHODS FOR THEIR SYNTHESIS	NOOGEN LLC
EP3183270	HIV ANTIBODY THERAPY AS TREATMENT SUBSTITUTE	CYTODYN INC
EP3183272	ASYMMETRIC MULTISPECIFIC ANTIBODIES	ARGEN-X N V
EP3183362	ELECTROCHEMICAL DETECTION OF MICROORGANISMS	UNIV NANYANG TECH
EP3184513	CRYSTALLINE AND AMORPHOUS FORMS OF OLAPARIB	OLON SPA
EP3184533	METAL COMPLEX, ITS METHOD OF PREPARATION AND USE	ARKEMA B V
EP3184616	METHOD FOR PRODUCING MONOGLYCERIDE-CONTAINING COMPOSITION	KAO CORP
EP3185887	METHOD FOR PREPARING CRYSTALLINE INSULIN OR INSULIN ANALOG COMPOSITIONS	MERCK SHARP & DOHME
EP3186216	THE OPTIMIZATION OF O-SULFONATED PHENOL PRODUCTION FOR CUMENE HYDROPEROXIDE CLEAVAGE	SABIC GLOBAL TECHNOLOGIES BV
EP3186227	NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS	NOVARTIS TIERGESUNDHEIT AG
EP3186233	PROBES FOR IMAGING HUNTINGTIN PROTEIN	CHDI FOUNDATION INC
EP3186242	INHIBITORS OF -AMINO- -CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE	TES PHARMA S R L
EP3186247	PROTEIN KINASE INHIBITORS	ASTAR BIOTECH LLC
EP3186269	COMPOSITIONS, METHODS AND KITS FOR TREATING COMPLEMENT RELATED DISORDERS	UNIV TUFTS
EP3186274	INTRACELLULAR OSTEOPONTIN REGULATES THE LINEAGE COMMITMENT OF LYMPHOID SUBSETS	DANA FARBER CANCER INST INC
EP3188747	ELEVATED INTRACRANIAL PRESSURE TREATMENT	UNIV BIRMINGHAM
EP3189022	SEPARATION PROCESS FOR C8 AROMATICS MIXTURE	SCG CHEMICALS CO LTD
EP3189023	PROCESS FOR THE ENHANCED SEPARATION OF ETHYLBENZENE	SCG CHEMICALS CO LTD
EP3189025	PROCESS FOR PRODUCING CHLOROTRIFLUOROETHYLENE	HONEYWELL INT INC
EP3189053	AN IMPROVED PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF	UNICHEM LAB LTD
EP3189065	STEVIA EXTRACTS ENRICHED IN REBAUDIOSIDE D, E, N AND/OR O AND PROCESS FOR THE PREPARATION THEREOF	PURECIRCLE USA INC
EP3189067	RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE	US HEALTH
EP3189071	NOVEL AMYLIN AND CALCITONIN RECEPTOR AGONIST	NOVO NORDISK AS
EP3189153	COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF	BOEHRINGER INGELHEIM INT
EP3189840	METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME	KEMPHARM INC
EP3190100	POLYMERIZABLE COMPOUND, POLYMER, POLYMERIZABLE COMPOSITION, AND FILM	FUJIFILM CORP
EP3190113	PYRROLOPYRIMIDINE COMPOUNDS USED AS TLR7 AGONIST	CHAI TAI TIANQING PHARMACEUTICAL GROUP CO LTD
EP3190120	CATALYST FOR SYNTHESIZING POLYOLEFINS	UNIV TOKYO
EP3191187	COMBINATION THERAPIES WITH ANTI-CD38 ANTIBODIES	JANSSEN BIOTECH INC
EP3191438	SWEETNESS ENHANCER	PEPSICO INC
EP3191446	METHOD FOR PREPARING ALPHA-HYDROXYCARBOXYLIC ACID ESTERS IN WHICH AMMONIA IS RECYCLED	EVONIK ROEHM GMBH
EP3191461	CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)-BENZOXAZOLE	PFIZER
EP3191469	2-H-INDAZOLE DERIVATIVES AS CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS AND THERAPEUTIC USES THEREOF	BETA PHARMA INC
EP3191489	PYRROLOPYRIMIDINES FOR USE IN INFLUENZA VIRUS INFECTION	JANSSEN SCIENCES IRELAND UC
EP3191496	NOVEL IMINES WITH TUNABLE NUCLEOPHILICITY AND STERIC PROPERTIES THROUGH METAL COORDINATION: APPLICATIONS AS LIGANDS AND METALLOORGANOCATALYSTS	UNIV KING ABDULLAH SCI & TECH
EP3191502	TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES	SEATTLE GENETICS INC
EP3193586	NEW PHYTOPHTHORA RESISTANCE GENE	UNIV WAGENINGEN
EP3193914	ORGAN PROTECTION IN PSMA-TARGETED RADIONUCLIDE THERAPY OF PROSTATE CANCER	MOLECULAR INSIGHT PHARM INC
EP3193934	COMPOSITIONS FOR IMPROVING THE HEALTH RELATED QUALITY OF LIFE OF RHEUMATOID ARTHRITIS PATIENTS	SANOFI BIOTECHNOLOGY
EP3194373	DIAGNOSTIC SYSTEM AND PROCESS FOR RAPID BACTERIAL INFECTION DIAGNOSIS	UNIV NORTHEASTERN
EP3194418	SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF	PREVACUS INC
EP3194420	IDENTIFYING STATUS OF MALE FERTILITY BY DETERMINING SPERM CAPACITATION	UNIV CORNELL
EP3194437	ANGIOPOETIN-LIKE 4 (ANGPTL4) ANTIBODIES AND METHODS OF USE	NOVARTIS AG
EP3194443	TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY	NOVARTIS AG
EP3194447	ANTIBODIES CAPABLE OF BINDING TWO EPITOPES ON TISSUE FACTOR PATHWAY INHIBITOR (1-161)	NOVO NORDISK AS
EP3194601	ADENO-ASSOCIATED VIRAL VECTORS FOR TREATING MYOCILIN (MYOC) GLAUCOMA	GENZYME CORP
EP3196181	METHOD FOR PRODUCING BUTADIENE AND DEVICE FOR PRODUCING BUTADIENE	SEKISUI CHEMICAL CO LTD
EP3196182	IMPROVED METHOD FOR PRODUCING 2-CHLORO-3,3,3,-TRIFLUOROPROPENE (HCFC-1233XF)	HONEYWELL INT INC
EP3196184	IRIDIUM COMPLEX PRODUCTION METHOD	TANAKA PRECIOUS METAL IND
EP3196211	HUMAN ANTIBODY SPECIFIC TO C-MET AND PREPARATION METHOD THEREFOR	PHARMABCINE INC
EP3196213	ANTIBODIES DIRECTED TO HER-3 AND USES THEREOF	DAIICHI SANKYO EUROPE GMBH
EP3197454	CONTINUOUS FLOW CARBOXYLATION REACTION	SARCODE BIOSCIENCE INC
EP3197473	PROTEINS INCREASING PANCREATIC BETA CELL NUMBER AND METHODS OF USE	UNIV OREGON
EP3197905	METHOD FOR PRODUCING ETHYLENEDIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS, AND THE USE THEREOF AS FLAME RETARDANTS	CLARIANT PLASTICS & COATINGS LTD
EP3197922	PROTEIN ISOLATION	IDEA TREA LLC
EP3198053	USE OF AT LEAST ONE BINARY GROUP 15 ELEMENT COMPOUND, A 13/15 SEMICONDUCTOR LAYER AND BINARY GROUP 15 ELEMENT COMPOUNDS.	PHILIPPS UNIVERSITÄT MARBURG
EP3199518	PROCESS FOR PRODUCING HIGH-PURITY AQUEOUS UREA SOLUTION IN UREA PRODUCTION PROCESS	TOYO ENGINEERING CORP
EP3199519	METHOD FOR PRODUCING METHIONINE	SUMITOMO CHEMICAL CO
EP3199544	PREPARATION METHOD FOR GLATIRAMER ACETATE	HYBIO PHARMACEUTICAL CO LTD
EP3200807	ANALYSIS OF T-CELL MONOTYPIA	UNIV OXFORD INNOVATION LTD
EP3200911	METHOD FOR LIQUID AUTHENTICATION BY DETECTION OF FLAVONOID DERIVATIVES	SICPA HOLDING SA
EP3201193	BENZENECARBOTHIOCCYCLOPENTA[C]PYRROLE-1,3-DIONE COMPOUNDS AND PROCESS FOR SYNTHESIS THEREOF	COUNCIL SCIENT IND RES
EP3201204	C5-C6-FUSED TRICYCLIC IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE	MERCK SHARP & DOHME
EP3201207	BORONIC ACID DERIVATIVES	MERCK PATENT GMBH
EP3201208	BORONIC ACID DERIVATIVES	MERCK PATENT GMBH
EP3201211	NON-CALORIC SWEETENERS AND METHODS FOR SYNTHESIZING	CONAGEN INC
EP3201213	MIR-29 MIMICS AND USES THEREOF	MIRAGEN THERAPEUTICS INC
EP3201215	METHODS OF PREPARING INTERMEDIATE OF FLUTICASONE PROPIONATE	AMPHASTAR PHARMACEUTICALS INC
EP3201218	BETA-HAIRPIN PEPTIDOMIMETICS	POLYPHOR AG
EP3201219	BETA-HAIRPIN PEPTIDOMIMETICS	POLYPHOR AG
EP3202757	POLYETHER DIOL AND METHOD FOR PRODUCING SAME	MITSUBISHI GAS CHEMICAL CO
EP3202872	ORGANIC LIGHT EMITTING ELEMENT	LG CHEMICAL LTD
EP3204040	TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS	IDERA PHARMACEUTICALS INC
EP3204120	METHODS AND COMPOSITIONS FOR INCREASING THE POTENCY OF ANTIFUNGAL AGENTS	PACIFIC NORTHWEST RES INST
EP3204386	SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH	SIGNAL PHARM LLC
EP3204410	BIPHASIC SINGLE-CHAIN INSULIN ANALOGUES	UNIV CASE WESTERN RESERVE
EP3204502	METHOD TO REDUCE ONCOGENIC POTENTIAL OF INDUCED PLURIPOTENT STEM CELLS FROM AGED DONORS	MEMORIAL SLOAN-KETTERING CANCER CENTER
EP3204511	MUTANT PORES	OXFORD NANOPORE TECH LTD
EP3205639	PROTECTING-GROUP INTRODUCING AGENT FOR HYDROXY GROUP AND/OR MERCAPTO GROUP	UNIV KYUSHU NAT UNIV CORP
EP3205649	NOVEL FLUORINATED UNSATURATED CYCLIC CARBONATE AND PROCESS FOR PRODUCING SAME	DAIKIN IND LTD
EP3205658	ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES	UNIVERSAL DISPLAY CORP
EP3206669	FORMULATIONS HAVING ANTI-INFLAMMATORY ACTIVITY AND ANTIMICROBIAL ACTIVITY AGAINST GRAM-POSITIVE BACTERIA	NATUREZA INC
EP3206689	INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF	LA JOLLA INST OF ALLERGY & IMMUNOLOGY
EP3207005	ETHYLENE SEPARATION WITH PRESSURE SWING ADSORPTION	CHEVRON PHILLIPS CHEMICAL CO LP
EP3207006	A PROCESS FOR PRODUCING HIGHLY PURE CHLORINATED ALKANES	SPOLEK PRO CHEMICKOU A HUTNI VYROBU AS
EP3207007	PROCESS	SPOLEK PRO CHEMICKOU A HUTNI VYROBU AS
EP3207010	COMPOSITIONS COMPRISING 1,1,1,2,3 PENTACHLOROPROPANE	ARKEMA FRANCE
EP3207011	COMPOSITIONS CONTAINING 1,1,1,3,3-PENTACHLOROPROPANE	ARKEMA FRANCE
EP3207012	PROCESS	SPOLEK PRO CHEMICKOU A HUTNI VYROBU AS
EP3207029	TRYPTAMIDE COMPOSITIONS AND METHODS OF USE	SIGNUM BIOSCIENCES INC
EP3207031	ATAXIA TELENGIECTASIA AND RAD3-RELATED (ATR) PROTEIN KINASE INHIBITORS	ATRIN PHARMACEUTICALS LLC
EP3207049	NOVEL CHIMERIC INSECTICIDAL PROTEINS TOXIC OR INHIBITORY TO LEPIDOPTERAN PESTS	MONSANTO TECHNOLOGY LLC
EP3207105	PROCESS FOR THE PRODUCTION OF HIGH VALUE CHEMICALS FROM BIOLOGICALLY PRODUCED MATERIALS	TOTAL RES & TECHNOLOGY FELUY
EP3208271	NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME	LG CHEMICAL LTD
EP3208279	MINI-HEPCIDIN PEPTIDES AND METHODS OF USING THEREOF	UNIV CALIFORNIA
EP3209328	INHIBITORS OF LACTATE TRANSPORTERS FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES	UNIV LONDON QUEEN MARY
EP3209645	AMPHOTERIC ESTER SULFONATES	EASTMAN CHEM CO
EP3209653	PROCESS FOR THE PREPARATION OF (R,S)-NICOTINE	NEXT GENERATION LABS LLC
EP3209661	PROCESS FOR PREPARING A POLYMORPH OF RIVAROXABAN	ZAKL FARM POLPHARMA SA
EP3209690	METHODS AND COMPOSITIONS FOR DOSING IN ADOPTIVE CELL THERAPY	JUNO THERAPEUTICS INC
EP3209696	METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF GLIOBLASTOMA	BIONTECH RNA PHARMACEUTICALS GMBH
EP3210965	PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL	GRUENENTHAL GMBH
EP3211005	THERAPEUTIC USE OF SPECIFIC LIGAND IN MSRV ASSOCIATED DISEASES	GENEURO SA
EP3211007	PHARMACEUTICAL COMPOSITION FOR TREATING CROHN'S DISEASE	EISAI R&D MAN CO LTD
EP3211085	ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR	UNIV PENNSYLVANIA
EP3211086	METHODS AND COMPOSITION TO GENERATE UNIQUE SEQUENCE DNA PROBES, LABELING OF DNA PROBES AND THE USE OF THESE PROBES	JANSSEN DIAGNOSTICS LLC
EP3211991	LETTUCE PLANTS COMPRISING RESISTANCE AGAINST NASONOVIA RIBISNIGRI BIOTYPE 1	NUNHEMS BV
EP3212218	GIP AGONIST COMPOUNDS AND METHODS	ZEALAND PHARMA AS
EP3212230	DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES	SEATTLE GENETICS INC
EP3212600	PRODUCTION OF SHORT CHAIN PERFLUOROALKYL IODIDES FROM HIGHER ORDER TELOMERS	CHEMOURS CO FC LLC
EP3212634	COMPOUNDS AND METHODS TO SUPPRESS AUTOIMMUNE RESPONSE	UNIV OREGON STATE
EP3212650	ADMINISTRATION OF UBIQUITIN-ACTIVATING ENZYME INHIBITOR AND CHEMOTHERAPEUTIC AGENTS	MILLENNIUM PHARM INC
EP3212651	ADMINISTRATION OF UBIQUITIN-ACTIVATING ENZYME INHIBITOR AND RADIATION	MILLENNIUM PHARM INC
EP3212666	HUMAN MONOCLONAL ANTIBODY SPECIFIC FOR THE F PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS (RSV)	ARIDIS PHARMACEUTICALS INC
EP3212702	PLASTICIZER COMPOSITIONS AND METHODS FOR MAKING PLASTICIZER COMPOSITIONS	DOW GLOBAL TECHNOLOGIES LLC
EP3212773	EFFICIENT DELIVERY OF THERAPEUTIC MOLECULES TO CELLS OF THE INNER EAR	MASSACHUSETTS EYE & EAR INFIRMARY
EP3212794	POLYNUCLEOTIDE AGENTS TARGETING SERPINC1 (AT3) AND METHODS OF USE THEREOF	ALNYLAM PHARMACEUTICALS INC
EP3213770	IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE	IDERA PHARMACEUTICALS INC
EP3214073	NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME	HEESUNG MAT LTD
EP3214082	PROCESS FOR MANUFACTURING PYRIMIDINE SULFAMIDE DERIVATIVES	ACTELION PHARMACEUTICALS LTD
EP3215142	IMMUNOREGULATORY AGENTS	FLEXUS BIOSCIENCES INC
EP3215163	BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT	BIOTHERA INC
EP3215499	IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES	EMERGENT VIROLOGY LLC
EP3215517	ETHER FUNCTIONALIZED LIGNIN FOR FUEL PRODUCTION	REN FUEL K2B AB
EP3215518	BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP	BICYCLE THERAPEUTICS LTD
EP3215522	T CELL RECEPTORS DIRECTED AGAINST BOB1 AND USES THEREOF	LEIDEN UNIV MEDICAL CENTER
EP3215524	FC-REGION VARIANTS WITH MODIFIED FCRN- AND PROTEIN A-BINDING PROPERTIES	HOFFMANN LA ROCHE
EP3216783	SULFONATE COMPOUND, PHOTOACID GENERATOR, AND PHOTOLITHOGRAPHIC RESIN COMPOSITION	SAN-APRO LTD
EP3216797	DINUCLEAR PLATINUM-CARBENE COMPLEXES AND THE USE THEREOF IN OLEDS	UDC IRELAND LTD
EP3216871	RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN MICE	REGENERON PHARMA
EP3218009	PROCESS FOR THE CONJUGATION OF A PEPTIDE OR PROTEIN WITH A REAGENT COMPRISING A LEAVING GROUP INCLUDING A PORTION OF PEG	POLYTHERICS LTD
EP3218367	PROCESS FOR THE PURIFICATION OF THE AXL TYROSINE RECEPTOR KINASE INHIBITOR "R428"	BERGENBIO AS
EP3218380	CRYSTALLINE FORM OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE HYDROGEN SULFATE	ARRAY BIOPHARMA INC
EP3218386	MODULATORY POLYNUCLEOTIDES	VOYAGER THERAPEUTICS INC
EP3218397	NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE	US HEALTH
EP3218406	BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF	MEDIMMUNE LTD
EP3218493	DISRUPTION OF ROCK1 GENE LEADS TO PLANTS WITH IMPROVED TRAITS	SCHMüLLING THOMAS
EP3219702	METHOD FOR RESOLUTION OF CITALOPRAM INTERMEDIATE 5-CYANOGEN DIOL	ZHEJIANG HUAHAI PHARM CO LTD
EP3219712	COUMARIN DYES AND CONJUGATES THEREOF	CYANAGEN SRL
EP3220437	ORGANIC ELECTROLUMINESCENT ELEMENT	HODOGAYA CHEMICAL CO LTD
EP3221291	METHODS OF MANUFACTURING TREPROSTINIL AND TREPROSTINIL DERIVATIVE PRODRUGS	INSMED INC
EP3221295	MONOCARBOXYLATE TRANSPORT MODULATORS AND USES THEREOF	NIROGYONE THERAPEUTICS INC
EP3221321	FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE	AKARNA THERAPEUTICS LTD
EP3221358	CD47 ANTIBODIES, METHODS, AND USES	JANSSEN PHARMACEUTICA NV
EP3221361	ANTI-TRANSFERRIN RECEPTOR / ANTI-BACE1 MULTISPECIFIC ANTIBODIES AND METHODS OF USE	GENENTECH INC
EP3222733	POLYNUCLEOTIDE CAPTURE MATERIALS, AND METHODS OF USING SAME	HANDYLAB INC
EP3223807	METHOD OF PREVENTING OR TREATING A PULMONARY DISEASE OR CONDITION	UNIV ILLINOIS
EP3223845	HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS	XENCOR INC
EP3223869	GELATIN PURIFICATION	ROUSSELOT B V
EP3224238	NOVEL CYSTOBACTAMIDES	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
EP3224266	METAL COMPLEXES OF SUBSTITUTED CATECHOLATES AND REDOX FLOW BATTERIES CONTAINING THE SAME	LOCKHEED MARTIN ADVANCED ENERGY STORAGE LLC
EP3224267	PHOSPHINIC VANADIUM COMPLEX, CATALYTIC SYSTEM COMPRISING SAID PHOSPHINIC VANADIUM COMPLEX AND PROCESS FOR THE (CO) POLYMERIZATION OF CONJUGATED DIENES	VERSALIS SPA
EP3225610	METHOD FOR MANUFACTURING COMPOUND	SUMITOMO CHEMICAL CO
EP3225630	OVARIAN CLEAR CELL CARCINOMA TEST METHOD AND TEST AGENT	PUBLIC UNIV CORP YOKOHAMA CITY UNIV
EP3226888	ADMINISTRATION OF A SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR	FERRING BV
EP3226897	ANTIBODIES TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE	MEMORIAL SLOAN KETTERING CANCER CENTER
EP3227254	CATALYTIC OXIDATION OF BUT-3-ENE-1,2-DIOL	ADISSEO FRANCE SAS
EP3227257	PROCESS FOR THE MANUFACTURE OF CARBOXYLIC ANHYDRIDE	SOLVAY ACETOW GMBH
EP3227260	PROCESS FOR THE PREPARATION OF LEVULINIC ACID	PRAJ IND LTD
EP3227268	PROCESS FOR PRODUCTION OF 2,5-BIS-HYDROXYMETHYLFURAN, 2,5-BIS-HYDROXYMETHYLTETRAHYDROFURAN, 1,6-HEXANEDIOL AND 1,2,6-HEXANETRIOL FROM 5-HYDROXYMETHYLFURFURAL	RENNOVIA INC
EP3227272	BIFUNCTIONAL do2pa DERIVATIVES, CHELATES WITH METALLIC CATIONS AND USE THEREOF	CENTRE NAT DE LA RECH SCIENT (CNRS)
EP3227276	COMBINATIONS FOR THE TREATMENT OF NEUROBLASTOMA	IGNYTA INC
EP3227284	PESTICIDALLY ACTIVE AMIDE HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS	SYNGENTA PARTICIPATIONS AG
EP3227299	FORMULATION INHIBITING EFFECTS OF LOW ACID ENVIRONMENT	MERCK SHARP & DOHME
EP3227339	CHIMERIC ANTIGEN RECEPTORS TARGETING G-PROTEIN COUPLED RECEPTOR AND USES THEREOF	MEMORIAL SLOAN-KETTERING CANCER CENTER
EP3228310	METHYLGLYOXAL BIS(GUANYL-HYDRAZONE) FOR REGULATING OSTEOPONTIN IN A SUBJECT	PATHOLOGICA LLC
EP3228628	NOVEL DERMATOPHAGOIDES FARINAE PROTEIN	TAIHO PHARMACEUTICAL CO LTD
EP3230241	PROCESS FOR THE PREPARATION OF CIS-2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL	EASTMAN CHEM CO
EP3230294	ORGANOMETALLIC SOLUTION BASED HIGH RESOLUTION PATTERNING COMPOSITIONS AND CORRESPONDING METHODS	INPRIA CORPORTION
EP3230298	3-SUBSTITUTED 5-AMINO-6H-THIAZOLO[4,5-D]PYRIMIDINE-2,7-DIONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION	HOFFMANN LA ROCHE
EP3230300	INHIBITORS FOR INHIBITING TUMOR METASTASIS	FORSCHUNGSVERBUND BERLIN EV
EP3230400	NEW PHOTOCHROMIC COMPOUNDS AND INTERMEDIATE COMPOUNDS FOR PRODUCTION THEREOF	KAUNAS UNIV OF TECH
EP3230461	LENTIVIRAL VECTOR-BASED JAPANESE ENCEPHALITIS IMMUNOGENIC COMPOSITION	PASTEUR INSTITUT
EP3230745	PLASMA AUTOANTIBODY BIOMARKERS FOR BASAL LIKE BREAST CANCER	UNIV ARIZONA STATE
EP3231791	HYDROXYSULTAINE- AND SULFOBETAINE-BASED GEMINAL ZWITTERIONIC LIQUIDS, METHOD FOR OBTAINING SAME, AND USE THEREOF AS WETTABILITY MODIFIERS HAVING CORROSION INHIBITING PROPERTIES	INST MEXICANO DEL PETRóLEO
EP3231795	METHOD FOR PREPARING 2,5-DISUBSTITUTED FURAN COMPOUND	NINGBO INST MAT TECH & ENG CAS
EP3231804	COMPOUNDS AND COMPOSITIONS FOR THE DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS	MASSACHUSETTS GEN HOSPITAL
EP3232490	ORGANIC LIGHT EMITTING DIODE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER	NOVALED GMBH
EP3233068	A PROCESS FOR PREPARATION OF BIOAVAILABLE WHITE CURCUMIN - A UNIQUE BLEND OF HYDROGENATED CURCUMINOIDS	AUREA BIOLABS PRIVATE LTD
EP3233079	(S)-N-(3-(6-ISOPROPOXYPYRIDIN-3-YL)-1H-INDAZOL-5-YL)-1-(2-(4-(4-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3,6-DIHYDROPYRIDIN-1(2H)-YL)-2-OXOETHYL)-3-(METHYLTHIO)PYRROLIDINE-3-CARBOXAMIDE COMPOSITIONS FOR PHARMACEUTICAL PREPARATIONS	MERCK SHARP & DOHME
EP3233107	NBP158 AND USES THEREOF	ZHANG WENTAO
EP3233174	INTRAOCULAR DELIVERY OF BIOACTIVE MOLECULES USING IONTOPHORESIS	KEMIN IND INC
EP3233192	COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY	UNIV WASHINGTON
EP3233772	ISOPRENE EXTRACTION WITH PRESERVED C5 FEEDSTOCK	SABIC GLOBAL TECHNOLOGIES BV
EP3233784	FLUORINE COMPOUNDS	MERCK PATENT GMBH
EP3233799	DOPAMINE D2 RECEPTOR LIGANDS	BROAD INST INC
EP3233808	METHODS FOR MEASUREMENT OF INHIBITION OF C-JUN N-TERMINAL KINASE IN SKIN	SIGNAL PHARM LLC
EP3233809	FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE	SIGNAL PHARM LLC
EP3233824	(S)-N-(3-(6-ISOPROPOXYPYRIDIN-3-YL)-1H-INDAZOL-5-YL)-1-(2-(4-(4-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3,6-DIHYDROPYRIDIN-1(2H)-YL)-2-OXOETHYL)-3- (METHYLTHIO)PYRROLIDINE-3-CARBOXAMIDE COMPOSITIONS FOR PHARMACEUTICAL PREPARATIONS	MERCK SHARP & DOHME
EP3233845	PARG INHIBITORY COMPOUNDS	CANCER RES TECH LTD
EP3233866	PYRAZOLOPYRIDINAMINES AS MKNK1 AND MKNK2 INHIBITORS	BAYER PHARMA AG
EP3233884	MICROBIAL TRANSGLUTAMINASES, SUBSTRATES THEREFOR AND METHODS FOR THE USE THEREOF	HOFFMANN LA ROCHE
EP3233893	ENHANCED PROTEIN EXPRESSION	DANISCO US INC
EP3233895	ANTI-ARRHYTHMICITY AGENTS	UNIV CALIFORNIA
EP3233897	ANTI IL-34 ANTIBODIES	UNIV NANTES
EP3233907	RODENT BISPECIFIC HETERODIMERIC PROTEINS	GENMAB AS
EP3233912	ANTIBODIES THAT BIND HUMAN C6 AND USES THEREOF	REGENESANCE B V
EP3233921	ANTI-C5 ANTIBODIES AND METHODS OF USE	CHUGAI PHARMACEUTICAL CO LTD
EP3234602	METHODS FOR IDENTIFYING MULTIPLE EPITOPES IN SELECTED SUB-POPULATIONS OF CELLS	APPRISE BIO INC
EP3234607	SANDWICH ASSAY DESIGN FOR SMALL MOLECULES	SIEMENS HEALTHCARE DIAGNOSTICS INC
EP3235827	AAV VIRONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR	GENZYME CORP
EP3237372	METHOD FOR PRODUCING OMEGA-HYDROXY FATTY ACID ESTER AND PRECURSOR COMPOUND THEREOF	KAO CORP
EP3237419	FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE	AKARNA THERAPEUTICS LTD
EP3237446	ANTI-PD-1 ANTIBODIES	ENUMERAL BIOMEDICAL HOLDINGS INC
EP3237450	ANTI-MERTK AGONISTIC ANTIBODIES AND USES THEREOF	UNIV ROCKEFELLER
EP3237622	METHODS FOR WOUND HEALING	ILYA PHARMA AB
EP3239130	CLEAN PROCESS FOR PREPARING CHLOROFORMYL SUBSTITUTED BENZENE	SHANGHAI FANGLUN NEW MAT TECH CO LTD
EP3239157	NOVEL GROUP 4 TRANSITION METAL COMPOUND AND USE THEREOF	HANWHA CHEMICAL CORP
EP3239167	CONOTOXIN PEPTIDE KAPPA-CPTX-BTL01, PREPARATION METHOD THEREFOR, AND USES THEREOF	BGI SHENZHEN
EP3239168	CONOTOXIN PEPTIDE -CPTX-BTL02, PREPARATION METHOD THEREFOR, AND USES THEREOF	BGI SHENZHEN
EP3239176	ANTI-ACTIVE GIP ANTIBODY	KAO CORP
EP3239177	NOVEL EGFRVIII ANTIBODY AND COMPOSITION COMPRISING SAME	PHARMABCINE INC
EP3240781	PROCESS FOR MANUFACTURING ETHYLENE OXIDE USING SCALED SELECTIVITY VALUES	DOW TECHNOLOGY INVESTMENTS LLC
EP3240799	S-ALKYLATED HEPCIDIN PEPTIDES AND METHODS OF MAKING AND USING THEREOF	UNIV CALIFORNIA
EP3240801	COMBINATION TUMOR IMMUNOTHERAPY	CHECKMATE PHARMACEUTICALS INC
EP3240802	GLUCAGON DERIVATIVES	HANMI PHARM IND CO LTD
EP3240803	METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS	NOVARTIS AG
EP3240817	REDUCTION OF ALDEHYDES IN AMINE CATALYSTS	HUNTSMAN PETROCHEMICAL LLC
EP3241435	ANIMAL MODELS AND THERAPEUTIC MOLECULES	KYMAB LTD
EP3241824	TRIFLUOROACETHYDRAZIDE COMPOUND AS WELL AS PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PREPARING MEDICAMENT	GUANGZHOU MAGPIE PHARMACEUTICALS CO LTD
EP3241843	SOLUBILITY OPTIMIZATION OF IMMUNOBINDERS	ESBATECH ALCON BIOMED RES UNIT
EP3241844	ANTIBODY AGAINST NEUROPILIN 1 AND USE THEREOF	SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
EP3241915	COMPOSITIONS AND METHODS FOR DETECTING WEST NILE VIRUS	GEN-PROBE INCORPORATED
EP3242865	METHOD OF PREPARING ESTERS OF LACTIC AND LACTYLATIC ACID IN ALCOHOLYSIS REACTION OF ALIPHATIC POLYESTER	WROCLAWSKIE CENTRUM BADAN EIT+ SP Z O O
EP3242891	MONOMERIC FC DOMAINS	INNATE PHARMA
EP3242964	ELECTROCHEMICAL AND PHOTOELECTROCHEMICAL OXIDATION OF 5-HYDROXYMETHYLFURFURAL TO 2,5-FURANDICARBOXYLIC ACID AND 2,5-DIFORMYLFURAN	WISCONSIN ALUMNI RES FOUND
EP3243818	POLYMERS OF BENZODITHIOPHENE AND THEIR USE AS ORGANIC SEMICONDUCTORS	MERCK PATENT GMBH
EP3243846	MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR THE PREPARATION OF BLOCK COPOLYMERS	DOW GLOBAL TECHNOLOGIES LLC
EP3244886	INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS	JANSSEN PHARMACEUTICALS INC
EP3245188	SYNTHESIS OF CARBAMATE OR UREA COMPOUNDS	NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO
EP3245195	PREPARATION OF FURFURAL USING MIXED SOLVENTS	BASF SE
EP3245200	2-(PYRAZIN-2-YLCARBONYLAMINOMETHYL)BENZIMIDAZOLIUM COMPOUNDS AS EPITHELIAL SODIUM CHANNEL INHIBITORS	BOEHRINGER INGELHEIM INT
EP3245225	COMPOSITIONS AND METHODS FOR TREATMENT AND DETECTION OF CANCERS
EP3245232	HETERODIMERIC CAS9 AND METHODS OF USE THEREOF	UNIV CALIFORNIA
EP3246301	BUTADIENE PRODUCTION SYSTEM AND BUTADIENE PRODUCTION METHOD	SEKISUI CHEMICAL CO LTD
EP3246315	CAPROLACTAM PREPARATION METHOD	HUBEI JINXIANGNING CHEMICAL ENG TECHENOLOGY CO LTD
EP3246337	TRANSGENIC PLANT HAVING THE PROPERTY OF AN ENHANCED SEED YIELD AND INCREASED GROWTH	TECHNISCHE UNIVERSITÄT KAISERSLAUTERN
EP3246395	COMPOUND FOR IDENTIFYING PLURIPOTENT CELLS	UNIV KYOTO
EP3247360	HETEROCYCLIC INHIBITORS OF MONOCARBOXYLATE TRANSPORTERS	SCRIPPS RESEARCH INST
EP3247701	ANTHELMINTIC COMPOUNDS, COMPOSITIONS AND METHOD OF USING THEREOF	MERIAL INC
EP3247718	MODULATION OF CHARGE VARIANTS IN A MONOCLONAL ANTIBODY COMPOSITION	ONCOBIOLOGICS INC
EP3248613	BETA-GLUCURONIDE DRUG LINKER CONJUGATES	SEATTLE GENETICS INC
EP3249029	HIGHLY BORATED DISPERSANT CONCENTRATES FOR LUBRICATING OIL COMPOSITIONS AND METHODS FOR FORMING SAME	INFINEUM INT LTD
EP3250211	NOVEL PROCESS FOR PREPARATION OF GLUCOCORTICOID STEROIDS	CORAL DRUGS PVT LTD
EP3250237	HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY	SUTRO BIOPHARMA INC
EP3250555	PROCESS FOR THE PRODUCTION OF CONDENSED IMIDAZOLO DERIVATIVES	NOVARTIS AG
EP3250564	DESIGN SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXIMER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY	UNIV MARYLAND
EP3250581	ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS	GALECTO BIOTECH AB
EP3250583	EXPRESSION OF KLEBSIELLA OXYTOCA POLYPEPTIDES INVOLVED IN LYSINE DECARBOXYLATION, AND METHODS AND APPLICATIONS THEREOF	CATHAY R&D CENTER CO LTD
EP3250584	MULTI-EPITOPIC CONSTRUCT	THROMBOSIS RES INST
EP3250586	NOVEL PROTEINS SPECIFIC FOR ANGIOGENESIS	PIERIS PHARMACEUTICALS GMBH
EP3250590	COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY
EP3250594	ANTI-TRANSTHYRETIN ANTIBODIES	PROTHENA BIOSCIENCES LTD
EP3250599	BIOMARKER	UNIV OXFORD INNOVATION LTD
EP3250604	mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLS	CELLECTIS
EP3250611	CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL 13R 2	UNIV CHICAGO
EP3250716	MICROSCOPE-FREE IMAGING	HARVARD COLLEGE
EP3251678	BENZOXABOROLE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS	ANACOR PHARMACEUTICALS INC
EP3252051	COMPOUND AND PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME	SAMSUNG ELECTRONICS CO LTD
EP3252052	PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT	TORAY INDUSTRIES
EP3252053	POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF HIV INFECTIONS	GILEAD SCIENCES INC
EP3252064	METALLOCENE COMPOUND	LG CHEMICAL LTD
EP3253210	2-(HET)ARYL-SUBSTITUTED CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PEST CONTROL AGENTS	BAYER CROPSCIENCE AG
EP3253382	PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY	INTERCEPT PHARMACEUTICALS INC
EP3253735	LATENT ACIDS AND THEIR USE	BASF SE
EP3253754	2-PHENYL-3H-IMIDAZO[4,5-B]PYRIDINE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN TYROSINE KINASE ROR1 ACTIVITY	KANCERA AB
EP3253764	MACROCYCLIC COMPOUNDS AS IRAK1/4 INHIBITORS AND USES THEREOF	MERCK PATENT GMBH
EP3253781	MODIFIED DKK2 PROTEIN, NUCLEIC ACID ENCODING THE SAME, PREPARATION METHOD THEREOF, AND USE THEREOF	MEDPACTO INC
EP3253783	SIGNALLING SYSTEM	UCL BUSINESS PLC
EP3253800	PROSTATE ANTIGEN STANDARDS AND USES THEREOF	OPKO DIAGNOSTICS LLC
EP3254755	HIGH DEGREE OF CONDENSATION TITANIUM-BASED INORGANIC-ORGANIC HYBRID SOLID MATERIAL, METHOD FOR PREPARING SAME AND USES THEREOF	CENTRE NAT RECH SCIENT
EP3255058	PROTEIN HAVING AFFINITY TO IMMUNOGLOBULIN, AND AFFINITY SEPARATION MEDIUM AND COLUMN FOR LIQUID CHROMATOGRAPHY USING SAME	MITSUBISHI CHEM CORP
EP3255061	SELECTIVE IMMUNODEPLETION OF ENDOGENOUS STEM CELL NICHE FOR ENGRAFTMENT	UNIV LELAND STANFORD JUNIOR
EP3256144	PEPTIDE INHIBITION OF CCR3-MEDIATED DISEASES OR CONDITIONS	UNIV ILLINOIS
EP3256451	IMIDAZOLYL TRICYCLIC ENONES AS ANTIOXIDANT IFLAMMATION MODULATORS	REATA PHARMACEUTICALS INC
EP3256484	NON-MEMBRANE DISRUPTIVE p53 ACTIVATING STAPLED PEPTIDES	AGENCY SCIENCE TECH & RES
EP3258960	LEPTOSPIRA IMMUNOPROTECTIVE PROTEINS AND METHODS OF IDENTIFICATION AND USE THEREOF	MERIAL INC
EP3258970	PROCESS FOR THE PURIFICATION OF GA-68 FROM ELUATE DERIVING FROM 68GE/ 68GA GENERATORS AND CHROMATOGRAPHIC COLUMNS FOR USE IN SAID PROCESS	ADVANCED ACCELERATOR APPLICATIONS INT S A
EP3259271	FLUORINATED TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID DERIVATIVES AND USES THEREOF	SCIFLUOR LIFE SCIENCES INC
EP3259278	PROCESSES FOR PREPARING FUNCTIONALIZED F-POSS MONOMERS	NBD NANOTECHNOLOGIES INC
EP3259283	HYBRID PROTEIN FOR THE IDENTIFICATION OF NEDDYLATED SUBSTRATES	SANTONICO ELENA
EP3260140	METHODS AND PRODUCTS FOR TRANSFECTING CELLS	FACTOR BIOSCIENCE INC
EP3260441	METHOD FOR PREPARING FORMAMIDE COMPOUND	SHANGHAI GREENCARBON HI-TECH CO LTD
EP3260460	LIGAND COMPOUND, ORGANIC CHROME COMPOUND, CATALYST SYSTEM FOR OLEFIN OLIGOMERIZATION, AND METHOD FOR OLEFIN OLIGOMERIZATION USING SAME	LG CHEMICAL LTD
EP3261741	CPC DISTRIBUTION CHROMATOGRAPHY OF CANNABINOIDS	BIONORICA ETHICS GMBH
EP3262021	TREATMENT METHOD, COMPOUNDS, AND METHOD OF INCREASING TRPV2 ACTIVITY	FEINSTEIN INST MEDICAL RES
EP3262047	IMIDAZOPYRIMIDINE AND IMIDAZOTRIAZINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME	SK BIOPHARMACEUTICALS CO LTD
EP3262063	IMMUNOTHERAPEUTIC TARGETING OF PLACENTAL-LIKE CHONDROITIN SULFATE USING CHIMERIC ANTIGEN RECEPTORS (CARS) AND IMMUNOTHERAPEUTIC TARGETING OF CANCER USING CARS WITH SPLIT-PROTEIN BINDING SYSTEMS	VAR2 PHARMACEUTICALS APS
EP3263568	BENZAMIDES	MERCK PATENT GMBH
EP3263572	METHOD FOR PRODUCING KAKEROMYCIN AND DERIVATIVES THEREOF	SEED RES INSTITUTE CO LTD
EP3263578	METHOD FOR PREPARING FRUCTOSE OR XYLULOSE FROM BIOMASS CONTAINING GLUCOSE OR XYLOSE USING BUTANOL, AND METHOD FOR SEPARATING THE SAME	KOREA RES INST CHEMICAL TECH
EP3263601	COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER	BRISTOL MYERS SQUIBB CO
EP3265073	DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION AND METHODS OF USE THEREOF	SHUTTLE PHARMACEUTICALS LLC
EP3265475	Constitutive yeast LLP promoter-based expression system	SANDOZ AG
EP3265480	SYSTEM FOR PRESENTING PEPTIDES ON THE CELL SURFACE	PETER UND TRAUDL ENGELHORN-STIFTUNG ZUR FÖRDERUNG DER LEBENSWISSENSCHAFTEN
EP3265560	HOMOLOGOUS RECOMBINATION FACTORS	SINAI HEALTH SYS
EP3265570	RETROVIRAL AND LENTIVIRAL VECTORS	UCL BUSINESS PLC
EP3265575	CD20 BINDING MOLECULES AND USES THEREOF	IGM BIOSCIENCES INC
EP3266767	METHOD FOR PREPARING AN ANTIFIBROTIC AGENT	DIPHARMA FRANCIS SRL
EP3266775	METHOD FOR PRODUCING 1,2,4-OXADIAZOLE DERIVATIVE	ASAHI GLASS CO LTD
EP3266791	LABELLED NUCLEOTIDES	ILLUMINA CAMBRIDGE LTD
EP3268038	ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO FLT3 PROTEINS	AGENSYS INC
EP3268050	PORE-FORMING PROTEIN CONJUGATE COMPOSITIONS AND METHODS	UNIV COLUMBIA
EP3268052	PREPARATIONS OF META-IODOBENZYLGUANDINE AND PRECURSORS THEREOF	MOLECULAR INSIGHT PHARM INC
EP3268338	CATALYST AGGLOMERATION REMEDIATION	FINA TECHNOLOGY
EP3268341	BUBBLE COLUMN REACTOR BASED DIGESTER ANDMETHOD FOR ITS USE	GRUPO PETROTEMEX SA DE CV
EP3268346	PROCESSES FOR THE PREPARATION OF UNSATURATED MALONATES	INT FLAVORS & FRAGRANCES INC
EP3268348	PROCESS FOR MAKING MIXTURES OF ENANTIOMERS, AND MIXTURES OF ENANTIOMERS	BASF SE
EP3268356	HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR USE	NOVARTIS AG
EP3268362	SUBSTITUTED PYRIDINES AND USES THEREOF	PELOTON THERAPEUTICS INC
EP3268371	METHOD OF MANUFACTURING STEREOISOMERS OF BUPRENORPHINE AND ANALOGUES THEREOF	SIEGFRIED AG
EP3268382	MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE	US HEALTH
EP3268383	CYCLIC GALANIN-ANALOGS AND USES THEREOF	LANTHIOPEP BV
EP3268384	PROCESS FOR PREPARING RECOMBINANT INSULIN USING MICROFILTRATION	MERCK SHARP & DOHME
EP3268386	FUSION PROTEIN COMPRISING A LIGAND BINDING DOMAIN OF VEGF AND PDGF
EP3269697	PROCESS FOR PRODUCING CONJUGATED DIENE	MITSUBISHI CHEM CORP
EP3269698	PROCESS FOR THE MANUFACTURE OF FLUORINATED OLEFINS	HONEYWELL INT INC
EP3269703	METHOD OF ISOMERIZING DIAMINODICYCLOHEXYLMETHANE	MITSUBISHI GAS CHEMICAL CO
EP3269704	METHOD OF ISOMERIZING 1,3,3-TRIMETHYL-1-(AMINOMETHYL)AMINOCYCLOHEXANE	MITSUBISHI GAS CHEMICAL CO
EP3269781	CURED-FILM-FORMING COMPOSITION, ALIGNMENT MATERIAL, AND PHASE DIFFERENCE MATERIAL	NISSAN CHEMICAL IND LTD
EP3270926	TRIAZOLYL PYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS	MERCK SHARP & DOHME
EP3270950	ISOLATED PEPTIDES AND FRAGMENTS THEREOF FROM FIBRINOGEN FOR USE AS DRUGS, PARTICULARLY IN SKIN INFLAMMATORY DISEASES	UNIV PARIS DESCARTES
EP3271323	PHOTOINITIATORS THAT ARE POLYMERIC OR POLYMERIZABLE FOR USE IN UV CURABLE PRESSURE SENSITIVE ADHESIVES	HENKEL IP & HOLDING GMBH
EP3271329	NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF	HANGZHOU DAC BIOTECH CO LTD
EP3271339	AMINO ACID ACYLATION REAGENTS AND METHODS OF USING THE SAME	REGENERON PHARMA
EP3271342	METHOD FOR MANUFACTURING FURAN-2,5-DICARBOXYLIC ACID (FDCA) FROM A SALT SOLUTION	PURAC BIOCHEM BV
EP3271346	ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME	UNIV NEVADA RENO
EP3271369	METHOD FOR PRODUCING D-GALACTURONIC ACID DERIVATIVES AND COMPOSITIONS DIRECTLY FROM PECTINS	éCOLE NAT SUPéRIEURE DE CHIMIE
EP3271375	CLOSTRIDIUM DIFFICILE TOXINS A AND/OR B ANTIGEN AND EPITOPE ANTIBODY, AND PHARMACEUTICAL USES THEREOF	IMMUNE BIOSOLUTIONS INC
EP3271380	PURIFICATION OF BONE MORPHOGENETIC PROTEINS (BMPS)	ST BIOCHIMICO ITALIANO GIOVANNI LORENZINI S P A
EP3271381	AMYLIN ANALOGUES	ZEALAND PHARMA AS
EP3271392	AGENTS FOR USE IN THE THERAPEUTIC OR PROPHYLACTIC TREATMENT OF MYOPIA OR HYPEROPIA	JONAS SHEFALI BRINDA
EP3271397	NOVEL MONOCLONAL ANTIBODY INHIBITORS TARGETING POTASSIUM CHANNEL KCNK9	UNIV JOHNS HOPKINS
EP3271402	ANTIBODIES TOWARDS AN EXTRACELLULAR REGION OF NBCN1	UNIV AARHUS
EP3273983	NOVEL CYTOTOXIC AGENTS THAT PREFERENTIALLY TARGET LEUKEMIA INHIBITORY FACTOR (LIF) FOR THE TREATMENT OF MALIGNANCIES AND AS NEW CONTRACEPTIVE AGENTS	EVESTRA INC
EP3273991	ANTI-CD89 CYTOTOXIC COMPLEX	FRAUNHOFER GES FORSCHUNG
EP3273994	CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS	UNIV SOUTHERN CALIFORNIA
EP3274327	POLYOL ESTERS OF METATHESIZED FATTY ACIDS AND USES THEREOF	ELEVANCE RENEWABLE SCIENCES
EP3274353	BISPHENOLATE TRANSITION METAL COMPLEXES, PRODUCTION AND USE THEREOF	EXXONMOBIL CHEMICAL PATENTS INC
EP3274364	ENGINEERED BOTULINUM NEUROTOXIN	HARVARD COLLEGE
EP3275855	METHODS FOR PRODUCING 2,6-DIMETHYL-1,5-HEPTADIEN-3-OL AND 2,6-DIMETHYL-1,5-HEPTADIEN-3-YL ACETATE	SHIN ETSU CHEMICAL CO LTD
EP3275868	METHOD FOR PRODUCING PYRAZOLE DERIVATIVE	ASAHI GLASS CO LTD
EP3275872	NEW TRIAZINE COMPOUNDS AS PHOTOSTABILISING AGENTS	3V SIGMA SPA
EP3275895	NEUROPILIN-1 SPECIFIC BINDING PEPTIDE, FUSION PROTEIN FUSED WITH SAME, AND USE THEREOF	AJOU UNIV INDUSTRY-ACADEMIC COOPERATION FOUNDATION
EP3275896	PROCESS FOR OBTAINING ANTIBODIES	UCB BIOPHARMA SPRL
EP3275968	ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	INDUSTRY-ACADEMIC COOPERATION FOUNDATION DANKOOK UNIV
EP3277270	COMPOSITIONS AND METHODS FOR TREATING ANEMIA	AKEBIA THERAPEUTICS INC
EP3277277	HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS	MUTABILIS
EP3277297	METHODS AND COMPOSITIONS FOR STIMULATION OF CELL PROLIFERATION AND PROVISION OF BIOLOGICALLY ACTIVE MIXTURES OF FGF2 ISOFORMS	SANBIO INC
EP3277305	ANTIGEN BINDING MOLECULES COMPRISING A TRIMERIC TNF FAMILY LIGAND	HOFFMANN LA ROCHE
EP3277625	METHOD FOR RECOVERING HCl FROM A HCl CONTAINING GAS STREAM	AKZO NOBEL CHEMICALS INT BV
EP3277677	1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS	MISSION THERAPEUTICS LTD
EP3277685	HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS	MUTABILIS
EP3277698	SI-CONTAINING FILM FORMING COMPOSITIONS AND METHODS OF USING THE SAME	L'AIR LIQUIDE SOCIéTé ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCéDéS GEORGES CLAUDE
EP3277718	DOSAGE REGIMEN FOR ANTI-MIF ANTIBODIES	BAXALTA GMBH
EP3277722	ANTIBODIES TO CANINE INTERLEUKIN-4 RECEPTOR ALPHA	INTERVET INT BV
EP3277727	TNFRSF14/ HVEM PROTEINS AND METHODS OF USE THEREOF	MEMORIAL SLOAN-KETTERING CANCER CENTER
EP3277832	MONOAZO DYES WITH CYCLIC AMINE AS FLUORESCENCE QUENCHERS	ENZO BIOCHEM INC
EP3279181	MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD FOR PRODUCING SAME	ZEON CORP
EP3279663	USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES	THE BRIGHAM AND WOMEN'S HOSPITAL INC
EP3279727	COMPOUND, RESIST COMPOSITION, AND METHOD FOR FORMING RESIST PATTERN IN WHICH SAME IS USED	MITSUBISHI GAS CHEMICAL CO
EP3280404	METHODS FOR SELECTING PHOSPHATASE SELECTIVE AND NON-SELECTIVE PHOSPHATASE INHIBITORS	MEDICAL RES COUNCIL
EP3280405	INHIBITORS AND THEIR USES	MEDICAL RES COUNCIL
EP3280694	MODIFIED MICROORGANISM FOR THE OPTIMIZED PRODUCTION OF 2,4-DIHYDROXYBURYRATE	METABOLIC EXPLORER SA
EP3280708	SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF	ARAXES PHARMA LLC
EP3280723	BACKBONE-CYCLIZED PEPTIDOMIMETICS	POLYPHOR AG
EP3281521	HUMANIZED IL-4 AND IL-4R ALPHA ANIMALS	REGENERON PHARMA
EP3281975	RESIN COMPOSITION COMPRISING PLASTICIZER COMPOSITION, AND PREPARATION METHOD THEREFOR	LG CHEMICAL LTD
EP3281976	PLASTICIZER COMPOSITION, RESIN COMPOSITION, AND PREPARATION METHODS THEREFOR	LG CHEMICAL LTD
EP3283077	BROMODOMAIN INHIBITORS	CELGENE QUANTICEL RES INC
EP3283106	THERAPEUTIC ANTIBODIES AND THEIR USES	PFIZER
EP3283171	DERIVATIVES OF AMPHOTERICIN B	REVOLUTION MEDICINES INC
EP3283456	A PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS OR ESTERS	LUCITE INT UK LTD
EP3283463	DIMERIC QUINACRINE DERIVATIVES AS AUTOPHAGY INHIBITORS FOR CANCER THERAPY	UNIV PENNSYLVANIA
EP3283465	CRYSTALLINE FGFR4 INHIBITOR COMPOUND AND USES THEREOF	EISAI R&D MAN CO LTD
EP3283471	METHOD OF PRODUCING FURAN CARBOXYLATES FROM ALDARIC ACIDS BY USING SOLID HETEROGENEOUS CATALYSTS	TEKNOLOGIAN TUTKIMUSKESKUS VTT OY
EP3283472	HEPATITIS B VIRAL ASSEMBLY EFFECTORS	UNIV INDIANA RES & TECH CORP
EP3283484	QUINOLINE DERIVATIVES AS INHIBITORS OF HEAT SHOCK FACTOR 1 PATHWAY ACTIVITY	CANCER RESEARCH TECH LTD
EP3283508	IMMUNOMODULATORY PROTEINS WITH TUNABLE AFFINITIES	ALPINE IMMUNE SCIENCES INC
EP3283527	COMBINATION THERAPY FOR CANCER	FIVE PRIME THERAPEUTICS INC
EP3283528	ANTI-VEGFR2 HUMAN ANTIBODY FOR ANTI-ANGIOGENIC AND TARGETED CANCER THERAPY
EP3284734	METHOD FOR PRODUCING 2-HALOGENATED BENZOIC ACIDS	SUMITOMO SEIKA CHEMICALS
EP3284736	FLUORINATION OF AROMATIC RING SYSTEMS	NUTECH VENTURES
EP3284756	GENERATION AND PROFILING OF FULLY HUMAN HUCAL GOLD-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38	MORPHOSYS AG
EP3285071	BIOMARKER COMPOSITION FOR DIAGNOSING STILL'S DISEASE, DIAGNOSTIC KIT, AND DIAGNOSTIC METHOD	AJOU UNIV INDUSTRY-ACADEMIC COOPERATION FOUNDATION
EP3285757	SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF	GTX INC
EP3285805	THERAPEUTIC ANTIBODIES AND USES THEREOF	MINOMIC INT LTD
EP3286165	METHOD AND SYSTEM FOR THE INTEGRATED PRODUCTION OF UREA AND MELAMINE	STAMICARBON
EP3286171	METHODS FOR HYDRAULIC ENHANCEMENT OF CROPS	ASILOMAR BIO INC
EP3286198	COMPOUNDS FOR TREATING PRURITIC CONDITIONS	TREVI THERAPEUTICS INC
EP3286206	NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS FOR TREATING MUSCLE WASTING DISEASES	ALIVEGEN USA INC
EP3286212	POLYPEPTIDES TARGETING HIV FUSION	VIIV HEALTHCARE UK (NO 5) LTD
EP3286213	METHODS AND COMPOSITIONS FOR COMBINATION IMMUNOTHERAPY	ETUBICS CORP
EP3286315	METHODS OF IDENTIFYING BACTERIA COMPRISING BINDING POLYPEPTIDES	GENENTECH INC
EP3287142	METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION	UNIV LEICESTER
EP3287436	COMPOSITIONS FOR USE IN THE TREATMENT OF BCAT1-MEDIATED DISEASES	ERGON PHARMACEUTICALS LLC
EP3287460	HEMISULFATE SALT OF 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID	MERCK & CIE
EP3287505	COMPOUND FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE	SAMSUNG SDI CO LTD
EP3288577	ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS	ALLYSTA PHARMACEUTICALS INC
EP3288582	NUCLEIC ACID CONSTRUCT	UCL BUSINESS PLC
EP3288590	MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS AND USES THEREOF	UNIV MICHIGAN REGENTS
EP3288917	PROCESS FOR ALDEHYDE MANUFACTURE	JOHNSON MATTHEY PLC
EP3288922	CATALYTIC HYDROGENATION OF SUBSTITUTED CYANOPYRIDINES AND PROCESS FOR PREPARING SUBSTITUTED PYRIDYLMETHYLBENZAMIDES	BAYER CROPSCIENCE AG
EP3288925	REAGENTS AND METHODS FOR BIOORTHOGONAL LABELING OF BIOMOLECULES IN LIVING CELLS	UNIV OREGON STATE
EP3288926	N-ARALKYLCARBONYL-PIPERAZINE AND -HOMOPIPERAZINE COMPOUNDS AND PERSONAL CARE COMPOSITIONS COMPRISING THE SAME	UNILEVER PLC
EP3288928	BUTYROLACTONES AS HERBICIDES	DU PONT
EP3288930	METHOD AND DEVICE FOR MANUFACTURING LACTIDE	PURAC BIOCHEM BV
EP3288933	OXINDOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF	MUSC FOUND FOR RES DEV
EP3288942	RSV ANTIVIRAL PYRAZOLO- AND TRIAZOLO-PYRIMIDINE COMPOUNDS	JANSSEN SCIENCES IRELAND UC
EP3288953	BIS(AMINOPHENYLPHENOL) LIGANDS AND TRANSITION METAL COMPOUNDS PREPARED THEREFROM	UNIVATION TECH LLC
EP3288960	SHORT SYNTHETIC PEPTIDE FOR TREATMENT AND/OR PROPHYLAXIS OF AUTOIMMUNE AND INFLAMMATORY DISORDERS
EP3288973	METHOD FOR MASS HUMANIZATION OF RABBIT ANTIBODIES	ABCHECK S R O
EP3288977	METHODS OF MEDIATING CYTOKINE EXPRESSION WITH ANTI CCR4 ANTIBODIES	DANA FARBER CANCER INST INC
EP3288979	IGF-1R ANTIBODY AND ITS USE FOR THE DIAGNOSIS OF CANCER	PIERRE FABRE MéDICAMENT
EP3288980	TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY	BRISTOL MYERS SQUIBB CO
EP3289087	METHODS AND COMPOSITIONS FOR PRODUCING BRACHYTIC CORN PLANTS	MONSANTO TECHNOLOGY LLC
EP3290423	OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF	JIANGSU VCARE PHARMATECH CO LTD
EP3290426	2-CYANOETHYL-CONTAINING ORGANOXYSILANE COMPOUND, SILSESQUIOXANE, AND MAKING METHODS	SHINETSU CHEMICAL CO
EP3290430	USE OF EXCESS CARBODIIMIDE FOR PEPTIDE SYNTHESIS AT ELEVATED TEMPERATURES	CEM CORP
EP3291830	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS	IMMATICS BIOTECHNOLOGIES GMBH
EP3291841	ONCOLYTIC HSV1 VECTOR AND METHODS OF USE	BRIGHAM & WOMENS HOSPITAL INC
EP3292098	VERY LOW WATER HEAT TRANSFER FLUID WITH REDUCED LOW TEMPERATURE VISCOSITY	EVANS COOLING SYSTEMS INC
EP3292102	ISOINDOLINONES, PROCESSES FOR THE PRODUCTION OF CHIRAL DERIVATIVES THEREOF AND USE THEREOF	UNIVERSITá DEGLI STUDI DI SALERNO
EP3292106	PROCESS FOR THE PREPARATION OF AMPHIPHILIC IMIDAZOLINIUM COMPOUNDS	BAYER ANIMAL HEALTH GMBH
EP3292136	PENICILLIN-G ACYLASES	CODEXIS INC
EP3292138	PRODUCTION OF LARGE-SIZED MICRODYSTROPHINS IN AN AAV-BASED VECTOR CONFIGURATION	ROYAL HOLLOWAY & BEDFORD NEW COLLEGE
EP3292149	ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS OF USE THEREOF	CYTOMX THERAPEUTICS INC
EP3292869	KAL1 PROTEIN CONTROLLING CELL CYCLE OF HEMATOPOIETIC STEM CELL, AND USE THEREOF	SEOUL NAT UNIV R&DB FOUNDATION
EP3293173	METHOD FOR PRODUCING ISOCYANATE	ASAHI CHEMICAL IND
EP3293175	METHODS FOR PURIFICATION OF SERINE PROTEASES	PORTOLA PHARM INC
EP3293199	CHIMERIC ANTIGEN RECEPTORS	HEINRICH HEINE UNIV DUESSELDORF
EP3293202	ANTI HUMAN INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN (IL1RAP) ANTIBODIES AND USES THEREOF	CANTARGIA AB
EP3294125	DEVICE AND METHOD FOR DETECTING CREATININE AND ALBUMIN TO CREATININE RATIO	INDIAN INST SCIENT
EP3294705	EBNA1 INHIBITORS AND METHODS USING SAME	WISTAR INST
EP3294713	SUBSTITUTED TETRAHYDROQUINOLINONE COMPOUNDS AS ROR GAMMA MODULATORS	AURIGENE DISCOVERY TECH LTD
EP3294725	PROCESS FOR PREPARING 4-AMINO-PYRIDAZINES	BASF SE
EP3294727	ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER	NOVALED GMBH
EP3294735	INHIBITORS OF INFLUENZA VIRUSES REPLICATION	VERTEX PHARMA
EP3294738	MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS	JANSSEN PHARMACEUTICALS INC
EP3294746	NOVEL SUBSTITUTED AMINOTHIAZOLOPYRIMIDINEDIONE FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION	HOFFMANN LA ROCHE
EP3294747	RUTHENIUM COMPLEXES, METHOD OF PRODUCING THEM, AND THEIR USE	UNIV WARSZAWSKI
EP3294759	METHODS FOR INCREASING PLANT GROWTH AND YIELD BY USING AN ICTB SEQUENCE	BENSON HILL BIOSYSTEMS INC
EP3294760	BACTERIA ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA	SYNLOGIC INC
EP3294769	TREATMENT FOR MULTIPLE MYELOMA (MM)	MORPHOSYS AG
EP3294775	MULTIMERIC PROTEIN PURITY DETERMINATION	REGENERON PHARMA
EP3294900	ALBUMIN-BASED NON-COVALENT COMPLEXES AND METHODS OF USE THEREOF	SPECTRAL PLATFORMS INC
EP3295962	TETRAPYRROLES CONJUGATES AS MRI CONTRAST AGENT	NANO4IMAGING GMBH
EP3296283	ETHERS OF BIS(HYDROXYMETHYL)CYCLOHEXANES	BASF SE
EP3296312	SYNTHESIS OF PROTECTED 3'-AMINO 5'-PHOSPHORAMIDITE NUCLEOSIDE MONOMERS	GERON CORP
EP3296319	METHODS FOR TREATING COLORECTAL CANCER	CENTRE NAT RECH SCIENT
EP3297661	METHOD OF IMPROVING CHARACTERISTICS OF PROTEINS	FULL SPECTRUM GENETICS INC
EP3297672	TRISPECIFIC BINDING PROTEINS AND METHODS OF USE	HARPOON THERAPEUTICS INC
EP3297678	AN IMPROVED PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF	LAURUS LABS PRIVATE LTD
EP3298004	COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF	BIOTHERYX INC
EP3298011	QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS	PRINCIPIA BIOPHARMA INC
EP3298027	ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS	MERIAL INC
EP3298044	HUMAN MONOCLONAL ANTIBODIES FRAGMENTS INHIBITING BOTH THE CATH-D CATALYTIC ACTIVITY AND ITS BINDING TO THE LRP1 RECEPTOR	INST NAT SANTE RECH MED
EP3299364	NEBIVOLOL SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF	ZHEJIANG AUSUN PHARMACEUTICAL CO LTD
EP3299384	TRUNCATED ROTAVIRUS VP4 PROTEIN AND APPLICATION THEREOF	UNIV XIAMEN
EP3301099	PHOSPHORESCENT HOMOLEPTIC TRIS-[DEUTERATED-2-(2-PYRIDINYL)PHENYL]-IRIDIUM COMPLEXES FOR USE IN LIGHT-EMITTING DEVICES	UNIVERSAL DISPLAY CORP
EP3301109	NOVEL DEPSIPEPTIDE AND USES THEREOF	NOVOBIOTIC PHARMACEUTICALS LLC
EP3301115	CONTINUOUS MULTISTEP PROCESS FOR PURIFYING ANTIBODIES	SANOFI SA
EP3302471	TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE	EISAI R&D MAN CO LTD
EP3302572	IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE	ARVINAS INC
EP3302576	MULTIVALENT TARGETING FLUORESCENT TRACER IN THE NEAR INFRARED RANGE FOR OPTICAL IMAGING	FLUOPTICS
EP3303269	PROCESS FOR THE SELECTIVE HYDROGENATION OF ACETYLENE TO ETHYLENE	UOP LLC
EP3303288	PROCESS FOR PREPARING CARBAZOLES	DOW GLOBAL TECHNOLOGIES LLC
EP3303317	METHODS AND COMPOSITIONS FOR INHIBITING THE INTERACTION OF MENIN WITH MLL PROTEINS	KURA ONCOLOGY INC
EP3303324	NOVEL CORROSION INHIBITORS	ECOLAB USA INC
EP3303335	HETEROCYCLIC COMPOUNDS FOR TREATING PSORIASIS	JS INNOPHARM SHANGHAI LTD
EP3303340	POLYKETIDES, METHODS OF USE AND PREPARATION	UNIV LEIDEN
EP3303342	IMIDAZO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS	MERCK SHARP & DOHME
EP3303374	METHODS AND PRODUCTS FOR FUSION PROTEIN SYNTHESIS	UNIV OXFORD INNOVATION LTD
EP3303379	TIGIT-BINDING AGENTS AND USES THEREOF	ONCOMED PHARM INC
EP3303384	NEUTRALIZING ANTI-INFLUENZA BINDING MOLECULES AND USES THEREOF	MEDIMMUNE LLC
EP3303636	COMPANION METHODS AND KITS FOR IL-2-BASED THERAPIES AND MESENCHYMAL STEM CELL-BASED THERAPIES	AELAN CELL TECH INC
EP3305754	PROCESS FOR PRODUCING HIGHLY UNSATURATED FATTY ACID OF HIGH PURITY IN HIGH YIELD	BIZEN CHEMICAL CO LTD
EP3305765	POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME	LG CHEMICAL LTD
EP3305771	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME	LG CHEMICAL LTD
EP3305796	ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES	UNIVERSAL DISPLAY CORP
EP3305802	NOVEL PEPTIDE AND COMPOSITION CONTAINING THE SAME	GEMVAX & KAEL CO LTD
EP3307322	HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF	PRIMATOPE THERAPEUTICS INC
EP3307705	PREPARATION OF HIGH CONDUCTIVITY COPPER FILMS	NAT RES COUNCIL CANADA
EP3307708	METHOD FOR PREPARING DIISOCYANATES IN THE GAS PHASE	COVESTRO DEUTSCHLAND AG
EP3307722	SOLID FORMS OF (Z)-4-(5-((3-BENZYL-4-OXO-2-THIOXOTHIAZOLIDIN-5-YLIDENE)METHYL)FURAN-2-YL)BENZOIC ACID	ADHAERE PHARMACEUTICALS INC
EP3307736	MANNITOL BASED GELATORS FOR OIL SPILLAGE APPLICATIONS	HINDUSTAN PETROLEUM CORP LTD
EP3307752	TERNARY MIXTURES OF 6'-SL, LNnT and LST c	GLYCOM AS
EP3307762	REPORTER CAS9 VARIANTS AND METHODS OF USE THEREOF	UNIV CALIFORNIA
EP3307763	MADS-BOX DOMAIN ALLELES FOR CONTROLLING SHELL PHENOTYPE IN PALM	MALAYSIAN PALM OIL BOARD MPOB
EP3307783	COMPOSITIONS AND CONJUGATES COMPRISING AN INTERLEUKIN AND POLYPEPTIDES THAT SPECIFICALLY BIND TGF-BETA	UNIV EMORY
EP3307784	CARBONIC ANHYDRASE IX-SPECIFIC ANTIBODIES AND USES THEREOF	NAT RES COUNCIL CANADA
EP3309138	METHOD FOR CO-PRODUCTION OF 2,3,3,3-TETRAFLUOROPROPYLENE AND 1,3,3,3-TETRAFLUOROPROPYLENE	ZHEJIANG QUZHOU JUXIN FLUORINE CHEMICAL CO LTD
EP3309141	ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT	HODOGAYA CHEMICAL CO LTD
EP3309149	6-BROMO-3-HYDROXY-2-PYRAZINECARBOXAMIDE CRYSTAL AND METHOD FOR PRODUCING SAME	TOYAMA CHEMICAL CO LTD
EP3309171	BLOOD-BRAIN BARRIER PERMEABLE PEPTIDE COMPOSITIONS	ICB INT INC
EP3309172	HUMANIZED ANTIBODY AGAINST AMYLOID BETA	AC IMMUNE SA
EP3309549	RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS	WATERS TECHNOLOGIES CORP
EP3309614	RADIATION SENSITIVE COMPOSITION	NISSAN CHEMICAL IND LTD
EP3310347	LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME	OPKO BIOLOGICS LTD
EP3310386	COMBINATION THERAPIES FOR HEME MALIGNANCIES WITH ANTI-CD38 ANTIBODIES AND SURVIVIN INHIBITORS	JANSSEN BIOTECH INC
EP3310755	A NOVEL PROCESS FOR THE PREPARATION OF TERIFLUNOMIDE	BIOCON LTD
EP3310782	IMIDAZO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS	MERCK SHARP & DOHME
EP3310786	DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOF	NANOPHAGIX LLC
EP3310790	METHOD OF TARGETING MISMATCHED DNA USING D8 SQUARE PLANAR METAL COMPLEXES	UNIV HONG KONG
EP3310792	PROCESS FOR PREPARING AN ACRYLOYLOYLOXYSILANE	DOW CORNING
EP3310793	PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE	DOW CORNING
EP3310795	POLYMERIZATION OF SILYL- AND FLUORO-CONTAINING MONOMERS	SCRIPPS RESEARCH INST
EP3310805	PD-1-CD28 FUSION PROTEINS AND THEIR USE IN MEDICINE	KOBOLD SEBASTIAN
EP3310811	ANTI-CD3 ANTIBODIES AND METHODS OF USE	GENENTECH INC
EP3310821	COMPOSITIONS CONTAINING 1,1-DISUBSTITUTED ALKENE COMPOUNDS FOR PREPARING POLYMERS HAVING ENHANCED GLASS TRANSITION TEMPERATURES	SIRRUS INC
EP3310854	HYDRAZIDE COMPOUNDS SUITABLE FOR NUCLEATING POLYLACTIC ACID POLYMER	3M INNOVATIVE PROPERTIES CO
EP3310883	PROCESS FOR PRODUCING TRANSPORT FUEL BLENDSTOCK	CADENHOUSE BEATY PATRICK JAMES
EP3310909	COMPOSITIONS AND METHODS FOR DIRECTING PROTEINS TO SPECIFIC LOCI IN THE GENOME	POSEIDA THERAPEUTICS INC
EP3310919	VECTORS FOR USE IN AN INDUCIBLE COEXPRESSION SYSTEM	ABSCI LLC
EP3311169	MODULATOR ASSAY	UCB BIOPHARMA SPRL
EP3311170	ANTIBODY	UCB BIOPHARMA SPRL
EP3311171	ANTIBODY EPITOPE	UCB BIOPHARMA SPRL
EP3312153	METHODS FOR MANUFACTURING AROMATIC HYDROCARBON, PARAXYLENE AND TEREPHTHALIC ACID	CHINA PETROLEUM & CHEM CORP
EP3312169	5-HT3 RECEPTOR ANTAGONISTS	TAKEDA PHARMACEUTICALS CO
EP3312177	TRICYCLIC DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	JEIL PHARMACEUTICAL CO LTD
EP3312285	METHOD OF PREPARING AROMATIC HYDROCARBON, P-XYLENE AND TEREPHTHALIC ACID, AND APPARATUS PRODUCING AROMATIC HYDROCARBON	CHINA PETROLEUM & CHEM CORP
EP3312895	ORGANIC SEMICONDUCTING MATERIAL COMPRISING AN ELECTRICAL N-DOPANT AND AN ELECTRON TRANSPORT MATRIX AND ELECTRONIC DEVICE COMPRISING THE SEMICONDUCTING MATERIAL	NOVALED GMBH
EP3313805	PROCESS FOR MANUFACTURING 1-CYCLOPROPYL-NAPHTHALENES	PATHEON AUSTRIA GMBH CO & KG
EP3313852	SUBSTITUTED PYRAZOLO/IMIDAZOLO BICYCLIC COMPOUNDS AS PDE2 INHIBITORS	MERCK SHARP & DOHME
EP3313857	POLYMER-CYCLODEXTRIN-LIPID CONJUGATES	WU NIAN
EP3313864	PRRSV MINOR PROTEIN-CONTAINING RECOMBINANT VIRAL VECTORS AND METHODS OF MAKING AND USE THEREOF	MERIAL INC
EP3313865	SYNTHETIC PEPTIDE COMPOUNDS AND METHODS OF USE	EASTERN VIRGINIA MEDICAL SCHOOL
EP3313867	A NUCLEIC ACID MOLECULE FOR CONFERRING INSECTICIDAL PROPERTIES IN PLANTS	SYNGENTA PARTICIPATIONS AG
EP3313869	CYCLIC RGD CELL-BINDING MOTIF AND USES THEREOF	SPIBER TECH AB
EP3313874	MASKING CHIMERIC ANTIGEN RECEPTOR T CELLS FOR TUMOR-SPECIFIC ACTIVATION	UNIV SOUTHERN CALIFORNIA
EP3313878	MATERIALS AND METHODS FOR PERFORMING HISTOCHEMICAL ASSAYS FOR HUMAN PRO-EPIREGULIN AND AMPHIREGULIN	VENTANA MED SYST INC
EP3314038	PURINE-BASED CORROSION INHIBITORS	ECOLAB USA INC
EP3314257	CELL TRACKING REAGENTS AND THEIR METHODS OF USE	LIFE TECHNOLOGIES CORP
EP3315489	METHOD FOR MANUFACTURING PENTAERYTHRITOL MERCAPTO CARBOXYLIC ACID ESTER, POLYMERIZABLE COMPOSITION, RESIN, OPTICAL MATERIAL, AND LENS	MITSUI CHEMICALS INC
EP3315499	CRYSTAL OF (6S,9aS)-N-BENZYL-6-[(4-HYDROXYPHENYL)METHYL]- 4,7-DIOXO-8-({6-[3-(PIPERAZIN-1-YL)AZETIDIN-1-YL]PYRIDIN- 2-YL}METHYL)-2-(PROP-2-EN-1-YL)-OCTAHYDRO-1H-PYRAZINO[2,1-c][1,2,4]TRIAZINE-1-CARBOXAMIDE COMPOUND	EISAI R&D MAN CO LTD
EP3315504	TETRACARBOXYLIC ACID DIESTER COMPOUND, POLYMER OF POLYIMIDE PRECURSOR AND METHOD FOR PRODUCING SAME, NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PATTERNING PROCESS, AND METHOD FOR FORMING CURED FILM	SHINETSU CHEMICAL CO
EP3316880	THIRD GENERATION TAXOIDS AND METHODS OF USING SAME	UNIV NEW YORK STATE RES FOUND
EP3317244	PROCESS FOR PRODUCING ACETIC ACID	CELANESE INT CORP
EP3317245	PROCESS FOR FLASHING A REACTION MEDIUM	CELANESE INT CORP
EP3317255	ARYL SULFONAMIDE COMPOUNDS AS CARBONIC ANHYDRASE INHIBITORS AND THEIR THERAPEUTIC USE	SIGNALCHEM LIFESCIENCES CORP
EP3317277	SOMATOSTATIN MODULATORS AND USES THEREOF	CRINETICS PHARMACEUTICALS INC
EP3317278	SOMATOSTATIN MODULATORS AND USES THEREOF	CRINETICS PHARMACEUTICALS INC
EP3317279	TRIAZA-SPIRODECANONES AS DDR1 INHIBITORS	HOFFMANN LA ROCHE
EP3317285	CHIRAL DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES	TP THERAPEUTICS INC
EP3317301	COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3	NOVARTIS AG
EP3318565	PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES	PFIZER
EP3318571	ION EXCHANGE CHROMATOGRAPHY WITH IMPROVED SELECTIVITY FOR THE SEPARATION OF POLYPEPTIDE MONOMERS, AGGREGATES AND FRAGMENTS BY MODULATION OF THE MOBILE PHASE	HOFFMANN LA ROCHE
EP3318574	POLYPEPTIDE HAVING BETA-GLUCOSIDASE ACTIVITY AND USES THEREOF	DSM IP ASSETS BV
EP3319641	NOVEL PSMA-SPECIFIC BINDING PROTEINS	UNIV MUENCHEN TECH
EP3319723	ZEOLITIC ADSORBENTS, METHOD FOR THE PRODUCTION THEREOF, AND USES OF SAME	IFP ENERGIES NOW
EP3319941	A TWO-STEP PROCESS FOR PREPARING 3-SUBSTITUTED PHENYLALKYLAMINES	SPECGX LLC
EP3319948	ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME	CELANESE INT CORP
EP3319951	METHOD FOR THE HYDROFORMYLATION OF 2-SUBSTITUTED BUTADIENES AND THE PRODUCTION OF SECONDARY PRODUCTS THEREOF, ESPECIALLY AMBROX	BASF SE
EP3319976	COMPOSITIONS AND METHODS FOR TREATING LUNG DISEASES AND LUNG INJURY	INSMED INC
EP3319977	PEPTIDE PURIFICATION USING MIXED-PHASE SOLID PHASE EXTRACTION MATERIAL	MAX PLANCK GESELLSCHAFT
EP3319980	FORMULATIONS FOR IMPROVING THE EFFICACY OF HYDROPHOBIC DRUGS	PEPTINOVO BIOPHARMA LLC
EP3319987	NOVEL P450-BM3 VARIANTS WITH IMPROVED ACTIVITY	CODEXIS INC
EP3320033	POLYETHYLENE TEREPHTHALATE DEPOLYMERIZATION	LOOP IND INC
EP3320095	SH3 DOMAIN DERIVATIVES	NEXT BIOMED THERAPIES OY
EP3320342	NEW HYDROGELS HAVING A SILYLATED STRUCTURE, AND METHOD FOR OBTAINING SAME	UNIV MONTPELLIER
EP3320911	ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS	ACCELERON PHARMA INC
EP3321276	FUSION PROTEINS FOR TREATING METABOLIC DISORDERS	NOVARTIS AG
EP3321286	BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES	ROCHE GLYCART AG
EP3321377	METHOD FOR DETERMINING SENSITIVITY TO SIMULTANEOUS INHIBITOR AGAINST PARP AND TANKYRASE	ASAN FOUND
EP3322293	ARYLOXYPYRIMIDINYL ETHERS AS HERBICIDES	DU PONT
EP3322420	BICYCLIC HETEROCYCLES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN	MERCK SHARP & DOHME
EP3322484	COMPOSITIONS AND METHODS FOR TREATING CANCER	MEDIMMUNE LLC
EP3322690	DIARYL AMINE ANTIOXIDANTS PREPARED FROM BRANCHED OLEFINS	LANXESS SOLUTIONS US INC
EP3322696	PROCESS FOR MAKING HYDROXYETHYL PIPERAZINE COMPOUNDS	DOW GLOBAL TECHNOLOGIES LLC
EP3322721	NOVEL IMMUNOGLOBULIN-BINDING PROTEINS AND THEIR USE IN AFFINITY PURIFICATION	NAVIGO PROTEINS GMBH
EP3322724	IL-26 INHIBITORS	CENTRE HOSPITALIER UNIV VAUDOIS CHUV
EP3322731	METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR	SQUIBB BRISTOL MYERS CO
EP3322733	HIDE1 COMPOSITIONS AND METHODS	COMPUGEN LTD
EP3322736	FUSION POLYPEPTIDES AND METHODS OF USE	PROSIT SOLE BIOTECHNOLOGY BEIJING CO LTD
EP3322804	NUCLEASE-INDEPENDENT TARGETED GENE EDITING PLATFORM AND USES THEREOF	UNIV RUTGERS
EP3322805	PURIFICATION OF NUCLEIC ACIDS USING COPPER-TITANIUM OXIDES	ABBOTT MOLECULAR INC
EP3323431	DIAGNOSTIC FOR CANCER	UNIV TOKYO
EP3324980	MULTI-TARGETED SINGLE ENTITY CONJUGATES	ALNYLAM PHARMACEUTICALS INC
EP3325097	COMPOSITIONS AND AGENTS AGAINST HEPATITIS B VIRUS AND USES THEREOF	ARCTURUS THERAPEUTICS INC
EP3325435	PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUOROPROPENE (1234YF)	MEXICHEM FLUOR SA DE CV
EP3325436	PROCESS FOR THE PREPARATION OF 3,3,3-TRIFLUOROPROPENE	MEXICHEM FLUOR SA DE CV
EP3325437	PROCESS FOR DRYING HYDRO(CHLORO)FLUOROOLEFINS	MEXICHEM FLUOR SA DE CV
EP3325444	METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM C	ACADIA PHARM INC
EP3325445	CONTROL OF AQUATIC WEEDS USING COMBINATIONS OF HALAUXIFEN, FLORPYRAUXIFEN AND OTHER AQUATIC HERBICIDES	DOW AGROSCIENCES LLC
EP3325449	HETEROCYCLIC COMPOUNDS, PARTICULARLY PYRIMIDINYLINDAZOLE COMPOUNDS FOR TREATING PARKINSON'S DISEASE	GLAXOSMITHKLINE IP DEV LTD
EP3325470	PESTICIDALLY ACTIVE 1,2,4-TRIAZOLE DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS	SYNGENTA PARTICIPATIONS AG
EP3325487	FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS	BODOR LABORATORIES INC
EP3325515	NOVEL BINDING PROTEINS BASED ON DI-UBIQUITIN MUTEINS AND METHODS FOR GENERATION	NAVIGO PROTEINS GMBH
EP3325516	A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA	DYAX CORP
EP3326218	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3326622	MODIFIED AXL PEPTIDES AND THEIR USE IN INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY	UNIV LELAND STANFORD JUNIOR
EP3326715	OXALIC ACID MONOAMIDE LIGAND, AND USES THEREOF IN COUPLING REACTION OF COPPER-CATALYZED ARYL HALOGEN SUBSTITUTE	SHANGHAI INST ORGANIC CHEMISTRY CAS
EP3327008	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME	LG CHEMICAL LTD
EP3327016	PREPARATION OF MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS	VERTEX PHARMA
EP3327027	CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF	PFIZER
EP3327030	VACCINES AND VACCINE COMPONENTS FOR INHIBITION OF MICROBIAL CELLS	PASTORAL GREENHOUSE GAS RES LTD
EP3327040	MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME	ALTOR BIOSCIENCE CORP
EP3327065	TOUCH SENSITIVE ELEMENT AND DISPLAY DEVISE COMPRISING THE SAME	LG DISPLAY CO LTD
EP3328187	NOVEL INSECT INHIBITORY PROTEINS	MONSANTO TECHNOLOGY LLC
EP3328379	BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION	UCB BIOPHARMA SPRL
EP3328419	PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF	MACROGENICS INC
EP3328425	COMBINED USE OF ANTI PD-1 AND ANTI M-CSF ANTIBODIES IN THE TREATMENT OF CANCER	NOVARTIS AG
EP3328426	TREATMENT OF PATIENTS DIAGNOSED WITH PANCREATIC DUCTAL ADENOCARCINOMA USING MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)	INNOCIMAB PTE LTD
EP3328542	NOVEL CATALYTIC COMPOSITION COMPRISING NICKEL AND A PHOSPHINE-TYPE LIGAND, AND USE THEREOF IN AN OLEFIN OLIGOMERISATION METHOD	IFP ENERGIES NOW
EP3328832	FUCOSIDASE INHIBITORS	HORIZON ORPHAN LLC
EP3328837	INHIBITOR OF THE MUTATED ISOCITRATE DEHYDROGENASE IDH1 R132H	BAYER PHARMA AG
EP3328852	FACTOR XIA NEW MACROCYCLE BEARING A NON-AROMATIC P2' GROUP	SQUIBB BRISTOL MYERS CO
EP3328880	THERAPEUTIC AGENTS	KING S COLLEGE LONDON
EP3328889	BISPECIFIC ANTIBODY CONSTRUCTS BINDING DLL3 AND CD3	AMGEN RES MUNICH GMBH
EP3328892	BISPECIFIC ANTIBODY CONSTRUCTS BINDING EGFRVIII AND CD3	AMGEN RES MUNICH GMBH
EP3329775	PROCESSES FOR THE SYNTHESIS OF DIARYLTHIOHYDANTOIN AND DIARYLHYDANTOIN COMPOUNDS	MEDIVATION PROSTATE THERAPEUTICS LLC
EP3330244	PRODUCTION METHOD FOR 2,3,3,3-TETRAFLUOROPROPENE	ZHEJIANG QUZHOU JUXIN FLUORINE CHEMICAL CO LTD
EP3330249	AMINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME	LG CHEMICAL LTD
EP3330258	1, 3, 5-TRIAZINE DERIVATIVE AND METHOD OF USING SAME	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
EP3330262	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE CONTAINING SAME	LG CHEMICAL LTD
EP3330342	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE USING SAME	HEESUNG MAT LTD
EP3330370	PROCESS FOR CULTIVATION OF CHO CELLS	NOVARTIS AG
EP3330404	COMPOSITIONS AND PROCESSES FOR DEPOSITING CARBON-DOPED SILICONCONTAINING FILMS	VERSUM MAT US LLC
EP3331064	USE OF 4,5-IMIDAZOLEDICARBOXYLIC ACID AS AN ELECTRODE ACTIVE MATERIAL	COMMISSARIAT ENERGIE ATOMIQUE
EP3331533	SYNTHESIS AND BIOLOGICAL ACTIVITY OF 2-METHYLENE ANALOGS OF CALCITRIOL AND RELATED COMPOUNDS	WISCONSIN ALUMNI RES FOUND
EP3331552	MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS	GLOBEIMMUNE INC
EP3331843	CYCLOPROPANATION OF SUBSTITUTED ALKENES	INT FLAVORS & FRAGRANCES INC
EP3331857	PROCESS FOR FLUORINATING COMPOUNDS	DOW AGROSCIENCES LLC
EP3331865	SYNTHESIS OF BENZODIAZEPINE DERIVATIVES	TRIO MEDICINES LTD
EP3331877	PYRAZOLE PYRIMIDINE DERIVATIVE AND USES THEREOF	YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD
EP3331880	N-(PYRIDIN-2-YL)-4-(THIAZOL-5-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC COMPOUNDS	UNIV SOUTH AUSTRALIA
EP3331890	PROTECTED ORGANOBORONIC ACIDS WITH TUNABLE REACTIVITY, AND METHODS OF USE THEREOF	UNIV ILLINOIS
EP3331891	CHIRAL REAGENTS FOR PREPARATION OF HOMOGENEOUS OLIGOMERS	EISAI R&D MAN CO LTD
EP3331900	PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS	IMMATICS BIOTECHNOLOGIES GMBH
EP3331902	CONSTRUCTS HAVING A SIRP-ALPHA DOMAIN OR VARIANT THEREOF	ALEXO THERAPEUTICS INC
EP3331908	ANTI-ANGPTL8 ANTIBODIES AND USES THEREOF	REGENERON PHARMA
EP3331915	IMMUNE-CHECKPOINT INHIBITORS FOR USE IN THE TREATMENT OF BLOOD-BORNE CANCERS	AMGEN RES MUNICH GMBH
EP3332810	FAST-ACTING INSULIN FORMULATION COMPRISING A SUBSTITUTED ANIONIC COMPOUND	ADOCIA
EP3333151	WATER ELIMINATION METHOD	DAIKIN IND LTD
EP3333194	ANTI-FAP ANTIBODIES AND METHODS OF USE	ROCHE GLYCART AG
EP3333264	CHIMERIC ANTIGEN RECEPTOR, AND T CELLS IN WHICH CHIMERIC ANTIGEN RECEPTOR IS EXPRESSED	YOO YOUNG PHARM CO LTD
EP3334705	CETYLATED FATTY ACIDS, SYSTEM FOR THE PREPARATION THEREOF AND USE THEREOF	PHARMANUTRA S P A
EP3334721	CGRP RECEPTOR ANTAGONISTS	LILLY CO ELI
EP3334731	PHENOXAZINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3334746	CONNEXIN 45 INHIBITION FOR THERAPY	UNIV SYDNEY
EP3334752	STEVIOL GLYCOSIDE TRANSPORT	DSM IP ASSETS BV
EP3334760	CAPPED AND UNCAPPED ANTIBODY CYSTEINES, AND THEIR USE IN ANTIBODY-DRUG CONJUGATION	PFIZER
EP3334804	METHODS FOR PRODUCING ALKYLBENZENES, PARAFFINS, OLEFINS AND OXO ALCOHOLS FROM WASTE PLASTIC FEEDSTOCKS	PROCTER & GAMBLE
EP3334824	PD-1 ANTIBODIES	INNOVENT BIOLOGICS SUZHOU CO LTD
EP3335043	METHOD FOR DIFFERENTIALLY DIAGNOSING ACTH-DEPENDENT CUSHING'S SYNDROME	CORCEPT THERAPEUTICS INC
EP3336098	SKIN PERMEABLE PEPTIDE AND METHOD FOR USING SAME	IUCF HYU
EP3336100	PEPTIDE HAVING EFFECT OF PREVENTING OR TREATING CENTRAL NERVOUS SYSTEM DISEASES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT	IUCF HYU
EP3336129	PROCESS FOR THE PREPARATION OF HYDROXYL-FUNCTIONALIZED POLYSILOXANES	HENKEL AG & CO KGAA
EP3336185	ANTIBODY	UNIV OSAKA
EP3337485	CRYSTALLINE FORMS OF IBRUTINIB	SUN PHARMACEUTICAL IND LTD
EP3337506	COMBINATIONS AND USES THEREOF	MORPHOSYS AG
EP3337519	COMPOSITIONS COMPRISING MACROCYCLE DERIVATIVES INCORPORATING BRIDGED MACROCYCLES AND METHODS OF PRODUCING AND USING SAME	SOUTHWESTERN OKLAHOMA STATE UNIV
EP3337778	METHODS FOR REMOVING ACIDIC IMPURITIES FROM HALOGENATED PROPENES	HONEYWELL INT INC
EP3337794	HYDROPHILIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES	MERCK PATENT GMBH
EP3337810	COMPOUND LIBRARY PREPARATION PROCESS BASED ON EXCHANGE REACTION BETWEEN DIFERENTLY SUBSTITUTED DIOXABOROLANES OR DIOXABORINANES	ECOLE SUPERIEURE PHYSIQUE & CHIMIE IND VILLE DE PARIS
EP3337812	METHOD FOR THE REDUCTION OF HOST CELL PROTEINS IN AFFINITY CHROMATOGRAPHY	HOFFMANN LA ROCHE
EP3337817	METHOD FOR THE REDUCTION OF HOST CELL PROTEINS IN AFFINITY CHROMATOGRAPHY	HOFFMANN LA ROCHE
EP3337901	ATYPICAL CYS HIS RICH THIOREDOXIN 4 (ACHT4) BLOCKERS AND METHODS OF USE THEREOF	YEDA RES & DEV
EP3339293	COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME	LG CHEMICAL LTD
EP3339294	PHARMACEUTICAL COMPOSITION AND APPLICATION REPLACING QUINOLONE DERIVATIVE, PHARMACEUTICAL ACCEPTABLE SALT, OR STEREOISOMER	UNIV JINAN
EP3339298	METHODS OF PREPARING OXA-BICYCLOALKENE	INT FLAVORS & FRAGRANCES INC
EP3339299	NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	AUTOPHAGYSCIENCES INC
EP3339311	VOLATILE MONOAMINO-DIALKOXYSILANES AND THEIR USE FOR CREATING SILICON-CONTAINING FILMS	VERSUM MAT US LLC
EP3339312	ORGANOAMINOSILANE PRECURSORS AND METHODS FOR DEPOSITING FILMS COMPRISING SAME	VERSUM MAT US LLC
EP3339314	MODIFIED NUCLEOTIDES FOR NUCLEIC ACID SYNTHESIS, KIT COMPRISING SUCH NUCLEOTIDES AND USE THEREOF FOR THE PRODUCTION OF SYNTHETIC NUCLEIC ACID SEQUENCES OR GENES	DNA SCRIPT
EP3339321	MODULATORS OF MYC, METHODS OF USING THE SAME AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC	TAIGA BIOTECHNOLOGIES INC
EP3341368	NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS	JANSSEN PHARMACEUTICA NV
EP3341370	CGRP RECEPTOR ANTAGONISTS	LILLY CO ELI
EP3341377	POLYFLUORENO[4,5-CDE]OXEPINE CONJUGATES AND THEIR USE IN METHODS OF ANALYTE DETECTION	AAT BIOQUEST INC
EP3341389	PEPTIDE INHIBITORS OF TELOMERASE TRANSLOCATION AND THERAPEUTIC USES THEREOF	MEDICAL COLLEGE WISCONSIN INC
EP3341393	MODIFIED ANTHRAX TOXIN PROTECTIVE ANTIGEN	US HEALTH
EP3341394	IMPROVED CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF	CELLIVERY THERAPEUTICS INC
EP3341396	IMPROVED CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF	CELLIVERY THERAPEUTICS INC
EP3341410	CHIMERIC ANTIGEN RECEPTORS WITH INTEGRATED CONTROLLABLE FUNCTIONS	CELLECTIS
EP3341415	ANTI-HYPUSINE ANTIBODIES AND USES THEREOF	HOFFMANN LA ROCHE
EP3341725	METHODS FOR DETECTING PHOSPHORYLATED ALPHA-SYNUCLEIN	PROTHENA BIOSCIENCES LTD
EP3341793	LIQUID, HYBRID UV/VIS RADIATION CURABLE RESIN COMPOSITIONS FOR ADDITIVE FABRICATION	DSM IP ASSETS BV
EP3342599	HEAT-SENSITIVE RECORDING MATERIAL	SANKO CO LTD
EP3342765	CATHEPSIN K INHIBITOR AND APPLICATION THEREOF	SUNSHINE LAKE PHARMA CO LTD
EP3342769	ORGANIC COMPOUND, METHOD FOR MANUFACTURING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME	DAINIPPON INK & CHEMICALS
EP3342774	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME	LG CHEMICAL LTD
EP3342786	ANTI-DLL3 ANTIBODY	CHUGAI PHARMACEUTICAL CO LTD
EP3342861	SPECIFICALLY PURIFIED ANTI-PRESEPSIN ANTIBODY	MOCHIDA PHARM CO LTD
EP3343658	COMPOSITION AND LIGHT-EMITTING ELEMENT IN WHICH SAME IS USED	SUMITOMO CHEMICAL CO
EP3344303	MENISCAL REPAIR ADHESIVE	COHERA MEDICAL INC
EP3344598	INHIBITING CPI FORMATION FROM ADIPONITRILE	INVISTA NORTH AMERICA SARL
EP3344622	GUANIDINE SUBSTITUTED IMIDAZO[4,5-c]RING COMPOUNDS	3M INNOVATIVE PROPERTIES CO
EP3344623	IMIDAZO[4,5-c]RING COMPOUNDS CONTAINING SUBSTITUTED GUANIDINE GROUPS	3M INNOVATIVE PROPERTIES CO
EP3344763	YEAST STRAINS CO-EXPRESSING EXOGENOUS GLUCOAMYLASES, THE METHOD FOR OBTAINING SAID YEAST STRAINS AND THE USE THEREOF TO PRODUCE BIOETHANOL	LESAFFRE & CIE
EP3344803	MODULAR POLYPEPTIDE LIBRARIES AND METHODS OF MAKING AND USING SAME	UNIV CALIFORNIA
EP3344805	METHOD FOR THE SELECTION OF APTAMERS FOR UNBOUND TARGETS	NEOVENTURES BIOTECHNOLOGY INC
EP3345596	INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER	RHODE ISLAND HOSPITAL
EP3345866	METHOD FOR PRODUCING A CYCLIC SILANE COMPOUND	EVONIK DEGUSSA GMBH
EP3345894	COMPOUND HAVING PROTEIN TYROSINE PHOSPHATASE SHP-1 AGONIST ACTIVITY
EP3345905	DEUTERATED BENZOQUINOLIZINE DERIVATIVES AS INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2	AUSPEX PHARMACEUTICALS INC
EP3345915	5-POSITION MODIFIED PYRAMIDINES AND THEIR USE	SOMALOGIC INC
EP3345917	ANTIPROTOZOAL COMPOUNDS	BACOBA AG
EP3345929	FUSION POLYPEPTIDE IN WHICH ANTI-INFLAMMATORY POLYPEPTIDE AND FERRITIN MONOMER FRAGMENT ARE BOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT	KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND
EP3346852	APPARATUSES AND METHODS FOR GENERATING A HIGH-CONCENTRATION PROTEIN PRODUCT FROM A BLANCHED BIOMASS	PARABEL LTD
EP3347018	INHIBITORS OF CYCLIN-DEPENDENT KINASES	DANA FARBER CANCER INST INC
EP3347348	PREPARATION OF 3-HYDROXY-3,6-DIMETHYLHEXAHYDROBENZOFURAN-2-ONE AND DERIVATIVES THEREOF	P2 SCIENCE INC
EP3347356	TRICYCLIC FUSED PYRIDIN-2-ONE DERIVATIVES AND THEIR USE AS BRD4 INHIBITORS	JUBILANT BIOSYS LTD
EP3347359	PROCESS FOR MAKING ISOIDIDE	ARCHER DANIELS MIDLAND CO
EP3347376	NOVEL IGFR-LIKE RECEPTOR AND USES THEREOF	HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH
EP3347468	COMBINATION COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES	MOLOGEN AG
EP3347929	METHODS OF PREPARING MULTILAYERED ELECTROCHROMIC SYSTEMS	YEDA RES & DEV
EP3348625	ORGANIC LIGHT-EMITTING DEVICE	LG CHEMICAL LTD
EP3348636	METHOD FOR MODIFYING GENOME SEQUENCE THAT SPECIFICALLY CONVERTS NUCLEOBASE OF TARGETED DNA SEQUENCE, AND MOLECULAR COMPLEX USED IN SAID METHOD	UNIV KOBE NAT UNIV CORP
EP3349582	NOVEL INSECT INHIBITORY PROTEINS	MONSANTO TECHNOLOGY LLC
EP3349775	SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS	MASSACHUSETTS INST TECHNOLOGY
EP3349793	ANTI-S100A8 FOR TREATING LEUKEMIA	UNIV LAVAL
EP3350144	PROCESS FOR THE CYCLOPROPANATION OF OLEFINS USING N-METHYL-N-NITROSO COMPOUNDS	GIVAUDAN SA
EP3350154	AN IMPROVED PROCESS FOR PREPARATION OF TRIENTINE DIHYDROCHLORIDE	EMCURE PHARMACEUTICALS LTD
EP3350160	AMPHOTERIC BETAINE COMPOUNDS	EASTMAN CHEM CO
EP3350162	MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS	JANSSEN PHARMACEUTICALS INC
EP3350178	NOVEL IMIDAZO [4,5-C]QUINOLINE AND IMIDAZO [4,5-C][1,5]NAPHTHYRIDINE DERIVATIVES AS LRRK2 INHIBITORS	PFIZER
EP3350179	CRYSTALLINE FORMS	IDORSIA PHARMACEUTICALS LTD
EP3350186	NANO- AND MICRO-SIZED PARTICLES OF 20-CAMPTOTHECIN OR DERIVATIVE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND TREATMENT OF CANCERS THEREWITH	CAO PHARMACEUTICALS INC
EP3350189	METAL COMPLEXES	UEA ENTERPRISES LTD
EP3350191	NUCLEOTIDE ANALOGS	UNIV CALIFORNIA
EP3350195	THE METHOD OF SYNTHESIS AND PURIFICATION OF A NUCLEOSIDE AND/OR A NUCLEOTIDE, A MODIFIED NUCLEOSIDE AND/OR NUCLEOTIDE, A DNA MOLECULE AND AN OLIGONUCLEOTIDE LIBRARY COMPRISING SAID MODIFIED NUCLEOSIDE AND/OR NUCLEOTIDE AND THE USE OF SAID OLIGONUCLEOTIDE LIBRARY	PURE BIOLOGICS SPOLKA AKCYJNA
EP3350213	T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS	US HEALTH
EP3350220	ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF	SCHOLAR ROCK INC
EP3350222	LIGANDS FOR INTEGRIN AVBETA6, SYNTHESIS AND USES THEREOF	UNIV MUENCHEN TECH
EP3350322	A NOVEL ENDOLYSIN POLYPEPTIDE	MICREOS HUMAN HEALTH BV
EP3350333	POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION	MODERNATX INC
EP3351536	ORGANIC LIGHT-EMITTING DEVICE	LG CHEMICAL LTD
EP3351552	2'- SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT	GILEAD SCIENCES INC
EP3351580	POLYMER CONJUGATE OF HEXA-COORDINATED PLATINUM COMPLEX	NIPPON KAYAKU KK
EP3352185	PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, DYE COMPOSITION, AND OXIDE SEMICONDUCTOR ELECTRODE	FUJIFILM CORP
EP3352283	ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY CELL, AND MODULE	DAIKIN IND LTD
EP3352752	DETECTING AND TREATING GROWTH HORMONE DEFICIENCY	AMMONETT PHARM LLC
EP3352856	METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2	AERPIO THERAPEUTICS INC
EP3353137	PROCESSES AND APPARATUSES FOR PRODUCTION OF BUTADIENE	UOP LLC
EP3353147	SYNTHESIS OF TERPHENYL COMPOUNDS	VECTUS BIOSYSTEMS LTD
EP3353152	METHOD	NORSK MEDISINSK SYKLOTRONSENTER AS
EP3353156	TEAD TRANSCRIPTION FACTOR AUTOPALMITOYLATION INHIBITORS	MASSACHUSETTS GEN HOSPITAL
EP3353157	FAR SUPERIOR OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS	UNIV CARNEGIE MELLON
EP3353161	TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS	US HEALTH
EP3353164	BI-HETEROARYL SUBSTITUTED 1,4-BENZODIAZEPINES AND USES THEREOF FOR THE TREATMENT OF CANCER	JANSSEN PHARMACEUTICA NV
EP3353171	ISOXAZOLINE-SUBSTITUTED BENZAMIDES AND ANALOGUES AS INSECTICIDES	SYNGENTA PARTICIPATIONS AG
EP3353172	ISOXAZOLINE-SUBSTITUTED BENZAMIDES AND ANALOGUES AS INSECTICIDES	SYNGENTA PARTICIPATIONS AG
EP3353173	PESTICIDALLY ACTIVE POLYCYCLIC DERIVATIVES WITH 5-MEMBERED SULFUR CONTAINING HETEROCYCLIC RING SYSTEMS	SYNGENTA PARTICIPATIONS AG
EP3353181	NEW BICYCLIC COMPOUNDS AS DUAL ATX/CA INHIBITORS	HOFFMANN LA ROCHE
EP3353184	NOVEL BRANCHED AMPHIPHILIC LIPIDS	UNIV BRETAGNE OCCIDENTALE
EP3353187	METAL CARBENE OLEFIN METATHESIS CATALYSTS	UMICORE AG & CO KG
EP3353195	POLYPEPTIDES HAVING CELLOBIOHYDROLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME	NOVOZYMES AS
EP3353201	RECOMBINANT IMMUNOGLOBULIN HEAVY CHAINS COMPRISING A SORTASE CONJUGATION LOOP AND CONJUGATES THEREOF	HOFFMANN LA ROCHE
EP3353212	OPTIMIZED ANTI-CD3 BISPECIFIC ANTIBODIES AND USES THEREOF	REGENERON PHARMA
EP3353214	AGENTS INHIBITING KALLIKREIN-8 FOR USE IN THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE	UNIV DUISBURG ESSEN
EP3353302	ACTIVATION OF TASTE RECEPTOR GENES IN MAMMALIAN CELLS USING CRISPR-CAS-9	B R A I N AG
EP3354636	METHOD FOR THE HYDROAMINOMETHYLATION OF CYCLIC DIENES TO DI-SECONDARY AMINES	OXEA GMBH
EP3354637	NEW POLYMORPHIC FORMS OF MINOCYCLINE BASE AND PROCESSES FOR THEIR PREPARATION	HOVIONE SCIENTIA LTD
EP3354651	TRIFLUOROMETHYL ALCOHOLS AS MODULATORS OF ROR-GAMMA-T	JANSSEN PHARMACEUTICA NV
EP3355890	HUMAN PLASMA KALLIKREIN INHIBITORS	BIOCRYST PHARM INC
EP3355907	BI-SPECIFIC THERAPEUTIC PROTEINS FOR TISSUE REPAIR	SILVER CREEK PHARMACEUTICALS INC
EP3356326	METHOD FOR PRODUCING MERCAPTANS BY HYDROGEN-ASSISTED DISULFIDE ENZYME HYDROGENOLYSIS	ARKEMA FRANCE
EP3356335	MICROBIOCIDAL OXADIAZOLE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3356359	INHIBITORS OF KRAS G12C MUTANT PROTEINS	ARAXES PHARMA LLC
EP3356362	2-(HET)ARYL-SUBSTITUTED CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS	BAYER CROPSCIENCE AG
EP3356368	BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLYL GROUPS, CARBAZOLYL GROUPS, BENZOFURANE GROUPS OR BENZOTHIOPHENE GROUPS FOR ORGANIC LIGHT EMITTING DIODES	IDEMITSU KOSAN CO
EP3356370	11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN	SITEONE THERAPEUTICS INC
EP3356379	PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS	APEIRON SYNTHESIS SA
EP3356390	METHODS AND COMPOSITIONS FOR ANTIBODY-EVADING VIRUS VECTORS	UNIV NORTH CAROLINA CHAPEL HILL
EP3356404	ANTI-PD1 ANTIBODIES AND METHODS OF USE	HOFFMANN LA ROCHE
EP3356407	BISPECIFIC ANTI-CD19XCD3 T CELL ACTIVATING ANTIGEN BINDING MOLECULES	HOFFMANN LA ROCHE
EP3356410	BISPECIFIC ANTI-CEAXCD3 T CELL ACTIVATING ANTIGEN BINDING MOLECULES	HOFFMANN LA ROCHE
EP3356411	BISPECIFIC ANTIBODIES SPECIFIC FOR PD1 AND TIM3	HOFFMANN LA ROCHE
EP3356412	TARGETING METASTASIS STEM CELLS THROUGH A FATTY ACID RECEPTOR (CD36)	FUNDACIO INST DE RECERCA BIOMEDICA IRB BARCELONA
EP3356419	TETRAVALENT MULTISPECIFIC ANTIBODIES	HOFFMANN LA ROCHE
EP3356524	ENHANCED GENE DELIVERY TO NATURAL KILLER CELLS, HEMATOPOIETIC STEM CELLS AND MACROPHAGES	VYCELLIX INC
EP3356561	THERAPEUTIC AND DIAGNOSTIC METHODS FOR AUTOIMMUNE DISEASES AND/OR INFLAMMATION	MOMENTA PHARMACEUTICALS INC
EP3357574	CATALYST COMPOSITION FOR HYDROFORMYLATION REACTION, AND HYDROFORMYLATION METHOD USING SAME	LG CHEMICAL LTD
EP3357899	METHOD FOR CHLORINATION AND DEHYDROGENATION OF ETHANE	ZHONGKE YIGONG XIAMEN CHEMICAL TECH CO LTD
EP3357912	SPIRO COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME	LG CHEMICAL LTD
EP3357925	SALT TYPE AND CRYSTAL TYPE OF 4H-PYRAZOLO [1, 5-ALPHA]BENZIMIDAZOLE COMPOUND AND PREPARATION METHOD AND INTERMEDIATE THEREOF	HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC
EP3357927	AEROGEL PRECURSOR, PREPARATION METHOD THEREFOR, AEROGEL PREPARED THEREFROM, AND AEROGEL PREPARATION METHOD USING SAME	LG CHEMICAL LTD
EP3357928	NOVEL DYES WITH PHOSPHINIC ACID, PHOSPHINATE, PHOSPHONATE AND PHOSPHONAMIDATE SUBSTITUENTS AS AUXOCHROMIC GROUPS AND METHODS FOR PREPARING THE SAME	MAX PLANCK GESELLSCHAFT
EP3358010	NOVEL ARTIFICIAL BIOLUMINESCENT ENZYMES	AIST
EP3358017	ANTIBODY FOR IMMUNOASSAY AND METHOD FOR PREPARING SAME	SEKISUI MEDICAL CO LTD
EP3359241	FORMULATIONS OF PTHRP ANALOGUES, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF	RADIUS HEALTH INC
EP3359511	METHOD AND SYSTEM FOR EXTRACTING STRANDED GAS FROM UNDERWATER ENVIRONMENTS, CONVERTING IT TO CLATHRATES, AND SAFELY TRANSPORTING IT FOR CONSUMPTION	PHOENIX STUART L
EP3359525	NEW ALKYNYL-SUBSTITUTED 3-PHENYLPYRROLIDINE-2,4-DIONES AND USE THEREOF AS HERBICIDES	BAYER CROPSCIENCE AG
EP3359536	COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR	PROTEOSTASIS THERAPEUTICS INC
EP3359542	SPIRO[3H-INDOLE-3,2 虂-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS	BOEHRINGER INGELHEIM INT
EP3359556	MODULATING GAMMA - C -CYTOKINE ACTIVITY	BIONIZ LLC
EP3359559	GLYCOSYLATED YGHJ POLYPEPTIDES FROM ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC)	UNIV SYDDANSK
EP3359673	PODOSPHAERA LEUCOTRICHA RESISTENCE PROVIDING GENES IN MALUS DOMESTICA	EDMUND MACH FOND
EP3360867	PREPARATION METHOD OF 2-MERCAPTOBENZOTHIAZOLE	SENNICS CO LTD
EP3360877	1,6- DIAZABICYCLO [3,2,1]OCTAN- 7- ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS	WOCKHARDT LTD
EP3360893	HIGH-AFFINITY AND SOLUBLE PDL-1 MOLECULE	GUANGZHOU INST BIOMED & HEALTH
EP3360895	PREPARATION COMPRISING FACTOR VIII AND VON WILLEBRAND FACTOR PEPTIDES	OCTAPHARMA AG
EP3361294	COLOR CONVERSION COMPOSITION, COLOR CONVERSION SHEET, AND LIGHT SOURCE UNIT, DISPLAY, LIGHTING SYSTEM, BACKLIGHT UNIT, LED CHIP AND LED PACKAGE CONTAINING SAME	TORAY INDUSTRIES
EP3361521	LIGHT-EMITTING ELEMENT	SUMITOMO CHEMICAL CO
EP3362066	COMBINATION THERAPY FOR TREATING MALIGNANCIES	AGIOS PHARMACEUTICALS INC
EP3362427	PRODUCTION OF PROPYLENE GLYCOL MONOALKYL ETHER	LYONDELL CHEMICAL TECH LP
EP3362436	PROCESS FOR THE CATALYTIC DIRECTED CLEAVAGE OF AMIDE-CONTAINING COMPOUNDS	UNIV ANTWERPEN
EP3362440	PROCESS FOR THE PRODUCTION OF 1,4-BUTANEDIOL AND TETRAHYDROFURAN FROM FURAN	SHELL INT RESEARCH
EP3362448	NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA	INVENTIVA
EP3362449	SIBIRILINE DERIVATIVES FOR USE FOR PREVENTING AND/OR TREATING DISORDERS ASSOCIATED WITH CELLULAR NECROPTOSIS	INST NAT SANTE RECH MED
EP3362454	EP4 ANTAGONISTS	EISAI R&D MAN CO LTD
EP3362459	ACETATE COMPLEXES AND METHODS FOR ACETATE QUANTIFICATION	GEN ELECTRIC
EP3362462	IN SITU DETECTION OF NUCLEOTIDE VARIANTS IN HIGH NOISE SAMPLES, AND COMPOSITIONS AND METHODS RELATED THERETO	ADVANCED CELL DIAGNOSTICS INC
EP3362464	METHODS FOR EXTRACTING PROTEINS FROM BLOOD PLASMA	PLASMA TECH LLC
EP3362469	GENERATING MAIZE PLANTS WITH ENHANCED RESISTANCE TO NORTHERN LEAF BLIGHT	PIONEER HI BRED INT
EP3362470	CHIMERIC ANTIGEN RECEPTORS CONTAINING A CHLOROTOXIN DOMAIN	HOPE CITY
EP3362471	PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING	TOLERO PHARMACEUTICALS INC
EP3362473	USE OF A FIBRINOGEN CAPTURE AGENT TO DETECT A CIZ1 B-VARIANT	CIZZLE BIOTECHNOLOGY LTD
EP3362480	ANTIBODY SPECIFICALLY BINDING TO ERBB3 AND USE THEREOF	ISU ABXIS CO LTD
EP3362569	CXCR6-TRANSDUCED T CELLS FOR TARGETED TUMOR THERAPY	UNIV MUENCHEN LUDWIG MAXIMILIANS
EP3363777	METHOD FOR PRODUCING DIOL	DAIKIN IND LTD
EP3363779	PRODUCTION METHOD OF ASYMMETRIC CHAIN CARBONATE	DAIKIN IND LTD
EP3363796	METHOD FOR PRODUCING HETEROCYCLIC COMPOUND	TAKEDA PHARMACEUTICALS CO
EP3364995	SINGLE-CHAIN CD27-RECEPTOR AGONIST PROTEINS	APOGENIX AG
EP3365318	BENZIL MONOKETALAND USE THEREOF	MERCK PATENT GMBH
EP3365322	PROCESS FOR PREPARING (Z)-ENDOXIFEN OF HIGH PURITY	US HEALTH
EP3365347	BORON COMPOUNDS AS INHIBITORS OF LIPOXYGENASE AND THE LIPOXYGENASE PATHWAY, AND PREPARATION AND USE THEREOF	UNIV LEIPZIG
EP3365366	TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION	SANOFI SA
EP3365373	BINDING MOLECULES THAT INHIBIT CANCER GROWTH	MERUS NV
EP3366307	COMPOSITIONS AND METHODS OF INHIBTING MASP-1 AND/OR MASP-3 FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	OMEROS CORP
EP3366667	METHOD OF ANALYSING A CELL OR OTHER BIOLOGICAL MATERIAL CONTAINING NUCLEIC ACID	BIOSTATUS LTD
EP3366673	CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING SAME	LG CHEMICAL LTD
EP3366676	CRYSTALLINE FORMS OF BEDAQUILINE FUMARATE AND PREPARATION METHODS THEREFOR	ZHEJIANG HISUN PHARM CO LTD
EP3366700	GELATIN, CHEMICALLY MODIFIED PRODUCT THEREOF, AQUEOUS COMPOSITION AND MEDICAL LAMINATE CONTAINING SAME, PRODUCTION METHOD FOR MEDICAL LAMINATE, AND CELL SHEET ISOLATION METHOD	TOKYO METRO IND TECH RES INST
EP3366749	COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE	SAMSUNG SDI CO LTD
EP3366750	STABILIZER AND STABILIZATION METHOD	FUJIFILM WAKO PURE CHEMICAL CORP
EP3368209	SYNTHESIS OF ORGANIC PEROXYDES USING AN OSCILLATORY FLOW MIXING REACTOR	ARKEMA FRANCE
EP3368501	IMPROVED CATALYST FOR ETHYLBENZENE CONVERSION IN A XYLENE ISOMERIZATION PROCESS	BP CORP NORTH AMERICA INC
EP3368513	PROCESS FOR THE SYNTHESIS OF PIRFENIDONE	PROCOS SPA
EP3368514	TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES	BAYER CROPSCIENCE AG
EP3368521	CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PEST CONTROL AGENTS	BAYER CROPSCIENCE AG
EP3368522	PYRIDINE OR PYRIMIDINE DERIVATIVES	HOFFMANN LA ROCHE
EP3368523	NOVEL PYRDAZINONE HERBICIDES	DU PONT
EP3368524	HETEROARYLCARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS	BOEHRINGER INGELHEIM INT
EP3368527	PALBOCICLIB SALTS	EGYT GYOGYSZERVEGYESZETI GYAR
EP3368534	VALBENAZINE SALTS AND POLYMORPHS THEREOF	NEUROCRINE BIOSCIENCES INC
EP3368538	WEE 1 KINASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME	UNIV COLORADO REGENTS
EP3368569	POLYPEPTIDES AGAINST IL-23	ABLYNX NV
EP3368578	ANTI-HTRA1 ANTIBODIES AND METHODS OF USE THEREOF	HOFFMANN LA ROCHE
EP3368579	HINGE MODIFIED ANTIBODY FRAGMENTS AND METHODS OF MAKING	HOFFMANN LA ROCHE
EP3368676	METHODS AND COMPOSITIONS FOR RAPID PLANT TRANSFORMATION	PIONEER HI BRED INT
EP3368678	GENETIC CONSTRUCT	QUETHERA LTD
EP3369724	PROCESS FOR THE PREPARATION OF IOPAMIDOL	BRACCO IMAGING SPA
EP3369727	AMINE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME	LG CHEMICAL LTD
EP3369732	ANDROGEN RECEPTOR MODULATING COMPOUNDS	ORION CORP
EP3371140	PROCESS FOR CONVERSION OF ACYCLIC C5 COMPOUNDS TO CYCLIC C5 COMPOUNDS AND CATALYST COMPOSITION FOR USE THEREIN	EXXONMOBIL CHEMICAL PATENTS INC
EP3371141	PRODUCTION OF CYCLIC C5 COMPOUNDS	EXXONMOBIL CHEMICAL PATENTS INC
EP3371147	INNOVATIVE PREPARATION AND CRYSTALLIZATION OF IOSIMENOL	OTSUKA PHARMA CO LTD
EP3371148	REGULATORS FOR CONTROLLING LINEAR AND PSEUDO-RING EXPANSION POLYMERIZATION OF VINYL MONOMERS	DISPOLTEC B V
EP3371150	PROCESS FOR PREPARING BRIVARACETAM	UCB BIOPHARMA SPRL
EP3371157	METHOD FOR PRODUCING 5-HYDROXYMETHYLFURFURAL IN THE PRESENCE OF CATALYSTS OF THE FAMILY OF HOMOGENEOUS SULFONIC ACIDS IN THE PRESENCE OF AT LEAST ONE APROTIC POLAR SOLVENT	IFP ENERGIES NOW
EP3371159	METHODS OF FORMING AROMATIC CONTAINING COMPOUNDS	UNIV MINNESOTA
EP3371195	SELECTIVE HDAC8 INHIBITORS AND THEIR USES	HOCHSCHULE DARMSTADT
EP3371206	METHODS OF MAKING FUCOSYLATED AND AFUCOSYLATED FORMS OF A PROTEIN	HOFFMANN LA ROCHE
EP3371223	BI-SPECIFIC ANTIBODIES FOR ENHANCED TUMOR SELECTIVITY AND INHIBITION AND USES THEREOF	MERCK PATENT GMBH
EP3371311	BI-FUNCTIONAL CHIMERIC PROTEINS AND USES THEREOF	ORIONIS BIOSCIENCES NV
EP3372281	POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY	VIIV HEALTHCARE CO
EP3372581	FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL	DAIKIN IND LTD
EP3372602	PYRROLOQUINOLINE QUINONE B CRYSTAL FORM AND PREPARATION METHOD THEREFOR	ZHUCHENG HAOTIAN PHARM CO LTD
EP3372605	SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS	ARRAY BIOPHARMA INC
EP3372607	CRYSTALLINE FORM OF BTK KINASE INHIBITOR AND PREPARATION METHOD THEREOF	JIANGSU HENGRUI MEDICINE CO
EP3372608	PROCESS FOR THE PREPARATION OF TRIS[3-(ALKOXYSILYL)PROPYL]ISOCYANURATS	EVONIK DEGUSSA GMBH
EP3372609	PROCESS FOR THE PREPARATION OF TRIS[3-(ALKOXYSILYL)PROPYL]ISOCYANURATES	EVONIK DEGUSSA GMBH
EP3373928	NOVEL FORMULATIONS	GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS US LLC
EP3373935	CYANOPYRIDINE DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE	MERCK SHARP & DOHME
EP3374027	RATIONAL DRUG DESIGN TARGETING RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS TO POLYMYXIN-CLASS ANTIBIOTICS	UNIV COLUMBIA
EP3374081	VANADIUM PYRIDINE-IMINE COMPLEX, CATALYTIC SYSTEM COMPRISING SAID VANADIUM PYRIDINE-IMMINE COMPLEX AND A (CO) POLYMERIZATION PROCESS OF CONJUGATED DIENES	VERSALIS SPA
EP3374336	METHODS FOR USING NITRIC OXIDE TO INHIBIT POPCORN POLYMERIZATION DURING BUTADIENE PROCESSING	SABIC GLOBAL TECHNOLOGIES BV
EP3374337	METHODS AND SYSTEMS FOR PURIFYING 1,3-BUTADIENE FROM A C4 HYDROCARBON STREAM	SABIC GLOBAL TECHNOLOGIES BV
EP3374340	PROCESS FOR PRODUCING ALDEHYDES	DOW TECHNOLOGY INVESTMENTS LLC
EP3374348	TRI-FUNCTIONAL CROSSLINKING REAGENTS	ETH ZUERICH
EP3374358	AZETIDINE DERIVATIVES FOR TAU IMAGING	LILLY CO ELI
EP3374378	CHARGE-REVERSED N-TERMINAL SPIDER SILK PROTEIN DOMAIN AND USES THEREOF	SPIBER TECH AB
EP3374392	IMPROVED SERUM ALBUMIN-BINDING IMMUNOGLOBULIN VARIABLE DOMAINS	ABLYNX NV
EP3374394	TRISPECIFIC MOLECULE COMBINING SPECIFIC TUMOR TARGETING AND LOCAL IMMUNE CHECKPOINT INHIBITION	UNIV MUENCHEN LUDWIG MAXIMILIANS
EP3374410	REACTIVE FLAME RETARDANTS FOR POLYURETHANE AND POLYISOCYANURATE FOAMS	ICL IP AMERICA INC
EP3374411	REACTIVE FLAME REARDANTS FOR POLYURETHANE AND POLYISOCYANURATE FOAMS	ICL IP AMERICA INC
EP3374478	LUBRICATING COMPOSITION COMPRISING THIOETHER-SUBSTITUTED PHENOLIC COMPOUND	LUBRIZOL CORP
EP3374479	BOROXINE BASED SEAL COMPATIBILITY AGENTS	AFTON CHEMICAL CORP
EP3375789	ANTI-PNEUMOCOCCAL HYPERIMMUNE GLOBULIN FOR THE TREATMENT AND PREVENTION OF PNEUMOCOCCAL INFECTION	ADMA BIOLOGICS INC
EP3376857	NON-HUMAN ANIMALS HAVING A HUMANIZED LYMPHOCYTE-ACTIVATION GENE 3	REGENERON PHARMA
EP3377049	CRYSTALLINE FORMS OF TAPENTADOL SALTS AND PROCESS FOR PREPARATION THEREOF	MSN LABORATORIES PRIVATE LTD
EP3377090	METHODS FOR TREATMENT OF BILE ACID-RELATED DISORDERS	NGM BIOPHARMACEUTICALS INC
EP3377468	ALLYL ALCOHOL BY CATALYTIC ISOMERIZATION OF A PROPYLENE OXIDE STREAM	LYONDELL CHEMICAL TECH LP
EP3377472	HOMOGENEOUS PROCESS FOR HYDRODEHALOGENATING HALOGENATED HETEROARYL COMPOUNDS	JOHNSON MATTHEY PLC
EP3377482	MODULATORS OF ROR-GAMMA	VITAE PHARMACEUTICALS INC
EP3377507	NEW 5-AZIDO-5-DEOXY-2 :3-ISOPROPYLIDENE-D-ARABINOSE COMPOUNDS; THEIR METHOD OF MANUFACTURE AND THEIR USE FOR THE SYNTHESIS OF ARA-N3, KDO-N3 AND 4EKDO-N3	CENTRE NAT RECH SCIENT
EP3377519	LABYRINTHOPEPTINS AS ANTI-VIRAL AGENTS	HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH
EP3377529	SIGLEC-10 ANTIBODIES	INNATE PHARMA
EP3377530	METHODS OF IDENTIFYING IMMUNE CELLS IN PD-L1 POSITIVE TUMOR TISSUE	VENTANA MED SYST INC
EP3377623	PROCESS FOR OBTAINING AN AQUEOUS EXTRACT ENRICHED WITH SMALL RNAS FROM A PLANT MATERIAL AND EXTRACTS RESULTING FROM THE PROCESS	ISP INVESTMENTS LLC
EP3377624	TOPICAL COMPOSITION COMPRISING A SMALL RNA TIGER LILY EXTRACT AND METHOD OF COSMETIC CARE TO REDUCE SKIN SIGNS OF AGING	ISP INVESTMENTS LLC
EP3378848	HYDROGENATION METHOD FOR SYNTHESIS OF METHANE AND METHANOL	KARLSRUHER INST TECHNOLOGIE
EP3378857	MATERIALS FOR ELECTRONIC DEVICES	MERCK PATENT GMBH
EP3378870	NOVEL ANTIMICROBIAL PEPTIDE AND USE THEREOF	NOVACELL TECH INC
EP3380117	GENETICALLY MODIFIED CELLS AND USES THEREOF	CARTHERICS PTY LTD
EP3380119	FMDV AND E2 FUSION PROTEINS AND USES THEREOF	MERIAL INC
EP3380122	ANTI-5T4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES	SYNTHON BIOPHARMACEUTICALS BV
EP3380452	SITE-SPECIFIC ISOTOPIC LABELING OF 1, 4-DIENE SYSTEMS	RETROTOPE INC
EP3380457	MONOSULFONIC PHENYLTETRAZOLE COMPOUNDS WITH APPLICATIONS	HANGZHOU JENNIFER BIOTECH CO LTD
EP3380460	PROCESS AND REACTOR FOR THE EPOXIDATION OF PROPENE	EVONIK DEGUSSA GMBH
EP3380462	METHODS FOR ANALYSIS AND RESOLUTION OF PREPARATIONS OF DIANHYDROGALACTITOL AND DERIVATIVES OR ANALOGS THEREOF	DEL MAR PHARMACEUTICALS BC LTD
EP3380471	COMT INHIBITING METHODS AND COMPOSITIONS	LIEBER INST FOR BRAIN DEVELOPMENT
EP3380477	METHOD FOR THE PREPARATION OF COMPOUNDS HAVING A 16-OXABICYCLO[10.3.1]PENTADECENE SCAFFOLD AND THE SUBSEQUENT PRODUCTS THEREOF	BASF SE
EP3380502	PEPTIDES	IMMUNOCORE LTD
EP3380517	POLYPEPTIDES INHIBITING CD40L	ABLYNX NV
EP3381068	ORGANIC SEMICONDUCTIVE LAYER COMPRISING PHOSPHINE OXIDE COMPOUNDS	NOVALED GMBH
EP3381461	PEPTIDES AND METHODS OF USING SAME	SERPIN PHARMA LLC
EP3381892	METHOD FOR PRODUCING POLYTHIOL COMPOUND, METHOD FOR PRODUCING CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED ARTICLE	HOYA LENS THAILAND LTD
EP3381893	POLYTHIOL COMPOUND MANUFACTURING METHOD, CURABLE COMPOSITION MANUFACTURING METHOD, AND CURED PRODUCT MANUFACTURING METHOD	HOYA LENS THAILAND LTD
EP3381894	POLYTHIOL COMPOSITION WITH IMPROVED LONG-TERM STORAGE STABILITY AND OPTICAL LENSES USING SAME	SKC CO LTD
EP3381895	METHOD FOR PRODUCING CARBOXYLIC ACID THIOESTER	MITSUBISHI CHEM CORP
EP3381899	INTERMEDIATE COMPOUND FOR PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS	VERTEX PHARMA
EP3381923	NOVEL METHOD FOR PREPARING LITHIUM BIS(FLUOROSULFONYL)IMIDE	CLS INC
EP3381936	GHRELIN O-ACYLTRANSFERASE (GOAT) AND USES THEREOF	UNIV CORDOBA
EP3381938	METHOD FOR INCREASING COLLAGEN YIELD, AND COLLAGEN PREPARED USING SAME	SEWON CELLONTEC CO LTD
EP3382023	GENE CAPABLE OF INCREASING PROTEIN CONTENT IN SEED, AND METHOD FOR UTILIZATION THEREOF	TOYOTA MOTOR CO LTD
EP3382024	GENE CAPABLE OF INCREASING PROTEIN CONTENT IN SEED, AND METHOD FOR UTILIZATION THEREOF	TOYOTA MOTOR CO LTD
EP3382025	GENE CAPABLE OF INCREASING PROTEIN CONTENT IN SEED, AND METHOD FOR UTILIZATION THEREOF	TOYOTA MOTOR CO LTD
EP3382395	VARICELLA ZOSTER	TANAKA PRECIOUS METAL IND
EP3383180	SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI	BASF SE
EP3383421	STAPLED HELICAL PEPTIDES AND METHODS OF SYNTHESIS	UNIV HONG KONG
EP3383422	CIRCULAR TANDEM REPEAT PROTEINS	HUTCHINSON FRED CANCER RES
EP3383440	SYNP162, A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN ROD PHOTORECEPTORS	FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RES
EP3383493	C5-C6-CARBOCYCLIC FUSED IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE	MERCK SHARP & DOHME
EP3383840	METHOD FOR PRODUCING ISOCYANATES	COVESTRO DEUTSCHLAND AG
EP3383842	PROCESS FOR PRODUCING HYDROGEN BIS(FLUOROSULFONYL)IMIDE	COORSTEK FLUOROCHEMICALS INC
EP3383854	WATER-SOLUBLE UV-ABSORBING COMPOUNDS AND USES THEREOF	NOVARTIS AG
EP3383861	ARYLATION METHOD	UMICORE AG & CO KG
EP3383867	COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY	CHIESI FARM SPA
EP3383870	SCREENING METHODS FOR ASPHALTENE STABILIZERS	BP CORP NORTH AMERICA INC
EP3383877	HETEROCYCLE COMPOUNDS AND USES THEREOF	SHANGHAI AEON BIOTECH CO LTD
EP3383885	CRYSTALLIZATION OF 25-HYDROXY-7-DEHYDROCHOLSTEROL	DSM IP ASSETS BV
EP3383911	ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1 AND THE THERAPEUTIC USES THEREOF	STCUBE & CO INC
EP3383924	REDOX POLYMERIZABLE COMPOSITION WITH PHOTOLABILE REDUCING AGENTS	3M INNOVATIVE PROPERTIES CO
EP3384065	PROCESS FOR THE GENERATION OF METALLIC FILMS	BASF SE
EP3384292	SEROLOGIC TEST FOR THERAPY CONTROL OF HPV16 POSITIVE CARCINOMA	ABVIRIS DEUTSCHLAND GMBH
EP3385250	CRYSTALS OF MONOVALENT CATION SALT OF 3-HYDROXYISOVALERIC ACID, AND METHOD FOR PRODUCING SAID CRYSTALS	KYOWA HAKKO BIO CO LTD
EP3385255	FUNGICIDAL COMPOUND, FUNGICIDE COMPOSITION AND PREPARATION AND USE THEREOF	ZHEJIANG BOSST CROPSCIENCE CO LTD
EP3385256	PREPARATION METHOD FOR EUTECTIC HYDRATE CRYSTAL FORM II OF AHU-377 AND DIOVAN TRISODIUM SALT	CRYSTAL PHARMATECH CO LTD
EP3385267	SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS	MILLENNIUM PHARM INC
EP3385274	MUTANT OF HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN	UNIV XIAMEN
EP3385387	SIMIAN ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF	GLAXOSMITHKLINE BIOLOGICALS SA
EP3386519	SIRNA STRUCTURES FOR HIGH ACTIVITY AND REDUCED OFF TARGET	NITTO DENKO CORP
EP3386919	A TIN-CONTAINING ZEOLITIC MATERIAL HAVING A BEA FRAMEWORK STRUCTURE	BASF SE
EP3386935	PRODUCTION OF XYLENE DERIVATIVES	RHODIA OPERATIONS
EP3386937	TWO-BED PARAFFIN TO OLEFIN ENHANCEMENT PROCESS	UOP LLC
EP3386946	PROCESS FOR PREPARING AN ALKANESULPHONIC ACID	EVONIK DEGUSSA GMBH
EP3386947	METHOD FOR PRODUCING N-RETINOYLCYSTEIC ACID ALKYL ESTER	ARDENIA INVESTMENTS LTD
EP3386978	BRIDGED PIPERIDINE DERIVATIVES	HOFFMANN LA ROCHE
EP3386980	COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR	PLEXXIKON INC
EP3386984	HEXAHYDROPYRAZINOTRIAZINONE DERIVATIVES AS KINASE INHIBITORS	UCB BIOPHARMA SPRL
EP3386986	GOLD PORPHYRIN-PEG CONJUGATES AND METHODS OF USE	UNIV HONG KONG
EP3386997	MONOMALEIMIDE-FUNCTIONALIZED PLATINUM COMPOUNDS FOR CANCER THERAPY	UNIV WIEN MED
EP3386998	DIASTEREOSELECTIVE SYNTHESIS OF PHOSPHATE DERIVATIVES AND OF THE GEMCITABINE PRODRUG NUC-1031	NUCANA PLC
EP3386999	PROCESS FOR PREPARING COMPOSITIONS COMPRISING ALKYL(ALKYL-GLUCOSIDE)URONATES, SAID COMPOSITIONS AND USE THEREOF AS A SURFACTANT	ECOLE NAT SUPERIEURE DE CHIMIE
EP3387015	TYPE II ANTI-CD20 ANTIBODY FOR REDUCING FORMATION OF ANTI-DRUG ANTIBODIES	HOFFMANN LA ROCHE
EP3387019	RELAXIN IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF USE	THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES
EP3387079	AMINIMIDE COMPOSITIONS	PPG IND OHIO INC
EP3387137	TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs)	CALIFORNIA INST OF TECHN
EP3388412	METHOD FOR PURIFYING PHENOL	LG CHEMICAL LTD
EP3388438	SPIRO-STRUCTURED COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME	LG CHEMICAL LTD
EP3388446	IMPROVED ANGIOGENESIS-INHIBITING PEPTIDE AND COMPOSITION FOR PREVENTING AND TREATING ANGIOGENESIS-RELATED DISEASE COMPRISING SAME AS ACTIVE INGREDIENT	AVIXGEN INC
EP3388450	HIV VACCINE BASED ON TARGETING MAXIMIZED GAG AND NEF TO DENDRITIC CELLS	BAYLOR RES INSTITUTE
EP3388496	ORGANIC LIGHT-EMITTING ELEMENT	LG CHEMICAL LTD
EP3389105	COMPOSITION AND LIGHT-EMITTING ELEMENT IN WHICH SAME IS USED	SUMITOMO CHEMICAL CO
EP3389106	ORGANIC ELECTROLUMINESCENT ELEMENT	HODOGAYA CHEMICAL CO LTD
EP3389109	HETEROCYCLE SUBSTITUTED PHOSPHOROUS DERIVATIVES AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME	SAMSUNG DISPLAY CO LTD
EP3389379	MICROBIOCIDAL PHENYLAMIDINE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3389662	PROCESS FOR THE PREPARATION OF TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS FOR USING THE SAME FOR THE TREATMENT OF CANCER	GENENTECH INC
EP3390327	METHODS AND SYSTEMS FOR RECOVERING DICYCLOPENTADIENE FROM PYGAS	SABIC GLOBAL TECHNOLOGIES BV
EP3390345	PROCESS FOR THE SEPARATION OF ORGANIC COMPOUNDS	VITO NV
EP3390357	BIARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS	MERCK SHARP & DOHME
EP3390359	(R)-N-(ADAMANTYL-2-YL)PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES FOR COSMETIC USE	DSM IP ASSETS BV
EP3390365	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3390370	BIS-TRIAZOLE COMPOUNDS WITH ANTI-BIOFILM AND ANTI-CORROSION PROPERTIES	UNIV DE TOULON
EP3390376	PROCESSES AND SYSTEMS FOR REMOVING AN ALKYL IODIDE IMPURITY FROM A RECYCLE GAS STREAM IN THE PRODUCTION OF ETHYLENE OXIDE	SHELL INT RESEARCH
EP3390384	QUINOLINE-3-CARBOXAMIDES AS H-PGDS INHIBITORS	ASTEX THERAPEUTICS LTD
EP3390387	HETEROARYLBENZIMIDAZOLE COMPOUNDS	BAYER PHARMA AG
EP3390388	LANTHANIDE COMPLEXES FOR CRYSTALLISING BIOLOGICAL MACROMOLECULES AND DETERMINING THE CRYSTALLOGRAPHIC STRUCTURE THEREOF	ECOLE NORMALE SUPERIEURE LYON
EP3390389	POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS	MERCK PATENT GMBH
EP3390392	ALKYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS	AMGEN INC
EP3390400	HETEROARYLHYDROXYPYRIMIDINONES AS AGONISTS OF THE APJ RECEPTOR	SQUIBB BRISTOL MYERS CO
EP3390404	TRICYCLIC COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS	NOVARTIS AG
EP3390412	WATER-SOLUBLE DERIVATIVES OF 3,5-DIPHENYL-DIAZOLE COMPOUNDS	MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WSS
EP3390424	FKBP DOMAIN WITH TRANSGLUTAMINASE RECOGNITION SITE	ROCHE DIAGNOSTICS GMBH
EP3390427	PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES	FRESENIUS KABI IPSUM S R L
EP3390441	HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES	GILEAD SCIENCES INC
EP3390450	ANTI-CD28 HUMANIZED ANTIBODIES FORMULATED FOR ADMINISTRATION TO HUMANS	OSE IMMUNOTHERAPEUTICS
EP3390452	NEW USE OF AN ANTI-CD303 TRANSMEMBRANE PROTEIN ANTIBODY	LAB FRANCAIS DU FRACTIONNEMENT
EP3390693	METHOD FOR GENERATING CARBON-BASED SECONDARY ENERGY CARRIERS OR BASIC CHEMICAL PRODUCTS	ZENTRUM FUER SONNENENERGIE UND WASSERSTOFF FORSCHUNG BADEN WUERTTEMBERG
EP3392232	FLUORENE MULTIFUNCTIONAL PHOTOINITIATOR AND PREPARATION AND USE THEREOF, AND PHOTOSENSITIVE RESIN COMPOSITION CONTAINING FLUORENE PHOTOINITIATOR AND USE THEREOF	CHANGZHOU TRONLY ADVANCED ELECTRONIC MAT CO LTD
EP3392234	METHOD FOR PRODUCING FERULIC ACID FROM CORNHUSK AT HIGH PURITY AND HIGH YIELD	CJ CHEILJEDANG CORP
EP3392236	METHOD FOR PRODUCING AROMATIC AMIDE DERIVATIVE	MITSUI CHEMICALS AGRO INC
EP3392239	DIALKYL SULFIDE, METHOD FOR PRODUCING DIALKYL SULFIDE, EXTREME-PRESSURE ADDITIVE, AND LUBRICATING FLUID COMPOSITION	DAINIPPON INK & CHEMICALS
EP3392242	NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEMICAL LTD
EP3392249	MACROCYCLES WITH HETROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS	SQUIBB BRISTOL MYERS CO
EP3392261	STEROIDAL COMPOUND, COMPOSITION CONTAINING THE SAME AND USE THEREOF	SHENZHEN TARGETRX INC
EP3392262	CYCLOPEPTIDE, PHARMACEUTICAL OR COSMETIC COMPOSITION COMPRISING THE SAME AND METHOD FOR PREPARING THE SAME
EP3392269	ANTI TENASCIN C ANTIBODIES TO TREAT INFLAMMATORY DISEASES	IMPERIAL INNOVATIONS LTD
EP3393470	METABOLISM RESISTANT FENFLURAMINE ANALOGS AND METHODS OF USING THE SAME	ZOGENIX INTERNATIONAL LTD
EP3393489	SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS	LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT
EP3393505	RECOMBINANT ZIKA VACCINES	THEMIS BIOSCIENCE GMBH
EP3393522	IMPROVED HYBRID DUAL RECOMBINANT AAV VECTOR SYSTEMS FOR GENE THERAPY	INST NAT SANTE RECH MED
EP3393613	A DYNAMIC MELT CRYSTALLIZATION PROCESS FOR PURIFYING DICYCLOPENTADIENE FROM A MIXED LIQUID HYDROCARBON STREAM	SABIC GLOBAL TECHNOLOGIES BV
EP3394020	INTERMOLECULAR REACTION OF PROPARGYL ETHERS WITH DIMETHYLFURAN IN THE PRESENCE OF GOLD(I) COMPLEXES	DSM IP ASSETS BV
EP3394021	CONVERSION OF A PERFLUORINATED VINYL ETHER INTO A PARTIALLY FLUORINATED SATURATED ETHER DERIVATIVE	3M INNOVATIVE PROPERTIES CO
EP3394023	METHODS FOR CONVERTING FLUORINATED COMPOUNDS	3M INNOVATIVE PROPERTIES CO
EP3394025	PREPARATION OF PHENYL COMPOUNDS	TNO
EP3394040	CFTR REGULATORS AND METHODS OF USE THEREOF	THE REGENTS OF THE UNIV OF CALIFORNIA A CALIFORNIA CORPORATION
EP3394045	COCRYSTAL, PRODUCTION METHOD THEREOF, AND MEDICAMENT CONTAINING COCRYSTAL	TAKEDA PHARMACEUTICALS CO
EP3394049	CYANOPYRROLIDINE DERIVATIVES AS INHIBITORS FOR DUBS	MISSION THERAPEUTICS LTD
EP3394071	HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS	MUTABILIS
EP3394083	CFTR REGULATORS AND METHODS OF USE THEREOF	UNIV CALIFORNIA
EP3394084	PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS	IMMATICS BIOTECHNOLOGIES GMBH
EP3394086	COMPOSITIONS WITH THERMOLABILE DYES	ROCHE DIAGNOSTICS GMBH
EP3394089	POLYPEPTIDES FOR INHIBITING COMPLEMENT ACTIVATION	GREENOVATION BIOTECH GMBH
EP3394266	NUCLEIC ACIDS ENCODING REPETITIVE AMINO ACID SEQUENCES RICH IN PROLINE AND ALANINE RESIDUES THAT HAVE LOW REPETITIVE NUCLEOTIDE SEQUENCES	XL PROTEIN GMBH
EP3394292	METHODS OF LIBRARY CONSTRUCTION FOR POLYNUCLEOTIDE SEQUENCING	SOMAGENICS INC
EP3395438	REACTOR	IHI CORP
EP3395786	BUTADIENE PREPARATION METHOD	LG CHEMICAL LTD
EP3395793	PROCESS FOR THE PREPARATION OF ALPHA-FUNCTIONALIZED KETONES	IGM GROUP B V
EP3395796	A CRYSTALLINE TRIHYDRATE FORM OF (3S,3S ) 4,4 -DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID)	QUANTUM GENOMICS
EP3395799	COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME	LG CHEMICAL LTD
EP3395800	HETEROCYCLIC QUATERNARY NITROGEN COMPOUNDS COMPRISING A POLYMERIC SUBSTITUENT AND THEIR USE AS A PHOTOLATENT CATALYST IN CURABLE COMPOSITIONS	HENKEL AG & CO KGAA
EP3395818	2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES	BAYER PHARMA AG
EP3395825	REAL TIME MONITORING AND CONTROL OF PROTEIN PRODUCTION PROCESSES USING IMPEDANCE SPECTROSCOPY	BAXALTA GMBH
EP3395832	ANTI P2X7 RECEPTOR ANTIBODIES AND FRAGMENTS THEREOF	BIOSCEPTRE INTERNATIONAL LTD
EP3395835	ANTIBODY HAVING ENHANCED ACTIVITY, AND METHOD FOR MODIFYING SAME	CHUGAI PHARMACEUTICAL CO LTD
EP3395952	COMPOSITION FOR PRODUCING D-PSICOSE COMPRISING D-PSICOSE 3-EPIMERASE AND SALT AND METHOD FOR PRODUCING D-PSICOSE USING SAME	CJ CHEILJEDANG CORP
EP3397615	MIXED DECYL MERCAPTANS COMPOSITIONS AND METHODS OF MAKING SAME	CHEVRON PHILLIPS CHEMICAL CO LP
EP3397630	PROCESS FOR THE PREPARATION OF PANTOPRAZOLE SODIUM SESQUIHYDRATE	KRKA TOVARNA ZDRAVIL D D NOVO MESTO
EP3397635	METHODS FOR THE MANUFACTURE OF AN AROMATIC BISIMIDE AND A POLYETHERIMIDE	SABIC GLOBAL TECHNOLOGIES BV
EP3397636	PROCESS FOR THE PREPARATION OF QUINOLINE-2(1H)-ONE DERIVATIVES	HONOUR R&D
EP3397637	COMPOUND FOR PHOTOACTIVE ORGANIC ELECTRONIC COMPONENTS AND PHOTOACTIVE ORGANIC ELECTRONIC COMPONENT CONTAINING THE COMPOUND	HELIATEK GMBH
EP3397640	XANTHINE DERIVATIVE INHIBITORS OF BET PROTEINS	INST NAT SANTE RECH MED
EP3397964	COMPOSITIONS AND METHODS FOR DETECTING AND TREATING OVARIAN CANCER	PROGASTRINE ET CANCERS S A R L
EP3397966	COMPOSITIONS AND METHODS FOR DETECTING AND TREATING GASTRIC CANCER	PROGASTRINE ET CANCERS S A R L
EP3398200	TIN-CONTAINING DOPANT COMPOSITIONS, SYSTEMS AND METHODS FOR USE IN ION IMPLANTATION SYSTEMS	PRAXAIR TECHNOLOGY INC
EP3398928	METHOD FOR PRODUCING CYCLOPENTYL ALKYL ETHER COMPOUND	ZEON CORP
EP3398932	METHOD FOR SELECTIVELY SYNTHESIZING CATIONIC LIPIDS	SAMYANG BIOPHARMACEUTICALS
EP3398950	NOVEL KINASE INHIBITOR AGAINST WILD-TYPE EGFR AND MUTATED EGFR	PRECEDO PHARMACEUTICALS CO LTD
EP3398951	SALT OF QUINOLONE COMPOUND, POLYMORPHS THEREOF, PREPARATION METHOD THEREFOR, COMPOSITION, AND APPLICATIONS	SHANGHAI PHARMACEUTICALS HOLDING CO LTD
EP3398952	SYNTHESIS PROCESS OF RUXOLITINIB	CHAI TAI TIANQING PHARMACEUTICAL GROUP CO LTD
EP3398956	NOVEL RIG-I LIGANDS AND METHODS FOR PRODUCING THEM	UNIV BONN RHEINISCHE FRIEDRICH WILHELMS
EP3398963	CHEMICALLY MODIFIED MRNA FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH THE CFTR GENE	UNIV TUEBINGEN MEDIZINISCHE FAKULTAET
EP3399040	METHOD OF PREPARING PORCINE CIRCOVIRUS TYPE 2 CAPSID PROTEIN AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
EP3399873	HIGHLY SOLUBLE STEVIOL GLYCOSIDES	PURECIRCLE USA INC
EP3399993	METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY	WILSON D TRAVIS
EP3400066	TREATMENTS AND PREVENTION OF OPIOID NEONATAL ABSTINENCE SYNDROME	OHIO STATE INNOVATION FOUNDATION
EP3400206	IMPROVED PROCESSES FOR PREPARING HALOGENATED ALKANES	BLUE CUBE IP LLC
EP3400208	PROCESS FOR THE PREPARATION OF ETHYLENE GLYCOL FROM SUGARS	TOPSOE HALDOR AS
EP3400227	QUINOLINE ANALOGS AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS	HOU XIAOLIN
EP3400238	MUTATED VON WILLEBRAND FACTOR	CSL BEHRING RECOMBINANT FACILITY AG
EP3400239	TETRAVALENT ANTI-PSGL-1 ANTIBODIES AND USES THEREOF	BIOALLIANCE CV
EP3400244	ANTI-CD37 CHIMERIC ANTIGEN RECEPTORS AND IMMUNE CELLS EXPRESSING THEM	UNIV OSLO HF
EP3401298	NOVEL FLUORINE-CONTAINING COMPOUND HAVING UNSATURATED BOND, AND SURFACE MODIFIER USING SAME	TOSOH FINECHEM CORP
EP3401299	REACTOR FOR CARRYING OUT EXOTHERMIC EQUILIBRIUM REACTIONS	AIR LIQUIDE
EP3401300	METHOD FOR CARRYING OUT EXOTHERMIC EQUILIBRIUM REACTIONS	AIR LIQUIDE
EP3401301	HYDROXYPIVALALDEHYDE PRODUCTION METHOD	MITSUBISHI GAS CHEMICAL CO
EP3401313	AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME	SAMSUNG DISPLAY CO LTD
EP3401316	CHEMICAL PROCESS	GLAXO GROUP LTD
EP3401327	DIFFERENTIAL IN TUMOUR GENE PRODUCTS AND USE OF SAME	ASTELLAS PHARMA INC
EP3401335	COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF	GENENTECH INC
EP3402494	CHIMERIC PROTEINS AND METHODS OF IMMUNOTHERAPY	UNIV LELAND STANFORD JUNIOR
EP3402515	IMPROVED METHODS FOR MONITORING IMMUNE STATUS OF A SUBJECT	BERENSON JAMES R
EP3402771	PROCESS FOR THE PREPARATION OF OLEFIN CONTAINING FLUORINE	SRF LTD
EP3402775	METHOD FOR THE PREPARATION OF SUBSTITUTED 2-ARYL-ETHANOLS	BAYER CROPSCIENCE AG
EP3402790	SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS INHIBITORS OF ROCK	SQUIBB BRISTOL MYERS CO
EP3402814	METHODS OF PRODUCING PATIENT-SPECIFIC ANTI-CANCER THERAPEUTICS AND METHODS OF TREATMENT THEREFOR	BERKELEY LIGHTS INC
EP3402851	BRANCHED POLYOL ADDITIVES FOR ELECTROPHORETIC MEDIA	E INK CALIFORNIA LLC
EP3402876	VASCULAR EXTRACELLULAR MATRIX HYDROGEL	UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION
EP3402911	PROCESS FOR PRODUCING OXALIC ACID	AVANTIUM KNOWLEDGE CENTRE BV
EP3403070	FLUORESCENCE ASSAY FOR QUANTIFICATION OF PICOLINATE AND OTHER COMPOUNDS IN OXIDIZERS AND OXIDIZING COMPOSITIONS	ECOLAB USA INC
EP3404013	PURIFICATION OF 1,4-BIS (4-PHENOXYBENZOYL)BENZENE BY CENTRIFUGAL FILTRATION	ARKEMA FRANCE
EP3404014	PRODUCTION METHOD FOR GRANULES OF CALCIUM SALT, AND SAID GRANULES	UNICAL
EP3404019	PROCESS FOR THE PREPARATION OF HIGH PURITY MIGLUSTAT	NAVINTA LLC
EP3404035	OXYSTEROL-STATIN COMPOUNDS FOR BONE GROWTH	WARSAW ORTHOPEDIC INC
EP3404073	HYDROPHILIC ISOCYANURATES CONTAINING ALOXYSILANE	EVONIK DEGUSSA GMBH
EP3404081	PROCESS AND INSTALLATION FOR THE CONVERSION OF CRUDE OIL TO PETROCHEMICALS HAVING AN IMPROVED PROPYLENE YIELD	SAUDI BASIC IND CORP
EP3404106	SELECTIVE GENE THERAPY EXPRESSION SYSTEM	GENETHON
EP3405034	PROCESS FOR THE PREPARATION OF 4-ALKOXY-3-HYDROXYPICOLINIC ACIDS	DOW AGROSCIENCES LLC
EP3405198	DEVICE FOR DETECTION OF VITAMIN D METABOLITES	AFFIMEDIX INC
EP3405454	INDOLINE DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF	YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD
EP3405462	PROCESS FOR THE PREPARATION OF GLYCEROL CARBONATE	UNIV BELFAST
EP3405467	PROCESS FOR THE SYNTHESIS OF INTERMEDIATES OF NEBIVOLOL	MENARINI INT OPERATIONS LUXEMBOURG SA
EP3405469	N-((1-PHENYL-9H-PYRIDO[3,4-B]INDOL-3-YL)METHYL)CINNAMAMIDES AS ANTICANCER AGENTS AND PREPARATION THEREOF	COUNCIL SCIENT IND RES
EP3405485	ENDOTHELIN-1 RECEPTOR BASED ENDOTHELIN-1 SPONGE	JAIN ARJUN
EP3405487	IgY ANTIBODIES FOR THE PREVENTION OF SEA LICE INFESTATION AND INFECTION	NORIFISH AS
EP3405490	MONO AND BISPECIFIC ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III AND CD3 AND THEIR USES	PFIZER
EP3405495	NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES	INNATE PHARMA
EP3406262	MONOCLONAL ANTIBODIES SPECIFIC FOR THE PIII ANTIGEN OF HUMAN ADENOVIRUS (ADV), PRODUCED AND SECRETED BY CELL HYBRIDOMAS, USEFUL FOR DETECTION AND DIAGNOSIS OF ADV INFECTION	UNIV PONTIFICIA CATOLICA CHILE
EP3406600	TRPM8 RECEPTOR AGONIST COMPOUNDS AND USES THEREOF	UNIV MIGUEL HERNANDEZ DE ELCHE
EP3406604	METHOD FOR PREPARING 3-((2S,5S)-4-METHYLENE-5-(3-OXOPROPYL)TETRAHYDROFURANE-2-YL) PROPANOL DERIVATIVE, AND INTERMEDIATE THEREFOR	YONSUNG FINE CHEMICAL CO LTD
EP3406608	THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE	AGIOS PHARMACEUTICALS INC
EP3406612	CARBOLINE DERIVATIVE SERVING AS BROMODOMAIN INHIBITOR	NINGBO WENDA PHARMA TECH LTD
EP3406617	USE OF PHOSPHINE OXIDE COMPOUNDS IN A SEMICONDUCTING LAYER COMPRISED IN AN ELECTRONIC DEVICE	NOVALED GMBH
EP3406627	IGG4 FC FRAGMENT COMPRISING MODIFIED HINGE REGION	HANMI PHARM IND CO LTD
EP3407414	NON-AQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY COMPRISING SAME	LG CHEMICAL LTD
EP3407717	MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO	DOW AGROSCIENCES LLC
EP3407718	MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO	DOW AGROSCIENCES LLC
EP3407720	MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO	DOW AGROSCIENCES LLC
EP3407889	ORGANIC COMPOUNDS	INTRA CELLULAR THERAPIES INC
EP3408257	LINKER MOLECULE AND USE THEREOF IN METHODS FOR PURIFYING PEPTIDES	BELYNTIC GMBH
EP3408260	CRYSTALLINE(2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-(ETHOXYMETHYL)-4-(3-HYDROXYISOXAZOLE-5-CARBOXAMIDO)-2-METHYLPENTANOIC ACID AND USES THEREOF	THERAVANCE BIOPHARMA R&D IP LLC
EP3408263	MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO	DOW AGROSCIENCES LLC
EP3408270	COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING	UNIV WICHITA STATE
EP3408277	EXTRACTION OF PHYTOSTEROLS FROM TALL OIL SOAP USING A SOLVENT SELECTED FROM DIBROMOMETHANE, BROMOFORM, TETRABROMOMETHANE OR A COMBINATION THEREOF	STORA ENSO OYJ
EP3408282	INCREASED TRIACYLGLYCEROL PRODUCTION IN MICROALGAE	TOTAL RAFFINAGE CHIMIE
EP3408289	COLLAGEN TYPE VII ALPHA 1 ASSAY	NORDIC BIOSCIENCE AS
EP3408349	CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING	UNIV RAMOT
EP3408381	ATTENUATED INFECTIOUS BRONCHITIS VIRUS	THE PIRBRIGHT INST
EP3409343	LIQUID HAVING OXYGEN ABSORBING ABILITY, METHOD FOR PRODUCING SAME, AND COMPLEX SOLUTION CONTAINING SAME	SHARP KK
EP3409356	FLUID BED AMMOXIDATION REACTION CATALYST, AND ACRYLONITRILE PRODUCTION METHOD	ASAHI CHEMICAL IND
EP3409656	PRODUCTION OF ADIPIC ACID AND DERIVATIVES FROM CARBOHYDRATE-CONTAINING MATERIALS	ARCHER DANIELS MIDLAND CO
EP3409667	AMIDE COMPOUNDS FOR THE TREATMENT OF HIV INFECTIONS	GILEAD SCIENCES INC
EP3409671	ISOTHIAZOLE DERIVATIVES AS GPR120 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES	JANSSEN PHARMACEUTICA NV
EP3409678	NEW HALOGEN GERMANIDES AND METHOD FOR THEIR PREPARATION	EVONIK DEGUSSA GMBH
EP3409680	SYNTHESIS OF BIS(ACYL)PHOSPHINES BY ACTIVATION OF UNREACTIVE METAL PHOSPHIDES	IGM GROUP B V
EP3409682	COMPOUND AND USE THEREOF AND PLATINUM COMPLEX AND LIPIDOSOME THEREOF	UNIV SHENYANG PHARMACEUTICAL
EP3411036	3,5-DISUBSTITUTED PYRAZOLES USEFUL AS CHECKPOINT KINASE 1 (CHK1) INHIBITORS, AND THEIR PREPARATIONS AND APPLICATIONS
EP3411346	DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS	UNIV DEGLI STUDI UDINE
EP3411347	MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS	UNIV DEGLI STUDI UDINE
EP3411349	METHOD OF INDUSTRIALLY PRODUCING MONOCHLOROACETIC ACID	PCC MCAA SP Z O O
EP3411350	METHOD OF PRODUCING HIGH-PURITY MONOCHLOROACETIC ACID	PCC MCAA SP Z O O
EP3411358	SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF	TAKEDA PHARMACEUTICALS CO
EP3411359	METHODS OF PREPARING HYDROXYLAMINE DERIVATIVES USEFUL IN THE PREPARATION OF ANTI-INFECTIVE AGENTS	MERCK SHARP & DOHME
EP3411388	TRUNCATED GLYCOPROTEIN G OF HERPES SIMPLEX VIRUS 2	SIMPLEXIA AB
EP3411389	NEW STREPTOCOCCAL PROTEASES	GENOVIS AB
EP3411391	UBIQUITIN VARIANTS AND USES THEREOF AS 53BP1 INHIBITORS	GOVERNING COUNCIL UNIV TORONTO
EP3411393	ADMINISTRATION OF ENGINEERED T CELLS FOR TREATMENT OF CANCERS IN THE CENTRAL NERVOUS SYSTEM	HOPE CITY
EP3411400	TREATMENT OF INFLAMMATORY DISEASES WITH INHIBITORS OF C5A ACTIVITY	INFLARX GMBH
EP3411402	BCMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS	AMGEN RES MUNICH GMBH
EP3411408	ANTI-ROR1 ANTIBODIES AND USES THEREOF	HUTCHINSON FRED CANCER RES
EP3411410	PD-1 ANTIBODIES	INNOVENT BIOLOGICS SUZHOU CO LTD
EP3412302	MODIFIED FGF-21 POLYPEPTIDES AND USES THEREOF	SQUIBB BRISTOL MYERS CO
EP3412644	INTEGRATED SYSTEM COMPRISING ELECTROCATALYSIS DEVICE OF GLYCEROL AND CHEMICAL CATALYSIS DEVICE OF BIOMASS	KOREA RES INST CHEMICAL TECH
EP3412645	METHOD FOR PRODUCING TETRAFLUOROPROPENE	DAIKIN IND LTD
EP3412650	METHOD FOR EXTRACTING 1,5-PENTANEDIAMINE FROM SOLUTION SYSTEM CONTAINING 1,5-PENTANEDIAMINE SALT	CATHAY R&D CENTER CO LTD
EP3412665	SUVOREXANT INTERMEDIATE AND PREPARATION METHOD THEREOF	ZHEJIANG HUAHAI PHARM CO LTD
EP3413887	INTERMEDIATES IN THE SYNTHESIS OF ERIBULIN AND RELATED METHODS OF SYNTHESIS	EISAI R&D MAN CO LTD
EP3413895	C5-C6-OXACYLIC FUSED IMINOTHIADIAZINE DIOXIDE COMPOUNDS BEARING AN ETHER LINKER AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE	MERCK SHARP & DOHME
EP3414215	MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS	YEDA RES & DEV
EP3414220	PROCESSES FOR CONVERTING OLEFINS TO ALCOHOLS, ETHERS, OR COMBINATIONS THEREOF	DOW TECHNOLOGY INVESTMENTS LLC
EP3414221	PROCESS TO PREPARE HIGHER ETHYLENE AMINES AND ETHYLENE AMINE DERIVATIVES	AKZO NOBEL CHEMICALS INT BV
EP3414222	PROCESS TO PREPARE HIGHER ETHYLENE AMINES AND ETHYLENE AMINE DERIVATIVES	AKZO NOBEL CHEMICALS INT BV
EP3414223	PROCESS TO CONVERT CYCLIC ALKYLENE UREAS INTO THEIR CORRESPONDING ALKYLENE AMINES	AKZO NOBEL CHEMICALS INT BV
EP3414227	PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS	SQUIBB BRISTOL MYERS CO
EP3414229	QUINOLINONE LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF	PHARMAKEA INC
EP3414232	PROCESS TO PREPARE HIGHER ETHYLENE AMINES AND ETHYLENE AMINE DERIVATIVES	AKZO NOBEL CHEMICALS INT BV
EP3414238	SUBSTITUTED -OXYIMIDAZOLYL-CARBOXAMIDES AS PEST CONTROL AGENTS	BAYER CROPSCIENCE AG
EP3414247	SPIROINDOLINONES AS DDR1 INHIBITORS	HOFFMANN LA ROCHE
EP3414253	C5-C6-OXACYLIC FUSED IMINOTHIAZINE DIOXIDE COMPOUNDS BEARING AN ETHER LINKER AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE	MERCK SHARP & DOHME
EP3414255	PREPARATIVE ELECTROPHORETIC METHOD FOR TARGETED PURIFICATION OF GENOMIC DNA FRAGMENTS	UNIV WASHINGTON
EP3414324	MULTIPLE LIGASE COMPOSITIONS, SYSTEMS, AND METHODS	RGENE INC
EP3415160	POLYPEPTIDES DERIVED FROM ENTEROCOCCUS AND THEIR USE FOR VACCINATION AND THE GENERATION OF THERAPEUTIC ANTIBODIES	UNIV FREIBURG ALBERT LUDWIGS
EP3415496	METHOD FOR PRODUCING 1, 2-BENZENE DIMETHANOL COMPOUND	SDS BIOTECH CORP
EP3415505	METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC)	WISTA LAB LTD
EP3415508	ELECTRON BUFFERING MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE	ROHM & HAAS ELECT MATERIALS KOREA LTD
EP3415512	NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME	LG CHEMICAL LTD
EP3415516	HAPTENS OF RISPERIDONE AND PALIPERIDONE	JANSSEN PHARMACEUTICA NV
EP3415528	FC FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS	SQUIBB BRISTOL MYERS CO
EP3415585	ORGANIC LIGHT-EMITTING ELEMENT	LG CHEMICAL LTD
EP3416205	LIGHT-EMITTING ELEMENT AND METHOD FOR MANUFACTURING SAME	SUMITOMO CHEMICAL CO
EP3416676	DOSING AND USE OF LONG-ACTING CLR/RAMP AGONISTS	ADEPTHERA LLC
EP3416740	PROCESSES TO CREATE MULTIPLE VALUE STREAMS FROM BIOMASS SOURCES	INTERCONTINENTAL GREAT BRANDS LLC
EP3416935	COMPOSITION AND METHOD FOR DISPERSING SCALES AND SOLID DEPOSITS	HINDUSTAN PETROLEUM CORP LTD
EP3416936	METHANOL PRODUCTION PROCESS	FUNDACIO INSTITUT CATALA DINVESTIGACIO QUIM ICIQ
EP3416946	TETRACYCLIC PYRIDONE COMPOUNDS AS ANTIVIRALS	NOVARTIS AG
EP3416959	PESTICIDALLY ACTIVE PYRAZOLE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3416966	PROCESS FOR THE PREPARATION OF 4-PHENYL-5-ALKOXYCARBONYL-2-THIAZOL-2-YL-1,4-DIHYDROPYRIMIDIN-6-YL]METHYL]-3-OXO-5,6,8,8A-TETRAHYDRO-1H-IMIDAZO[1,5-A]PYRAZIN-2-YL]-CARBOXYLIC ACID	HOFFMANN LA ROCHE
EP3416983	ANTIBODIES FOR IL-17C	MORPHOSYS AG
EP3416984	CHIMERIC CANINE ANTI-CD20 ANTIBODY	ELANCO US INC
EP3417055	NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS RESISTANT TO PRE-EXISTING HUMAN NEUTRALIZING ANTIBODIES	UNIV LELAND STANFORD JUNIOR
EP3417454	METHOD FOR COATING METAL SURFACES WITH SPIN TRANSITION COMPOUNDS	UNIV WIEN TECH
EP3417701	GENETICALLY MODIFIED MICE AND ENGRAFTMENT	REGENERON PHARMA
EP3418275	NOVEL 2,3,5-SUBSTITUTED THIOPHENE COMPOUND AS PROTEIN KINASE INHIBITOR	KOREA INST SCI & TECH
EP3418386	COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF HEPATITIS B VIRUS	ARROWHEAD PHARMACEUTICALS INC
EP3419744	COMPOSITION COMPRISING A FLUORINE-CONTAINING SURFACTANT	UNIV INNSBRUCK
EP3419957	AROMATIC COMPOUNDS FROM FURANICS	TNO
EP3419974	PROCESS FOR THE SEPARATION OF ENANTIOMERS OF PIPERAZINE DERIVATIVES	ASCENEURON SA
EP3419975	IMINOTHIADIAZINANE DIOXIDE DERIVATIVES AS PLASMEPSIN V INHIBITORS	UCB BIOPHARMA SPRL
EP3419984	METHOD FOR PREPARING A MONOSACCHARIDE AND/OR OLIGOSACCHARIDE AND/OR POLYSACCHARIDE MIXTURE BY PURIFYING A LIGNOCELLULOSIC MATERIAL HYDROLYSATE	INST POLYTECHNIQUE GRENOBLE
EP3419995	NOVEL IMMUNOSTIMULATING VECTOR SYSTEM	PROVECS MEDICAL GMBH
EP3419999	ANTIBODIES HAVING SPECIFICITY FOR BTLA AND USES THEREOF	INST NAT SANTE RECH MED
EP3420001	BINDING MEMBERS TO PD-L1	CELL MEDICA SWITZERLAND AG
EP3421446	METHODS AND APPARATUS FOR PRODUCING A LOW-MOISTURE CARBOXYLIC ACID WET CAKE	GRUPO PETROTEMEX SA DE CV
EP3421449	PRODUCTION METHOD FOR 1,1'-BINAPHTHYL DERIVATIVE, AND 1,1'-BINAPHTHYL DERIVATIVE	UNIV KYOTO
EP3421457	PYRIMIDINE FGFR4 INHIBITORS	EISAI R&D MAN CO LTD
EP3421464	RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AS WELL AS PREPARATION METHOD AND USE THEREOF	BEIJING TIDE PHARMACEUTICAL CO LTD
EP3421470	SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES IN CRYSTALLINE FORM	ADVERIO PHARMA GMBH
EP3421489	ANTI-MESOTHELIN CHIMERIC ANTIGEN RECEPTORS	US HEALTH
EP3421603	GENE THERAPY FOR NEURODEGENERATIVE DISORDERS	GENZYME CORP
EP3423426	PROCESS FOR PRODUCING EXO-TETRAHYDRODICYCLOPENTADIENE	MONUMENT CHEMICAL HOUSTON LLC
EP3423432	INTEGRATED SYNTHESIS OF AMMONIA AND UREA	THYSSENKRUPP IND SOLUTIONS AG
EP3423440	5-METHYL-6-PHENYL-4,5-DIHYDRO-2H-PYRIDAZIN-3-ONE DERIVATIVE	OTSUKA PHARMA CO LTD
EP3423442	METHOD FOR THE MANUFACTURE OF CYCLODODECASULFUR	EASTMAN CHEM CO
EP3423455	SEMICONDUCTING POLYMER	BASF SE
EP3423457	PROCESS FOR THE PREPARATION OF AN ANTIBODY-RIFAMYCIN CONJUGATE	HOFFMANN LA ROCHE
EP3423459	METHOD OF PURIFYING ANTIFUNGAL COMPOUNDS AND EXOPOLYSACCHARIDES FROM A MICROBIAL CELL CULTURE	BAYER CROPSCIENCE LP
EP3423460	METHOD OF PRODUCING HIGH PURITY D-PSICOSE	CJ CHEILJEDANG CORP
EP3423464	PROCESS AND NEW INTERMEDIATES FOR THE PREPARATION OF 11-METHYLENE STEROIDS	BIONICE S L U
EP3423467	NEW DIFLUOROKETAMIDE DERIVATIVES AS HTRA1 INHIBITORS	HOFFMANN LA ROCHE
EP3423470	IMMUNOMODULATORS	SQUIBB BRISTOL MYERS CO
EP3423477	NEW ANTIMICROBIAL PEPTIDES, THEIR VARIANTS AND USES	CHAIN ANTIMICROBIALS OY
EP3423484	HUMAN NEUTRALIZING ANTIBODIES BINDING TO INFLUENZA B NEURAMINIDASE	JANSSEN VACCINES & PREVENTION BV
EP3423485	MUTANT PORE	OXFORD NANOPORE TECH LTD
EP3423486	MUTANT PORE	OXFORD NANOPORE TECH LTD
EP3423487	MUTANT PORES	OXFORD NANOPORE TECH LTD
EP3423495	ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR)	YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD
EP3423497	MONOCLONAL ANTIBODIES THAT SPECIFICALLY RECOGNIZE CANINE DLA-DR ANTIGEN AND THEIR USES	INST IMMUNOLOGII I TERAPII DOSWIADCZALNEJ POLSKIEJ AKADEMII NAUK
EP3424532	INFLUENZA VIRUS ANTIBODY COMPOSITIONS	THE SEC DEP FOR HEALTH
EP3424537	SMALL MOLECULE DRUG CONJUGATES	EIDGENOESSICHE TECHNISCHE HOCHSCHULE ZUERICH
EP3424903	METHOD FOR PRODUCING SULFOXIDE DERIVATIVE	KUMIAI CHEMICAL INDUSTRY CO
EP3424911	POSACONAZOLE, COMPOSITION, INTERMEDIATE, PREPARATION METHOD THEREFOR, AND USES THEREOF	ZHEJIANG AUSUN PHARMACEUTICAL CO LTD
EP3424932	BORONOPHTHALIDES FOR THERAPEUTIC USE	ANACOR PHARMACEUTICALS INC
EP3424934	ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES	UNIVERSAL DISPLAY CORP
EP3424935	PYRIDYL CARBENE PHOSPHORESCENT EMITTERS	UNIVERSAL DISPLAY CORP
EP3424936	METAL COMPLEXES	MERCK PATENT GMBH
EP3424946	A FUSION PROTEIN HAVING TRANSCRIPTION MODULATING DOMAIN AND A PROTEIN TRANSDUCTION DOMAIN, AND AN INHIBITOR FOR TRANSCRIPTION FACTOR FUNCTION COMPRISING THE SAME	UNIV YONSEI IACF
EP3424948	VASCULAR ENDOTHELIAL GROWTH FACTOR TARGETING PEPTIDE-ELASTIN FUSION POLYPEPTIDE AND SELF-ASSEMBLING NANOSTRUCTURE, WHICH ARE FOR INHIBITING ANGIOGENESIS	IUCF HYU ERICA CAMPUS
EP3425687	ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC THIN FILM COMPRISING SAME, AND USE THEREOF	AIST
EP3426348	3-DESOXY DERIVATIVE AND PHARMACEUTICAL COMPOSITIONS THEREOF	INTERCEPT PHARMACEUTICALS INC
EP3426639	TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME	MILLIKEN & CO
EP3426641	IMMUNOPROTEASOME INHIBITOR ANALOGS	UNIV CALIFORNIA
EP3426654	DIRECT PALLADIUM-CATALYZED AROMATIC FLUORINATION	HARVARD COLLEGE
EP3426656	TRICYCLIC COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS	NOVARTIS AG
EP3426668	PRECIOUS METAL COMPOUNDS	UMICORE AG & CO KG
EP3426672	PEPTOID AFFINITY LIGANDS	MIKE ANN LLC
EP3426673	PEPTOID AFFINITY LIGANDS	MIKE ANN LLC
EP3426750	PHOSPHORESCENT FERRO-MAGNETIC PARTICLE FORMULATION AND METHOD OF NON-DESTRUCTIVE TESTING THEREWITH	ILLINOIS TOOL WORKS
EP3426788	PLANT REGULATORY ELEMENTS AND USES THEREOF	MONSANTO TECHNOLOGY LLC
EP3427580	HUMAN ARCAP TRANSGENIC MOUSE
EP3427728	PHARMACEUTICAL COMPOSITIONS COMPRISING NITROXYL DONORS	CARDIOXYL PHARMACEUTICALS INC
EP3428145	METHOD FOR PRODUCING FLUORINATED COMPOUND	DAIKIN IND LTD
EP3428149	CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME	SAMSUNG DISPLAY CO LTD
EP3428152	COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME	LG CHEMICAL LTD
EP3428162	ANTHELMINTIC COMPOUNDS AND COMPOSITIONS AND METHOD OF USING THEREOF	MERIAL INC
EP3428169	6,6A-DIHYDRO FURO[3,2-B]FURAN-2-(5H)ONE DERIVATIVES, THEIR PREPARATION AND USE FOR TREATING TUMORS	UNIV DELLA CALABRIA
EP3428170	ANTI-INFLUENZA POLYCYCLIC PYRIDONE DERIVATIVE AND PRODRUG THEREOF	SHIONOGI & CO
EP3428177	PEPTIDE EXHIBITING HAIR GROWTH PROMOTING ACTIVITY AND/OR MELANIN PRODUCTION PROMOTING ACTIVITY AND USE THEREOF	CAREGEN CO LTD
EP3428182	ANTI-INFLAMMATORY PEPTIDES AND COMPOSITION COMPRISING THE SAME	KAEL GEMVAX CO LTD
EP3428192	ANTI-CD28 HUMANIZED ANTIBODIES	OSE IMMUNOTHERAPEUTICS
EP3428194	IMPROVED DUAL SPECIFICITY POLYPEPTIDE MOLECULE	IMMATICS BIOTECHNOLOGIES GMBH
EP3428256	PROCESS FOR PREPARING AN IODINATED FATTY ACID ETHYL ESTER
EP3428287	CONFORMATIONALLY-PREORGANIZED, MINIPEG-CONTAINING GAMMA-PEPTIDE NUCLEIC ACIDS	UNIV CARNEGIE MELLON
EP3428986	STABLE AND EFFICIENT ELECTROLUMINESCENT MATERIALS	UNIVERSAL DISPLAY CORP
EP3428989	LIGHT-EMITTING ELEMENT	SUMITOMO CHEMICAL CO
EP3429352	PROCESS FOR CONVERTING S-ENANTIOMER TO ITS RACEMIC FORM	FMC CORP
EP3429585	BRIDGED BICYCLIC INHIBITORS OF MENIN-MLL AND METHODS OF USE	KURA ONCOLOGY INC
EP3429633	A METHOD OF ENGINEERING DRUG-SPECIFIC HYPERSENSITIVE T-CELLS FOR IMMUNOTHERAPY BY GENE INACTIVATION	CELLECTIS
EP3429994	2-CYANOISOINDOLINE DERIVATIVES FOR TREATING CANCER	MISSION THERAPEUTICS LTD
EP3429998	PROCESS FOR PREPARING QUINOLIN-2-YL-PHENYLAMINE DERIVATIVES AND THEIR SALTS	RATIOPHARM GMBH
EP3430002	FUROIC ACID PREPARATION METHOD	UNIV LILLE
EP3430012	4,6 DIHYDROPYRROLO [3,4-C]PYRAZOLE-5 (1H)-CARBONITRILE DERIVATES FOR TREATING CANCER	MISSION THERAPEUTICS LTD
EP3430020	A PREPARATION METHOD OF DIASTEREOMERICALLY PURE TENOFOVIR ALAFENAMIDE OR ITS SALTS	ZENTIVA KS
EP3430031	PEPTIDES WITH ANTI-CANCER ACTIVITY	IDP DISCOVERY PHARMA S L
EP3430032	NOVEL ALPHA-1-MICROGLOBULIN DERIVED PROTEINS AND THEIR USE	A1M PHARMA AB
EP3430038	COMPOSITIONS AND METHODS FOR CD20 IMMUNOTHERAPY	HUTCHINSON FRED CANCER RES
EP3430051	ANTI-PY1235-MET IMMUNOLOGICAL BINDING REAGENT	THE US SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
EP3430054	METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND ANTI-GPC3 ANTIBODIES	CHUGAI PHARMACEUTICAL CO LTD
EP3430093	ENERGY CURABLE COMPOSITIONS COMPRISING POLYMERIC AMINOACRYLATES	SUN CHEMICAL CORP
EP3430407	COMPOSITIONS, DEVICES, AND METHODS FOR CELL SEPARATION	QT HOLDINGS CORP
EP3431103	TARGETING ABCB5 FOR CANCER THERAPY	BRIGHAM & WOMENS HOSPITAL INC
EP3431460	NOVEL FORMULATION AND METHOD OF SYNTHESIS	GE HEALTHCARE LTD
EP3431470	EPOXY COMPOUND, CURABLE COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING EPOXY COMPOUND, AND REACTIVE DILUENT	JXTG NIPPON OIL & ENERGY CORP
EP3431475	SOLID FORMS OF A SELECTIVE CDK4/6 INHIBITOR	PFIZER
EP3431483	METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST COMPONENT AND OLEFIN POLYMERIZATION CATALYST EACH COMPRISING SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING SAID OLEFIN POLYMERIZATION CATALYST	JAPAN POLYETHYLENE CORP
EP3431504	ANTI-PHOSPHOLIPASE D4 ANTIBODY	SBI BIOTECH CO LTD
EP3431614	CATALYST-FREE SURFACE FUNCTIONALIZATION AND POLYMER GRAFTING	ILLUMINA INC
EP3433224	CURCUMIN PURIFICATION	BIOPTEQ SPRL
EP3433225	NOVEL DERIVATIVES OF CURCUMINOIDS AND USE THEREOF AS AN ANTICANCER AGENT
EP3433234	ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS	MERCK SHARP & DOHME
EP3433236	CYANOPYRIMIDINE DERIVATIVES SUITABLE AS COMPONENTS IN LIQUID CRYSTAL MEDIA	MERCK PATENT GMBH
EP3433238	PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF PROSTATE CANCER	UNIV JOHNS HOPKINS
EP3433243	NOVEL DERIVATIVES AND THEIR USE AS SELECTIVE INHIBITORS OF CASPASE-2	INST NAT SANTE RECH MED
EP3433244	HERBICIDES	SYNGENTA PARTICIPATIONS AG
EP3433250	HERBICIDES	SYNGENTA PARTICIPATIONS AG
EP3433252	MICROBIOCIDAL OXADIAZOLE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3433268	PURIFICATION OF GLUCAGON-LIKE PEPTIDE 1 ANALOGS	BACHEM HOLDING AG
EP3433273	BINDING MOLECULES TO CD38 AND PD-L1	BIOMUNEX PHARMACEUTICALS
EP3433276	EARLY INTERVENTION METHODS TO PREVENT OR AMELIORATE TOXICITY	SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST
EP3434664	AZEOTROPE COMPOSITIONS COMPRISING 3,3,3-TRIFLUOROPROPENE AND HYDROGEN FLUORIDE AND PROCESSES FOR SEPARATION THEREOF	CHEMOURS CO FC LLC
EP3434665	METHOD FOR PRODUCING -FLUORO ACRYLIC ACID ESTER, AND COMPOSITION CONTAINING HIGHLY-PURE FLUOROCYCLOPROPANE DERIVATIVE, AND COMPOSITION CONTAINING HIGHLY-PURE -FLUORO ACRYLIC ACID ESTER	AGC INC
EP3434670	NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING SAME	LG CHEMICAL LTD
EP3434673	EGFR INHIBITOR FREE BASE OR ACID SALT POLYCRYSTALLINE FORM, PREPARATION METHOD THEREFOR, AND APPLICATION	JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD
EP3434682	ELECTRON-ACCEPTING COMPOUND, COMPOSITION FOR CHARGE TRANSPORT FILM, AND LIGHT-EMITTING ELEMENT USING SAME	MITSUBISHI CHEM CORP
EP3434687	NOVEL OXYNTOMODULIN DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR TREATING OBESITY COMPRISING THE SAME	HANMI SCIENCE CO LTD
EP3435472	LIQUID ELECTROLYTE COMPRISING AN ALKALI METAL SALT OF A PHOSPHATE COMPOUND	DAIKIN IND LTD
EP3436019	SOLID FORMS OF (1S,4S)-4-(2-(((3S4R)-3-FLUOROTETRAHYDRO-2H-PYRAN-4-YL) AMINO)-8-((2,4,6-TRICHLOROPHENYL) AMINO)-9H-PURIN-9-YL)-1-METHYLCYCLOHEXANE-1-CARBOXAMIDE AND METHODS OF THEIR USE	SIGNAL PHARM LLC
EP3436025	METHODS FOR THE SEPARATION AND DETECTION OF AN OXYSTEROL	WARSAW ORTHOPEDIC INC
EP3436079	CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE	KITE PHARMA INC
EP3436172	SYSTEM AND METHOD TO REMOVE ACIDIC SPECIES FROM A RICH MEG STREAM BY STRIPPING	CAMERON SOLUTIONS INC
EP3436419	METHODS AND APPARATUSES FOR PHENOL FRACTIONATION IN A SINGLE DIVIDING WALL COLUMN	HONEYWELL INT INC
EP3436422	PRODUCTION OF 1,5-PENTANEDIOL VIA UPGRADING OF TETRAHYDROFURFURYL ALCOHOL	WISCONSIN ALUMNI RES FOUND
EP3436425	AN IMPROVED PROCESS FOR THE PREPARATION OF BUTORPHANOL TARTRATE	HIKAL LTD
EP3436427	METHOD AND COMPOSITION FOR TREATING NEURONAL HYPER-EXCITABILITY	UNIV CALIFORNIA
EP3436429	BISCARBODIIMIDES AND POLYCARBODIIMIDES AND METHOD FOR THEIR PREPARATION	DOW GLOBAL TECHNOLOGIES LLC
EP3436432	SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF	GENENTECH INC
EP3436435	SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS	JANSSEN PHARMACEUTICALS INC
EP3436437	SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS	JANSSEN PHARMACEUTICALS INC
EP3436456	FUSED HEXACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY	UCB BIOPHARMA SPRL
EP3436458	FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY	UCB BIOPHARMA SPRL
EP3436459	FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY	UCB BIOPHARMA SPRL
EP3436460	FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY	UCB BIOPHARMA SPRL
EP3436463	CRYSTALLINE FORMS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6-(3-METHYL-1H- PYRAZOL-4-YL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE HEMIHYDRATE	TAKEDA PHARMACEUTICALS CO
EP3436471	RECOMBINASE MUTANTS	ILLUMINA INC
EP3436478	MULTISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF A NEOPLASM OF THE URINARY TRACT	LINDHOFER HORST DR
EP3436481	DUAL FUNCTION ANTIBODIES SPECIFIC TO GLYCOSYLATED PD-L1 AND METHODS OF USE THEREOF	STCUBE INC
EP3436483	ERBB2-TARGETING ANTIBODY	ST BIOCHIMICO ITALIANO GIOVANNI LORENZINI S P A
EP3436558	SURFACTANTS FOR SPOT PREVENTION IN AUTOMATIC DISHWASHING COMPOSITIONS	ROHM & HAAS
EP3437657	ANTIBODY MODIFIED BY SUBSTITUTING CYSTEINE AT AMINO ACID POSITIONS 80 AND 171 OF KABAT NUMBERING	SYSMEX CORP
EP3438081	METHOD FOR PRODUCING BUTADIENE	LG CHEMICAL LTD
EP3438082	RESTARTING METHOD	NIPPON KAYAKU KK
EP3438102	GLYCIDYL ESTER COMPOUND PREPARATION METHOD	KOLON INC
EP3438104	HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME	SAMSUNG DISPLAY CO LTD
EP3438113	TETRADENTATE LIGAND, AND PRODUCTION METHOD THEREFOR, SYNTHETIC INTERMEDIATE THEREOF, AND TRANSITION METAL COMPLEX THEREOF	TAKASAGO PERFUMERY CO LTD
EP3438116	LABELLED NUCLEOTIDES	ILLUMINA CAMBRIDGE LTD
EP3438271	DECANEDIOIC ACID PRODUCED BY MICROBIAL FERMENTATION AND PREPARATION METHOD THEREOF	CATHAY R&D CENTER CO LTD
EP3439622	A PROCESS FOR SYNTHESIZING AN AMIDO ALKYL BETAINE STARTING FROM AN ALCOHOL, AN AMIDO ALKYL BETAINE PREPARED BY THE PROCESS WITH INCREASED VISCOSITY, AND USE THEREOF AS A VISCOELASTIC SURFACTANT	RHODIA OPERATIONS
EP3439641	COMPOSITIONS, KITS AND METHODS FOR MAINTAINING EYELID HYGIENE	OCUSOFT INC
EP3439653	REDUCING TUMOR BURDEN BY ADMINISTERING CCR1 ANTAGONISTS IN COMBINATION WITH PD-1 INHIBITORS OR PD-L1 INHIBITORS	CHEMOCENTRYX INC
EP3439658	SOLUBLE C5aR ANTAGONISTS	CHEMOCENTRYX INC
EP3439689	METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR	REGENERON PHARMA
EP3440057	SILICONE ATOMS CONTAINING IVACAFTOR ANALOGUES	PROTEOSTASIS THERAPEUTICS INC
EP3440062	PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED ISOXAZOLINE COMPOUNDS - CRYSTALLINE TOLUENE SOLVATE OF (S)-AFOXOLANER	MERIAL INC
EP3440094	TDP-43 MITOCHONDRIAL LOCALIZATION INHIBITOR FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE	UNIV CASE WESTERN RESERVE
EP3440101	CD8-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING	INDI MOLECULAR INC
EP3440106	T CELL RECEPTORS	ADAPTIMMUNE LTD
EP3440155	ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME	ROHM & HAAS ELECT MATERIALS KOREA LTD
EP3441086	ANTI-PD-1 MONOCLONAL ANTIBODY	AKESO BIOPHARMA INC
EP3441379	PROCESS FOR THE PRODUCTION OF E-1,3,3,3-TETRAFLUOROPROPENE BY DEHYDROFLUORINATION	CHEMOURS CO FC LLC
EP3441767	APPARATUS FOR DETECTING DEGREE OF MALIGNANCY OF CIRCULATING TUMOR CELL UNIT, AND KIT FOR SAME	ON CHIP BIOTECHNOLOGIES CO LTD
EP3442584	COMBINATIONS OF PBD-BASED ANTIBODY DRUG CONJUGATES WITH BCL-2 INHIBITORS	SEATTLE GENETICS INC
EP3442931	CONTINUOUS METHOD FOR PRODUCING GRIGNARD ADDUCTS AND A DEVICE FOR CARRYING OUT SAME	FRAUNHOFER GES FORSCHUNG
EP3442941	PROCESS FOR PREPARATION OF CARMUSTINE	INTAS PHARMACEUTICALS LTD
EP3442993	METHODS AND KITS FOR THE RAPID DETECTION OF THE ESCHERICHIA COLI O25B-ST131 CLONE	INST NAT SANTE RECH MED
EP3443009	ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS	SYMPHOGEN AS
EP3443123	METHODS AND COMPOSITIONS FOR DETECTING SINGLE T CELL RECEPTOR AFFINITY AND SEQUENCE	UNIV TEXAS
EP3444235	PRODUCTION OF ACETIC ACID WITH AN INCREASED PRODUCTION RATE	CELANESE INT CORP
EP3444244	PREPARATION PROCESS FOR HIGH-PURITY DABIGATRAN ETEXILATE	ZHEJIANG HUAHAI PHARM CO LTD
EP3444257	ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE	BOE TECHNOLOGY GROUP CO LTD
EP3444261	2,2-DIFLUOROPROPIONAMIDE DERIVATIVE OF BARDOXOLONE METHYL, PHARMACEUTICAL COMPOSITIONS AND POLYMORPHS THEREOF FOR USE IN TREATING CERTAIN CONDITIONS	REATA PHARMACEUTICALS INC
EP3444271	IL-15 AND IL-15RAPLHA SUSHI DOMAIN BASED MODULOKINES	CYTUNE PHARMA
EP3445357	BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EGFR AND METHODS OF USE	DANA FARBER CANCER INST INC
EP3445370	METHODS FOR THE PREPARATION OF OBETICHOLIC ACID AND DERIVATIVES THEREOF	INTERCEPT PHARMACEUTICALS INC
EP3445451	COMPOSITIONS AND METHODS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND DISORDERS CHARACTERIZED BY LYSOSOMAL DYSFUNCTION	BAYLOR COLLEGE MEDICINE
EP3445743	PRODRUG OF AMINO ACID DERIVATIVE	TAISHO PHARMA CO LTD
EP3445754	LIGNIN RECOVERY AND FURFURAL PRODUCTION FROM BIOMASS PREHYDROLYSATE STREAMS	FPINNOVATIONS
EP3445763	NOVEL CRYSTALLINE SALT FORMS OF 3-(1,2,4-TRIAZOLO[4,3-A]PYRIDINE-3-YLETHYNYL)-4-METHYL-N-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)-3-TRIFLUOROMETHYLPHENYL)BENZAMIDE FOR MEDICAL APPLICATION	LLC 芦FUSION PHARMA禄
EP3445766	NEW ANTIMICROBIAL COMPOUND	SINTEF TTO AS
EP3445776	RLMA-INACTIVATED FILAMENTOUS FUNGAL HOST CELL	NOVOZYMES AS
EP3447042	MANUFACTURING METHOD OF 1,2-DICHLOROHEXAFLUOROCYCLOPENTENE	BEIJING YUJI SCIENCE AND TECH CO LTD
EP3447051	METHOD FOR PREPARING TYROSINE KINASE INHIBITOR AND DERIVATIVE THEREOF	JIANGSU HENGRUI MEDICINE CO
EP3447052	METHODS OF PREPARING NEW IDH1 INHIBITORS	AGIOS PHARMACEUTICALS INC
EP3447057	ORGANIC SEMICONDUCTORS	CAMBRIDGE DISPLAY TECH LTD
EP3447059	SILICON-CONTAINING SULFURIC ACID ESTER SALT	NISSHINBO HOLDINGS INC
EP3447060	NOVEL ORGANOSILICON COMPOUND AND METHOD FOR PRODUCING SAME	SHINETSU CHEMICAL CO
EP3447070	COMPOUNDS FOR TREATING THE REMYELINATION BLOCKADE IN DISEASES ASSOCIATED WITH THE EXPRESSION OF HERV-W ENVELOPE PROTEIN	GENEURO SA
EP3448380	1,5-DISUBSTITUTED 1,2,3-TRIAZOLES ARE INHIBITORS OF RAC/CDC42 GTPASES	UNIV PUERTO RICO
EP3448386	ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF	SAMUMED LLC
EP3448389	QUINAZOLINE AND INDOLE COMPOUNDS TO TREAT MEDICAL DISORDERS	ACHILLION PHARMACEUTICALS INC
EP3448429	HUMANIZED AFFINITY MATURED ANTI-FCRN ANTIBODIES	SYNTIMMUNE INC
EP3448522	NOVEL SUBSTITUTED IMIDAZOPYRIDINE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN-2,3-DIOXYGENASE	IOMET PHARMA LTD
EP3448836	METHODS AND SYSTEMS FOR THE MANUFACTURE OF AN AROMATIC PHTHALIC BISIMIDE AND A POLYETHERIMIDE	SABIC GLOBAL TECHNOLOGIES BV
EP3448838	ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF	SAMUMED LLC
EP3448853	COMPOUNDS FOR MODULATING AQUAPORINS	APOGLYX AB
EP3448861	A PROCESS FOR THE PREPARATION OF 2-PYRAZOLO[1,5-A]PYRAZIN-2-YLPYRIDO[1,2-A]PYRIMIDIN-4-ONE	HOFFMANN LA ROCHE
EP3448864	SILSESQUINOXANES AS TRANSPORT COMPOUNDS	UNIV DARMSTADT TECH
EP3448868	miRNA TRANSCRIPTOME METHODS AND COMPOSITIONS	BIO RAD LABORATORIES
EP3448882	ANTI-KK-LC-1 T CELL RECEPTORS	US HEALTH
EP3448992	ANTIMICROBIAL AGENTS AGAINST SALMONELLA BACTERIA	LYSANDO AG
EP3449017	TARGETED MEASURE OF TRANSCRIPTIONAL ACTIVITY RELATED TO HORMONE RECEPTORS	UNIV TEXAS
EP3450420	METHOD FOR INCREASING UV TRANSMITTANCE OF ETHYLENE GLYCOL	CHANGCHUN MEIHE SCIENCE AND TECH DEVELOPMENT CO LTD
EP3450426	METHOD FOR SYNTHESIZING SILODOSIN AND INTERMEDIATE THEREOF	ZHEJIANG TIANYU PHARMACEUTICAL CO LTD
EP3450434	DEUTERATED DERIVATIVES OF RUXOLITINIB	CONCERT PHARMACEUTICALS INC
EP3450439	METHOD FOR PRODUCING MONOMER FOR SINGLE-STRANDED NUCLEIC ACID MOLECULE	SUMITOMO CHEMICAL CO
EP3450448	THERAPEUTIC PEPTIDE FOR EXCITATORY NEUROTOXICITY-RELATED INJURIES	BIOCELLS BEIJING BIOTECH CO LTD
EP3450452	MODIFIED FIBROIN	SPIBER INC
EP3450458	HUMAN ANTIBODIES TO GFR 3 AND METHODS OF USE THEREOF	REGENERON PHARMA
EP3450560	MODIFIED TRANSFERRIN DNA BINDING DOMAIN, RECOMBINANT DNA POLYMERASE AND PREPARATION METHOD THEREFOR	FOREGENE COMPANY LTD
EP3451064	ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE AND IMAGE-FORMING DEVICE	KYOCERA DOCUMENT SOLUTIONS INC
EP3452071	CHIMERIC NEUROTOXINS	IPSEN BIOPHARM LTD
EP3452436	IN-KIT PREPARATION OF GALLIUM-68 LABELLED RADIOPHARMACEUTICALS	AZIENDA USL DI REGGIO NELL EMILIA
EP3452438	INTEGRATED TECHNIQUES FOR PRODUCING BIO-METHANOL	ULTRA CLEAN ECOLENE INC
EP3452442	ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME	ROHM & HAAS ELECT MATERIALS KOREA LTD
EP3452463	AMIDE-SUBSTITUTED PYRIDINYLTRIAZOLE DERIVATIVES AND USES THEREOF	BAYER PHARMA AG
EP3452471	ORGANIC MOLECULES, ESPECIALLY FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3452476	HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS	INCYTE HOLDINGS CORP
EP3452487	CATALYTIC SUPPORT AND USES THEREOF	SCG CHEMICALS CO LTD
EP3452491	QUANTITATIVE PROFILING OF PROGESTERONE METABOLITES FOR THE PREDICTION OF SPONTANEOUS PRETERM DELIVERY	UNIV INDIANA RES & TECH CORP
EP3452495	ADENO-ASSOCIATED VIRUS POLYNUCLEOTIDES, POLYPEPTIDES AND VIRIONS	CHILDRENS MEDICAL RES INSTITUTE
EP3452497	ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING THE SAME	NOVOZYMES AS
EP3452502	THE CONTORSBODY - A SINGLE CHAIN TARGET BINDER	HOFFMANN LA ROCHE
EP3452583	ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A	PREC BIOSCIENCES INC
EP3452590	PLATE MAGNET	STEMCELL TECH INC
EP3453695	A PROCESS FOR THE PRODUCTION OF OLEFINS AND USE THEREOF	DO CARMO ROBERTO WERNECK
EP3453696	METHOD FOR PRODUCING CONJUGATED DIENE	KURARAY CO
EP3453708	PROCESS FOR THE PREPARATION OF 5-CHLORO-N-(2-ISOPROPOXY-5-METHYL-4-PIPERIDIN-4-YL-PHENYL)-N-2-(ISOPROPYLSULFONYL)PHENYL)-2,4-DIAMINE DI-HYDROCHLORIDE	NOVARTIS AG
EP3453713	BUFADIENOLIDE COMPOUNDS SUBSTITUTED IN POSITION 3 BY AN AMINE GROUP FOR USE IN THE TREATMENT OF CANCER	NEUPHARMA INC
EP3453723	ANTI-ASIC1 ANTIBODIES AND USES THEREOF	REGENERON PHARMA
EP3454854	PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE	GLOBAL BLOOD THERAPEUTICS INC
EP3454887	TARGETED MUTANT INTERFERON-BETA AND USES THEREOF	ORIONIS BIOSCIENCES NV
EP3455202	METHOD FOR PURIFYING AN AQUEOUS LACTIC ACID SOLUTION	FUTERRO SA
EP3455203	VINYLOGOUS PHENETHYLAMINES AS NEUROTRANSMITTER RELEASERS	RES TRIANGLE INST
EP3455213	METHOD FOR PURIFYING CANNABINOID COMPOUNDS	SYMRISE AG
EP3455239	PARTICLE FOR THE ENCAPSIDATION OF A GENOME ENGINEERING SYSTEM	FLASH THERAPEUTICS
EP3455242	SEPARATION METHOD	GE HEALTHCARE BIOPROCESS R&D AB
EP3455243	SEPARATION MATRIX	GE HEALTHCARE BIOPROCESS R&D AB
EP3455246	METHOD FOR THE AFFINITY PURIFICATION OF RECOMBINANT PROTEINS BASED ON THE LECTIN ACTIVITY OF THE CRD OF A GALECTIN	UNIV DE LORRAINE
EP3455248	ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER AND PD1 BINDING MOIETY	HOFFMANN LA ROCHE
EP3455253	C-TERMINALLY FUSED TNF FAMILY LIGAND TRIMER-CONTAINING ANTIGEN BINDING MOLECULES	HOFFMANN LA ROCHE
EP3455254	ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER AND A TENASCIN BINDING MOIETY	HOFFMANN LA ROCHE
EP3455255	ANTI-CTLA-4 ANTIBODIES	AGENCY SCIENCE TECH & RES
EP3455257	ANTI-PD-L1 ANTIBODIES	IGM BIOSCIENCES INC
EP3455258	METHODS OF TREATING SKIN CANCER BY ADMINISTERING A PD-1 INHIBITOR	REGENERON PHARMA
EP3455307	LIQUID INK CONTAINING A HYDANTOIN CO-SOLVENT	HEWLETT PACKARD DEVELOPMENT CO
EP3455322	HYDROFLUOROOLEFINS AND METHODS OF USING SAME	3M INNOVATIVE PROPERTIES CO
EP3456190	ANTIBODY PRODUCING NON-HUMAN MAMMALS	MERUS NV
EP3456330	CORTEXOLONE 17ALPHA-VALERATE FOR USE IN THE TREATMENT OF TUMOURS	COSMO TECHNOLOGIES LTD
EP3456339	NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC	IMMATICS BIOTECHNOLOGIES GMBH
EP3456346	PD-1 AND LAG-3 BINDING MOLECULES AND METHODS OF USE THEREOF	MACROGENICS INC
EP3456720	NOVEL CRYSTALLINE SALT FORM OF 2,2-DIMETHYL-6-((4-((3,4,5-TRIMETHOXYPHENYL)AMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE FOR MEDICAL APPLICATION	LIMITED MOLECULAR TECH
EP3456736	ANTIBODY VARIANTS	TILLOTTS PHARMA AG
EP3456743	ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS	KINIKSA PHARMACEUTICALS LTD
EP3458053	USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS	BIOHAVEN PHARM HOLDING CO LTD
EP3458439	2-ETHYLIDENE-1,5-DIMETHYL-3,3-DIPHENYLPYRROLIDINE ANALOGS AND METHODS FOR THEIR SYNTHESIS AND USE	ALERE SAN DIEGO INC
EP3458441	PROCESS FOR THE MANUFACTURE OF 6-ALKYNYL-PYRIDINE DERIVATIVES	BOEHRINGER INGELHEIM INT
EP3458445	KRAS G12C INHIBITORS	MIRATI THERAPEUTICS INC
EP3458448	METHODS OF USING FASN INHIBITORS	FORMA THERAPEUTICS INC
EP3458454	NOVEL MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER	UNIV RUTGERS
EP3458455	NOVEL PYRAZINE COMPOUNDS WITH OXYGEN, SULFUR AND NITROGEN LINKER FOR THE TREATMENT OF INFECTIOUS DISEASES	HOFFMANN LA ROCHE
EP3458469	INTERMEDIATES FOR THE SYNTHESIS OF BILE ACID DERIVATIVES, IN PARTICULAR OF OBETICHOLIC ACID	NZP UK LTD
EP3458472	METHOD FOR PURIFICATION AND ACTIVATION OF BOTULINUM NEUROTOXIN	HARVARD COLLEGE
EP3458478	ANTI PD-1 AND ANTI-LAG3 ANTIBODIES FOR CANCER TREATMENT	BOEHRINGER INGELHEIM INT
EP3458480	ANTIBODY DIRECTED AGAINST THE ENDOTHELIN RECEPTOR BETA SUB-TYPE	COMMISSARIAT ENERGIE ATOMIQUE
EP3458485	TETHERED INTERLEUKIN-2 TO ITS RECEPTOR IL-2RBETA, A PLATFORM TO ENHANCE NATURAL KILLER AND REGULATORY T CELL ACTIVITY	MASSACHUSETTS GEN HOSPITAL
EP3459560	ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER	US HEALTH
EP3459564	PLASMA KALLIKREIN BINDING PROTEINS	DYAX CORP
EP3459925	METHOD FOR PREPARING 2-HYDROXYL-4-(2, 3-DISUBSTITUTED BENZYLOXY)-5-SUBSTITUTED BENZALDEHYDE DERIVATIVE	INST MATERIA MEDICA CAMS
EP3459944	AZEPANYL-DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME WITH ANTIPARASITIC ACTIVITY	MERCK PATENT GMBH
EP3459946	HETEROCYCLIC COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE INCLUDING THE SAME	SAMSUNG DISPLAY CO LTD
EP3459947	NOVEL CHIRAL PHASE-TRANSFER CATALYST, AND METHOD FOR PREPARING -AMINO ACID BY USING SAME	UNIV YEUNGNAM RES COOPERATION FOUNDATION
EP3459954	NOVEL POLYMORPH OF TRIAZOLO PYRAZINE DERIVATIVE AND METHOD FOR PREPARING SAME	ABION INC
EP3459956	COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME	LG CHEMICAL LTD
EP3460050	CELL CULTURING METHOD, CULTURE MEDIUM, AND CULTURE MEDIUM KIT	FUJIFILM CORP
EP3460062	ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, AND METHODS OF USING SAME FOR INCREASING PLANT YIELD AND/OR AGRICULTURAL CHARACTERISTICS	EVOGENE LTD
EP3461815	NOVEL POLY SULFONATED FLUORESCENCE DYES	ATTO TEC GMBH
EP3461830	ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND	SAMSUNG ELECTRONICS CO LTD
EP3461831	ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND	SAMSUNG ELECTRONICS CO LTD
EP3461834	NEUROACTIVE STEROIDS	SAGE THERAPEUTICS INC
EP3462173	ANTIBODIES TO RISPERIDONE AND USE THEREOF	JANSSEN PHARMACEUTICA NV
EP3463435	ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF	MEDIMMUNE LTD
EP3463647	MIXED OXIDES FOR THE OXIDATIVE CLEAVAGE OF LIPIDS USING OXYGEN TO AFFORD MONO- AND DI-CARBOXYLIC ACIDS	CATALISI INNOVATIVA PER IL RICICLO DEL CARBONIO E
EP3463654	CATALYST SYSTEMS AND ETHYLENE OLIGOMERIZATION METHOD	CHEVRON PHILLIPS CHEMICAL CO LP
EP3464231	PROCESS FOR THE PREPARATION OF PURIFIED DICARBOXYLIC ACIDS	NOVAMONT SPA
EP3464235	PROCESS FOR THE PREPARATION OF POLYSANTOL-TYPE COMPOUNDS	FIRMENICH & CIE
EP3464239	PROCESS FOR PRODUCING METHYL MERCAPTAN FROM DIMETHYL SULFIDE	NOVUS INT INC
EP3464244	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3464248	3-OXO-2,6-DIPHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES	BAYER PHARMA AG
EP3464251	MICROBIOCIDAL OXADIAZOLE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3464255	BIOMASS CONVERSION	TNO
EP3464260	UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS	UNIV MUENCHEN TECH
EP3464261	HERBICIDAL URACILPYRID	BASF SE
EP3464276	NEW CRYSTALLINE FORM OF N-[5-(3,5-DIFLUORO-BENZYL)-1H-INDAZOL-3-YL]-4-(4-METHYL-PIPERAZIN-1-YL)-2-(TETRAHYDRO-PYRAN-4-YLAMINO)-BENZAMIDE	NERVIANO MEDICAL SCIENCES SRL
EP3464278	XANTHONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE	HOFFMANN LA ROCHE
EP3464286	PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER	GENENTECH INC
EP3464289	ULTRA-POTENT VINCA ALKALOIDS: ADDED MOLECULAR COMPLEXITY FURTHER DISRUPTS THE TUBULIN DIMER-DIMER INTERFACE	SCRIPPS RESEARCH INST
EP3464293	MOLECULAR PROBES FOR DETECTION AND IMAGING OF PANCREATIC CANCER	UNIV PORTLAND STATE
EP3464299	LANTHANIDE TOOLBOX FOR ORGANELLE SPECIFIC MOLECULAR IMAGING	NEW LIFE MEDICINE TECH COMPANY LIMITED
EP3464300	NOVEL COMPOUNDS, FUNCTIONALISED DIOXABOROLANE OR DIOXABORINANE DERIVATIVES, METHOD FOR PREPARING SAME AND USES THEREOF	ECOLE SUPERIEURE DE PHYSIQUE ET CHIMIE IND DE LA VILLE DE PARIS
EP3464310	TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING	HOFFMANN LA ROCHE
EP3464315	METHODS FOR THE PREPARATION OF DEOXYCHOLIC ACID, AND INTERMEDIATES USEFUL IN THE PREPARATION OF DEOXYCHOLIC ACID	BIONICE S L U
EP3464323	PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES	AADIGEN LLC
EP3464324	ANGIOTENSIN-1-RECEPTOR ANTAGONISTS	FERRING BV
EP3464352	CONSTRUCTION AND CHARACTERIZATION OF MULTIMERIC IL-15-BASED MOLECULES WITH CD3 BINDING DOMAINS	ALTOR BIOSCIENCE CORP
EP3464354	ANTIBODIES THAT BIND TO HUMAN ANTI-M脺LLERIAN HORMONE (AMH) AND THEIR USES	KOHLMANN ANGELICA
EP3464361	ANTI-CD40 ANTIBODIES AND THEIR USES	ABBVIE BIOTHERAPEUTICS INC
EP3464373	USE OF ANTI-PD-1 ANTIBODY IN THE TREATMENT OF PATIENTS WITH COLORECTAL CANCER	SQUIBB BRISTOL MYERS CO
EP3465811	NONAQUEOUS ELECTROLYTE COMPOSITIONS COMPRISING FLUORINATED SULFONES	DU PONT
EP3466255	NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE	REGENERON PHARMA
EP3466916	ORGANIC AMINE SALT COMPOUND HAVING ANIONS SERVING AS CO2 DONORS AND APPLICATION OF SAME AS FOAMING AGENT	UNIV SHANDONG TECHNOLOGY
EP3466919	PROCESS FOR PRODUCTION OF 1,6-HEXANEDIOL FROM 1,2-6-HEXANETRIOL	ARCHER DANIELS MIDLAND CO
EP3466937	PHOTOELECTRIC CONVERSION ELEMENT, TWO-DIMENSIONAL SENSOR, IMAGE SENSOR AND IMAGING DEVICE	CANON KK
EP3466939	NEW DAPAGLIFLOZIN CRYSTAL FORM AND PREPARATION METHOD AND USE THEREOF	JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD
EP3466950	NOVEL BETA-LACTAMASE INHIBITORS	MEDSHINE DISCOVERY INC
EP3466978	FUSION PROTEIN FOR IMPROVING PROTEIN EXPRESSION FROM TARGET mRNA	UNIV KYUSHU NAT UNIV CORP
EP3467083	LIQUID DETERGENT COMPOSITION FOR TEXTILE PRODUCTS	KAO CORP
EP3467102	COMPOSITION COMPRISING FUSION PROTEIN OF RV2299C AND ESAT-6 FOR PROMOTING MATURATION OF DENDRITIC CELL	QURATIS INC
EP3467928	NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME	CENTRAL GLASS CO LTD
EP3468526	FRAGRANCE MATERIAL	TAKASAGO PERFUMERY CO LTD
EP3468949	CRYSTALLINE PHARMACEUTICAL CO-CRYSTALS OF GLYCOPYRRONIUM BROMIDE WITH LACTOSE	HOVIONE SCIENTIA LTD
EP3468963	DIHYDROPYRIMIDINYL BENZAZEPINE CARBOXAMIDE COMPOUNDS	HOFFMANN LA ROCHE
EP3468977	FXR (NR1H4) MODULATING COMPOUNDS	GILEAD SCIENCES INC
EP3468979	MOLECULAR WHITE-LIGHT EMITTER	PHILIPPS UNIV MARBURG
EP3468982	RECOVERY OF LACTOSE FROM AN AQUEOUS SOLUTION	COOL SEPARATIONS B V
EP3468998	ANTI-TNFRSF25 ANTIBODIES	PELICAN THERAPEUTICS INC
EP3469070	HERPESVIRUS WITH MODIFIED GLYCOPROTEIN B	UNIV BOLOGNA ALMA MATER STUDIORUM
EP3469072	HERPESVIRUS WITH MODIFIED GLYCOPROTEIN H FOR PROPAGATION IN A CELL	UNIV BOLOGNA ALMA MATER STUDIORUM
EP3470392	METHOD FOR PRODUCING UNSATURATED NITRILE	ASAHI CHEMICAL IND
EP3470393	XYLYLENE DIISOCYANATE COMPOSITION, XYLYLENE DIISOCYANATE MODIFICATION COMPOSITION, TWO-COMPONENT RESIN STARTING MATERIAL, AND RESIN	MITSUI CHEMICALS INC
EP3470397	CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR	FIBROGEN INC
EP3470402	CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS	PHARMATROPHIX INC
EP3470414	BENZODIAZEPINE DERIVATIVE WITH ACTIVITY ON THE CENTRAL NERVOUS AND VASCULAR SYSTEMS	UNIV LA HABANA
EP3470423	IMMUNOSUPPRESSIVE TGF-BETA SIGNAL CONVERTER	BAYLOR COLLEGE MEDICINE
EP3470432	METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST	SANOFI BIOTECHNOLOGY
EP3471730	PHARMACEUTICAL SALTS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND CRYSTALLINE FORMS THEREOF	BETA PHARMA INC
EP3472128	COMPOUND COMPRISING CERTAIN LEVEL OF BIO-BASED CARBON	CLARIANT INT LTD
EP3472134	PROCESS FOR PREPARING COMPOUNDS USEFUL AS INTERMEDIATES FOR THE PREPARATION OF RALTEGRAVIR	PHARMATHEN SA
EP3472139	PROCESS FOR THE EPOXIDATION OF A TETRASUBSTITUTED ALKENE	BASF AGRO BV
EP3472160	BICYCLIC PYRIDINE, PYRAZINE, AND PYRIMIDINE DERIVATIVES AS PI3K BETA INHIBITORS	JANSSEN PHARMACEUTICA NV
EP3472162	HETEROARYL ESTROGEN RECEPTOR MODULATORS AND USES THEREOF	HOFFMANN LA ROCHE
EP3472173	COATINGS FOR COMPONENTS OF ELECTROCHEMICAL CELLS	SION POWER CORP
EP3472191	METABOLICALLY STABLE PEPTIDE ANALOGS	UNIV STRASBOURG
EP3472195	METABOLICALLY STABLE SPEXIN PEPTIDE ANALOGS	UNIV STRASBOURG
EP3472207	BINDING MOLECULES BINDING PD-L1 AND LAG-3	F STAR DELTA LTD
EP3472314	PREPARATION OF FACTOR XA DERIVATIVES	PORTOLA PHARM INC
EP3473611	TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF	ARBUTUS BIOPHARMA CORP
EP3473621	METHOD FOR PRODUCING DIPHENYLMETHANE DERIVATIVE	DAE WOONG PHARMA
EP3473625	PREPARATION METHOD FOR CHIRAL PYRROLOPYRIMIDINE COMPOUND	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
EP3473630	BORON-BASED PRODRUG STRATEGY FOR INCREASED BIOAVAILABILITY AND LOWER-DOSAGE REQUIREMENTS FOR DRUG MOLECULES CONTAINING AT LEAST ONE PHENOL (OR AROMATIC HYDROXYL) GROUP	XAVIER UNIV OF LOUISIANA
EP3473632	NOVEL DIPHENYLMETHANE PROTECTIVE AGENT	SEKISUI MEDICAL CO LTD
EP3473648	HUMAN ANTIBODIES TO PD-L1	REGENERON PHARMA
EP3473725	FERMENTATION TECHNIQUE WITH PICHIA YEAST EXPRESSING RECOMBINANT PROTEIN	JIANGSU JLAND BIOTECH CO LTD
EP3475252	CATALYSTS AND PROCESSES FOR PRODUCING ALDEHYDES	EASTMAN CHEM CO
EP3475265	COMPOUNDS FOR THE DETECTION OF SENESCENT CELLS	UNIV MANCHESTER
EP3475273	3-AMINO-1,2,4-TRIAZINE DERIVATIVES AND THEIR USE FOR CONTROLLING UNDESIRED PLANT GROWTH	BAYER CROPSCIENCE AG
EP3475278	(DIS)SYMMETRIC AZOMETHINE-TYPE DIRECT DYE COMPRISING AT LEAST ONE PYRAZOLOPYRIDINE UNIT, PROCESS FOR DYEING KERATIN FIBERS USING THIS DYE	OREAL
EP3475279	TRIAZOLOPYRIDINES AS GAMMA-SECRETASE MODULATORS	HOFFMANN LA ROCHE
EP3475288	PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL	RICHTER GEDEON NYRT
EP3475303	ANTI-CD19 ANTIBODY FORMULATIONS	MORPHOSYS AG
EP3475340	P(CN)3 REACTIONS WITH LITHIUM DICYNAMIDE PRODUCING LITHIATED CARBON PHOSPHONITRIDE EXTENDED SOLIDS	THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS THE SECRETARY OF THE NAVY
EP3475706	MHC-E RESTRICTED EPITOPES, BINDING MOLECULES AND RELATED METHODS AND USES	JUNO THERAPEUTICS INC
EP3476824	METHOD FOR PRODUCING 2,6-NAPHTHALENE DICARBOXYLIC ACID	UENO FINE CHEMICALS IND LTD
EP3476828	METHOD FOR PRODUCING IRON COMPLEX AND METHOD FOR PRODUCING ESTER COMPOUND USING IRON COMPLEX	KURARAY CO
EP3476830	POLYMETHINE COMPOUNDS AND THEIR USE AS FLUORESCENT LABELS	ILLUMINA CAMBRIDGE LTD
EP3476845	ORGANIC THIN-FILM TRANSISTOR, ORGANIC SEMICONDUCTOR FILM, COMPOUND, ORGANIC-THIN-FILM-TRANSISTOR COMPOSITION, AND ORGANIC-THIN-FILM-TRANSISTOR MANUFACTURING METHOD	FUJIFILM CORP
EP3476849	EPOXY COMPOUND, CURABLE COMPOSITION CONTAINING THIS, AND CURED PRODUCT OF CURABLE COMPOSITION	JXTG NIPPON OIL & ENERGY CORP
EP3478650	HIGH RESOLUTION SYSTEMS, KITS, APPARATUS, AND METHODS USING LATERAL FLOW FOR HIGH THROUGHPUT MICROBIOLOGY APPLICATIONS	GEN AUTOMATION LAB TECH INC
EP3478651	PROCESS FOR THE PREPARATION OF ALPHA, BETA UNSATURATED ALDEHYDES BY OXIDATION OF ALCOHOLS IN THE PRESENCE OF A LIQUID PHASE	BASF SE
EP3478656	DICARBAZOLBIPHENYL DERIVATES FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3478657	DICARBAZOLBIPHENY DERIVATES FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3478658	PHARMACEUTICAL COMPOSITIONS AND METHODS FOR POTENTIATING GENE SILENCING	OLIX PHARMACEUTICALS INC
EP3478660	METHOD FOR THE PURIFICATION OF ETHOXYQUIN	BASF SE
EP3478668	NOVEL TRIAZINE PRECONDENSATE AND METHOD FOR OBTAINING THE SAME	BOREALIS AGROLINZ MELAMINE
EP3478682	[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS	SQUIBB BRISTOL MYERS CO
EP3478683	DIAZEPINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEPATITIS B INFECTIONS	NOVIRA THERAPEUTICS INC
EP3478698	METHOD FOR THE SEPARATION OF ENANTIOMERIC MIXTURES FROM METAL COMPLEXES	MERCK PATENT GMBH
EP3478710	FUSION PROTEIN FOR USE IN THE TREATMENT OF HVG DISEASE	MEDIZINISCHE HOCHSCHULE HANNOVER
EP3478745	PROCESSES AND SYSTEMS FOR REMOVING WATER AND SALT FROM A NEUTRALIZED POLYETHER POLYOL	COVESTRO LLC
EP3478748	DUAL CURABLE THIOL-ENE COMPOSITION, COMPRISING A POLYTHIOL, AN UNSATURATED COMPOUND, A PHOTOINITIATOR AND AN ORGANIC HYDROPEROXIDE, AS WELL AS A CROSS-LINKED POLYMER SEALANT PREPARED THEREFROM FOR USE IN AEROSPACE	3M INNOVATIVE PROPERTIES CO
EP3480183	PRODUCTION METHOD FOR (METH)ACRYLIC ACID OR ESTER THEREOF	MITSUBISHI CHEM CORP
EP3480185	METHOD FOR PREPARING POLYTHIOL COMPOUND, METHOD FOR PREPARING CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT	HOYA LENS THAILAND LTD
EP3480188	METHOD FOR PREPARING URATE-ANION EXCHANGER 1 INHIBITOR	TIANJIN INSTITUTE OF PHARMACEUTICAL RES CO LTD
EP3480189	METHOD FOR PRODUCING PROPYLENE OXIDE	SUMITOMO CHEMICAL CO
EP3480191	METHOD FOR PRODUCING BICYCLIC COMPOUND	ONO PHARMACEUTICAL CO
EP3480194	NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEMICAL LTD
EP3480246	MIXTURES OF SALTS FOR DISSOLVING CELLULOSE	UNIV SANTIAGO COMPOSTELA
EP3481794	RENEWABLE ISOPARAFFINS AS DILUENT IN HYDROMETALLURGICAL LIQUID-LIQUID EXTRACTION PROCESS	OUTOTEC FINLAND OY
EP3481796	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3481797	PHOTOCHLORINATION OF CHLOROFORM TO CARBON TETRACHLORIDE	OCCIDENTAL CHEM CO
EP3481815	1,3-DIHYDROXY-PHENYL DERIVATIVES USEFUL AS IMMUNOMODULATORS	SQUIBB BRISTOL MYERS CO
EP3481826	TYROSINE KINASE INHIBITORS	RIGEL PHARMACEUTICALS INC
EP3481827	IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USE THEREOF	JEIL PHARMACEUTICAL CO LTD
EP3481829	FUSED PYRIMIDINE DERIVATIVES	HOFFMANN LA ROCHE
EP3481848	GENOMIC SEQUENCES ENCODING FOR AN ATTENUATED MUTANT ZIKA VIRUS	INST NAT SANTE RECH MED
EP3481851	METHOD FOR THE FERMENTATIVE PRODUCTION OF MOLECULES OF INTEREST BY MICROORGANISMS COMPRISING GENES CODING SUGAR PHOSPHOTRANSFERASE SYSTEM (PTS)	METABOLIC EXPLORER SA
EP3483146	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME	HEESUNG MAT LTD
EP3483152	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME	LG CHEMICAL LTD
EP3483161	INTERMEDIATES USED TO MAKE ENTECAVIR	ZHEJIANG AUSUN PHARMACEUTICAL CO LTD
EP3483163	TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES AS CB2 RECEPTOR ANTAGONISTS	HOFFMANN LA ROCHE
EP3483170	ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING ORGANOMETALLIC COMPOUND	SAMSUNG ELECTRONICS CO LTD
EP3483177	CHIMERIC ANTIGEN RECEPTORS	CELGENE CORP
EP3483183	IMMUNOCONJUGATE COMPRISING HUMANISED RS7 ANTIBODIES	IMMUNOMEDICS INC
EP3483234	USE OF SPECIALISED DERIVATIVES OF QUATERNISED NITROGEN COMPOUNDS AS ADDITIVES IN FUELS AND LUBRICANTS	BASF SE
EP3484293	LACTONASE ENZYMES AND METHODS OF USING SAME	FORNIA BIOSOLUTIONS INC
EP3484471	METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3- CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE	MEREO BIOPHARMA 1 LTD
EP3484495	NOVEL FATTY ACID MODIFIED UROCORTIN-2 ANALOGS FOR THE TREATMENT OF DIABETES AND CHRONIC KIDNEY DISEASE	LILLY CO ELI
EP3484614	ORGANOGELS ALLOWING REDUCTION AND CONTROL OF THE EVAPORATION OF VOLATILE ORGANIC LIQUIDS	CENTRE NAT RECH SCIENT
EP3484841	DECENE OLIGOMERS	CHEVRON PHILLIPS CHEMICAL CO LP
EP3484848	HEAT-SENSITIVE RECORDING MATERIAL	KOEHLER SE AUGUST PAPIERFABRIK
EP3484853	METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE	MEREO BIOPHARMA 1 LTD
EP3484857	CATALYST FOR CURABLE COMPOSITIONS CONTAINING HEXAHYDROTRIAZINE STRUCTURAL UNITS	SIKA TECH AG
EP3484860	EPOXIDATION PROCESS	SCIENT DESIGN CO
EP3484862	COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTON ASSOCIATED WITH GOUT OR HYPERURICEMIA	ARTHROSI THERAPEUTICS INC
EP3484867	INHIBITORS OF TRYPTOPHAN 2,3-DIOXYGENASE	NETHERLANDS TRANSLATIONAL RES CENTER B V
EP3484875	PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS	LILLY CO ELI
EP3484884	FUSED PYRIMIDINE DERIVATIVES	HOFFMANN LA ROCHE
EP3484891	REAGENTS FOR REVERSIBLY PROTECTING BIOLOGICAL MOLECULES	BIOMERIEUX SA
EP3484909	ANTISECRETORY FACTOR 17	LANTMAENNEN AS FAKTOR AB
EP3484912	METHODS AND COMPOSITIONS RELATING TO COVALENTLY CIRCULARIZED NANODISCS	HARVARD COLLEGE
EP3484921	ANTI-IL-22R ANTIBODIES	ARGENX BVBA
EP3486232	METHOD FOR PRODUCING 5-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID	API CORP
EP3486236	SYNTHESIS METHOD AND INTERMEDIATE FOR PROTHIOCONAZOLE AND ENANTIOMER THEREOF	ORIENTAL LUZHOU AGROCHEMICALS CO LTD
EP3486238	POLYFUNCTIONAL OXETANE COMPOUND AND PREPARATION METHOD THEREFOR	CHANGZHOU TRONLY ADVANCED ELECTRONIC MAT CO LTD
EP3486245	2-AMINO-N-(PIPERIDIN-1-YL-PYRIDIN-3-YL) PYRAZOLO[1,5ALPHA]PYRIMIDINE-3-CARBOXAMID AS INHIBITOR OF ATR KINASE	VERTEX PHARMA
EP3486248	IMPROVED METHODS FOR THE ACYLATION OF MAYTANSINOL	IMMUNOGEN INC
EP3486249	99MTC-EDDA/HYNIC-IPSMA AS A RADIOPHARMACEUTICAL FOR DETECTING THE OVEREXPRESSION OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN	INSTITUTO NAC DE INVESTIGACIONES NUCLEARES
EP3486272	AROMATIC POLYTHIOL COMPOUND FOR OPTICAL MATERIAL	SKC CO LTD
EP3487851	AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS	NOVARTIS AG
EP3487859	ANTIMETASTATIC 2H-SELENOPHENO[3,2-H]CHROMENES, SYNTHESIS THEREOF, AND METHODS OF USING SAME AGENTS	LATVIAN INST ORGANIC SYNTHESIS
EP3487860	CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PEST CONTROL AGENTS	BAYER CROPSCIENCE AG
EP3487861	DIORGANYLPHOSPHINIC ACID SALTS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF	CLARIANT PLASTICS & COATINGS LTD
EP3487866	PREFORMED CATALYTIC SYSTEM COMPRISING A RARE-EARTH METALLOCENE	MICHELIN & CIE
EP3487870	MONOMERIC STREPTAVIDIN MUTANTS, METHODS OF USING THE SAME AND PROCESSES OF MANUFACTURING PROTEINS	UNIV NEW YORK STATE RES FOUND
EP3487873	IMPROVED FILAMENTOUS FUNGAL HOST	NOVOZYMES AS
EP3487967	ALIPHATIC TETRAHEDRAL BORATE COMPOUNDS FOR LUBRICATING COMPOSITIONS	LUBRIZOL CORP
EP3489213	COMPOSITION FOR USE IN A METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE CARBONYL COMPOUNDS	BASF SE
EP3489218	METHOD FOR THE PRODUCTION OF PHENYLAMINOHYDROXYANTHRACHINONES	LANXESS DEUTSCHLAND GMBH
EP3489226	INHIBITORS OF SODIUM GLUCOSE COTRANSPORTER 1	LEXICON PHARMACEUTICALS INC
EP3489239	PROCESSES AND INTERMEDIATES FOR MAKING A JAK INHIBITOR	INCYTE HOLDINGS CORP
EP3489243	CARBENE COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES	UNIV SOUTHERN CALIFORNIA
EP3489249	ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME	SAMSUNG ELECTRONICS CO LTD
EP3489251	IMPROVED VACCINES AND METHODS FOR USING THE SAME	UNIV PENNSYLVANIA
EP3489256	ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER	HOFFMANN LA ROCHE
EP3489264	CHAIN SHUTTLING AGENTS AND THEIR USE FOR THE PREPARATION OF BLOCK COPOLYMERS	DOW GLOBAL TECHNOLOGIES LLC
EP3489396	MOLECULE LIBRARY CONSTRUCTED ON THE BASIS OF BACKBONE STRUCTURE OF MICROPROTEIN	AIST
EP3490961	OXIDATIVE DEHYDROGENATION (ODH) OF ETHANE	SHELL INT RESEARCH
EP3490962	OXIDATIVE DEHYDROGENATION (ODH) OF ETHANE	SHELL INT RESEARCH
EP3490964	PROCESS FOR PRODUCING HALOGENATED OLEFINS	CHEMOURS CO FC LLC
EP3490967	PARAFFIN REMOVAL FROM C4 CONTAINING STREAMS	LYONDELL CHEMICAL TECH LP
EP3490973	POLYMORPHIC FORMS OF BELINOSTAT AND PROCESSES FOR PREPARATION THEREOF	FRESENIUS KABI ONCOLOGY LTD
EP3490975	O-SUBSTITUTED HYDROXAMIC ACIDS	UNIV JOHNS HOPKINS
EP3490991	COELENTERAZINE ANALOGUES	PROMEGA CORP
EP3490998	PHENOLATE TRANSITION METAL COMPLEXES, PRODUCTION AND USE THEREOF	EXXONMOBIL CHEMICAL PATENTS INC
EP3490999	SYNTHESIS OF M-TERPHENYL PENDANT BIS-ETHER LIGANDS AND METAL COMPLEX AND THEIR USE IN OLEFIN POLYMERIZATION	DOW GLOBAL TECHNOLOGIES LLC
EP3491004	DIAGNOSTIC METHODS, THERAPEUTIC AGENTS AND USES THEREOF	METABOLON INC
EP3491172	METHOD AND SYSTEM FOR THE PRODUCTION OF HYDROCARBONS	THYSSENKRUPP IND SOLUTIONS AG
EP3491384	COMPOSITIONS AND METHODS FOR RAPID CLONING OF T-CELL RECEPTORS	HEALTH RESEARCH INC
EP3492448	4-ALKOXY-3-(TRIFLUOROMETHYL)BENZYL ALCOHOL PRODUCTION METHOD	MITSUBISHI TANABE PHARMA CORP
EP3492450	QUATERNARY AMMONIUM COMPOUND AND SUPPRESSION OF GENERATION OF VOLATILE ORGANIC COMPOUND FROM POLYACETAL UTILIZING SAME	ASAHI CHEMICAL IND
EP3492451	PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS	JANSSEN PHARMACEUTICA NV
EP3492465	S1P1 AGONIST AND APPLICATION THEREOF	SHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD
EP3492474	INTERMEDIATES USED IN THE PRODUCTION OF DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS	GLAXOSMITHKLINE LLC
EP3492480	ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES	UNIVERSAL DISPLAY CORP
EP3492560	IMPROVED LIQUID PHASE ALKYLATION PROCESS	EXXONMOBIL CHEMICAL PATENTS INC
EP3494103	1-HYDROXYMETHYL-1,2,2,6-TETRAMETHYL-CYCLOHEXANE AND DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICALS	BASF SE
EP3494113	ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3494120	OXADIAZOLOPYRIDINE DERIVATES FOR USE AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS	BOEHRINGER INGELHEIM INT
EP3494121	BORON-CONTAINING COMPOUNDS	VENATORX PHARMACEUTICALS INC
EP3495339	REACTION PRODUCT PREPARATION METHOD	NGK INSULATORS LTD
EP3495344	FLUORENE DERIVATIVE, ORGANIC LIGHT EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR	LG CHEMICAL LTD
EP3495350	COMPOUND INHIBITING FORMATION OF C-MYC/MAX/DNA COMPLEX	NAT CANCER CT
EP3495352	CRYSTAL FORM OF ANDROGEN RECEPTOR ANTAGONIST MEDICATION, PREPARATION METHOD THEREFOR, AND USE	CRYSTAL PHARMACEUTICAL SUZHOU CO LTD
EP3495353	AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN	KOEI CHEMICAL CO
EP3495357	4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE	UNIV COLUMBIA
EP3495362	IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	UNIV SHANDONG
EP3495373	HYDROCARBYLOXYDISILANES	DOW SILICONES CORP
EP3495387	BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR VASCULAR DISEASES	ROCHE GLYCART AG
EP3495392	ANTI-CGRP COMPOSITIONS AND USE THEREOF	ALDERBIO HOLDINGS LLC
EP3495415	RUBBER COMPOSITION, TIRE, ADDITIVE, AND HYDRAZIDE COMPOUND	BRIDGESTONE CORP
EP3496715	COMPOUNDS USEFUL FOR ALTERING THE LEVELS OF BILE ACIDS FOR THE TREATMENT OF DIABETES AND CARDIOMETABOLIC DISEASE	MERCK SHARP & DOHME
EP3496716	COMPOUNDS USEFUL FOR ALTERING THE LEVELS OF BILE ACIDS FOR THE TREATMENT OF DIABETES AND CARDIOMETABOLIC DISEASE	MERCK SHARP & DOHME
EP3496724	PROTEIN KINASE REGULATORS	NANJING GATOR MEDITECH COMPANY LTD
EP3496737	APOM-FC FUSION PROTEINS, COMPLEXES THEREOF WITH SPHINGOSINE L-PHOSPHATE (SIP), AND METHODS FOR TREATING VASCULAR AND NON-VASCULAR DISEASES	CHILDRENS MEDICAL CT CORP
EP3496951	SILVER ION CARBOXYLATE N-HETEROAROMATIC COMPLEXES AND USES	EASTMAN KODAK CO
EP3497084	PROCESS FOR THE PREPARATION OF 3-AMINO-1-(2,6-DISUBSTITUTED-PHENYL)PYRAZOLES	BAYER CROPSCIENCE AG
EP3497086	AMINO PYRIMIDINE SSAO INHIBITORS	LILLY CO ELI
EP3497087	CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS	NEUPHARMA INC
EP3497088	EPOXIDATION PROCESS	SCIENT DESIGN CO
EP3497093	SULFONYL PYRIDYL TRP INHIBITORS	HOFFMANN LA ROCHE
EP3497096	AN ANTIMICROBIAL COMPOUND	THE UNIV OF DURHAM
EP3497103	PYRIDOPYRIMDINONE CDK2/4/6 INHIBITORS	PFIZER
EP3497104	SOLID STATE FORMS OF LUMATEPERONE DITOSYLATE SALT	ASSIA CHEM IND LTD
EP3497446	METHOD AND COMPOSITION FOR DETECTION OF PEPTIDE CYCLIZATION USING PROTEIN TAGS	HOFFMANN LA ROCHE
EP3497492	OPTICAL COMPENSATION FILM HAVING REVERSED WAVELENGTH DISPERSION	AKRON POLYMER SYSTEMS INC
EP3498292	USPA2 PROTEIN CONSTRUCTS AND USES THEREOF	GLAXOSMITHKLINE BIOLOGICALS SA
EP3498369	METHOD FOR PRODUCING OXIDE CATALYST, METHOD FOR PRODUCING UNSATURATED NITRILE AND METHOD FOR PRODUCING UNSATURATED ACID	ASAHI CHEMICAL IND
EP3498688	METHOD FOR PRODUCING N-( -ALKOXYETHYL)FORMAMIDE	MITSUBISHI CHEM CORP
EP3498691	NOVEL CATIONIC PHOTOINITIATOR, AND PREPARATION METHOD THEREFOR AND APPLICATIONS THEREOF	CHANGZHOU TRONLY NEW ELECTRONIC MAT CO LTD
EP3498705	2-ACETYL-6-(2-(2-(4-BROMOBENZYLIDENE)HYDRAZINYL)THIAZOLE-4-YL)-3,7,9-TRIHYDROXY-8,9B-DIMETHYLDIBENZO[B,D]FURAN-1(9BH)-ONE EXHIBITING AN INHIBITORY EFFECT ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME	OBSHESTVO S OGRANICHENNOI OTVETSTVENNOSTJU INNOVATIE PHARMACOLOGY RES IPHAR
EP3498715	ANTI-HCMV VIRUS COMPOUND	MEDSHINE DISCOVERY INC
EP3498719	TERTIARY HYDROXYL FUNCTIONAL ALKOXYSILANES AND METHODS FOR PREPARING THEREOF	HENKEL AG & CO KGAA
EP3498722	METHOD FOR PREPARING OLIGOMERIC MANNURONIC DIACID	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO LTD
EP3498729	THERAPEUTIC TARGETS FOR ALZHEIMER'S DISEASE	UNIV BIRMINGHAM
EP3498732	ANTI-NERVE GROWTH FACTOR ANTIBODIES AND METHODS OF PREPARING AND USING THE SAME	NEXVET AUSTRALIA PTY LTD
EP3498809	FATTY GLYCERIDE PREPARATION METHOD	ZHEJIANG MED XINCHANG PHARM
EP3498828	METHOD FOR TREATING SOLUTION CONTAMINATED WITH PORCINE CIRCOVIRUSES	ASAHI KASEI MEDICAL CO LTD
EP3498849	AXMI115 VARIANT INSECTICIDAL GENE AND METHODS FOR ITS USE	ATHENIX CORP
EP3500546	PROPENYLAMINES AND METHODS OF MAKING AND USING SAME	3M INNOVATIVE PROPERTIES CO
EP3500550	CROSS-LINKED POLYGLYCEROL ESTERS	EVONIK DEGUSSA GMBH
EP3500551	PROCESS FOR PREPARING SUBSTITUTED BIPHENYLS	BASF SE
EP3500553	PROCESS FOR PRODUCING AN ISOCYANATE AND AT LEAST ONE FURTHER CHEMICAL PRODUCT IN AN INTEGRATED PRODUCTION	COVESTRO DEUTSCHLAND AG
EP3500554	PROCESS FOR CONVERSION OF DIMETHYL SULFIDE TO METHYL MERCAPTAN	CHEVRON PHILLIPS CHEMICAL CO LP
EP3500573	GABA(A) RECEPTOR MODULATORS AND METHODS TO CONTROL AIRWAY HYPERRESPONSIVENESS AND INFLAMMATION IN ASTHMA	UWM RES FOUNDATION INC
EP3500577	ORGANIC SEMICONDUCTING COMPOUNDS	MERCK PATENT GMBH
EP3500586	CONTINUOUS PROCESS FOR REDUCING HETEROGENEITY OF THERAPEUTIC PROTEIN	ENZENE BIOSCIENCES LTD
EP3500593	T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME	IMMATICS BIOTECHNOLOGIES GMBH
EP3500673	CARBOXYLATED 2'-AMINO-LNA NUCLEOTIDES AND OLIGONUCLEOTIDES COMPRISING THE SAME	PANZNER STEFFEN
EP3500859	MARKER FOR NEURAL STEM CELLS	XINTELA AB
EP3502142	BISPECIFIC ANTIBODY AND ANTIBODY CONJUGATE FOR TUMOUR THERAPY AND USE THEREOF	BENHEALTH BIOPHARMACEUTIC SHENZHEN CO LTD
EP3502240	TARGETING BCL11A DISTAL REGULATORY ELEMENTS FOR FETAL HEMOGLOBIN REINDUCTION	CHILDRENS MEDICAL CT CORP
EP3503895	ANTIVIRAL PRODRUGS OF TENOFOVIR	MERCK SHARP & DOHME
EP3504177	PROCESS FOR THE PREPARATION OF CYCLIC KETONES	SRF LTD
EP3504185	NOVEL SUBSTITUTED N'-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS	MERCK SHARP & DOHME
EP3504194	N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE	NOVARTIS AG
EP3504200	HETEROCYCLICALLY SUBSTITUTED BIPHENYLS, ESPECIALLY FOR USE IN OPTOELECTRONIC APPARATUSES	CYNORA GMBH
EP3504210	7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION	HOFFMANN LA ROCHE
EP3504218	COMPOSITION COMPRISING SILICON AND METHOD FOR PREPARING SAME	SILINNOV SCRL
EP3504229	REGULATION OF GENE EXPRESSION USING ENGINEERED NUCLEASES	SANGAMO THERAPEUTICS INC
EP3504249	DIALKYL PEROXIDE COMPOSITION FOR MODIFYING THE RHEOLOGY OF POLYPROPYLENE IN MOLTEN STATE	ARKEMA FRANCE
EP3504340	TAGGED NUCLEOTIDES USEFUL FOR NANOPORE DETECTION	HOFFMANN LA ROCHE
EP3504546	MARKER COMPOSITIONS, AND METHODS FOR MAKING AND USING SAME	UNITED COLOR MFG INC
EP3505498	METHOD FOR RECYCLING MOTHER LIQUOR IN PTA REFINED UNIT	TIANHUA INST OF CHEMICAL MACHINERY AND AUTOMATION CO LTD
EP3505506	METHOD FOR PRODUCING 3,7-DIMETHYL-7-OCTENOL AND METHOD FOR PRODUCING 3,7-DIMETHYL-7-OCTENYL CARBOXYLATE COMPOUND	SHINETSU CHEMICAL CO
EP3505511	DIAZADIENYL COMPOUND, RAW MATERIAL FOR FORMING THIN FILM, AND METHOD FOR PRODUCING THIN FILM	ADEKA CORP
EP3505516	CRYSTAL OF SALT OF QUINAZOLINE DERIVATIVE	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
EP3505524	ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES	UNIVERSAL DISPLAY CORP
EP3506983	SUBSTITUTED UREAS AND METHODS OF MAKING AND USING SAME	MEBIAS DISCOVERY LLC
EP3507267	MAGNETIC SEPARATION AND RECYCLE OF CATALYST COMPONENTS IN A BIO-MASS TO GLYCOLS PROCESS	SHELL INT RESEARCH
EP3507271	PROCESS FOR PREPARING SALICYLOYL-L-CARNITINE HYDROCHLORIDE	DRUGON PHARMA SWITZERLAND AG
EP3507273	PRODUCTION OF TERT- BUTYL HYDROPEROXIDE SOLUTION AND PROCESS TO FORM PRODUCTS THEREFROM	LYONDELL CHEMICAL TECH LP
EP3507278	SUBSTITUTED TRICYCLIC HETEROCYCLIC COMPOUNDS	SQUIBB BRISTOL MYERS CO
EP3507291	FUSED BICYCLIC SGC STIMULATORS	CYCLERION THERAPEUTICS INC
EP3507293	PROCESS FOR THE GENERATION OF THIN INORGANIC FILMS	BASF SE
EP3507294	BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3508472	ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE	SAMSUNG DISPLAY CO LTD
EP3508473	METHOD FOR PRODUCING CARBAMIC ACID ESTER	AIST
EP3508483	DIHYDROPYRIMIDINE COMPOUND AND PREPARATION METHOD AND USE THEREOF	SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD
EP3508489	A PROCESS FOR THE PREPARATION OF ACYLPHOSPHANES	ETH ZUERICH
EP3508554	PHOTOCHROMIC OPTICAL MATERIAL AND PREPARATION METHOD THEREFOR	JIANGSU SHIKEXINCAI COMPANY LTD
EP3508620	UREYLENE ADDITIVE, ITS USE AND A PREPARATION METHOD THEREFOR	ATOTECH DEUTSCHLAND GMBH
EP3509155	NON-AQUEOUS ELECTROLYTE SOLUTION ADDITIVE, NON-AQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY, COMPRISING NON-AQUEOUS ELECTROLYTE SOLUTION ADDITIVE	LG CHEMICAL LTD
EP3510007	18F]-LABELLED LACTATE DERIVATIVE AS PET RADIOTRACER	UNIV LOUVAIN
EP3510016	PROCESS FOR THE PRODUCTION OF N-BOC-2-AMINO-3,3-DIMETHYLBUTYRIC ACID	SIEGFRIED NANTONG PHARMACEUTICALS CO LTD
EP3510017	PARTIALLY FLUORINATED AROMATIC ESTERS	3M INNOVATIVE PROPERTIES CO
EP3510024	PYRIDYL SUBSTITUTED INDOLE COMPOUNDS	SQUIBB BRISTOL MYERS CO
EP3510033	COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS	NOVARTIS AG
EP3510035	DUAL PROTECTED PRO-COELENTERAZINE SUBSTRATES	PROMEGA CORP
EP3510036	IMIDAZOQUINOLINE DERIVATIVES AND THEIR USE IN THERAPY	GLAXOSMITHKLINE BIOLOGICALS SA
EP3510038	METAL COMPLEXES CONTAINING ALLYL LIGANDS	MERCK PATENT GMBH
EP3510043	USE OFMCM7 TO OBTAIN ACETIC ACID-RESISTANT YEAST STRAINS	LESAFFRE & CIE
EP3510044	AMYLIN ANALOGUES	ZEALAND PHARMA AS
EP3510045	MONOCLONAL ANTIBODIES AGAINST HEMAGGLUTININ OF H5-SEROTYPE INFLUENZA VIRUSES AND THEIR USES, HYBRIDOMAS PRODUCING SAID ANTIBODIES, COMPOSITIONS AND DIAGNOSTIC KITS	INST BIOTECHNOLOGII I ANTYBIOTYKOW
EP3511309	METHOD FOR PREPARING ETHYLENE IN PROPYLENE PREPARATION PROCESS USING PROPANE DEHYDROGENATION REACTION	HYOSUNG CHEMICAL CORP
EP3511314	SYSTEM FOR PRODUCING ESTER COMPOSITION, AND METHOD FOR PRODUCING ESTER COMPOSITION, USING SAME	LG CHEMICAL LTD
EP3511315	METHOD FOR PRODUCING N-METHYL-PARA-ANISIDINE	OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU IFOTOP
EP3511321	ORGANIC LIGHT-EMITTING ELEMENT, AND LIGHT-EMITTING MATERIAL AND COMPOUND FOR USE THEREIN	TOYO BOSEKI
EP3511324	IMIDE COMPOUND AND USE THEREOF	SUMITOMO CHEMICAL CO
EP3512026	ELECTROLYTE ADDITIVE AND LITHIUM SECONDARY BATTERY ELECTROLYTE COMPRISING SAME	LG CHEMICAL LTD
EP3512027	ELECTROLYTE ADDITIVE AND ELECTROLYTE, COMPRISING SAME, FOR LITHIUM SECONDARY BATTERY	LG CHEMICAL LTD
EP3512835	A PROCESS FOR PURIFICATION OF CARFILZOMIB INTERMEDIATE	FRESENIUS KABI ONCOLOGY LTD
EP3512843	PLANT GROWTH REGULATOR COMPOUNDS	SYNGENTA PARTICIPATIONS AG
EP3512856	NOVEL CYTOTOXIC AGENTS AND CONJUGATES THEREOF	POLYTHERICS LTD
EP3512857	SPIRO BICYCLIC INHIBITORS OF MENIN-MLL INTERACTION	JANSSEN PHARMACEUTICA NV
EP3512861	CYCLIC DINUCLEOTIDES AS STING (STIMULATOR OF INTERFERON GENES) AGONISTS	TAKEDA PHARMACEUTICALS CO
EP3512863	2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREATMENT	ATEA PHARMACEUTICALS INC
EP3512882	ANTI-C-MET ANTIBODIES AND ANTIBODY DRUG CONJUGATES THEREOF FOR EFFICIENT TUMOR INHIBITION	MERCK PATENT GMBH
EP3513191	HUMAN OTIC PROGENITOR IDENTIFICATION AND ISOLATION	UNIV SHEFFIELD
EP3514134	PROCESS FOR THE SEPARATION OF OXYMETHYLENE ETHERS	RWTH AACHEN
EP3514135	FLUORENE PHOTOINITIATOR, PREPARATION METHOD THEREFOR, PHOTOCURABLE COMPOSITION HAVING SAME, AND USE OF SAME IN PHOTOCURING FIELD	CHANGZHOU TRONLY ADVANCED ELECTRONIC MAT CO LTD
EP3514159	ALUMINIUM METAL ORGANIC FRAMEWORK MATERIAL	TEXAS A & M UNIV SYS
EP3514165	NUCLEOSIDE DERIVATIVE OR SALT THEREOF, REAGENT FOR SYNTHESIZING POLYNUCLEOTIDE, METHOD FOR PRODUCING POLYNUCLEOTIDE, POLYNUCLEOTIDE, AND METHOD FOR PRODUCING BINDING NUCLEIC ACID MOLECULE	NEC SOLUTION INNOVATORS LTD
EP3514168	PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CELL-TARGETED MOLECULES COMPRISING THE SAME	MOLECULAR TEMPLATES INC
EP3514173	DKK-1 ANTIBODIES	LILLY CO ELI
EP3514174	MATERIALS AND METHODS FOR PERFORMING HISTOCHEMICAL ASSAYS FOR HUMAN PRO-EPIREGULIN AND AMPHIREGULIN	VENTANA MED SYST INC
EP3514883	ELECTROLYTE ADDITIVE AND LITHIUM SECONDARY BATTERY ELECTROLYTE COMPRISING SAME	LG CHEMICAL LTD
EP3515864	SiH-FREE VINYLDISILANES	DOW SILICONES CORP
EP3515894	INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES	NOVARTIS AG
EP3515897	PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME	ABIDE THERAPEUTICS INC
EP3515899	SOLKETAL-ETHERS, PRODUCTION METHOD AND USES THEREOF	CEPSA S A U
EP3515900	COMPOUNDS COMPRISING TWO OR MORE EXOVINYLENE CYCLIC-CARBONATE UNITS	BASF SE
EP3515915	PROCESS FOR PREPARING BETA-LACTAMASE INHIBITOR HYDROXYLUREA INTERMEDIATES	MERCK SHARP & DOHME
EP3515918	PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE	BASF AGRO BV
EP3515920	NEW ANTIMICROBIAL COMPOUNDS, THEIR USE FOR THE TREATMENT OF MAMMALIAN INFECTIONS AND A NEW METABOLIC MECHANISM	LEIBNIZ INST FUER NATURSTOFF FORSCHUNG UND INFEKTIONSBIOLOGIE E V HANS KNOELL INST HKI
EP3515924	CRYSTALLINE FORMS	IDORSIA PHARMACEUTICALS LTD
EP3515929	HEPATITIS B THERAPEUTIC VACCINES	THEVAX GENETICS VACCINE CO LTD
EP3516728	SILYL ESTER PHOSPHINATES AS ELECTROLYTE ADDITIVES	BASF SE
EP3517531	METHOD FOR PRODUCING (R)-5-(3,4-DIFLUOROPHENYL)-5-[(3-METHYL-2-OXOPYRIDIN-1(2H)-YL)METHYL]IMIDAZOLIDINE-2,4-DIONE AND INTERMEDIATE FOR PRODUCING SAME	KAKEN PHARMA CO LTD
EP3517536	AMINOTRIAZINE DERIVATIVES USEFUL AS TANK-BINDING KINASE INHIBITOR COMPOUNDS	GILEAD SCIENCES INC
EP3517625	METHODS FOR DETERMINING LYMPHOCYTE RECEPTOR CHAIN PAIRS	THE UNIV OF BRITISH COLUMBIA UNIV INDUSTRY LIAISON OFFICE
EP3518303	N-(4-(8-(PHENYL)NAPHTHALEN-2-YL)PHENYL)-N,N'-DI(PHENYL)-AMINE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN ORGANIC ELECTROLUMINESCENCE DEVICES	SAMSUNG DISPLAY CO LTD
EP3518304	N-(((PHENYL)NAPHTHALEN-2-YL)PHENYL)-N-(PHENYL)-DIBENZOTHIOPHENAMINE, -DIBENZOFURANAMINE AND -9H-FLUORENYLAMINE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN ORGANIC ELECTROLUMINESCENCE DEVICES	SAMSUNG DISPLAY CO LTD
EP3518334	NON-AQUEOUS ELECTROLYTE SOLUTION ADDITIVE, NON-AQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY, COMPRISING NON-AQUEOUS ELECTROLYTE SOLUTION ADDITIVE	LG CHEMICAL LTD
EP3518911	METHODS FOR TREATING OVARIAN CANCER	RADIUS HEALTH INC
EP3519051	TREATMENT CANCERS USING COMBINATION COMPRISING PARP INHIBITORS	BEIGENE LTD
EP3519069	EQUIPMENT AND PROCESS FOR PROCESSING OF A PRODUCT STREAM RESULTING FROM A CAPROLACTONE PRODUCTION	PERSTORP AB
EP3519382	AN IMPROVED PROCESS FOR THE PREPARATION OF LACOSAMIDE	UNICHEM LAB LTD
EP3519387	TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS	DONG A ST CO LTD
EP3519396	NEW STRIGOLACTONE ANALOGS AND THEIR USAGE IN PLANT CONTROL	UNIV KING ABDULLAH SCI & TECH
EP3519398	PYRIDINE COMPOUND	DAIICHI SANKYO CO LTD
EP3519401	MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR	VERTEX PHARMA
EP3519407	DIMETHYLAMINOETHANOL SALT OF A GLP-1 RECEPTOR MODULATOR	CELGENE INT II SARL
EP3519416	CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE	MERCK SHARP & DOHME
EP3519417	COMPOUNDS WITH DIAZADIBENZOFURANE OR DIAZADIBENZOTHIOPHENE STRUCTURES	MERCK PATENT GMBH
EP3519418	BRIDGED PIPERIDINE DERIVATIVES	HOFFMANN LA ROCHE
EP3519423	ENDOSOMOLYTIC AGENTS FOR GENE THERAPY	UCB BIOPHARMA SPRL
EP3519429	BACTERIAL INHIBITORS	MEHARRY MEDICAL COLLEGE
EP3519437	BISPECIFIC ANTIBODIES AGAINST CD3	HOFFMANN LA ROCHE
EP3519822	CELL MARKERS	CENTRE NAT RECH SCIENT
EP3519823	MEMBRANE MARKERS	CENTRE NAT RECH SCIENT
EP3521266	SUBSTITUTED BIS(TRIFLUOROVINYL)BENZENE COMPOUND	TOSOH FINECHEM CORP
EP3521279	METHODS FOR PROTECTING AND DEPROTECTING A DIOL GROUP	FUJIFILM CORP
EP3521281	1-[(PYRIDIN-3-YL-SULFONYL)-1H-PYRROL-3-YL]METHANAMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	JIANGSU JIBEIER PHARMACEUTICAL CO LTD
EP3521282	QUINAZOLINE DERIVATIVES USED TO TREAT HIV	GILEAD SCIENCES INC
EP3521286	FUSED 1,4-DIHYDRODIOXIN DERIVATIVES AS INHIBITORS OF HEAT SHOCK TRANSCRIPTION FACTOR 1	CANCER RESEARCH TECH LTD
EP3521293	PROCESS FOR THE PREPARATION OF AN INHIBITOR OF PHOSPHODIESTERASE 4	DIPHARMA FRANCIS SRL
EP3521312	A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA	INNATE PHARMA SA
EP3521314	NEW ANTIBODY-DRUG CONJUGATES AND USE THEREOF IN TREATMENT	UNIV RABELAIS FRANCOIS
EP3521422	SUBSTANTIALLY ANIMAL PROTEIN-FREE RECOMBINAT FURIN AND METHODS FOR PRODUCING SAME	BAXALTA GMBH
EP3522246	ORGANIC ELECTROLUMINESCENT ELEMENT	NIPPON STEEL CHEMICAL & MAT CO LTD
EP3522715	MICROBIOCIDAL OXADIAZOLE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3522919	VACCINE	GLAXOSMITHKLINE BIOLOGICALS SA
EP3523269	ALKYLAROMATIC CONVERSION CATALYST	SHELL INT RESEARCH
EP3523273	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3523286	NOVEL HYDROCARBON POLYMERS HAVING EXO-VINYLENE CYCLIC CARBONATE TERMINAL GROUPS	BOSTIK SA
EP3523291	CYANO-SUBSTITUTED HETEROCYCLES WITH ACTIVITY AS INHIBITORS OF USP30	MISSION THERAPEUTICS LTD
EP3523293	SUBSTITUTED PYRROLIDINES AND THEIR USE IN THE TREATMENT OF CYSTIC FIIBROSIS	ABBVIE SARL
EP3523295	DEUTERATED N-(5-(2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDO)-2-FLUOROPHENYL)-2-((4-ETHYLPIPERAZIN-1 -YL)METHYL)QUINOLINE-6-CARBOXAMIDE	CANCER RESEARCH TECH LTD
EP3523297	NOVEL FURAZAN-3-CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN TREATMENT OF CANCER	UNIV BERLIN FREIE
EP3523299	2-(HET)ARYL-SUBSTITUTED CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PEST CONTROL AGENTS	BAYER CROPSCIENCE AG
EP3523307	PROCESS FOR THE PREPARATION OF DORAOLZMIDE HYDROCHLORIDE	INDOCO REMEDIES LTD
EP3523313	DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS	LOMOX LTD
EP3523315	INHIBITORS OF GLUCOCORTICOID RECEPTOR	ORIC PHARMACEUTICALS INC
EP3523316	MELANOCORTIN-1-RECEPTOR AGONISTS	DSM IP ASSETS BV
EP3523320	PEPTIDES FOR BINDING EPIDERMAL GROWTH FACTOR	3M INNOVATIVE PROPERTIES CO
EP3523322	FGF21 RESPONSIVE REPORTER GENE CELL LINE	SVAR LIFE SCIENCE AB
EP3523324	METHOD OF PREPARING PEPTIDES COMPRISING A LIPOPHILICALLY MODIFIED LYSINE SIDE CHAIN	SANOFI SA
EP3524590	METHOD FOR PRODUCING 1, 4-DICYANOCYCLOHEXANE, 1, 4-BIS(AMINOMETHYL)CYCLOHEXANE AND 1, 4-CYCLOHEXANEDICARBOXYLIC ACID	MITSUBISHI GAS CHEMICAL CO
EP3524598	A SOLID FORM OF (S)-3-(4-((4-MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE HYDROCHLORIDE	CELGENE CORP
EP3524601	N-{3-[3-CYCLOPROPYL-5-(2-FLUORO-4-IODOPHENYLAMINO)-6,8-DIMETHYL-2,4,7-TRIOXO-3,4,6,7-TETRAHYDRO-2H-PYRIDO[4,3-D]PYRIMIDIN-1-YL]-PHENYL}-CYCLOPROPANECARBOXAMIDE DIMETHYL SULPHOXIDE SOLVATE AS AN MEK1/2 INHIBITOR	R PHARM JOINT STOCK COMPANY R PHARM JSC
EP3524609	3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF	GLACEUM INC
EP3524615	GENE FOR INCREASING PLANT WEIGHT AND METHOD FOR USING THE SAME	TOYOTA MOTOR CO LTD
EP3524685	INTERLEUKIN -13 BINDING PROTEINS	ABBVIE BAHAMAS LTD
EP3525830	PYRROLOBENZODIAZEPINE CONJUGATES	MEDIMMUNE LTD
EP3526185	PROCESS FOR THE PRODUCTION OF 2-ALKYLALKANOL	JOHNSON MATTHEY DAVY TECHNOLOGIES LTD
EP3526190	METHOD OF PREPARING HYDROXYALKYLCARBOXYLIC ACID ESTERS	BASF SE
EP3526192	MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO	DOW AGROSCIENCES LLC
EP3526203	N-ARYL AND N-HETEROARYL PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE	MERCK SHARP & DOHME
EP3526204	NEAR-IR ABSORPTIVE COMPOUNDS AND DEVICES INCORPORATING THE SAME	GENTEX CORP
EP3526208	NEW COMPOUNDS AND USES THEREOF FOR DETECTION OF TARGET MOLECULES IN A SAMPLE	UNIV GENEVE
EP3526213	URINARY POLYAMINES AS PROSTATE CANCER DETECTION BIOMARKERS	NEW LIFE MEDICINE TECH COMPANY LIMITED
EP3526223	METHOD FOR ISOLATION AND PURIFICATION OF NALTREXONE	SANECA PHARMACEUTICALS A S
EP3526229	PROCESS FOR PREPARING GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES	BOEHRINGER INGELHEIM INT
EP3526239	HIF 1-ALPHA ANTISENSE OLIGONUCLEOTIDES	OLIPASS CORP
EP3527192	AMINO ACID DERIVATIVES AND THEIR USES	JOHNSON & JOHNSON CONSUMER INC
EP3527280	SELECTIVE MODIFICATION OF POLYMER SUBUNITS TO IMPROVE NANOPORE-BASED ANALYSIS	UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
EP3527550	PROCESS FOR ETHERIFICATION OF MIXED OLEFINIC LIGHT NAPHTHA AND SIMULTANEOUS REDUCTION OF METHANOL IN THE PRODUCT	INDIAN OIL CORP LTD
EP3527553	EPSILON-CAPROLACTAM PRODUCTION METHOD	SUMITOMO CHEMICAL CO
EP3527555	NOVEL COMPOUND, AND MODIFIED CONJUGATED DIENE-BASED POLYMER CONTAINING FUNCTIONAL GROUP DERIVED FROM COMPOUND	LG CHEMICAL LTD
EP3527559	GAMMA-BUTYROLACTONE COMPOSITION AND METHOD FOR PRODUCING SAME	MITSUBISHI CHEM CORP
EP3527563	DNA-PK INHIBITORS	VERTEX PHARMA
EP3527569	DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA FOR USE IN TREATING DRYE EYE	VITAE PHARMACEUTICALS LLC
EP3527575	BIS(OXYMETHYL)PHOSPHINIC ACID AND BIOGENIC METAL SALTS THEREOF AS REGULATORS OF PLANT GROWTH AND DEVELOPMENT	SINYASHIN KIRILL OLEGOVICH
EP3527580	CONTINUOUS, SOLVENT-FREE AND NON-ENZYMATIC PEPTIDE SYNTHESIS BY REACTIVE EXTRUSION	CENTRE NAT RECH SCIENT
EP3528332	ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY COMPRISING SAME	LG CHEMICAL LTD
EP3528811	METHODS OF TREATING DEPRESSION	RUNDLE RES LLC
EP3528942	SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES	UMICORE AG & CO KG
EP3529231	CRYSTALLINE DIETHYLAMINE TETRATHIOMOLYBDATE AND ITS PHARMACEUTICAL USES	UCL BUSINESS PLC
EP3529238	BIS-DIOX(OL)ANE COMPOUNDS	KONINKLIJKE COOEPERATIE COSUN U A
EP3529253	PROCESS	JOHNSON MATTHEY PLC
EP3529262	METHODS FOR PROMOTING T CELLS RESPONSE	INST NAT SANTE RECH MED
EP3529275	PROTEINS AND USES	UCB BIOPHARMA SPRL
EP3529361	SECRETABLE VARIANT IMMUNOMODULATORY PROTEINS AND ENGINEERED CELL THERAPY	ALPINE IMMUNE SCIENCES INC
EP3530638	IMPROVED METHOD FOR EXTRACTING HUMIC SUBSTANCES FROM CARBON	FERTINAGRO BIOTECH SL
EP3530658	HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME	SAMSUNG DISPLAY CO LTD
EP3530662	METHOD FOR PREPARING HEPTAZINES	CENTRE NAT RECH SCIENT
EP3530663	PROCESS FOR PREPARING GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS	ADVANOMICS CORP
EP3530667	PEPTIDE HAVING ANTI-OBESITY AND ANTI-DIABETES EFFICACY AND USE THEREOF	CAREGEN CO LTD
EP3531129	IMMUNOASSAY METHOD USING ANTI-HUMAN BNP FRAGMENT (4-32) ANTIBODY	SEKISUI MEDICAL CO LTD
EP3532024	COSMETIC USE AND METHOD FOR IMPROVING PHYSIOLOGICAL FUNCTIONS OF THE SKIN BY INCREASING THE EXPRESSION OF UBIAD1	ISP INVESTMENTS LLC
EP3532455	IMPROVED SYNTHESIS OF MONO-CHLORINATED ACETOPHENONE	SIEGFRIED AG
EP3532458	BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF	BOEHRINGER INGELHEIM INT
EP3532471	PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR AND HYDROXYLAMINE SUBSTITUENTS	SYNGENTA PARTICIPATIONS AG
EP3532473	HETEROBICYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES	SQUIBB BRISTOL MYERS CO
EP3532478	CRYSTALLINE FORMS OF DARUNAVIR FREE BASE, HYDRATE, SOLVATES AND SALTS	GILEAD SCIENCES INC
EP3532486	ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS	JANSSEN PHARMACEUTICA NV
EP3532490	ADAPTER CHIMERIC ANTIGEN RECEPTOR EXPRESSING CELLS FOR TARGETING OF MULTIPLE ANTIGENS	MILTENYI BIOTEC GMBH
EP3532499	ANTI-IL-33 ANTIBODIES AND USES THEREOF	LILLY CO ELI
EP3532578	LUBRICANT ADDITIVE COMPOSITIONS COMPRISING PHOSPHOROUS CONTAINING COMPOUNDS AND USES THEREOF	AFTON CHEMICAL CORP
EP3532642	DIGITAL ANALYSIS OF BLOOD SAMPLES TO DETERMINE EFFICACY OF CANCER THERAPIES FOR SPECIFIC CANCERS	MASSACHUSETTS GEN HOSPITAL
EP3533345	CHLOROGENIC ACID-CONTAINING COMPOSITION MANUFACTURING METHOD	KAO CORP
EP3533784	SPIRO BENZOANTHRACENE-FLUORENE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONIC DEVICES, DISPLAYS AND LIGHTING DEVICES	NOVALED GMBH
EP3533796	AMINO PYRAZOLOPYRIMIDINE COMPOUND USED AS NEUROTROPHIC FACTOR TYROSINE KINASE RECEPTOR INHIBITOR	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
EP3533798	DIBENZOPYRROMETHENE BORON CHELATE COMPOUND, NEAR INFRARED LIGHT ABSORBING MATERIAL, THIN FILM, AND ORGANIC ELECTRONIC DEVICE	NIPPON KAYAKU KK
EP3533802	ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE	US HEALTH
EP3533803	AMYLOID-BETA BINDING ANTIBODIES	ABBVIE INC
EP3535238	AMINOOXYLIPIDS FOR THE CONSTRUCTION OF SELF-ASSEMBLING LIPOSOMAL SYSTEMS ENABLING THEIR SUBSEQUENT MODIFICATION BY BIOLOGICALLY FUNCTIONAL MOLECULES	VS CHEMICKO TECHNOLOGICKA V PRAZE
EP3535284	DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS	US HEALTH
EP3535298	ANTIBODIES TO PD-1 AND USES THEREOF	JOUNCE THERAPEUTICS INC
EP3535352	METHODS OF REDUCING PHOSPHORUS CONTENT IN LIQUID HYDROCARBONS	LYONDELL CHEMICAL TECH LP
EP3536315	INHIBITOR OF ATP-DEPENDENT REVERSE TRANSPORTERS OF CELLS AND METHOD FOR PRODUCING SAME	AKTSIONERNOE OBSHCHESTVO TATKHIMFARMPREPARATY
EP3536683	POLYISOCYANATE COMPOSITION AND ISOCYANATE POLYMER COMPOSITION	ASAHI CHEMICAL IND
EP3536686	METHOD FOR PRODUCING A RADIOPHARMACEUTICAL COMPOSITION	NIHON MEDIPHYSICS CO LTD
EP3536692	PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME	MILLENNIUM PHARM INC
EP3536703	CONSENSUS PROSTATE ANTIGENS, NUCLEIC ACID MOLECULES ENCODING THE SAME AND USES THEREOF	UNIV PENNSYLVANIA
EP3536704	GENE THERAPY FOR RENAL FAILURE	BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC
EP3536748	A MODIFIED COLLAGEN	INNOCOLL PHARM LTD
EP3538503	A PROCESS FOR THE PRODUCTION OF FLUORINATED CYCLOBUTANE	HONEYWELL INT INC
EP3538508	RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS	XIMO AG
EP3538510	PROCESS FOR THE PREPARATION OF MONO-PROTECTED alpha,omega-DIAMINO ALKANES	SYNTHON BIOPHARMACEUTICALS BV
EP3538512	NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES	BAYER ANIMAL HEALTH GMBH
EP3538519	INDAZOLE DERIVATIVES AS ALPHA V INTEGRIN ANTAGONISTS	SQUIBB BRISTOL MYERS CO
EP3538527	AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS	SQUIBB BRISTOL MYERS CO
EP3539545	CRYSTALLINE FORM OF GNRH RECEPTOR ANTAGONIST AND PREPARATION METHOD THEREFOR	JIANGSU HENGRUI MEDICINE CO
EP3539941	METHOD FOR PREPARING TRIMETHYLOLPROPANE	LG CHEMICAL LTD
EP3539953	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEMICAL LTD
EP3539955	METHOD FOR PREPARING TETRAZINES	CENTRE NAT RECH SCIENT
EP3539961	POLYCYCLIC AMIDE DERIVATIVES AS CDK9 INHIBITORS	ASTRAZENECA AB
EP3539964	BASE ACETAMIDE GLYCERIN ETHER MOLECULE, CHEMICAL SYNTHESIS METHOD THEREFOR, AND APPLICATIONS THEREOF IN FIELD OF GENE THERAPY	UNIV BEIJING
EP3539965	AN IMPROVED PROCESS FOR THE PREPARATION OF (3R,4R)-(1-BENZYL-4-METHYLPIPERIDIN-3-YL)-METHYLAMINE	UNICHEM LAB LTD
EP3539968	NOVEL TRITYL PROTECTING AGENT	SEKISUI MEDICAL CO LTD
EP3539970	POLYMERIZABLE COMPOUND, COMPOUND, AND METHOD FOR PRODUCING BORANOPHOSPHATE OLIGOMER	UNIV TOKYO SCIENCE FOUND
EP3539972	ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME	SAMSUNG DISPLAY CO LTD
EP3539990	HER3 INHIBITION IN LOW-GRADE SEROUS CANCERS	DANA FARBER CANCER INST INC
EP3540053	AMYLASES AND GLUCOAMYLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM	BASF ENZYMES LLC
EP3540062	IMMUNOGLOBULIN VARIABLE REGION CASSETTE EXCHANGE	HUMANIGEN INC
EP3541770	PROCESSES AND SYSTEMS FOR ACHIEVING HIGH CARBON CONVERSION TO DESIRED PRODUCTS IN A HYBRID CATALYST SYSTEM	DOW GLOBAL TECHNOLOGIES LLC
EP3541771	PROCESS FOR PRODUCING 1,2-PROPANEDIOL FROM GLYCEROL	ARCHER DANIELS MIDLAND CO
EP3541778	ELECTROCHEMICAL METHOD FOR PRODUCING ARYL ALKYL CARBONATES AND DIARYL CARBONATES	COVESTRO DEUTSCHLAND AG
EP3541793	METHOD FOR PRODUCING TRIARYLORGANOBORATES	COVESTRO DEUTSCHLAND AG
EP3541794	4-((6-(2-(2,4-DUFLUOROPHENYL)-1,1-DIFLUORO-2-HYDROXY-3-(5-MERCAPTO-1H-1,2,4-TRIAZOL-1-YL)PROPYL)PYRIDIN-3-YL)OXY)BENZONITRILE AND PROCESSES OF PREPARATION	DOW AGROSCIENCES LLC
EP3541807	CRYSTALLINE FORMS OF A MAGL INHIBITOR	ABIDE THERAPEUTICS INC
EP3541814	2-SUBSTITUTED AMINO-NAPHTH[1,2-D]IMIDAZOL-5-ONE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF CROSS REFERENCE TO RELATED APPLICATIONS	BIOELECTRON TECH CORP
EP3541893	PROCESS AND SYSTEM FOR CONVERSION OF CRUDE OIL TO PETROCHEMICALS AND FUEL PRODUCTS INTEGRATING VACUUM GAS OIL HYDROTREATING AND STEAM CRACKING	SAUDI ARABIAN OIL CO
EP3543229	METHOD FOR PREPARING OPTICALLY PURE (R)-4-N-PROPYL-DIHYDROFURAN-2(3H)-ONE	BEIJING ABLEPHARMTECH CO LTD
EP3543230	ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE	SAMSUNG DISPLAY CO LTD
EP3543248	PHOSPHORESCENT PtAg2 COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF	FUJIAN INST RES STR MATTER CAS
EP3543252	METHOD FOR INCREASING THE SECRETION LEVELS OF INTERLEUKIN 2 AND PROTEINS DERIVED FROM IT	CT INMUNOLOGIA MOLECULAR
EP3543697	METHOD FOR THE SELECTION OF BIOLOGICAL BINDING MOLECULES	AVA LIFESCIENCE GMBH
EP3544613	GSK-3 INHIBITORS	SQUIBB BRISTOL MYERS CO
EP3544727	OLIGOMERIZATION PROCESS INVOLVING CRYSTALLINE MOLECULAR SIEVE	HINDUSTAN PETROLEUM CORP LTD
EP3544928	METHOD FOR STORING ENERGY IN THE FORM OF HYDRAZINE CARBONATE	SCHAEFFLER TECHNOLOGIES AG
EP3544945	PROCESS FOR PREPARING (POLY)ALKYLATED PHENOLS	DSM IP ASSETS BV
EP3544946	DIPHENOL PRILLS AND METHOD FOR OBTAINING THE SAME	RHODIA OPERATIONS
EP3544955	IMPROVED PROCESS FOR PREPARING ASTACENE	BASF SE
EP3544961	POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4	UNIV VANDERBILT
EP3544962	DIAMINOTRIAZINE COMPOUNDS	BASF SE
EP3544973	TETRAZOLINONE COMPOUNDS AND ITS USE AS PEST CONTROL AGENTS	SUMITOMO CHEMICAL CO
EP3544976	N-[5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)-PHENYL]-ACETAMIDE FREE BASE HEMIHYDRATE, METHODS OF MANUFACTURE AND USES THEREOF	AICURIS ANTI INFECTIVE CURES GMBH
EP3544977	A MALEATE SALT OF THE FREE BASE OF N-[5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)-PHENYL]-ACETAMIDE, PHARMACEUTICAL FORMULATIONS, METHODS OF MANUFACTURE AND USES THEREOF FOR THE TREATMENT OF HERPES VIRUSES	AICURIS ANTI INFECTIVE CURES GMBH
EP3544980	GSK-3 INHIBITORS	SQUIBB BRISTOL MYERS CO
EP3544981	BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS	ENTERPRISE THERAPEUTICS LTD
EP3544982	CHEMICAL PROCESS FOR PREPARING IMIDAZOPYRROLIDINONE DERIVATIVES AND INTERMEDIATES THEREOF	NOVARTIS AG
EP3544985	BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED)	MERCK PATENT GMBH
EP3545009	PHOTOINITATORS	COLOPLAST AS
EP3545121	PROCESS	AVANTIUM KNOWLEDGE CENTRE BV
EP3545965	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS	IMMATICS BIOTECHNOLOGIES GMBH
EP3545978	TRIAZINE BASED RADIOPHARMACEUTICALS AND RADIOIMAGING AGENTS	MOLECULAR INSIGHT PHARM INC
EP3546439	METHOD FOR PRODUCING (Z)-1-CHLORO-2,3,3-TRIFLUORO-1-PROPENE	AGC INC
EP3546440	REMOVAL UNIT FOR METHANOL AND ACETONE AND SYSTEM COMPRISING SAME FOR PREPARING PHENOL AND BISPHENOL A	LG CHEMICAL LTD
EP3546441	METHOD FOR PREPARING ACRYLIC ACID AND METHYL ACRYLATE	DALIAN INST CHEM & PHYSICS CAS
EP3546443	METHOD FOR PRODUCING FLUORINE-CONTAINING DIALKYL CARBONATE COMPOUNDS	SAMHWA PAINTS IND CO LTD
EP3546453	NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME	LG CHEMICAL LTD
EP3546472	METHOD FOR PURIFYING P1,P4-DI(URIDINE 5'-)TETRAPHOSPHATE	YAMASA CORP
EP3546474	CRP CAPTURE/DETECTION OF GRAM POSITIVE BACTERIA	HARVARD COLLEGE
EP3546484	IN VITRO PRODUCTION OF RED BLOOD CELLS WITH SORTAGGABLE PROTEINS	WHITEHEAD INST BIOMEDICAL RES
EP3546494	CURING AGENT FOR WATER-BASED EPOXY RESIN, WATER-BASED EPOXY RESIN COMPOSITION, AND CURED PRODUCT THEREOF	MITSUBISHI GAS CHEMICAL CO
EP3546942	BIOCHIP	NIPPON LIGHT METAL CO
EP3548457	AN IMPROVED PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUOROPROPENE	SRF LTD
EP3548461	MECHANOCHEMICAL SYNTHESIS OF RADIOGRAPHIC AGENTS INTERMEDIATES	BRACCO IMAGING SPA
EP3548477	NITROGEN-CONTAINING HETEROCYCLES FOR USE IN OLEDS	MERCK PATENT GMBH
EP3548485	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3548486	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3548495	PYRAZOLOPYRIMIDINE DERIVATIVES AS CAM KINASE INHIBITORS	GILEAD SCIENCES INC
EP3548498	SILVER ION ALPHA-OXY CARBOXYLATE-OXIME COMPLEXES FOR PHOTOLITHOGRAPHIC PROCESSES TO GENERATE ELECTRICALLY CONDUCTING METALLIC STRUCTURES	EASTMAN KODAK CO
EP3548501	NOVEL RUTHENIUM COMPLEX, METHOD OF ITS PRODUCTION AND ITS USE IN REACTION OF OLEFINE METATHESIS	UNIV WARSZAWSKI
EP3548504	PEPTIDE-BASED PROTEASOME INHIBITORS FOR TREATING CONDITIONS MEDIATED BY SENESCENT CELLS AND FOR TREATING CANCER	UNITY BIOTECHNOLOGY INC
EP3548505	CYTOPLASMIC MALE STERILITY GENE ORF147 OF PIGEONPEA, AND USES THEREOF	INTERNATIONAL CROPS RES INSTITUTE FOR THE SEMI ARID TROPICS ICRISAT
EP3548508	NEW COMPOUNDS AS PEPTIDIC TRIGONAL GLP1/GLUCAGON/GIP RECEPTOR AGONISTS	SANOFI SA
EP3548511	METHODS AND MATERIALS FOR CLONING FUNCTIONAL T CELL RECEPTORS FROM SINGLE T CELLS	UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION
EP3548613	BACTERIAL GLUTAMINYL CYCLASES AND INHIBITORS THEREOF FOR USE IN THE TREATMENT OF PERIODONTITIS	FRAUNHOFER GES FORSCHUNG
EP3549601	NON-LIPIDATED VARIANTS OF NEISSERIA MENINGITIDIS ORF2086 ANTIGENS	WYETH LLC
EP3549936	1,2,4-OXADIAZOLE BENZOIC ACID COMPOUND AND ITS USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE	PTC THERAPEUTICS INC
EP3549941	ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE	SAMSUNG DISPLAY CO LTD
EP3549943	SALT COMPRISING SILICON-CONTAINING PHOSPHATE ANION, AND LUBRICANT	NISSHINBO HOLDINGS INC
EP3549944	ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND	SAMSUNG ELECTRONICS CO LTD
EP3550362	COMPOUND, COMPOSITION FOR FORMING ORGANIC FILM, SUBSTRATE FOR MANUFACTURING SEMICONDUCTOR APPARATUS, METHOD FOR FORMING ORGANIC FILM, AND PATTERNING PROCESS	SHINETSU CHEMICAL CO
EP3551209	INSULIN-FC FUSIONS AND METHODS OF USE	AKSTON BIOSCIENCES CORP
EP3551221	NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME	IMMATICS BIOTECHNOLOGIES GMBH
EP3551598	PROCESS FOR SELECTIVE ETHYLENE OLIGOMERIZATION WITH ANTIFOULING COMPONENTS	SAUDI ARABIAN OIL CO
EP3551605	PROCESS FOR PRODUCING (METH)ACRYLIC ESTERS	ARKEMA FRANCE
EP3551610	BICYCLO[1.1.1]PENTANE INHIBITORS OF DUAL LEUCINE ZIPPER (DLK) KINASE FOR THE TREATMENT OF DISEASE	UNIV TEXAS
EP3551614	DIMERIC CONTRAST AGENTS	BRACCO IMAGING SPA
EP3551617	COMPOSITIONS AND METHODS RELATED TO PYRIDINOYLPIPERIDINE 5-HT1F AGONISTS	COLUCID PHARMACEUTICALS INC
EP3551623	ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME	ROHM & HAAS ELECT MATERIALS KOREA LTD
EP3551633	SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS	LEO PHARMA AS
EP3551634	SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS	LEO PHARMA AS
EP3551635	THIENO-INDENO-MONOMERS AND POLYMERS	BASF SE
EP3551652	GLP-1/GLP-2 DUAL AGONISTS	ZEALAND PHARMA AS
EP3551664	ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127	OSE IMMUNOTHERAPEUTICS
EP3553046	PRODUCTION METHOD FOR N ( HYDROXYETHYL) FORMAMIDE, PRODUCTION METHOD FOR N ( ALKOXYETHYL) FORMAMIDE, PRODUCTION DEVICE FOR N ( HYDROXYETHYL) FORMAMIDE, AND PRODUCTION DEVICE FOR N ( ALKOXYETHYL) FORMAMIDE	MITSUBISHI CHEM CORP
EP3553047	METHOD FOR PURIFYING N-( -ALKOXYETHYL)FORMAMIDE, METHOD FOR PRODUCING HIGH-PURITY N-( -ALKOXYETHYL)FORMAMIDE, AND DEVICE FOR PURIFYING N-( -ALKOXYETHYL)FORMAMIDE	MITSUBISHI CHEM CORP
EP3553066	GLYCOLURIL RING-CONTAINING ORGANOSILICON COMPOUND AND MAKING METHOD	SHINETSU CHEMICAL CO
EP3553068	HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM	ICL IP AMERICA INC
EP3553205	METHOD AND DEVICE FOR PRODUCING OXIDATION PRODUCTS	FORSCHUNGSZENTRUM JUELICH GMBH
EP3555035	INITIATOR SYSTEM FOR CATIONIC POLYMERIZATION OF OLEFINS	ARLANXEO CANADA INC
EP3555042	PROCESS FOR PREPARATION OF ISOPROTERENOL HYDROCHLORIDE	EMCURE PHARMACEUTICALS LTD
EP3555043	PROCESS FOR MANUFACTURING HYDROXYETHYL ETHYLENE AMINES	NOURYON CHEMICALS INT BV
EP3555048	NEW PICOLINIC ACID DERIVATIVES AND THEIR USE AS INTERMEDIATES	NOVARTIS AG
EP3555053	HERBICIDAL PHENYLTRIAZOLINONES	BASF SE
EP3555083	PESTICIDALLY ACTIVE AZETIDINE SULFONES AMIDE ISOXAZOLINE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3555086	1,4-THIAZINE DIOXIDE AND 1,2,4-THIADIAZINE DIOXIDE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE	AMGEN INC
EP3555099	PROCESS FOR PREPARING BTK INHIBITORS	HOFFMANN LA ROCHE
EP3555102	HERBICIDAL COMPOUNDS	SYNGENTA PARTICIPATIONS AG
EP3555107	PROCESS FOR THE PREPARATION OF (S)-2-((2-((S)-4-(DIFLUOROMETHYL)-2-OXOOXAZOLIDIN-3-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)AMINO) PROPANAMIDE	HOFFMANN LA ROCHE
EP3555110	DENTAL COMPOSITION	DENTSPLY DETREY GMBH
EP3555118	INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE	PIONEER HI BRED INT
EP3555139	IMMUNE CELLS EXPRESSING AN ANTIGEN BINDING RECEPTOR AND A CHIMERIC COSTIMULATORY RECEPTOR	MILTENYI BIOTEC GMBH
EP3555284	COMPOSITIONS AND METHODS USING CAS9 WITH ENHANCED SPACER ACQUISITION FUNCTION	UNIV ROCKEFELLER
EP3555325	SEPARATION OF RARE EARTH METALS	UNIV BELFAST
EP3556205	HUMANIZED MOUSE MODEL	AUSTRIA DEBRA
EP3556206	GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF	REGENERON PHARMA
EP3556742	1-HALOALKADIENE AND PROCESS FOR PREPARING THE SAME AND A PROCESS FOR PREPARING (9E,11Z)-9,11-HEXADECADIENYL ACETATE	SHINETSU CHEMICAL CO
EP3556750	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING SAME	LG CHEMICAL LTD
EP3556761	PYRROLO-AROMATIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF	THE NATIONAL INSTITUTES OF PHARMACEUTICAL RES
EP3556777	MULTISPECIFIC ANTIBODY CONSTRUCTS	UCB BIOPHARMA SPRL
EP3556790	LOW VISCOSITY CROSSLINKERS CONTAINING ALKOXYSILANE GROUPS	EVONIK DEGUSSA GMBH
EP3556857	CDC45L PEPTIDES AND VACCINES INCLUDING THE SAME	ONCOTHERAPY SCIENCE INC
EP3557254	PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF	VIB VZW
EP3557255	PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF	VIB VZW
EP3558213	LILY OF THE VALLEY ODORANT	FIRMENICH & CIE
EP3558300	SOLID PHARMACEUTICAL FORMULATIONS OF ASIMADOLINE	TIOGA PHARMACEUTICALS INC
EP3558396	DIFFERENTIAL DIAGNOSIS OF PARKINSON'S DISEASE	GE HEALTHCARE LTD
EP3558907	PROCESS TO PREPARE PROPYLENE	GASOLFIN B V
EP3558909	PARALLEL REACTOR SYSTEM FOR ETHYLBENZENE DEHYDROGENATION	FINA TECHNOLOGY
EP3558911	PROCESS AND PLANT FOR PRODUCING OLEFINS	LINDE AG
EP3558916	METHOD FOR MANUFACTURING OF BISPHENOL A	SABIC GLOBAL TECHNOLOGIES BV
EP3558918	METHOD FOR DECREASING THE CONCENTRATION OF A METAL IN A MONOMER COMPOSITION COMPRISING BIS(BENZOYL)BENZENE	SOLVAY SPECIALTY POLYMERS USA
EP3558926	METHOD OF PRODUCING DIAMINES AND POLYAMINES OF THE DIPHENYLMETHANE SERIES	COVESTRO DEUTSCHLAND AG
EP3558927	METHOD OF PRODUCING DIAMINES AND POLYAMINES OF THE DIPHENYLMETHANE SERIES	COVESTRO DEUTSCHLAND AG
EP3558928	METHOD OF PRODUCING DIAMINES AND POLYAMINES OF THE DIPHENYLMETHANE SERIES AT DIFFERENT PRODUCTION CAPACITIES	COVESTRO DEUTSCHLAND AG
EP3558929	METHOD OF PRODUCING DIAMINES AND POLYAMINES OF THE DIPHENYLMETHANE SERIES AT DIFFERENT PRODUCTION CAPACITIES	COVESTRO DEUTSCHLAND AG
EP3558930	NEW PROCESS FOR EARLY SACUBITRIL INTERMEDIATES	NOVARTIS AG
EP3558940	PROCESS FOR PREPARING AN ISOCYANATE	COVESTRO DEUTSCHLAND AG
EP3558945	PROCESS FOR THE PREPARATION OF A 2-PYRIDYLETHYLCARBOXAMIDE DERIVATIVE	BAYER CROPSCIENCE AG
EP3558951	METHOD FOR THE MANUFACTURING OF DELMOPINOL	LUNDBECK PHARMACEUTICALS ITALY S P A
EP3558953	METHOD FOR THE MANUFACTURING OF 2-(3-(ALKYL AND ALKENYL)MORPHOLINO)-ETHAN-1-OLS	LUNDBECK PHARMACEUTICALS ITALY S P A
EP3558954	IMPROVED PROCESS FOR THE MANUFACTURE OF R-6-HYDROXY-8-[1-HYDROXY-2-[2-(4-METHOXYPHENYL)-1,1-DIMETHYLETHYLAMINOETHYL]-2H-1,4-BENZOXAZIN-3(4H)-ONE HYDROCHLORIDE	INKE SA
EP3558961	POLYMORPHS	SYNGENTA PARTICIPATIONS AG
EP3558968	IMIDAZOPYRAZINE INHIBITORS OF BRUTON'S TYROSINE KINASE	ACERTA PHARMA BV
EP3558979	NOVEL BENZYLAMINO SUBSTITUTED QUINAZOLINES AND DERIVATIVES AS SOS1 INHIBITORS	BOEHRINGER INGELHEIM INT
EP3558989	TRIAZOLO[1,5-A]PYRIDINE DERIVATIVES AS IMMUNOMODULATORS	INCYTE CORP
EP3558997	AMINO-TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER	ASTRAZENECA AB
EP3559009	COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY	CALITHERA BIOSCIENCES INC
EP3559022	VIRULENCE ATTENUATED BACTERIA BASED PROTEIN DELIVERY	UNIV BASEL
EP3559023	A MULTI-EPITOPE DNA VACCINE FOR HEARTWATER	AGRICULTURAL RESEARCH COUNCIL
EP3559155	PROCESS FOR STEAM CRACKING HYDROCARBONS	EXXONMOBIL CHEMICAL PATENTS INC
EP3559170	INTEGRATED PROCESS FOR THE PRODUCTION OF BENZENE AND XYLENES FROM HEAVY AROMATICS	SAUDI ARABIAN OIL CO
EP3559248	IN VITRO GLYCOENGINEERING OF ANTIBODIES	HOFFMANN LA ROCHE
EP3560493	OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS	CORCEPT THERAPEUTICS INC
EP3560909	PRODUCTION METHOD FOR HIGH-QUALITY ADIPIC ACID	HENAN SHENMA NYLON CHEMICAL CO LTD
EP3560911	PROCESS FOR CONVERTING S-ENANTIOMER TO ITS RACEMIC FORM	FMC CORP
EP3560915	POLYPEPTIDES HAVING OXIDOREDUCTASE ACTIVITY AND THEIR USES	PURAC BIOCHEM BV
EP3560924	IMIDAZOLONYL QUINOLINES AND THEIR USE AS ATM KINASE INHIBITORS	MERCK PATENT GMBH
EP3560928	FUSED IMIDAZOLE COMPOUND HAVING INDOLEAMINE 2,3-DIOXYGENASE INHIBITORY ACTIVITY	SHENZHEN CHIPSCREEN BIOSCIENCES CO LTD
EP3560939	METHOD FOR PRODUCING CYCLOMETALATED IRIDIUM COMPLEX	AIST
EP3560941	ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOUND INCLUDING THE ORGANOMETALLIC COMPOUND	SAMSUNG ELECTRONICS CO LTD
EP3560954	MODIFIED J-CHAIN	IGM BIOSCIENCES INC
EP3561061	NOVEL L-TRYPTOPHAN EXPORT PROTEIN AND METHOD FOR PRODUCING L-TRYPTOPHAN USING SAME	CJ CHEILJEDANG CORP
EP3562573	PURIFIED TEREPHTHALIC ACID (PTA) VENT DRYER VAPOR EFFLUENT TREATMENT	BP CORP NORTH AMERICA INC
EP3562797	NEW GENERATION PRIMARY EXPLOSIVE	ATILIM UNIV
EP3562802	RESIN WITH PROMOTER AND ANTIOXIDANT	DOW GLOBAL TECHNOLOGIES LLC
EP3562804	PURIFIED TEREPHTHALIC ACID (PTA) VENT STEAM UTILIZATION	BP CORP NORTH AMERICA INC
EP3562809	PYRAZOLOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF	HOFFMANN LA ROCHE
EP3562815	A CATALYST COMPOSITION FOR A PRODUCTION PROCESS OF - LACTONE FROM CARBON DIOXIDE AND 1,3-BUTADIENE	PTT GLOBAL CHEMICAL PUBLIC CO LTD
EP3562816	NRF2 ACTIVATOR	BIOGEN MA INC
EP3562822	POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS	MITOBRIDGE INC
EP3562829	CATALYSIS OF DEHYDROCOUPLING REACTIONS BETWEEN AMINES AND SILANES	DOW SILICONES CORP
EP3562831	CATALYSTS	BOREALIS AG
EP3562832	REVERSIBLY PROTECTED NUCLEOTIDE REAGENTS WITH HIGH THERMAL STABILITY	ROCHE DIAGNOSTICS GMBH
EP3563111	GREEN PRIMARY EXPLOSIVE	ATILIM UNIV
EP3563916	METHOD AND DEVICE FOR INVERSE SEPARATION OF AROMATICS	AXENS
EP3564207	METHOD FOR PRODUCING ALCOHOL COMPOUND	KANEKA CORP
EP3564208	METHOD FOR PREPARING 2-(CYCLOHEXENYLENE) MALONIC ACID DERIVATIVE AND USE THEREOF	ORIENTAL LUZHOU AGROCHEMICALS CO LTD
EP3564212	METHOD FOR PRODUCING ALIPHATIC ISOCYANATE	HANWHA CHEMICAL CORP
EP3564218	METHOD FOR PREPARING 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID	VIWIT PHARMACEUTICAL CO LTD
EP3564219	PROCESS FOR PREPARING OXADIAZACYCLO COMPOUND AND USE THEREOF	ORIENTAL LUZHOU AGROCHEMICALS CO LTD
EP3564224	CRYSTALLINE FORM OF VORTIOXETINE HYDROBROMIDE AS ANTIDEPRESSANT DRUG	DIPHARMA FRANCIS SRL
EP3564226	METHOD FOR PRODUCING GLYCERIC ACID ESTER	KAO CORP
EP3564246	A GOLD(III) COMPLEX, A CONJUGATE OF THE GOLD(III) COMPLEX, A PHARMACEUTICAL COMPOSITION COMPRISING THE GOLD(III) COMPLEX AND USES AND A PROCESS FOR PREPARING THE GOLD(III) COMPLEX	UNIV ALMERIA
EP3564249	NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME	LG CHEMICAL LTD
EP3564252	MODIFIED NUCLEOTIDE LINKERS	ILLUMINA CAMBRIDGE LTD
EP3564258	FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN	SQUIBB BRISTOL MYERS CO
EP3564264	VACCINE COMPOSITION COMPRISING A MUTATION OF HUMAN INTERLEUKIN-15	CT INGENIERIA GENETICA BIOTECNOLOGIA
EP3564267	PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY	CSL BEHRING GMBH
EP3564674	HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE	VENTANA MED SYST INC
EP3565801	CONVERSION OF WASTE PLASTIC TO PROPYLENE AND CUMENE	SABIC GLOBAL TECHNOLOGIES BV
EP3565805	SYNTHESIS OF BENZYLANILINYL PHENYL PHENOL LIGANDS	UNIVATION TECH LLC
EP3565807	OXADIAZOLE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSIS	ICAHN SCHOOL MED MOUNT SINAI
EP3565821	SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS	UNIVATION TECH LLC
EP3565826	USE OF THE CPCR REGULATOR GENE FOR OBTAINING NEW RECOMBINANT STRAINS OF BACILLUS THURINGIENSIS WITH REDUCED SPORULATION CAPACITY	AGRONOMIQUE INST NAT RECH
EP3565828	A SIRP1 ALPHA-41BBL FUSION PROTEIN AND METHODS OF USE THEREOF	KAHR MEDICAL LTD
EP3565830	COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-MESOTHELIN IMMUNOTHERAPY	LENTIGEN TECH INC
EP3566703	PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL	ALLERGAN INC
EP3566706	THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE	AGIOS PHARMACEUTICALS INC
EP3567026	NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME	LG CHEMICAL LTD
EP3567042	CDK INHIBITORS	G1 THERAPEUTICS INC
EP3568387	PROCESS FOR THE CONVERSION OF ETHYLENE GLYCOL TO ETHYLENEDIAMINE EMPLOYING A ZEOLITE CATALYST	BASF SE
EP3568389	PROCESS FOR THE PURIFICATION OF CAPROLACTAM FROM A SOLUTION OF CRUDE CAPROLACTAM WITHOUT ORGANIC SOLVENT EXTRACTION	AQUAFILSLO D O O
EP3568392	HETEROCYCLENE DERIVATIVES AS PEST CONTROL AGENTS	BAYER AG
EP3568403	CHEMICAL COMPOUNDS FOR COATING OF NANOSTRUCTURES	SPAGO NANOMEDICAL AB
EP3569616	MONOCLONAL ANTIBODY RESISTING AGAINST PD-1 AND APPLICATIONS THEREOF	TAIZHOU HANZHONG BIOPHARMACEUTICS INC
EP3569619	CD123 SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY	CELLECTIS
EP3570882	NOVEL STABLE FORMULATION FOR FXIA ANTIBODIES	BAYER PHARMA AG
EP3571178	MULTIPLE-STAGE CATALYST SYSTEM FOR SELF-METATHESIS WITH CONTROLLED ISOMERIZATION AND CRACKING	SAUDI ARABIAN OIL CO
EP3571193	POTASSIUM CHANNEL MODULATORS	CADENT THERAPEUTICS INC
EP3571208	IMMUNOPROTEASOME INHIBITORS	PRINCIPIA BIOPHARMA INC
EP3571238	POLYOL BLENDS USEFUL FOR PRODUCING VISCOELASTIC FOAM	DOW GLOBAL TECHNOLOGIES LLC
EP3572397	METHOD FOR PRODUCING N-( -HYDROXYETHYL)FORMAMIDE AND METHOD FOR PRODUCING N-VINYLFORMAMIDE	MITSUBISHI CHEM CORP
EP3572401	ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF	FUJIAN COSUNTER PHARMACEUTICAL CO LTD
EP3572408	METHOD FOR PURIFYING AN AMINO ACID-N-CARBOXY ANHYDRIDE	SHINETSU CHEMICAL CO
EP3572412	PYRIDINE DERIVATIVE AS ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF	FUJIAN COSUNTER PHARMACEUTICAL CO LTD
EP3572413	1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE DERIVATIVE AS WEE1 INHIBITOR	SHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD
EP3572421	PEPTIDE, COMPLEX OF PEPTIDE AND SIRNA AND USE THEREOF	POSITEC POWER TOOLS SUZHOU CO LTD
EP3572515	GLYCOPROTEIN HORMONE LONG-ACTING SUPERAGONISTS	TROPHOGEN INC
EP3572517	HUMANIZED UNIVERSAL LIGHT CHAIN MICE	REGENERON PHARMA
EP3572876	MONOMER, POLYMER, NEGATIVE RESIST COMPOSITION, PHOTOMASK BLANK, AND RESIST PATTERN FORMING PROCESS	SHINETSU CHEMICAL CO
EP3573942	TRANSALKYLATION PROCESS AND CATALYST COMPOSITION USED THEREIN	EXXONMOBIL CHEMICAL PATENTS INC
EP3573943	METHOD FOR OBTAINING PURE 1,3-BUTADIENE	BASF SE
EP3573949	PROCESS FOR THE CONVERSION OF MONOETHANOLAMINE TO ETHYLENEDIAMINE EMPLOYING A NANOCRYSTALLINE ZEOLITE OF THE MOR FRAMEWORK STRUCTURE	BASF SE
EP3573950	PROCESS FOR THE PREPARATION OF STABLE TOLUENE DIAMINE RESIDUE/WATER BLENDS, RELATED COMPOSITIONS, AND METHODS OF USING SUCH BLENDS AS A FUEL	COVESTRO LLC
EP3573963	NRF2 ACTIVATOR	BIOGEN MA INC
EP3573986	BICYCLIC BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION	UCB BIOPHARMA SPRL
EP3574005	CD28 COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTOR THERAPY	NOVARTIS AG
EP3575296	TRIAZINE COMPOUND, COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE	SAMSUNG SDI CO LTD
EP3575307	CARBONATE-CONTAINING SILANE COMPOUND AND MAKING METHOD	SHINETSU CHEMICAL CO
EP3575377	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3575798	PROTEOLYTIC DIGESTION OF CARDIAC TROPONIN I	SIEMENS HEALTHCARE DIAGNOSTICS INC
EP3576120	NITRILE-SUBSTITUTED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM	SILATRONIX INC
EP3577097	WASTE STREAM UPGRADING IN A PROPYLENE OXIDE/STYRENE COPRODUCTION PROCESS	LYONDELL CHEMICAL TECH LP
EP3577098	MIXTURE FOR USE AS A LIQUID SORPTION AGENT IN METHANOL SYNTHESIS AND METHANOL SYNTHESIS PROCESS USING SAID MIXTURE	SIEMENS AG
EP3577101	MATERIALS FOR ELECTRONIC DEVICES	MERCK PATENT GMBH
EP3577105	PRODUCTION OF N-SUBSTITUTED AROMATIC HYDROXYLAMINE	SOLVIAS AG
EP3577114	PROCESS FOR PREPARING HALOGENATED IMIDAZOPYRIDINE DERIVATIVES	BAYER AG
EP3578256	ANTIFOULING OLIGOMERIZATION CATALYST SYSTEMS	SAUDI ARABIAN OIL CO
EP3578537	METHOD FOR PRODUCING GAMMA,DELTA-UNSATURATED ALCOHOL	KURARAY CO
EP3578547	SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME	UNIV QUEENSLAND
EP3578558	HIGHLY EFFECTIVE PHOTOPROTECTIVE AGENTS	3V SIGMA SPA
EP3578559	DYE FOR FLUORESCENT STAINING OF STRATUM CORNEUM, MANNER OF ITS SYNTHESIS AND APPLICATION IN MICROSCOPY, INCLUDING IDENTIFICATION OF ROUTES OF SUBSTANCES PENETRATION TO THE SKIN AND ASSESSMENT OF STRUCTURAL DISORDERS OF THIS LAYER	GDANSKI UNIV MEDYCZNY
EP3578560	QUINAZOLINE COMPOUND	ASTELLAS PHARMA INC
EP3578564	NOVEL HETEROLEPTIC IRIDIUM COMPLEXES	UNIVERSAL DISPLAY CORP
EP3578587	NOVEL COMPOUND HEXADECAPHLORETHOL ISOLATED FROM ISHIGE OKAMURAE AND USE THEREOF	JEJU NATIONAL UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION
EP3580190	IN VIVO STABLE HG-197(M) COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF IN NUCLEAR MEDICAL DIAGNOSTICS AND ENDORADIONUCLIDE THERAPY (THERANOSTICS)	HELMHOLTZ ZENTRUM DRESDEN
EP3580205	PROCESS FOR THE PREPARATION OF CYCLOPROPYLDIKETOPIPERAZINES AND OF A KEY INTERMEDIATE OF DS-5272	FIS FABBRICA ITALIANA SINTETICI SPA
EP3580206	PROCESS FOR PREPARING D-GLUCARO-6,3-LACTONE	BASF SE
EP3580208	NOVEL HETEROCYCLIC COMPOUND, ITS PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME	DAE WOONG PHARMA
EP3580214	GERMINATION PROMOTERS	SYNGENTA PARTICIPATIONS AG
EP3580222	INDANYLAMINOAZADIHYDROBENZOFURANYLACETIC ACIDS, PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DIABETES	BOEHRINGER INGELHEIM INT
EP3580228	MODIFIED NANOPORES, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF	OXFORD NANOPORE TECH LTD
EP3581555	NOVEL SODIUM DIACETATE CRYSTAL AND SOLID DIALYSIS PREPARATION COMPRISING SAID CRYSTAL	FUSO PHARMACEUTICAL IND
EP3581570	CARBAZOLE-PYRIDINE-TRIFLUOROMETHYLPHENYL DERIVATIVES AND RELATED COMPOUNDS FOR USE AS TADF LUMINESCENT EMITTERS IN OLEDS	CYNORA GMBH
EP3581582	PHARMACEUTICAL COMPOUND	VALLAURIX PTE LTD
EP3581594	COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN	SUMITOMO CHEMICAL CO
EP3582780	AMINO PYRIMIDINE COMPOUNDS USEFUL AS SSAO INHIBITORS	LILLY CO ELI
EP3583087	PROCESS FOR RECOVERY OF LIGHT ALKYL MONO-AROMATIC COMPOUNDS FROM HEAVY ALKYL AROMATIC AND ALKYL-BRIDGED NON-CONDENSED ALKYL AROMATIC COMPOUNDS	SAUDI ARABIAN OIL CO
EP3583089	METHOD AND DEVICE FOR CONVERTING CARBON DIOXIDE INTO METHANOL	SIEMENS AG
EP3583092	COMPOUNDS FOR OPTICALLY ACTIVE DEVICES	MERCK PATENT GMBH
EP3583093	PROCESS FOR PREPARING SUBSTITUTED BIPHENYLS	BASF SE
EP3583094	PROCESS FOR THE PREPARATION OF 2-CYANOIMIDAZOLE COMPOUNDS	ADAMA MAKHTESHIM LTD
EP3583100	COMPOUNDS CONTAINING SI ATOMS FOR OPTICALLY ACTIVE DEVICES	MERCK PATENT GMBH
EP3583104	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3583129	CD70 BINDING MOLECULES AND METHODS OF USE THEREOF	KITE PHARMA INC
EP3584248	CYCLIC AMINOORGANOXYSILANE COMPOUND AND PROCESS FOR PRODUCING THE SAME	SHINETSU CHEMICAL CO
EP3584250	BIS(DIAZADIENE)COBALT COMPOUNDS, METHOD OF MAKING AND METHOD OF USE THEREOF	VERSUM MAT US LLC
EP3584252	HUMAN IMMUNODEFICIENCY VIRUS ANTIGENS, VECTORS, COMPOSITIONS, AND METHODS OF USE THEREOF	JANSSEN VACCINES & PREVENTION BV
EP3585763	PROCESS FOR METHANOL PRODUCTION	CASALE SA
EP3585764	PROCESS FOR THE PREPARATION OF UNSATURATED CARBOXYLIC ACIDS BY CARBONYLATION OF ALLYL ALCOHOLS AND THEIR ACYLATION PRODUCTS	BASF SE
EP3585767	A PROCESS AND SYSTEM TO CAPTURE AMMONIA FROM A PURGE GAS OF A UREA PLANT	CASALE SA
EP3585773	SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI	BASF SE
EP3585774	NOVEL SUBSTITUTED SULFOXIMINE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS	MERCK SHARP & DOHME
EP3585785	PROCESS FOR THE PREPARATION OF METHYL-4-[(4,5-DIHYDRO-3-METHOXY-4-METHYL-5-OXO-1H-1,2,4-TRIAZOLE-1-YL)CARBONYL)SULPHAMOYL]-5-METHYLTHIOPHENE-3-CARBOXYLATE	BAYER CROPSCIENCE AG
EP3585808	MODIFIED SERPINS FOR THE TREATMENT OF BRADYKININ-MEDIATED DISEASE	UMC UTRECHT HOLDING BV
EP3585873	PROCESS FOR MAKING SOLID METHYLGLYCINE DIACETATE (MGDA) ALKALI METAL SALT, AND SOLID PARTICLES	BASF SE
EP3585902	METHOD FOR THE PREPARATION OF (3E,7E)-HOMOFARNESIC ACID OR (3E,7E)-HOMOFARNESIC ACID ESTER	BASF SE
EP3587348	PARTIALLY HYDROGENATED CHLOROSILANES AND METHODS FOR PREPARING SAME BY SELECTIVE HYDROGENATION	EVONIK OPERATIONS GMBH
EP3587387	ACETIC ACID PRODUCTION METHOD	DAICEL CORP
EP3587406	2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER	FORMA THERAPEUTICS INC
EP3587411	PIPERIDINE OR THIOMORPHOLINE LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND USES THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG	MERCK SHARP & DOHME
EP3587418	INHIBITORS OF CREB BINDING PROTEIN (CBP)	FORMA THERAPEUTICS INC
EP3587425	ULTRAVIOLET ABSORBING COMPOUND AND APPLICATIONS THEREOF
EP3587448	HETERODIMERIC PROTEINS	XENCOR INC
EP3587534	THERMOCHROMIC COLOR MEMORIZING COMPOSITION AND THERMOCHROMIC COLOR MEMORIZING MICROCAPSULE PIGMENT ENCLOSING SAME	PILOT INK CO LTD
EP3589607	A PROCESS FOR PRODUCING FLUTEMETAMOL	GE HEALTHCARE LTD
EP3589608	PROCESS FOR PREPARING AN UNSATURATED ALCOHOL	BASF SE
EP3589609	PROCESS FOR THE PRODUCTION OF ALLYL COMPOUNDS BY DEOXYDEHYDRATION OF GLYCEROL	UNIV LIEGE
EP3589611	EFFICIENT SCALABLE SYNTHESES OF ABSCISIC ACID, 8'-ACETYLENE ABSCISIC ACID AND 8'-CYCLOPROPYL ABSCISIC ACID	NAT RES COUNCIL CANADA
EP3589612	METHOD FOR THE PRODUCTION OF FLUOROALKYL NITRILES AND OF THE CORRESPONDING FLUOROALKYL TETRAZOLES	BAYER CROPSCIENCE AG
EP3589615	PYRIDYL DERIVATIVES AS BROMODOMAIN INHIBITORS	GLAXOSMITHKLINE IP NO 2 LTD
EP3589622	METHOD FOR PREPARING 3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-YLIUM IODIDE	PROVEPHARM LIFE SOLUTIONS
EP3589625	ISOQUINOLIN AND NAPHTHYDRIN COMPOUNDS	LILLY CO ELI
EP3589630	CYCLIC SULFAMIDE COMPOUNDS AND METHODS OF USING SAME	ASSEMBLY BIOSCIENCES INC
EP3589631	IMIDAZO[4,5-c]RING COMPOUNDS CONTAINING GUANIDINE SUBSTITUTED BENZAMIDE GROUPS	3M INNOVATIVE PROPERTIES CO
EP3590517	HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS	CORCEPT THERAPEUTICS INC
EP3590530	ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES	BIONTECH CELL & GENE THERAPIES GMBH
EP3590917	METHOD FOR THE PREPARATION OF DIALKYLDICARBONATES BY AMINE OXIDES	LANXESS DEUTSCHLAND GMBH
EP3590934	PYRAZOLYL QUINOXALINE KINASE INHIBITORS	ASTEX THERAPEUTICS LTD
EP3590936	METHOD FOR PRODUCING HETEROCYCLIC COMPOUND	TAKEDA PHARMACEUTICALS CO
EP3590942	HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR	FUJIAN COSUNTER PHARMACEUTICAL CO LTD
EP3590946	METHOD FOR THE PREPARATION OF ALKYLALKOXYSILANES	EVONIK OPERATIONS GMBH
EP3590947	METHOD FOR PRODUCING TRANSITION METAL-ISOCYANIDE COMPLEX	UNIV KYUSHU NAT UNIV CORP
EP3590962	SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS	SINGH BIOTECHNOLOGY LLC
EP3591072	DETECTION OF IMMUNOGLOBULIN LIGHT CHAIN RESTRICTION BY RNA IN SITU HYBRIDIZATION	ADVANCED CELL DIAGNOSTICS INC
EP3592452	PROCESS FOR PREPARING ISOCYANATES	DOW GLOBAL TECHNOLOGIES LLC
EP3592725	METHOD OF MAKING ACRYLIC ACID FROM LACTIC ACID OR LACTIDE USING MOLTEN SALT CATALYSTS	PROCTER & GAMBLE
EP3592729	CATALYTIC C-X-BOND METATHESIS THROUGH ARYLATION	STUDIENGESELLSCHAFT KOHLE MBH
EP3592730	PRODRUGS OF SULFASALAZINE, PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE DISEASE	TRULY TRANSLATIONAL SWEDEN AB
EP3592733	2- OR 3-IMIDAZOLINES AS CARBAPENEMASES INHIBITORS	CENTRE NAT RECH SCIENT
EP3592734	AMINE SALT OF (1R,3S)-3-(5-CYANO-4-PHENYL-1,3-THIAZOL-2-YLCARBAMOYL)CYCLOPENTANE CARBOXYLIC ACID	PALOBIOFARMA SL
EP3592745	PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS	ALMAC DISCOVERY LTD
EP3592756	LINCOSAMIDE DERIVATIVES, PREPARATION AND USE THEREOF AS ANTIMICROBIAL AGENT	MIKROBIOLOGICKY USTAV AV CR V V I
EP3592760	METHOD FOR PURIFYING PROTEINS USING SILICATE	LIHME PROTEIN SOLUTIONS APS
EP3594197	ACETIC ACID PRODUCTION METHOD	DAICEL CORP
EP3594203	SUBSTITUTED PYRROLIDINE COMPOUND AND USE THEREOF	TAKEDA PHARMACEUTICALS CO
EP3594207	ELECTROCHEMICAL ENERGY STORAGE DEVICES	GENTEX CORP
EP3594223	TREATMENT OF BIOFILMS	AMICOAT AS
EP3594225	A NOVEL PAENIBACILLUS STRAIN, ANTIFUNGAL COMPOUNDS, AND METHODS FOR THEIR USE	BAYER CROPSCIENCE LP
EP3594238	ANTIBODY COMPOSITIONS FOR TUMOR TREATMENT	REGENERON PHARMA
EP3594262	BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR MANUFACTURING A BIO-ELECTRODE	SHINETSU CHEMICAL CO
EP3594360	COLORIMETRIC DETECTION OF NUCLEIC ACID AMPLIFICATION	LUCIRA HEALTH INC
EP3595668	BENZAZEPINE COMPOUNDS, CONJUGATES, AND USES THEREOF	SILVERBACK THERAPEUTICS INC
EP3596033	SIMPLIFIED METHOD FOR OBTAINING PURE 1,3-BUTADIENE	BASF SE
EP3596039	PROCESS FOR MANUFACTURING CHAIN-EXTENDED HYDROXYETHYLETHYLENEAMINES, ETHYLENEAMINES, OR MIXTURES THEREOF	NOURYON CHEMICALS INT BV
EP3596045	METHOD FOR MANUFACTURING 2-HYDROXY-4-(METHYLTHIO)BUTYRIC ACID	ADISSEO FRANCE SAS
EP3596054	5-CARBOXAMIDE-2-THIOBARBITURIC ACIDS AND USE THEREOF AS MEDICAMENTS	FONDAZIONE ST ITALIANO TECNOLOGIA
EP3596064	TOSYLACETATE BASED COMPOUNDS AND DERIVATIVES THEREOF AS PHGDH INHIBITORS	BOEHRINGER INGELHEIM INT
EP3596091	CHROMATOGRAPHIC COMPOSITIONS	WATERS TECHNOLOGIES CORP
EP3596106	PEPTIDE LIBRARY CONSTRUCTING METHOD	HUNAN ZONSEN PEPLIB BIOTECH CO LTD
EP3596113	ANTIGEN RECEPTORS AND USES THEREOF	BIONTECH CELL&GENE THERAPIES GMBH
EP3596180	ADHESIVE ARTICLES AND METHODS OF MAKING THE SAME	3M INNOVATIVE PROPERTIES CO
EP3596464	TARGET DETECTION USING A MONOVALENT ANTIBODY	NANOTAG BIOTECHNOLOGIES GMBH
EP3597037	HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI	REGENERON PHARMA
EP3597038	HUMANIZED RODENTS THAT EXPRESS HEAVY CHAINS CONTAINING VL DOMAINS	REGENERON PHARMA
EP3597186	MYC G-QUADRUPLEX STABILIZING SMALL MOLECULES AND THEIR USE	US HEALTH
EP3597210	USE OF AMINO ACID SEQUENCES FROM MYCOBACTERIUM TUBERCULOSIS OR CORRESPONDING NUCLEIC ACIDS THEREOF FOR DIAGNOSIS AND PREVENTION OF TUBERCULAR INFECTION, DIAGNOSTIC KIT AND VACCINE THEREFROM	CELLESTIS LTD
EP3597630	DISSIMILAR-METAL SALT ASSEMBLY WHICH IS DENDRIMER HAVING FOUR OR MORE TYPES OF DISSIMILAR-METAL SALT COMPOUNDS PRECISELY INTEGRATED THEREIN, AND PRODUCTION METHOD FOR SUBNANO METAL PARTICLES	TOKYO INST TECH
EP3597641	LOW-ENERGY CONSUMPTION PROCESS WITH REDUCED AMMONIA CONSUMPTION, FOR THE PRODUCTION OF HIGH-PURITY MELAMINE THROUGH THE PYROLYSIS OF UREA, AND RELATIVE PLANT	EUROTECNICA MELAMINE LUXEMBOURG ZWEIGNIEDERLASSUNG IN ITTIGEN
EP3597644	AMINE CATIONIC LIPIDS AND USES THEREOF	DICERNA PHARMACEUTICALS INC
EP3597649	SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS	DART NEUROSCIENCE CAYMAN LTD
EP3597657	UNIVERSAL TAGS WITH NON-NATURAL NUCLEOBASES	SIEMENS HEALTHCARE DIAGNOSTICS INC
EP3598868	NEW POLYIMINO KETOALDEHYDES	NOVUM SPERO LTD
EP3599231	ACETIC ACID PRODUCTION METHOD	DAICEL CORP
EP3599234	STEREOSELECTIVE PROCESS	BOEHRINGER INGELHEIM INT
EP3599237	PHARMACEUTICAL COMPOSITION OF THE GLUCOSYLCERAMIDE SYNTHASE INHIBITOR ELIGLUSTAT FOR THE TREATMENT GAUCHER'S DISEASE COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P450 METABOLISM OF THE PATIENT	GENZYME CORP
EP3599244	COMPOSITION FOR PROTEIN DETECTION	ACQUASCIENCE LTD
EP3601203	PROCESS FOR SYNTHESIZING FLUORINATED CYCLIC ALIPHATIC COMPOUNDS	UNIV MUENSTER WESTFAELISCHE WILHELMS
EP3601206	PROCESS FOR PREPARING AN ANTICORROSION COMPONENT FOR AN ANTIFREEZE	BASF SE
EP3601211	CATALYTIC PROCESS FOR SYNTHESIZING N,N-DIMETHYL GLUCAMINE FROM N-METHYL GLUCAMINE	CLARIANT INT LTD
EP3601218	NEW METHOD FOR PRODUCING 2-ACRYLAMIDO-2-METHYLPROPANE SULPHONIC ACID	SPCM SA
EP3601219	CRYSTALLINE FORM HYDRATED WITH 2-ACRYLAMIDO-2-METHYLPROPANE SULPHONIC ACID	SPCM SA
EP3601220	ENHANCED OIL RECOVERY METHOD USING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID	SPCM SA
EP3601221	METHOD FOR TREATING A SUSPENSION OF SOLID PARTICLES IN WATER USING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANESULFONIC ACID	SPCM SA
EP3601222	FRACTURING FLUID COMPRISING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULPHONIC ACID AND HYDRAULIC FRACTURING METHOD	SPCM SA
EP3601225	SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS	JANSSEN PHARMACEUTICALS INC
EP3601240	PROCESS FOR MAKING ARYLOMYIN RING ANALOGS	HOFFMANN LA ROCHE
EP3601243	NEW CATALYTIC SYSTEM FOR SCALABLE PREPARATION OF INDOXACARB	ADAMA MAKHTESHIM LTD
EP3601244	NOVEL IONIC LIQUIDS RESULTING FROM THE ASSOCIATION OF A SPECIFIC CATION AND A SPECIFIC ANION	COMMISSARIAT ENERGIE ATOMIQUE
EP3601247	INTEGRATED PROCESS FOR THE PRODUCTION OF FUEL COMPONENTS FROM GLYCERIN	ENI SPA
EP3601252	TETRAHYDRATE OF H3 LIGAND, ITS PROCESS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME	BIOPROJET SOC CIV
EP3601257	AROMATIC COMPOUNDS	MERCK PATENT GMBH
EP3601263	NOVEL PYRIDAZINONE HERBICIDES	FMC CORP
EP3601266	SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS	JANSSEN PHARMACEUTICALS INC
EP3601268	PROCESS FOR THE PREPARATION OF 6-(CYCLOPROPANEAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE	SQUIBB BRISTOL MYERS CO
EP3601273	4-PIPERIDIN-N-(PYRIMIDIN-4-YL)CHROMAN-7-SULFONAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS	GENENTECH INC
EP3601281	CRYSTALLINE FORMS OF 4-(1-(1,1-DI(PYRIDIN-2-YL)ETHYL)-6-(3,5-DIMETHYLISOXAZOL-4-YL)-1H- PYRROLO[3,2-B]PYRIDIN-3-YL)BENZOIC ACID THAT INHIBITS BROMODOMAIN	PLEXXIKON INC
EP3601282	NOVEL PYRIDO[2,3-B]INDOLE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION	HOFFMANN LA ROCHE
EP3601287	2,6-DISUBSTITUTED-9-CYCLOPENTYL-9H-PURINES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS	UNIV PALACKEHO
EP3601288	ISOMERICALLY PURE 18F-LABELLED TETRAHYDROFOLATES	MERCK PATENT GMBH
EP3601290	11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN	SITEONE THERAPEUTICS INC
EP3601295	PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE	BASF AGRO BV
EP3601298	PROCESS FOR PREPARING CHIRAL 2,3-DIHYDROTHIAZOLO[3,2-A]PYRIMIDIN-4-IUM COMPOUNDS	BASF SE
EP3601304	METAL COMPLEXES	MERCK PATENT GMBH
EP3601305	PROCESS FOR PRODUCING ISOPROPYLIDENE BIS(CYCLOPENTADIENYL)ZIRCONIUM DICHLORIDE	LANXESS ORGANOMETALLICS GMBH
EP3601310	UNYLINKER RAPID CLEAVAGE	ROCHE INNOVATION CT COPENHAGEN AS
EP3601347	COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PROSTATE CANCER USING PROGASTRIN BINDING MOLECULE	PROGASTRINE ET CANCERS S A R L
EP3604263	METHOD FOR THE SYNTHESIS OF 9,10-BIS(CHLOROMETHYL)ANTHRACENE	UNIV CASTILLA LA MANCHA
EP3604265	METHOD FOR PRODUCING cis,cis-1,2,4-CYCLOHEXANE TRICARBOXYLIC ACID CRYSTAL	MITSUBISHI GAS CHEMICAL CO
EP3604266	ACETIC ACID PRODUCTION METHOD	DAICEL CORP
EP3604272	PROCESS FOR THE PREPARATION OF GABAPENTIN	DIVIS LABORATORIES LTD
EP3604278	PROCESS FOR THE PURIFICATION OF ACROLEIN	EVONIK OPERATIONS GMBH
EP3604280	NMP DISTILLING APPARATUS	MITSUBISHI CHEM ENG CORP
EP3604296	ORGANIC LIGHT EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER IN ORGANIC LIGHT EMITTING ELEMENT	HEESUNG MAT LTD
EP3604317	POLYFLUOROALKYL PHOSPHORIC ACID ESTER OR SALT THEREOF, AND RELEASE AGENT HAVING SAME AS ACTIVE INGREDIENT	UNIMATEC CO LTD
EP3604333	PROTEINS COMPRISING AMINO-TERMINAL PROXIMAL SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS AND CELL-TARGETING IMMUNOGLOBULIN-TYPE BINDING REGIONS CAPABLE OF SPECIFICALLY BINDING CD38	MOLECULAR TEMPLATES INC
EP3604339	THERAPEUTIC ANTIBODIES AGAINST ROR-1 PROTEIN AND METHODS FOR USE OF SAME	UNIV CALIFORNIA
EP3605631	ORGANIC SEMICONDUCTOR ELEMENT, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC SEMICONDUCTOR FILM PRODUCTION METHOD, ORGANIC SEMICONDUCTOR FILM, AND COMPOUND AND POLYMER USED THEREFOR	FUJIFILM CORP
EP3606524	DEUTERATED (S)-2-(4-(PIPERIDIN-3-YL)PHENYL)-2H-INDAZOLE-7-CARBOXAMIDE	COMBIPHOS CATALYSTS INC
EP3606665	A METHOD OF SYNTHESISING A PT(II) COMPLEX; A PT(II) COMPLEX; USE OF SUCH A COMPLEX AS A PHOTOACTIVATABLE CATALYST IN A HYDROSILYLATION REACTION	JOHNSON MATTHEY PLC
EP3606871	PROCESS FOR THE PRODUCTION OF FORMALDEHYDE-STABILIZED UREA	JOHNSON MATTHEY PLC
EP3606901	VETIVER ODORANT	FIRMENICH & CIE
EP3606902	VETIVER ODORANT	FIRMENICH & CIE
EP3606907	RACEMIC BETA-AMINOSULFONE COMPOUNDS	QUIM SINTETICA S A
EP3606923	(+)-ALPHA DIHYDROTETRABENAZINE SUCCINATE SALT	ADEPTIO PHARMACEUTICALS LTD
EP3606926	HETEROAROMATIC COMPOUNDS USEFUL IN THERAPY	CUROVIR AB
EP3606929	BETA-NICOTINATE ESTER NUCLEOTIDES AND PROCESSES FOR PREPARING SAME	UNIV CORNELL
EP3606930	DIHYDROCARBYL-SILYL-BRIDGED-1.3 DISUBSTITUTED-2-INDENYL METALLOCENE COMPLEXES FOR OLEFIN POLYMERIZATION	SABIC GLOBAL TECHNOLOGIES BV
EP3606932	INDUSTRIAL-SCALE D-MANNOSE EXTRACTION FROM D-MANNOSE BISULFITE ADDUCTS	BORREGAARD AS
EP3606936	RECOVERY PROCESS	NOVOZYMES AS
EP3606953	FGFR3 BINDING MOLECULES	COVAGEN AG
EP3606980	A PROCESS TO PREPARE A CYCLIC OLIGOMER AND A CYCLIC OLIGOMER OBTAINABLE THEREBY AND A PROCESS TO POLYMERIZE IT	SULZER MANAGEMENT AG
EP3608302	PROCESS FOR PREPARING A 5-ALKEN-1-YNE COMPOUND, (6Z)-1,1-DIALKOXY-6-NONEN-2-YNE COMPOUND, (2E,6Z)-2,6-NONADIENAL AND (2E)-CIS-6,7-EPOXY-2-NONENAL, AND 1,1-DIALKOXY-6-NONEN-2-YNE COMPOUND	SHINETSU CHEMICAL CO
EP3608307	ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE COMPOUND	LG DISPLAY CO LTD
EP3608310	METHOD FOR SEPARATING AND PURIFYING 2-CHLORO-3-TRIFLUOROMETHYLPYRIDINE	ISHIHARA SANGYO KAISHA
EP3608323	PYRAN FUSED RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF	BEIJING TIENYI LUFU PHARMATECH CO LTD
EP3608324	METHOD FOR PREPARING 2-ARYLMALONAMIDE AND APPLICATIONS OF METHOD	ORIENTAL LUZHOU AGROCHEMICALS CO LTD
EP3608334	TATK-CDKL5 FUSION PROTEINS, COMPOSITIONS, FORMULATIONS, AND USE THEREOF	UNIV BOLOGNA ALMA MATER STUDIORUM
EP3609874	IONIC COMPOUNDS COMPRISING 1,3-DIALKYL-4,5,6,7-TETRAHYDRO-1H-BENZO[D]IMIDAZOL-3-IUM CATIONS FOR USE IN COATINGS AND ADHESIVES	NITTO DENKO CORP
EP3609875	AN IMPROVED PROCESS FOR THE PREPARATION OF N-(3-ETHYNYLPHENYL)-7-METHOXY-6-(3-MORPHOLINOPROPOXY) QUINAZOLIN -4-AMINE DIHYDROCHLORIDE	NATCO PHARMA LTD
EP3609900	METHOD FOR PREPARING ARYLALKOXYSILANES BY DEHYDROGENATIVE SILYLATION	DOW SILICONES CORP
EP3609928	DIENE ELASTOMER MODIFIED BY A GROUP COMPRISING A SILICON ATOM, PROCESS FOR THE SYNTHESIS THEREOF AND RUBBER COMPOSITION CONTAINING SAME	MICHELIN & CIE
EP3609978	ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3610005	PEPTIDE LIGASE AND USE THEREOF	UNIV OXFORD INNOVATION LTD
EP3610884	PEPTIDE CONTAINING CONJUGATES FOR DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES	MERCK SHARP & DOHME
EP3610924	ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF	SQUIBB BRISTOL MYERS CO
EP3611153	METHOD FOR PRODUCING ACETIC ACID	DAICEL CORP
EP3611154	METHOD FOR PRODUCING ACETIC ACID	DAICEL CORP
EP3611169	NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING	BAYER PHARMA AG
EP3611173	ORGANIC LIGHT EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER IN ORGANIC LIGHT EMITTING ELEMENT	HEESUNG MAT LTD
EP3611176	NITROGEN-CONTAINING CYCLIC COMPOUND AND COLOR-CHANGING FILM COMPRISING SAME	LG CHEMICAL LTD
EP3611177	NOVEL TRANSITION METAL COMPOUND AND METHOD FOR PREPARING SAME	LG CHEMICAL LTD
EP3611240	ORGANIC ELECTROLUMINESCENCE DEVICE	LG DISPLAY CO LTD
EP3611270	KITS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS	UNIV MIAMI
EP3612237	GENE THERAPY	OSPEDALE SAN RAFFAELE SRL
EP3612519	PHENYL-2-HYDROXY-ACETYLAMINO-2-METHYL-PHENYL COMPOUNDS	LILLY CO ELI
EP3612520	AN ISOXAZOLE DERIVATIVES AS NUCLEAR RECEPTOR AGONISTS AND USED THEREOF	IL DONG PHARMA
EP3612521	CURABLE RESIN SYSTEM	HUNTSMAN ADVANCED MAT AMERICAS LLC
EP3612525	PD-1/PD-L1 INHIBITORS	GILEAD SCIENCES INC
EP3612534	PROCESS FOR THE PREPARATION OF PIPERAZINE RING FOR THE SYNTHESIS OF PYRAZINOCARBAZOLE DERIVATIVES	TECNIMEDE SOC TECNICO MEDICINAL SA
EP3612535	PROCESS FOR THE PREPARATION OF PIRLINDOLE ENANTIOMERS AND ITS SALTS	TECNIMEDE SOC TECNICO MEDICINAL SA
EP3612538	QUINONE-METHIDE PRECURSORS WITH BODIPY CHROMOPHORE, METHOD OF PREPARATION, BIOLOGICAL ACTIVITY AND APPLICATION IN FLUORESCENT LABELLING	RUDJER BOSKOVIC INST
EP3612568	CELL	AUTOLUS LTD
EP3612620	4-ETHYL-OCTENE-2/3-NITRILE AS A FRAGRANCE	SYMRISE AG
EP3613734	PROCESS FOR PRODUCING PYRROLE COMPOUND	TAKEDA PHARMACEUTICALS CO
EP3613737	NOVEL INHIBITOR OF CYCLIN-DEPENDENT KINASE CDK9	GENFLEET THERAPEUTICS SHANGHAI INC
EP3613745	SOLID FORMS AND FORMULATIONS OF (S)-4-(8-AMINO-3-(1-(BUT-2-YNOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-A]PYRAZIN-1-YL)-N-(PYRIDIN-2-YL)BENZAMIDE	ACERTA PHARMA BV
EP3613748	METHOD FOR THE PREPARATION OF TRIALKYL GALLIUM COMPOUNDS AND THEIR USE	UMICORE AG & CO KG
EP3613752	ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND	SAMSUNG ELECTRONICS CO LTD
EP3615037	TRIAZOLE BISPHOSPHONATE GERANYLGERANYL DIPHOSPHATE SYNTHASE INHIBITORS	UNIV NEBRASKA
EP3615314	METHOD OF MAKING A THREE-DIMENSIONAL OBJECT USING PPSU	SOLVAY SPECIALTY POLYMERS USA
EP3615499	METHOD FOR PURIFYING 1,1,1,2,2-PENTAFLUOROPROPANE	ARKEMA FRANCE
EP3615500	METHOD FOR THE PRODUCTION AND PURIFICATION OF 2,3,3,3-TETRAFLUOROPROPENE	ARKEMA FRANCE
EP3615506	NOVEL COMPOUNDS OF FORMULA (I) AND USE THEREOF IN THERMOCHROMIC PIGMENT COMPOSITIONS	SOC BIC
EP3615516	IMIDAZOPYRAZINE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, AND THEIR USES AS LUCIFERINS	PASTEUR INSTITUT
EP3615518	PROCESS FOR THE MANUFACTURE OF VORTIOXETINE HBR ALPHA-FORM	H LUNDBECK AS
EP3615519	PROPENE RECOVERY BY SCRUBBING WITH A SOLVENT/WATER MIXTURE	BASF SE
EP3615522	C5-ANILINOQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER	ASTRAZENECA AB
EP3615526	PHENOXYQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER	ASTRAZENECA AB
EP3615530	SUBSTITUTED SUCCINIMIDE DERIVATIVES AS PESTICIDES	BASF SE
EP3615533	FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS	NOVARTIS AG
EP3615543	PROCESS FOR PREPARING OPTICALLY ACTIVE 2,3-DIHYDROTHIAZOLO[3,2-A]PYRIMIDIN-4-IUM COMPOUNDS	BASF SE
EP3615545	PYRROLOPYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF INFLUENZA VIRUS REPLICATION	COCRYSTAL PHARMA INC
EP3615556	PROTEINS AND PEPTIDE TAGS WITH ENHANCED RATE OF SPONTANEOUS ISOPEPTIDE BOND FORMATION AND USES THEREOF	UNIV OXFORD INNOVATION LTD
EP3616706	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS	IMMATICS BIOTECHNOLOGIES GMBH
EP3616720	PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT	SHIONOGI & CO
EP3616727	INSULIN ANALOG CONJUGATES AND USE THEREOF	HANMI PHARM IND CO LTD
EP3617201	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3617216	ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND	SAMSUNG ELECTRONICS CO LTD
EP3617218	DIHYDROARTEMISININ-STEROID CONJUGATE AND PREPARATION METHOD AND USE THEREOF	YUNBAIYAO ZHENGWU SCIENCE AND TECH SHANGHAI CO LTD
EP3617220	HIGH PH PROTEIN REFOLDING METHODS	SQUIBB BRISTOL MYERS CO
EP3619183	BY-PRODUCT STREAM UPGRADING IN A PROPYLENE OXIDE/STYRENE COPRODUCTION PROCESS	LYONDELL CHEMICAL TECH LP
EP3619186	PROCESS FOR THE PRODUCTION OF SEMIFLUORINATED ALKANES	NOVALIQ GMBH
EP3619194	PROCESS AND PLANT FOR THE SYNTHESIS OF UREA	CASALE SA
EP3619199	PREPARATION OF 2-([1,2,3]TRIAZOL-2-YL)-BENZOIC ACID DERIVATIVES	IDORSIA PHARMACEUTICALS LTD
EP3619202	TRISUBSTITUTED PYRIMIDINE COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CANCER, RETINAL DISORDERS, AND CARDIOMYOPATHIES	FONDAZIONE ST ITALIANO TECNOLOGIA
EP3619207	SUBSTITUTED 5-(HALOALKYL)-5-HYDROXY-ISOXAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI	BASF SE
EP3619212	2-(HET)ARYL-SUBSTITUTED CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS	BAYER AG
EP3619215	PROCESS TO CONVERT CRUDE ASCOMYCIN INTO PURIFIED PIMECROLIMUS	MEDA PHARMA GMBH & CO KG
EP3619217	PROCESS FOR PREPARING CHIRAL 2,3-DIHYDROTHIAZOLO[3,2-A]PYRIMIDIN-4-IUM COMPOUNDS	BASF SE
EP3620447	IONIZABLE CATIONIC LIPIDS	TRANSLATE BIO MA INC
EP3620452	PROCESS FOR THE PREPARATION OF LENVATINIB	INDENA SPA
EP3620454	CARBOXYLIC ACID DERIVATIVE AS AT2R RECEPTOR ANTAGONIST	SHANDONG DANHONG PHARMACEUTICAL CO LTD
EP3621941	USE OF PRECURSORS FOR THE PRODUCTION OF CARBON-11-LABELLED AMINO ACIDS AND DERIVATIVES THEREOF	ABX ADVANCED BIOCHEMICAL COMPOUNDS GMBH
EP3621948	AMINO (METH)ACRYLATES	ALLNEX BELGIUM SA
EP3621949	PROCESS FOR THE SYNTHESIS OF N-ACYL AMINO ACIDS WITHOUT THE USE OF SOLVENTS OR ACID CHLORIDE	SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC
EP3621959	METHOD FOR THE SYNTHESIS OF AN N-ACYL COMPOUND WITHOUT THE USE OF ORGANIC SOLVENT OR ACID CHLORIDE	SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC
EP3621960	THIENOPYRIDINES AND BENZOTHIOPHENES USEFUL AS IRAK4 INHIBITORS	SQUIBB BRISTOL MYERS CO
EP3621970	ORGANOBORON COMPLEXES FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3621971	CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3621972	BENZOTHIAZOLE-CONTAINING SILANES, METHOD FOR THE PREPARATION AND USE THEREOF	EVONIK OPERATIONS GMBH
EP3622081	PROCESS FOR PRODUCING AN AZAPHILONE IN TALAROMYCES ATROROSEUS	UNIV DANMARKS TEKNISKE
EP3622292	GENETICALLY ENCODED POTASSIUM ION INDICATORS	UNIV GRAZ MEDIZINISCHE
EP3622813	ANIMAL MODELS AND THERAPEUTIC MOLECULES	KYMAB LTD
EP3622953	COMBINATION TREATMENT OF CANCER	SCANDION ONCOLOGY AS
EP3623360	PRODUCTION METHOD FOR 1 AMINO CYCLOPROPANE CARBOXYLIC ACID NONHYDRATE	SUMITOMO CHEMICAL CO
EP3623361	LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS	NOVARTIS AG
EP3623374	STEM CELL CULTURES	SCRIPPS RESEARCH INST
EP3623376	SECONDARY AMINE, RADICAL, AND ALKOXY AMINE COMPOUND
EP3623444	ORGANIC ELECTROLUMINESCENT DEVICES AND METAL COMPLEX COMPOUNDS	UDC IRELAND LTD
EP3623463	TALE TRANSCRIPTIONAL ACTIVATORS	MASSACHUSETTS GEN HOSPITAL
EP3624922	ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE	BASF SE
EP3625196	METHOD FOR RECOVERING A STREAM OF C2+ HYDROCARBONS IN A RESIDUAL REFINERY GAS AND ASSOCIATED FACILITY	TECHNIP FRANCE
EP3625199	HYDROFORMYLATION METHOD FOR THE LARGE-SCALE PRODUCTION OF ALDEHYDES AND/OR ALCOHOLS	BASF SE
EP3625201	METHODS OF MAKING A POLYFLUORINATED ALLYL ETHER AND COMPOUNDS RELATING TO THE METHODS	3M INNOVATIVE PROPERTIES CO
EP3625210	SILICA-BASED ZINC CATALYSTS. THEIR PREPARATION AND USE IN THE ALKOXYCARBONYLATION OF AMINES	COVESTRO DEUTSCHLAND AG
EP3625211	PROCESS FOR PREPARING METHIONINE	EVONIK OPERATIONS GMBH
EP3625220	CGRP RECEPTOR ANTAGONISTS	LILLY CO ELI
EP3625221	3-METHYL-PYRROLIDINE-2,5-DIONE DERIVATIVES USEFUL AS CGRP RECEPTOR ANTAGONISTS	LILLY CO ELI
EP3625222	PHENYL DERIVATIVES AS PGE2 RECEPTOR MODULATORS	IDORSIA PHARMACEUTICALS LTD
EP3625223	PYRIMIDINE DERIVATIVES	IDORSIA PHARMACEUTICALS LTD
EP3625224	N-SUBSTITUTED INDOLE DERIVATIVES	IDORSIA PHARMACEUTICALS LTD
EP3625228	PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS	IDORSIA PHARMACEUTICALS LTD
EP3625236	A PROCESS FOR PREPARING AN OPTICALLY ACTIVE CINEOLE DERIVATIVE	BASF AGRO BV
EP3625237	A METHOD FOR SEPARATING OPTICALLY ACTIVE HYDROXY CINEOLE DERIVATIVES	BASF AGRO BV
EP3625239	A HAFNIUM COMPLEX; A SUPPORTED HAFNIUM COMPLEX; METHODS OF FORMING A POLYMER USING SUCH COMPLEXES	UNIVATION TECH LLC
EP3625250	SINGLE CHAIN VH-L1-CKAPPA-L2-CH1- ANTIBODIES	TRIANNI INC
EP3625280	POLYISOCYANATE (P) AND METHOD FOR THE PRODUCTION THEREOF	BASF SE
EP3625347	INDUCIBLE PROMOTER FOR GENE EXPRESSION AND SYNTHETIC BIOLOGY	AGRONOMIQUE INST NAT RECH
EP3626704	ISOCYANATE PRODUCTION METHOD	ASAHI CHEMICAL IND
EP3626705	ISOCYANATE PRODUCTION METHOD	ASAHI CHEMICAL IND
EP3626706	METHOD FOR INCREASING THE GUANIDINE CARBONATE YIELD IN A COMBINED MELAMINE PROCESS AND GUANIDINE CARBONATE TREATMENT PROCESS	BOREALIS AGROLINZ MELAMINE
EP3626723	INTERMEDIATE OF ERIBULIN AND PREPARATION METHOD THEREFOR	SELECTION BIOSCIENCE LLC
EP3626729	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS	IMMATICS BIOTECHNOLOGIES GMBH
EP3626731	NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS	IMMATICS BIOTECHNOLOGIES GMBH
EP3626819	TRANSGENIC MOUSE WHICH PRODUCES HYBRID ANTIBODIES CONTAINING HUMAN VARIABLE REGIONS AND MOUSE CONSTANT REGIONS	REGENERON PHARMA
EP3628041	OXIDATIVE COUPLING OF METHANE	SHELL INT RESEARCH
EP3628677	METHOD FOR PREPARING A CYCLOPEPTIDE
EP3628680	MODULATION OF COMPLEMENT ACTIVITY	RA PHARMACEUTICALS INC
EP3628686	HUMANIZATION OF RABBIT ANTIBODIES USING A UNIVERSAL ANTIBODY FRAMEWORK	ESBATECH ALCON BIOMED RES UNIT
EP3628687	BCMA CHIMERIC ANTIGEN RECEPTORS	BLUEBIRD BIO INC
EP3628731	NOVEL ANTI-PRESEPSIN ANTIBODY	MOCHIDA PHARM CO LTD
EP3630111	COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS	ENTASIS THERAPEUTICS INC
EP3630710	PROCESS FOR PREPARING METHACROLEIN	ROHM & HAAS
EP3630711	PROCESS FOR PREPARING METHACROLEIN	ROHM & HAAS
EP3630712	PROCESS FOR PREPARING METHACROLEIN	ROHM & HAAS
EP3630713	PROCESS FOR PREPARING METHACROLEIN	ROHM & HAAS
EP3630714	METHOD AND DEVICE FOR PURIFYING ACETONE/WATER MIXTURES BY MEANS OF DOUBLE-EFFECT DISTILLATION	RHODIA ACETOW GMBH
EP3630715	CALCIUM L-LACTATE FRAMEWORKS AS NATURALLY DEGRADABLE CARRIERS	UNIV CALIFORNIA
EP3630718	PROCESS FOR THE MANUFACTURING OF METHANE SULFONIC ACID	BASF SE
EP3630720	PROCESS FOR PREPARING METHIONINE	EVONIK OPERATIONS GMBH
EP3630726	CRYSTALLINE SOLID FORMS OF SALTS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-YL) OXY]PHENYL}-N'-(4-FLUORPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE, PROCESSES FOR MAKING, AND METHODS OF USE	EXELIXIS INC
EP3630727	PROCESS FOR MANUFACTURING A CYCLIC UREA ADDUCT OF AN ETHYLENEAMINE COMPOUND	NOURYON CHEMICALS INT BV
EP3630729	PYRIMIDINE COMPOUND	OTSUKA PHARMA CO LTD
EP3630730	POLYSUBSTITUTED PYRIMIDINES INHIBITING THE FORMATION OF PROSTAGLANDIN E2, A METHOD OF PRODUCTION THEREOF AND USE THEREOF	USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I
EP3630737	BORATED BENZOXAZINE FOR USE IN THE SYNTHESIS OF POLYBENZOXAZINE	MICHELIN & CIE
EP3630756	PROCESS FOR THE PREPARATION OF A NOVEL UMECLIDINIUM SYNTHESIS INTERMEDIATE	OLON SPA
EP3630761	KRAS G12C INHIBITORS AND METHODS OF USING THE SAME	AMGEN INC
EP3630764	HEXACYCLIC HETEROAROMATIC COMPOUNDS FOR ELECTRONIC DEVICES	MERCK PATENT GMBH
EP3630780	1,3-DIAZO-4-OXA-[3.3.1]-BICYCLIC DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND THEIR USE AS A MEDICAMENT, IN PARTICULAR FOR TREATING DIABETES	UNIV PISA
EP3630781	PRODUCTION OF TRIALKYLINDIUM COMPOUNDS IN THE PRESENCE OF CARBOXYLATES	UMICORE AG & CO KG
EP3630784	PREPARATION OF ISOCYANATOSILANES	MOMENTIVE PERFORMANCE MAT INC
EP3630786	SYNTHESIS AND USE OF AMINOPNICTOGENS	UNIV DRESDEN TECH
EP3630927	COMPOUND COMPRISING POLYAMINE, ACIDIC AND BORON FONCTIONALITIES AND ITS USE AS A LUBRICANT ADDITIVE	TOTAL MARKETING SERVICES
EP3632902	1,2,4-OXADIAZOLE BENZOIC ACID COMPOUND AND ITS USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE	PTC THERAPEUTICS INC
EP3632905	METHOD FOR PREPARING N-ACYL ORTHO-AMINOBENZAMIDE	MAX RUDONG CHEMICALS CO LTD
EP3632912	PYRIDOQUINAZOLINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS	ONCOSTELLAE S L
EP3632917	METHOD FOR PREPARING HETEROCYCLIC DERIVATIVE COMPOUND, COMPOSITION CONTAINING SAME COMPOUND, AND HYDRATE OF SAME COMPOUND	JW PHARMACEUTICAL CORP
EP3632921	ANCILLARY LIGANDS FOR ORGANOMETALLIC COMPLEXES	UNIVERSAL DISPLAY CORP
EP3633383	FAST PROTEIN SEQUENCING	REGENERON PHARMA
EP3634928	METHOD OF INCREASING ALPHA-OLEFIN CONTENT	LIQUIDPOWER SPECIALTY PRODUCTS INC
EP3634939	METHODS OF MAKING COMPOUNDS HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY	EASTMAN CHEM CO
EP3634940	COMPOUNDS AND MIXTURES WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INCLUDING SUCH COMPOUNDS	EASTMAN CHEM CO
EP3634957	NMDA RECEPTOR MODULATORS, COMPOSITIONS COMPRISING SAME AND USE OF THESE COMPOUNDS IN THE TREATMENT OF DISEASES INVOLVING THE CENTRAL NERVOUS SYSTEM	ADPUERIVITAM
EP3634958	CYCLOPROPYL UREA FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS	SQUIBB BRISTOL MYERS CO
EP3634961	(4-(([1,2,4]TRIAZOLO[4,3-A]PYRIDINE-6-YL)OXY)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL) UREIDO DERIVATIVES AS ANTI-INFLAMMATORY P38 MAPK INHIBITORS FOR TREATING DISEASES OF THE RESPIRATORY TRACT	CHIESI FARM SPA
EP3634971	BODIPY COMPOUNDS FOR USE IN DISPLAY DEVICES	NITTO DENKO CORP
EP3634977	METHOD OF ISOLATION OF POLYPEPTIDE-APTAMER-POLYMER CONJUGATES	GEN ELECTRIC
EP3636627	NOVEL CYCLOPROPYLMETHOXY DERIVATIVES	INT FLAVORS & FRAGRANCES INC
EP3636630	PRODUCTION METHOD FOR 1 AMINO CYCLOPROPANE CARBOXYLIC ACID NONHYDRATE	SUMITOMO CHEMICAL CO
EP3636641	ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3636652	MODIFIED POLYMERIZATION INITIATOR AND PREPARATION METHOD THEREFOR	LG CHEMICAL LTD
EP3636725	ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE COMPOUND	LG DISPLAY CO LTD
EP3637488	ORGANIC ELECTROLUMINESCENCE DEVICE	LG DISPLAY CO LTD
EP3638645	CONTINUOUS PROCESS FOR THE CONVERSION OF OLEFINS AND CARBON DIOXIDE TO ACRYLATES VIA SOLUTION PHASE REACTOR	CHEVRON PHILLIPS CHEMICAL CO LP
EP3638650	PROCESS FOR THE PREPARATION OF SUBSTITUTED PHENOXYPHENYL ALCOHOLS	BASF AGRO BV
EP3638653	PROCESS FOR PREPARING 3,4-DICHLORO-N-(2-CYANOPHENYL)-5-ISOTHIAZOLECARBOXAMIDE	BAYER AG
EP3638654	MELT ADDITIVE COMPOUNDS, METHODS OF USING THE SAME, AND ARTICLES AND COMPOSITIONS INCLUDING THE SAME	3M INNOVATIVE PROPERTIES CO
EP3638659	NEW WATER SOLUBLE MONO-BRANCHED AND DI-BRANCHED COMPLEXING AGENTS, AND CORRESPONDING LANTHANIDE COMPLEXES	CISBIO BIOASSAYS
EP3638663	PRODUCTION OF TRI-METHYL BENZENE DERIVATIVES	RHODIA OPERATIONS
EP3638665	HERBICIDALLY ACTIVE 3-PHENYLISOXAZOLINE-5-CARBOXAMIDES OF TETRAHYDRO AND DIHYDROFURAN CARBOXYLIC ACIDS AND ESTERS	BAYER AG
EP3638666	HERBICIDALLY ACTIVE 3-PHENYLISOXAZOLINE-5-CARBOXAMIDES OF TETRAHYDRO AND DIHYDROFURAN CARBOXAMIDES	BAYER AG
EP3638670	SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES AS MAP4K1 MODULATORS FOR THE TREATMENT OF CANCER DISEASES	BAYER PHARMA AG
EP3638698	ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS	REGENERON PHARMA
EP3638749	ORGANIC MOLECULE, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3640231	METHOD AND ASSEMBLY FOR RECOVERING ETHYLENE	LINDE AG
EP3640238	METHOD FOR THE PREPARATION OF DI- AND POLYAMINES OF THE DIPHENYL METHANE SERIES	COVESTRO DEUTSCHLAND AG
EP3640255	METHOD FOR PRODUCING SILICON COMPOUND, AND SILICON COMPOUND	SHINETSU CHEMICAL CO
EP3642181	METHOD FOR PREPARING INTERMEDIATE OF 4-METHOXYPYRROLE DERIVATIVE	DAE WOONG PHARMA
EP3642213	TRIDENTATE IMINOPYRROLYL NICKEL COMPLEXES AND THEIR USE AS CATALYSTS FOR THE REACTION OF POLYMERISATION OF ETHYLENE TO HYPERBRANCHED POLYETHYLENE	INST SUPERIOR TECNICO
EP3642303	COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES	KYULUX INC
EP3642311	PRODUCTION OF RENEWABLE BASE OIL AND DIESEL BY PRE-FRACTIONATION OF FATTY ACIDS	NESTE OYJ
EP3642343	IMPROVED PROTEIN EXPRESSION STRAINS	ALBUMEDIX LTD
EP3643308	COUMARIN-LIKE CYCLIC COMPOUND AS MEK INHIBITOR AND USE THEREOF	CSTONE PHARMACEUTICALS
EP3643699	METHOD FOR THE PURIFICATION OF ANILINE	COVESTRO DEUTSCHLAND AG
EP3643709	ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF	KANGPU BIOPHARMACEUTICALS LTD
EP3643720	ORGANIC COMPOUNDS, ORGANIC SEMICONDUCTOR LAYER AND ORGANIC ELECTRONIC DEVICE	NOVALED GMBH
EP3645307	SILANE, RUBBER MIXTURE CONTAINING THE SILANE AND VEHICLE TYRE HAVING THE RUBBER MIXTURE IN AT LEAST ONE COMPONENT	CONTINENTAL REIFEN DEUTSCHLAND GMBH
EP3645484	METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS COBALT CATALYSIS	LONZA AG
EP3645491	POLYORGANOSILOXANE COMPOSITIONS CONTAINING A 2-SUBSTITUTED-1-ALKYNYL-1-CYCLOHEXANOL USEFUL AS A HYDROSILYLATION REACTION INHIBITOR	DOW SILICONES CORP
EP3645498	PROCESS FOR RECOVERING ACETIC ACID FROM AN AQUEOUS STREAM COMPRISING THE SAME	NOURYON CHEMICALS INT BV
EP3645506	PROCESS FOR THE PREPARATION OF A MIXTURE OF CHELATING AGENTS, MIXTURE OF CHELATING AGENTS AND METHODS OF USING THEM	KEMIRA OYJ
EP3645507	PROCESS FOR MANUFACTURING A COMPLEXING AGENT	BASF SE
EP3645509	METHOD FOR PREPARING SUBSTITUTED 4-AMINOINDANE DERIVATIVES	BAYER AG
EP3645515	4-(3,4-DIHYDRONAPHTH-1-YL OR 2H-CHROMEN-4-YL)-5-HYDROXY-2H-PYRADIZIN-3-ONES AS HERBICIDES	FMC CORP
EP3645518	SYNTHESIS OF OMECAMTIV MECARBIL	AMGEN INC
EP3645522	ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3645524	ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3645535	NEW SALT OF N-(2,6-DIETHYLPHENYL)-8-({4-[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]-2-METHOXYPHENYL}AM INO)-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H]QUINAZOLINE-3-CARBOXAMIDE, ITS PREPARATION AND FORMULATIONS CONTAINING IT	SERVIER LAB
EP3645539	PYRIDO-IMIDAZO RIFAMYCIN DERIVATIVES AS ANTIBACTERIAL AGENT	BIOFER SPA
EP3645540	SILOLE AND GERMOLE FUSED RING PHOTOCHROMIC COMPOUNDS	TRANSITIONS OPTICAL LTD
EP3645543	SYNERGISTIC COMBINATIONS OF PLATINUM AND RHODIUM COMPOUNDS AS CATALYSTS IN HYDROSILYLATION	HERAEUS DEUTSCHLAND GMBH & CO KG
EP3645550	COMPSTATIN ANALOGS WITH INCREASED SOLUBILITY AND IMPROVED PHARMACOKINETIC PROPERTIES	UNIV PENNSYLVANIA
EP3645555	POLYPEPTIDES HAVING TREHALASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME	NOVOZYMES AS
EP3645565	BISPECIFIC ANTIBODIES TO ROR1 AND CD3	UCL BUSINESS LTD
EP3645570	VISTA ANTIGEN-BINDING MOLECULES	HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD
EP3645571	HER3 ANTIGEN-BINDING MOLECULES	HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD
EP3645609	ISOCYANATE-FUNCTIONAL SILICONE-POLYETHER COPOLYMER, SILICONE-POLYETHER-URETHANE COPOLYMER FORMED THEREWITH, SEALANTS COMPRISING SAME, AND RELATED METHODS	DOW SILICONES CORP
EP3645615	METHOD FOR PRODUCING A SILANE, METHOD FOR MODIFYING A SILICA WITH THE SILANE, AND MODIFIED SILICA	CONTINENTAL REIFEN DEUTSCHLAND GMBH
EP3645677	CETANE-BOOSTING FUEL ADDITIVES, METHOD OF MANUFACTURE, AND USES THEREOF	SABIC GLOBAL TECHNOLOGIES BV
EP3645786	PROCESS FOR SEPARATING LIGNIN FROM LIGNOCELLULOSIC MATERIALS	FUNDACION TECNALIA RES & INNOVATION
EP3647304	METHOD FOR PREPARING 2-FLUOROACRYLATE	LINHAI TIANYU PHARMACEUTICAL CO LTD
EP3647318	LINKAGE MODIFIED OLIGOMERIC COMPOUNDS	IONIS PHARMACEUTICALS INC
EP3647322	STABILIZED FIBRONECTIN BASED SCAFFOLD MOLECULES	SQUIBB BRISTOL MYERS CO
EP3647392	LIGHT-EMITTING MATERIAL, COMPOUND, LONG-PERSISTENT PHOSPHOR AND LIGHT-EMITTING ELEMENT	KYULUX INC
EP3648866	METHOD AND SYSTEM FOR SEPARATING A STARTING MIXTURE	LINDE AG
EP3648882	CATALYSTS FOR POLYESTEROL SYNTHESIS	BASF SE
EP3648890	PROCESS TO TREAT CARBONATITIC NON-SULFIDIC ORES AND COLLECTOR COMPOSITION THEREFOR	NOURYON CHEMICALS INT BV
EP3649101	METHOD FOR THE PREPARATION OF 4-(HEPTAFLUORO-2-PROPYL) ANILINES	LONZA AG
EP3649104	PROCESS FOR PRODUCING LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS	VITAWORKS IP LLC
EP3649105	SODIUM METHYL GLYCINE-N,N-DIACETIC ACID COMPOUND, PROCESS TO PREPARE IT AND USE THEREOF	NOURYON CHEMICALS INT BV
EP3649109	ETHYNYL COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE FOR THE TREATMENT OF MALARIA	SANOFI SA
EP3649111	POLYAROMATIC MOLECULE HAVING A NITRILE OXIDE FUNCTION	ARKEMA FRANCE
EP3649119	NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS	GALAPAGOS NV
EP3649124	FLUOROPIPERIDINE COMPOUNDS AS PURE 5-HT6 RECEPTOR ANTAGONISTS	SUVEN LIFE SCIENCES LTD
EP3649134	PROCESS FOR PREPARING BICYCLIC ENOLETHER	FIRMENICH & CIE
EP3649145	IMPROVED REP PROTEIN FOR USE IN A DIAGNOSTIC ASSAY	DEUTSCHES KREBSFORSCH
EP3649160	IRON COMPOUND USED AS A CATALYST FOR HYDROSILYLATION, DEHYDROGENATIVE SILYLATION AND CROSSLINKING OF SILICONE COMPOSITIONS	ELKEM SILICONES FRANCE S A S
EP3649179	PRODUCTION PLANT FOR PRODUCING A CHEMICAL PRODUCT BY REACTING H-FUNCTIONAL REACTANTS WITH PHOSGENE, AND METHOD FOR OPERATING SAME	COVESTRO DEUTSCHLAND AG
EP3649214	TERBIUM AND DYSPROSIUM COMPLEXES WITH OPTIMISED ANTENNA, USED AS LUMINESCENT MARKERS	ECOLE NORMALE SUPERIEURE LYON
EP3650435	DISSOCIATION OF 1,4-BIS (4-PHENOXYBENZOYL)BENZENE - LEWIS ACID COMPLEX IN A PROTIC SOLVENT	ARKEMA FRANCE
EP3650439	SALTS OR CO-CRYSTALS OF 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL	GRUENENTHAL GMBH
EP3650442	METHOD FOR THE PREPARATION OF DIFLUOROMETHYL PYRAZOLE CARBOXYLIC ALKYL ESTER AND ITS ACID	LONZA AG
EP3650450	CRYSTAL FORM II OF THIENOPYRIDINE DERIVATIVE BISULFATE AND PREPARATION METHOD THEREFOR AND USE THEREOF	ZHONGRONG KAITE BEIJING BIOTECHNOLOGY CO LTD
EP3650452	METHOD FOR PRODUCING IODINE-CONTAINING SILICON COMPOUND	SHINETSU CHEMICAL CO
EP3650456	PURIFICATION AGENT FOR SUGAR CHAIN OR GLYCOPEPTIDE, AND USE THEREOF	SUMITOMO BAKELITE CO
EP3650457	METHOD FOR PRODUCING A RECOMBINANT PEPTIDE AND RESULTANT PEPTIDE	IVIX COMPANY LTD
EP3650557	METHOD FOR DETERMINATION OF RESTRICTION EFFICIENCY OF ENDONUCLEASES MEDIATING DOUBLE-STRAND BREAKS IN DNA TARGET SEQUENCES	UNIV JUSTUS LIEBIG GIESSEN
EP3652137	PROCESS AND FACILITY FOR PRODUCING PROPYLENE BY COMBINING PROPANE DEHYDROGENATION AND A STEAM CRACKING METHOD WITH PROPANE RECIRCULATION INTO THE STEAM CRACKING METHOD	LINDE AG
EP3652138	PROCESS AND FACILITY FOR PRODUCING PROPYLENE BY COMBINING PROPANE HYDROGENATION AND A STEAM CRACKING METHOD WITH PRE-SEPARATION STEPS IN THE TWO METHODS FOR PARTIALLY REMOVING HYDROGEN AND METHANE	LINDE AG
EP3652141	PREPARATION OF DIESTERS OF (METH)ACRYLIC ACID FROM EPOXIDES	EVONIK DEGUSSA GMBH
EP3652142	PROCESS FOR THE PREPARATION AND PURIFICATION OF MISOPROSTOL	CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS PRIVATE CO LTD
EP3652148	AMORPHOUS FORM OF VILANTEROL TRIFENATATE AND PROCESSES FOR THE PREPARATION THEREOF	HOVIONE SCIENTIA LTD
EP3652152	UREA FINISHING AND OFF-GAS TREATMENT PLANT AND PROCESS	STAMICARBON
EP3652154	PROCESS TO PREPARE ETHYLENE AMINES AND ETHYLENE AMINE DERIVATIVES	NOURYON CHEMICALS INT BV
EP3652155	PROCESS TO PREPARE HIGHER ETHYLENE AMINES OR UREA DERIVATIVES THEREOF	AKZO NOBEL CHEMICALS INT BV
EP3652157	1,3-DIAZA-SPIRO-[3.4]-OCTANE DERIVATIVES	GRUENENTHAL GMBH
EP3652168	5-MEMBERED AND BICYCLIC HETEROCYCLIC AMIDES AS INHIBITORS OF ROCK	SQUIBB BRISTOL MYERS CO
EP3652171	COOLING COMPOSITION	FIRMENICH & CIE
EP3652176	NOVEL SUBSTITUTED XANTHINE DERIVATIVES	BOEHRINGER INGELHEIM INT
EP3652182	2-OXO-1-IMIDAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES	UCB BIOPHARMA SRL
EP3652183	2-OXO-1,3-OXAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES	UCB BIOPHARMA SRL
EP3652187	IMPROVED PROCESS FOR PREPARING IMETELSTAT	GERON CORP
EP3652198	CELL FACTORY HAVING IMPROVED IRON-SULFUR CLUSTER DELIVERY	BIOSYNTIA APS
EP3652215	IMPROVED DUAL SPECIFICITY POLYPEPTIDE MOLECULE	IMMATICS BIOTECHNOLOGIES GMBH
EP3652232	INORGANIC TIN COMPOUNDS AND USE THEREOF	COVESTRO DEUTSCHLAND AG
EP3653604	METHOD FOR THE PREPARATION OF ISOCYANATE BY PARTIALLY ADIABATIC PHOSGENATION OF THE CORRESPONDING AMINE	COVESTRO DEUTSCHLAND AG
EP3653605	METHOD FOR THE PREPARATION OF ISOCYANATE BY PARTIALLY ADIABATIC PHOSGENATION OF THE CORRESPONDING AMINE	COVESTRO DEUTSCHLAND AG
EP3653616	FULLERENE DERIVATIVES, AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME	SAMSUNG ELECTRONICS CO LTD
EP3653726	PROBES FOR IMPROVED MELT DISCRIMINATION AND MULTIPLEXING IN NUCLEIC ACID ASSAYS	LUMINEX CORP
EP3653735	REPTILE SKIN PRODUCT AND PRODUCTION METHOD FOR REPTILE SKIN PRODUCT	CITIZEN WATCH CO LTD
EP3655006	ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE	AKSTON BIOSCIENCES CORP
EP3655380	PHOTOCHEMICAL SEPARATIONS AND COMPOSITIONS	UNIV FLORIDA STATE RES FOUND INC
EP3655381	PROCESS FOR THE PRODUCTION OF 2,3,3,3-TETRAFLUOROPROPENE	ARKEMA FRANCE
EP3655385	PROCESS OF PRODUCTION OF 3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-NONA-2E,7E-DIEN-4-YNE-1,6-DIOL	DSM IP ASSETS BV
EP3655395	PROCESS FOR THE PREPARATION OF N-((1R,2S,5R)-5-(TERT	SQUIBB BRISTOL MYERS CO
EP3655399	PROCESS FOR PREPARING ALKANEDIOL AND DIALKYL CARBONATE	SHELL INT RESEARCH
EP3655407	PYROPHEOPHORBIDE CONJUGATE AND USE THEREOF IN THE TREATMENT OF CANCER AND AS A FLUORESCENT MARKER	INST NAT SANTE RECH MED
EP3655408	CONFORMATIONAL RESTRICTION OF CYANINE FLUOROPHORES IN FAR-RED AND NEAR-IR RANGE	US HEALTH
EP3655413	PRODUCTION OF GLUFOSINATE BY REACTION OF 3-[N-BUTOXY(METHYL)PHOSPHORYL]-1-CYANOPROPYL ACETATE TO AFFORD A MIXTURE OF N-BUTYL (3-AMINO-3-CYANOPROPYL)METHYLPHOSPHINATE AND (3-AMINO-3-CYANOPROPYL)METHYLPHOSPHINIC ACID AMMONIUM SALT	BASF SE
EP3655414	DEFEROXAMINE DERIVATIVES AS MEDICAMENTS	BIOTECHNOLOGICKY USTAV AV CR V V I
EP3655415	PROCESS FOR PREPARING PLATINUM ORGANOSILOXANE COMPLEXES USING AN ENONE ADDITIVE	DOW SILICONES CORP
EP3655416	PROCESS FOR PREPARING PLATINUM ORGANOSILOXANE COMPLEXES	DOW SILICONES CORP
EP3655419	PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF OBETICHOLIC ACID AND DERIVATIVES THEREOF	BIONICE S L U
EP3655424	PEPTIDES MODULATING SPERM MOTILITY BY MODULATING THE PHOSPHOPROTEIN PHOSPHATASE 1 COMPLEX.	UNIV OF WOLVERHAMPTON
EP3655425	PEPTIDES WITH ANTIBIOTIC POTENTIAL AGAINST MYCOBACTERIUM TUBERCULOSIS	ADENIUM BIOTECH APS
EP3655532	A TWO-COMPONENT VECTOR LIBRARY SYSTEM FOR RAPID ASSEMBLY AND DIVERSIFICATION OF FULL-LENGTH T-CELL RECEPTOR OPEN READING FRAMES	GENOVIE AB
EP3656765	SALTS OR CO-CRYSTALS OF 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL	GRUENENTHAL GMBH
EP3656766	2,5-BIS(AMINOMETHYL)FURAN PRODUCTION METHOD	MITSUBISHI GAS CHEMICAL CO
EP3656776	INDOLOCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME	SFC CO LTD
EP3656777	COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME, BACKLIGHT UNIT, AND DISPLAY DEVICE	LG CHEMICAL LTD
EP3656779	BORYLIMIDE CATALYSTS	SCG CHEMICALS CO LTD
EP3656782	PEPTIDE AMIDE COMPOUND AND PREPARATION METHOD AND MEDICAL USE THEREOF	SICHUAN HAISCO PHARMACEUTICAL CO LTD
EP3656856	LIVE, ATTENUATED CORONAVIRUS COMPRISING A VARIANT REPLICASE GENE ENCODING POLYPROTEINS COMPRISING A MUTATION IN NSP-10.	THE PIRBRIGHT INST
EP3658192	GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF	ABBVIE INC
EP3658249	METHOD FOR PURIFYING (METH)ACRYLIC ESTERS	ARKEMA FRANCE
EP3658522	IMMUNOMODULATOR COMPOUNDS	CHEMOCENTRYX INC
EP3658524	METHOD FOR THE PRODUCTION OF CANNABINOIDS FROM TYPES OF INDUSTRIAL HEMP	INALCO S R L
EP3658528	A METHOD FOR PRODUCTION OF METHYL METHACRYLATE BY OXIDATIVE ESTERIFICATION USING A HETEROGENEOUS CATALYST	ROHM & HAAS
EP3658540	PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE LAUROXIL	INTERQUIM SA
EP3658545	METHOD FOR PREPARING 3-[(3S)-7-BROMO-2-OXO-5-(PYRIDIN-2-YL)-2,3-DIHYDRO-1H-[1,4]-BENZODIAZEPIN-3-YL]PROPIONIC ACID METHYL ESTER, AND COMPOUNDS USEFUL IN THAT METHOD	MOEHS IBERICA SL
EP3658549	PROCESS FOR PREPARING AND PURIFYING THE LFA-1 ANTAGONIST LIFITEGRAST	INTERQUIM SA
EP3658564	METAL COMPLEXES	MERCK PATENT GMBH
EP3658570	TYROSINASE ANTISENSE OLIGONUCLEOTIDES	OLIPASS CORP
EP3659995	METHOD FOR PRODUCING BIS-ACYLOXYLATED EXOMETHYLENE COMPOUND	KURARAY CO
EP3659998	AROMATIC AMINE COMPOUND, CURING AGENT FOR EPOXY COMPOUND, CURABLE COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND METHOD FOR PRODUCING AROMATIC AMINE COMPOUND	TOKYO OHKA KOGYO CO LTD
EP3660002	METHOD FOR ISOLATING CAPROLACTAM FROM THE UPPER LACTAM PHASE COMPRISING THE STEPS OF 1) DISTILLATION, 2) REFINING WITH HYDROGEN IN THE PRESENCE OF A NOBEL METAL CATALYST AND 3) RECTIFICATION	VS CHEMICKO TECHNOLOGICKA V PRAZE
EP3660012	COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE	SAMSUNG SDI CO LTD
EP3660024	POLYCYCLIC AROMATIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME	SFC CO LTD
EP3660033	LONG-ACTING COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS	APELLIS PHARMACEUTICALS INC
EP3660047	HUMAN ANTIBODIES TO FEL D1 AND METHODS OF USE THEREOF	REGENERON PHARMA
EP3661873	1,1,1-TRIS(ORGANOAMINO)DISILANE COMPOUNDS AND METHOD OF PREPARING SAME	DOW SILICONES CORP
EP3661913	A UREA PRODUCTION PROCESS AND PRODUCTION PLANT USING CO2 PRODUCED BY OXY-COMBUSTION	SAIPEM SPA
EP3661920	3-ACYL-BENZAMIDES AND THEIR USE AS HERBICIDES	BAYER AG
EP3661925	NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS	INFLAZOME LTD
EP3661929	ISOCHROMAN COMPOUNDS AND USES THEREOF	SUNOVION PHARMACEUTICALS INC
EP3661932	COMPOSITIONS AND METHODS FOR STABILIZING BENZOTHIAZOLE LUCIFERIN ANALOGS	PROMEGA CORP
EP3661936	[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-6(5H)-ONE DERIVATIVES	LILLY CO ELI
EP3661939	INTERMEDIATE COMPOUNDS AND METHDODS	BOEHRINGER INGELHEIM INT
EP3663283	CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THIN FILM FORMED FROM THE COMPOSITION	SAMSUNG DISPLAY CO LTD
EP3663284	IMPROVED METHOD FOR THE PREPARATION OF TRIACETONAMINE	EVONIK OPERATIONS GMBH
EP3663290	POLYMETHINE COMPOUNDS AND THEIR USE AS FLUORESCENT LABELS	ILLUMINA CAMBRIDGE LTD
EP3663292	DIPHENYLMETHANE DERIVATIVE IN CRYSTALLINE FORM	DAE WOONG PHARMA
EP3663298	ORGANIC THIN FILM AND ORGANIC THIN FILM TRANSISTOR AND ELECTRONIC DEVICE	SAMSUNG ELECTRONICS CO LTD
EP3663300	ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE	SAMSUNG DISPLAY CO LTD
EP3663304	SURFACE TREATMENT AGENT AND SURFACE TREATMENT METHOD USING THE SAME	SHINETSU CHEMICAL CO
EP3663306	LIGAND COMPOUND, TRANSITION METAL COMPOUND, AND CATALYST COMPOSITION CONTAINING SAME	LG CHEMICAL LTD
EP3663308	ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND	SAMSUNG ELECTRONICS CO LTD
EP3663382	SULPHUR-CONTAINING POLYESTER	OLEON N V
EP3665151	TWO-STEP PROCESS FOR CONVERTING CYCLIC ALKYLENE UREAS INTO THEIR CORRESPONDING ALKYLENE AMINES	NOURYON CHEMICALS INT BV
EP3665154	REACTIVE SEPARATION PROCESS TO CONVERT CYCLIC ALKYLENE UREAS INTO THEIR CORRESPONDING ALKYLENE AMINES	NOURYON CHEMICALS INT BV
EP3665170	PESTICIDALLY ACTIVE THIOPHENE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3665174	[1,2,4]TRIAZOLO DERIVATIVES AS PDE1 INHIBITORS FOR THE TREATMENT OF DIABETES	LILLY CO ELI
EP3665269	USE OF MAGNETIC CELLS TO MANIPULATE NON-MAGNETIC CELLS	GREINER BIO ONE NORTH AMERICA INC
EP3665291	INTEGRATION SITES IN CHO CELLS	BOEHRINGER INGELHEIM INT
EP3666778	A CRYSTALLINE CYCLIC BORONIC ACID ESTER DERIVATIVE, METHOD FOR THE PREPARATION AND THERAPEUTIC USES THEREOF	REMPEX PHARMACEUTICALS INC
EP3666779	ORGANIC ELECTROLUMINESCENT DEVICES COMPRISING HOST COMPOUNDS	CYNORA GMBH
EP3667804	ELECTROLYTE SOLUTION CONTAINING UNSATURATED CYCLIC CARBONATES, ELECTROCHEMICAL DEVICE AND LITHIUM-ION SECONDARY BATTERY COMPRISING THE SAME	DAIKIN IND LTD
EP3668519	USE OF GINSENOSIDE M1 FOR MANUFACTURING MEDICAMENT FOR TREATING ORAL CANCER
EP3668826	ETHANE OXIDATIVE DEHYDROGENATION	SHELL INT RESEARCH
EP3668827	ETHANE OXIDATIVE DEHYDROGENATION	SHELL INT RESEARCH
EP3668830	ELECTROCHEMICAL METHOD FOR PRODUCING VALERIC ACID	STICHTING WAGENINGEN RES
EP3668831	METHOD FOR CONTINUOUSLY PRODUCING ACRYLIC ACID N-BUTYL ESTER OR ACRYLIC ACID ISOBUTYL ESTER	BASF SE
EP3668848	PROCESS FOR PRODUCING (METH)ACRYLATES FROM GLYCEROL CARBONATE	BASF SE
EP3668849	PROCESS FOR PREPARING CYCLIC CARBONATES	BASF SE
EP3668850	AMBER ODORANT	FIRMENICH & CIE
EP3668855	HERBICIDAL COMPOUNDS	SYNGENTA PARTICIPATIONS AG
EP3668864	NOVEL N-(2,2-DIFLUOROETHYL)-N-[(PYRIMIDINYLAMINO)PROPANYL]ARYLCARBOXAMIDES	BOEHRINGER INGELHEIM INT
EP3668870	6-AMINO-7,9-DIHYDRO-8H-PURIN-8-ONE DERIVATIVES AS IMMUNOSTIMULANT TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS	SQUIBB BRISTOL MYERS CO
EP3668871	6-AMINO-7,9-DIHYDRO-8H-PURIN-8-ONE DERIVATIVES AS IMMUNOSTIMULANT TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS	SQUIBB BRISTOL MYERS CO
EP3668873	IMIDAZO[1,2-A]IMIDAZOL-2-ONE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS PARKINSON'S DISEASE	HOFFMANN LA ROCHE
EP3668874	PYRROLOBENZODIAZEPINE CONJUGATES	MEDIMMUNE LTD
EP3668879	NOVEL COMPOUNDS	GLAXOSMITHKLINE IP DEV LTD
EP3668880	INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE	IDORSIA PHARMACEUTICALS LTD
EP3668985	METHOD OF PURIFYING GLYCOSYLATED PROTEIN FROM HOST CELL GALECTINS AND OTHER CONTAMINANTS	JUST EVOTEC BIOLOGICS INC
EP3670499	PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS	ASTRAZENECA AB
EP3670523	5-METHOXY. 3'-OH UNBLOCKED, FAST PHOTOCLEAVABLE TERMINATING NUCLEOTIDES AND METHODS FOR NUCLEIC ACID SEQUENCING	AGILENT TECHNOLOGIES INC
EP3670526	METHOD FOR THE FERMENTATIVE PRODUCTION OF L-LYSINE USING C. GLUTAMICUM STRAINS WITH A MUTATED KUP TRANSPORTER	EVONIK OPERATIONS GMBH
EP3670528	SCLEROSTIN BINDING AGENTS	UCB PHARMA SA
EP3672943	MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3672953	BENZIMIDAZOLE DERIVATIVES USEFUL AS POTASSIUM CHANNEL INHIBITORS	ACESION PHARMA APS
EP3672956	ORGANIC TRIAZINE CONTAINING MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3672967	AZAINDOLYLPYRIDONE AND DIAZAINDOLYLPYRIDONE COMPOUNDS	SPRINT BIOSCIENCE AB
EP3672971	TRIAZOLO PYRIDINES AS MODULATORS OF GAMMA-SECRETASE	BOEHRINGER INGELHEIM INT
EP3672978	PROCESS FOR MAKING IXAZOMIB OR INTERMEDIATES THEREFOR	SYNTHON BV
EP3672979	CHEMICALLY STABLE LIGNIN DERIVATIVE AND METHOD FOR PREPARING SAME	INSTITUT NATIONAL DE RECH POUR LAGRICULTURE LALIMENTATION ET LENVIRONNEMENT
EP3674282	DIHYDROXYBIPHENYL COMPOUND, BISPHOSPHITE COMPOUND, CATALYST, METHOD FOR PRODUCING ALDEHYDES, AND METHOD FOR PRODUCING ALCOHOL	MITSUBISHI CHEM CORP
EP3674299	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3674308	ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME	SAMSUNG ELECTRONICS CO LTD
EP3676279	CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS	SQUIBB BRISTOL MYERS CO
EP3677329	PROCESS FOR PREPARING GUANIDINO ACETIC ACID	EVONIK OPERATIONS GMBH
EP3677580	CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME	LG CHEMICAL LTD
EP3679014	METHOD FOR CLEANING PHOSGENE CONDUCTING APPARATUS	COVESTRO DEUTSCHLAND AG
EP3679017	CO-CRYSTAL OF AN ORALLY AVAILABLE HIF PROLYL HYDROXYLASE INHIBITOR	SANDOZ AG
EP3679039	TYROSINE ANALOGUES DERIVATIVES AS RHO- KINASE INHIBITORS	CHIESI FARM SPA
EP3679059	NEW IMPROVED GLUCOSE ISOMERASES	METGEN OY
EP3679107	MOISTURE CURING POLYURETHANE HOT-MELT ADHESIVE HAVING GOOD ADHESION TO POLAR SUBSTRATES	SIKA TECH AG
EP3680228	METHOD FOR REMOVING PRIMARY ALCOHOL IN ESTERIFICATION, AND METHOD FOR PRODUCING ESTER COMPOSITION, INCLUDING SAME	LG CHEMICAL LTD
EP3680243	PENTACYCLIC COMPOUND	EISAI R&D MAN CO LTD
EP3680665	TIME-RESOLVED FLUORESCENT IMMUNOCHROMATOGRAPHIC TEST STRIP FOR DETECTING VANCOMYCIN AS WELL AS PREPARATION METHOD AND APPLICATION THEREOF	BEIJING DIAGREAT BIOTECHNOLOGIES CO LTD
EP3681285	MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3681286	MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3681855	METHOD FOR RECOVERY OF METHACROLEIN AND METHANOL FROM METHACROLEIN DIMETHYLACETAL	DOW GLOBAL TECHNOLOGIES LLC
EP3681867	MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3681868	MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3681869	MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3681870	MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3681890	MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES	MERCK PATENT GMBH
EP3681972	ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3681973	ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3681987	LILY OF THE VALLEY ODORANT	FIRMENICH & CIE
EP3682905	MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF	MODERNATX INC
EP3683207	N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOSTERIC MODULATORS OF NR2B	CADENT THERAPEUTICS INC
EP3683223	COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME	NOVALED GMBH
EP3684183	HERBICIDALLY ACTIVE PYRIDYL-/PYRIMIDYL-PYRIMIDINE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3684487	PROCESS FOR SEPARATING FURANIC COMPOUNDS, IN PARTICULAR 5- HYDROXYMETHYLFURFURAL, FROM DIMETHOXYSULFOXIDE BY LIQUID-LIQUID EXTRACTIONS	IFP ENERGIES NOW
EP3684751	CATALYST FOR THE OXIDATIVE ESTERIFICATION OF ALDEHYDES TO CARBOXYLIC ACID ESTERS	ROEHM GMBH
EP3684759	CRYSTAL FORM OF A DITHIOLENE NICKEL COMPLEX	BASF SE
EP3684763	PYRIMIDIN-4-CARBAMATE OR UREA DERIVATIVES AS HERBICIDES	SYNGENTA PARTICIPATIONS AG
EP3684764	PYRAZINE-4CARBAMATE OR -UREA DERIVATIVES AS HERBICIDES	SYNGENTA PARTICIPATIONS AG
EP3684777	PROCESS FOR THE PRODUCTION OF ORGANOHYDRIDOCHLOROSILANES	MOMENTIVE PERFORMANCE MAT INC
EP3684783	GENE EXPRESSION INHIBITORS	PIVARIS BIOSCIENCE GMBH
EP3684835	COLOUR-STABLE CURING COMPOSITIONS CONTAINING POLYISOCYANATE (CYCLO)ALIPHATIC DIISOCYANATES	BASF SE
EP3686179	METHOD FOR OPERATING A PLANT FOR THE SYNTHESIS OF METHANOL	THYSSENKRUPP IND SOLUTIONS AG
EP3686189	PRODUCTION METHOD FOR 5-HYDROXY-1H-IMIDAZOLE-4-CARBOXAMIDE路3/4HYDRATE	FUJIFILM CORP
EP3686206	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3686208	INTERMEDIATES FOR PREPARING HALICHONDRIN COMPOUNDS AND PREPARATION METHOD THEREFOR	BEIJING TIENYI LUFU PHARMATECH CO LTD
EP3686251	RADIATION CURABLE INKJET INKS FOR INTERIOR DECORATION	AGFA NV
EP3687979	RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE	OREAL
EP3687984	PROCESS FOR PREPARING MIXTURES OF EPOXIDIZED FATTY ACID ESTERS	PROVIRON HOLDING N V
EP3687996	SALTS OF PYRROLOTRIAZINE DERIVATIVES USEFUL AS TAM INHIBITORS	INCYTE CORP
EP3688002	SYNTHESIS OF CYCLIC ORGANIC COMPOUNDS AND METALLOCENES	UNIVATION TECH LLC
EP3688052	ACTIVATOR FOR ACCELERATED ADHESION DEVELOPMENT	SIKA TECH AG
EP3689846	POLYMERIZABLE MONOMER, POLYMER COMPOUND FOR CONDUCTIVE POLYMER, AND METHOD FOR PRODUCING THE POLYMER COMPOUND	SHINETSU CHEMICAL CO
EP3689850	ELECTROLYTES FOR ELECTROCHEMICAL GENERATOR	COMMISSARIAT ENERGIE ATOMIQUE
EP3689856	SYMMETRICAL IMINES AND A METHOD OF SYNTHESIZING SYMMETRICAL IMINES	WOJSKOWY INST TECHNIKI INZYNIERYJNEJ IM PROFESORA JOZEFA KOSACKIEGO
EP3689867	COMPOSITION, ORGANIC SEMICONDUCTOR LAYER AND ELECTRONIC DEVICE	NOVALED GMBH
EP3689888	ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME	SAMSUNG ELECTRONICS CO LTD
EP3691784	PROCESS FOR THE TRANSITION METAL CATALYZED CYANATION OF ARYL/VINYL HALIDES	STUDIENGESELLSCHAFT KOHLE MBH
EP3692031	PESTICIDALLY ACTIVE PYRROLE DERIVATIVES	SYNGENTA PARTICIPATIONS AG
EP3692126	PRO-FRAGRANCES AND METHOD OF PREPARATION THEREOF	HENKEL AG & CO KGAA
EP3692127	PRO-FRAGRANCES AND METHOD OF PREPARATION THEREOF	HENKEL AG & CO KGAA
EP3693355	FLEXIBLE MANUFACTURE OF MTBE OR ETBE AND ISONONANOL	EVONIK OPERATIONS GMBH
EP3693437	COMPOUNDS AND ORGANIC ELECTRONIC DEVICES	MERCK PATENT GMBH
EP3694840	PIPERAZINE DERIVATIVES AS MAGL INHIBITORS	HOFFMANN LA ROCHE
EP3694868	METHOD FOR PRODUCING AN ANTITUMORAL ARENAVIRUS AS WELL AS ARENAVIRUS MUTANTS	ABALOS THERAPEUTICS GMBH
EP3696173	METHOD FOR PRODUCING 2,5-BIS(AMINOMETHYL) TETRAHYDROFURAN	MITSUBISHI GAS CHEMICAL CO
EP3696246	ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3697749	ETHERIFICATION PROCESS	BP PLC
EP3697755	NOVEL SYNTHESIS METHOD FOR THE PREPARATION OF DIBENZOATE COMPOUNDS, SUCH AS 4-[BENZOYL(METHYL)AMINO]PENTANE-2-YL DIBENZOATE	SABIC GLOBAL TECHNOLOGIES BV
EP3697782	ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES	CYNORA GMBH
EP3697788	BIS(PENTAHYDROXYHEXYL)AMINO SUBSTITUTED 2-{[(3-AMINO-PYRAZIN-2-YL)FORMAMIDO]METHYL}-1H-1,3-BENZODIAZOL-3-IUM DERIVATIVES AS ENAC INHIBITORS FOR TREATING RESPIRATORY DISEASES	ENTERPRISE THERAPEUTICS LTD
EP3700884	METHOD FOR PRODUCING ETHYLENEAMINES	BASF SE
EP3700885	SEPARATION OF N-METHYLETHYLENEDIAMINE FROM EDA-CONTAINING MIXTURES	BASF SE
EP3700886	METHOD FOR THE PRODUCTION OF ETHYLENEAMINES	BASF SE
EP3700887	IMPROVEMENTS IN OR RELATING TO ORGANIC MATERIAL	UNIV LIEGE
EP3700888	HIGH PRESSURE CARBAMATE CONDENSER	STAMICARBON
EP3700893	VECTOR CONTROL COMPOSITIONS, METHODS AND PRODUCTS UTILIZING SAME	SYNGENTA PARTICIPATIONS AG
EP3700895	POLYCYCLIC AMIDES AS MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS	SUVEN LIFE SCIENCES LTD
EP3700913	PRODRUGS OF SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF	BAYER AG
EP3700922	VESICLE INCORPORATING TRANSMEMBRANE PROTEIN	AQUAPORIN AS
EP3700925	NOVEL T-CELL RECEPTOR	UNIV COLLEGE CARDIFF CONSULTANTS LTD
EP3704082	MULTINUCLEAR COMPLEXES AND THEIR PREPARATION	UNIV FREE STATE
EP3704085	PROCESS OF MAKING ORGANIC COMPOUNDS	GIVAUDAN SA
EP3704116	PROCESS FOR THE SYNTHESIS OF 2-BENZHYDRYL-3 QUINUCLIDINONE	PROCOS SPA
EP3704134	ANTIMICROBIAL TETRAPEPTIDES	DSM IP ASSETS BV
EP3704146	TRIFAB-CONTORSBODY	HOFFMANN LA ROCHE
EP3705483	ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE	SAMSUNG ELECTRONICS CO LTD
EP3707121	UREA PRODUCTION PROCESS AND PLANT	STAMICARBON
EP3707140	PURINE BASED COMPOUNDS AS TOLL-LIKE RECEPTOR 9 ANTAGONIST	COUNCIL SCIENT IND RES
EP3707141	SUBSTITUTED 2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONES AND USE OF SAME	BAYER AG
EP3707142	PYRROLOPYRAZINE DERIVATIVES AS ALPHA V INTEGRIN INHIBITORS	BRISTOL MYERS SQUIBB CO
EP3707229	CYCLOHEXENE PROPANAL DERIVATIVES AS PERFUMING INGREDIENTS	FIRMENICH & CIE
EP3708572	SENSOR FOR DETECTING GAS ANALYTE	CARRIER CORP
EP3709011	SENSOR FOR DETECTING GAS ANALYTE	CARRIER CORP
EP3710438	TRIAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS	BRISTOL MYERS SQUIBB CO
EP3710469	POLYPEPTIDES WITH IMPROVED ARABINOSE TRANSPORT SPECIFICITY	DSM IP ASSETS BV
EP3710485	ANTI-SEZ6 ANTIBODY DRUG CONJUGATES AND METHODS OF USE	ABBVIE STEMCENTRX LLC
EP3712148	CRYSTAL FORM OF URAT1 INHIBITOR, AND PREPARATION METHOD THEREFOR	MEDSHINE DISCOVERY INC
EP3712152	4,5,6,7-TETRAHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE AND 1,4,5,6,7,8-HEXAHYDROIMIDAZO[4,5-D]AZEPINE DERIVATIVES AS JANUS KINASE INHIBITORS	TOPIVERT PHARMA LTD
EP3713418	BENZOXABOROLE COMPOUNDS	BASF SE
EP3713909	METHOD FOR PRODUCING VINYL ACETATE	WACKER CHEMIE AG
EP3713923	2-PHENYLPYRIMIDINE-4-CARBOXAMIDES AS AHR INHIBITORS	BAYER AG
EP3713927	PYRIDINONE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS	NOVARTIS AG
EP3713936	SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI	BASF SE
EP3713939	IMPROVED PROCESS FOR THE SYNTHESIS OF LINKER-DRUG VC-SECO	BYONDIS BV
EP3713946	SULFONIUM SALTS OF DNTT AND RELATED COMPOUNDS AS SOLUBLE PHOTOCLEAVABLE PRECURSORS FOR ORGANIC SEMICONDUCTORS FOR USE IN ORGANIC FIELD-EFFECT TRANSISTORS	CLAP CO LTD
EP3714060	PROCESS FOR THE PURIFICATION OF A SIALIC ACID FROM A FERMENTATION BROTH	JENNEWEIN BIOTECHNOLOGIE GMBH
EP3714070	A NOVEL CIP2A VARIANT AND USES THEREOF	TURUN YLIOPISTO
EP3715339	PREPARATION METHOD OF BETA-HYDROXYCARBOXYLIC ACID ESTER	SHENYANG GOLD JYOUKI TECH CO LTD
EP3715469	LABELING METHOD FOR NUCLEIC ACID	KURUME RES PARK CO LTD
EP3717025	IMAGING AGENTS	UCB BIOPHARMA SRL
EP3717448	PROCESS FOR THE CONTINUOUS PREPARATION OF 1,2-PROPYLENE DIAMINE (1,2-PDA) AND DIMETHYLDIETHYLENE TRIAMINE (DMDETA)	BASF SE
EP3717464	NITRATION	ETH ZUERICH
EP3717488	SUBSTITUTED FURANOPYRIMIDINE COMPOUNDS AS PDE1 INHIBITORS	DART NEUROSCIENCE LLC
EP3717495	PHOSPHORESCENT PLATINUM (II) ANHC COMPLEXES	UNIV DRESDEN TECH
EP3720854	SOLID PHASE SYNTHESIS OF NIR FLUORESCENT PROBE	BRACCO IMAGING SPA
EP3720861	CHEMICAL PROCESS FOR THE SYNTHESIS OF HERBICIDAL PYRAZOLIDINEDIONE COMPOUNDS	SYNGENTA PARTICIPATIONS AG
EP3720862	SYNTHESIS OF NOROXYMORPHONE	SIEGFRIED AG
EP3720863	2-(2'-DIARYLAMINOPHENYL)BORABENZENE DERIVATIVE AND ORGANIC ELECTRONIC DEVICE INCLUDING THE DERIVATIVE	LG CHEMICAL LTD
EP3723858	FIXAXFX BISPECIFIC ANTIBODY WITH COMMON LIGHT CHAIN	KYMAB LTD
EP3724157	METHOD FOR SIMULTANEOUSLY ELIMINATING ISOBUTANAL AND ACETONE FROM OLEFINIC FEEDSTOCKS BY ADSORPTION ON A ZEOLITE MATERIAL	IFP ENERGIES NOW
EP3724199	PROCESS FOR PREPARING SHAPED METAL-ORGANIC FRAMEWORK MATERIALS	MOF TECH LIMITED
EP3724203	PREPARATION OF METAL-PYRIDINE DERIVATIVE COMPLEXES FOR USE IN MEDICAL IMAGING	UNIV OF NORTHUMBRIA AT NEWCASTLE
EP3724209	ELASTOMERIC PEPTIDE	MILANO POLITECNICO
EP3728167	A PROCESS FOR THE PREPARATION OF CRISABOROLE	OLON SPA
EP3728184	METHOD FOR PRODUCING CARBODIIMIDES	LANXESS DEUTSCHLAND GMBH
EP3728186	PROCESS FOR THE PREPARATION OF METHYL MERCAPTAN	ARKEMA FRANCE
EP3728213	PROCESS TO CONTINUOUSLY PREPARE A CYCLIC CARBONATE	NEW GREEN WORLD B V
EP3728215	PREPARATION OF RACEMIC NICOTINE BY REACTION OF ETHYL NICOTINATE WITH N-VINYLPYRROLIDONE IN THE PRESENCE OF AN ALCOHOLATE BASE AND SUBSEQUENT PROCESS STEPS	SIEGFRIED AG
EP3728218	AMINO INDOLE COMPOUNDS USEFUL AS TLR INHIBITORS	SQUIBB BRISTOL MYERS CO
EP3728261	CO-CRYSTAL OF AN ORALLY AVAILABLE JANUS KINASE INHIBITOR	SANDOZ AG
EP3728264	DIAZAINDOLE COMPOUNDS	SQUIBB BRISTOL MYERS CO
EP3728532	ODOROUS ACETALS OF ETHYL VANILLIN AND ETHYL VANILLIN DERIVATIVES	S H KELKAR AND COMPANY LTD
EP3730505	A MOLECULAR MAGNETIC MATERIAL AND A METHOD FOR PREPARATION THEREOF	UNIV JAGIELLONSKI
EP3730506	ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES	UNIVERSAL DISPLAY CORP
EP3731872	PROCESS FOR PROVIDING PEGYLATED PROTEIN COMPOSITION	HOFFMANN LA ROCHE
EP3732183	METAL COMPLEX COMPRISING AMIDINE AND THIOPHENE FUSED CYCLOPENTADIENYL LIGANDS	ARLANXEO NETHERLANDS BV
EP3735405	METHOD FOR PRODUCING METHYLENE-DIPHENYLENE-DIISOCYANATES AND POLYMETHYLENE-POLYPHENYLENE-POLYISOCYANATES	COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG
EP3736267	MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE	ABBVIE OVERSEAS SARL
EP3736270	MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE	ABBVIE OVERSEAS SARL
EP3737671	PROCESS FOR THE PREPARATION OF 4-(4-AMINOPHENYL)MORPHOLIN-3-ONE	RICHTER GEDEON NYRT
EP3737756	METHODS AND SYSTEMS FOR SUPERCOILING DNA	STICHTING VU
EP3737765	ENHANCED IMMUNE CELLS USING DUAL SHRNA AND COMPOSITION INCLUDING THE SAME	CUROCELL INC
EP3740493	INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE	IDORSIA PHARMACEUTICALS LTD
EP3741763	COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME	SAMSUNG DISPLAY CO LTD
EP3744416	METHOD AND SYSTEM FOR SYNTHESISING METHANOL	THYSSENKRUPP IND SOLUTIONS AG
EP3746453	PROCESS FOR THE CONVERSION OF A SOLID MATERIAL CONTAINING HEMICELLULOSE, CELLULOSE AND LIGNIN	AVANTIUM KNOWLEDGE CENTRE BV
EP3749637	DIFUNCTIONAL BIPHENYL COMPOUNDS, PREPARATION, AND USES	ARIANEGROUP SAS
EP3749670	5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA	UNIV PALACKEHO
EP3752484	INDUSTRIAL PROCESS FOR CONTINUOUSLY SYNTHESIZING ALKANE-SULPHONIC ACID	ARKEMA FRANCE
EP3752490	HERBICIDAL 3-AZASPIRO[5.5]UNDECANE-8,10-DIONE COMPOUNDS	SYNGENTA PARTICIPATIONS AG
EP3755445	METHOD FOR SELECTIVELY SEPARATING IMPURITIES PRESENT IN A HYDRO-ALCOHOLIC CUT BY RECYCLING THROUGH A LIQUID-LIQUID EXTRACTION COLUMN	IFP ENERGIES NOW
EP3755700	CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS	BAYER AG
EP3757085	PERFLUORINATED POLYOLS AND THEIR USE FOR THE ENANTIOMERIC SEPARATION OF CHIRAL ANIONS	CENTRE NAT RECH SCIENT
EP3765475	SUBSTITUTED PYRIDOPYRROLOPYRIMIDINE RIBONUCLEOSIDES FOR THERAPEUTIC USES	USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I
EP3766886	COMPOUND, COLOR CONVERSION FILM COMPRISING SAME, BACK-LIGHT UNIT, AND DISPLAY DEVICE	LG CHEMICAL LTD
EP3770166	ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME	SAMSUNG ELECTRONICS CO LTD
EP3774726	PROCESS FOR PRODUCING 4,4`-DICHLORODIPHENYL SULFOXIDE	BASF SE
EP3774807	PROCESS FOR PREPARING BICYCLIC GUANIDINES	WACKER CHEMIE AG
EP3774823	POLYMORPH OF SODIUM NERIDRONATE AND PREPARATION PROCESS THEREOF	ABIOGEN PHARMA SPA
EP3775925	METHOD	UNILEVER PLC
EP3778546	METHOD FOR PREPARING (METH)ACRYLIC ACID ESTER-BASED COMPOUND	LG CHEMICAL LTD
EP3778595	PANCREATITIS TREATMENT	CALCIMEDICA INC
EP3778700	FLUORINATED ETHER COMPOUND, FLUORINATED ETHER COMPOSITION, COATING LIQUID AND ARTICLE	AGC INC
EP3781578	METHOD FOR THE DEHYDROGENATION OF DICHLOROSILANE	WACKER CHEMIE AG
EP3784652	ENHANCED CONVERSION OF TAURINE TO ALKYL TAURATE AMIDE USING PHOSPHORIC ACID CATALYSTS	UNILEVER PLC
EP3793971	OPTIMIZATION OF 2-EH PRODUCT RECOVERY SYSTEM USING PROCESS INTENSIFICATION	SABIC GLOBAL TECHNOLOGIES BV
EP3807258	PHOTOCHROMIC ANNELATED NAPHTHOPYRANE SYSTEMS WITH SPECIAL SUBSTITUENTS, FOR ATTAINING RAPID LIGHTENING SPEEDS	RODENSTOCK GMBH
EP3810579	METHOD FOR PREPARATION OF N-CARBOXYANHYDRIDES	LONZA AG
EP3816169	METHOD FOR PRODUCING ACYL-GERMANIUM DERIVATIVES	EVONIK OPERATIONS GMBH
EP3816171	NOVEL PHOSPHACYCLIC PHOSPHITES	EVONIK OPERATIONS GMBH
EP3816172	PHOSPHACYCLIC PHOSPHITES FROM THE ENOL 1-HYDROXY-2-ACETONAPHTHONE	EVONIK OPERATIONS GMBH
EP3816173	PHOSPHACYCLIC PHOSPHITES FROM PYRIDOINE AND FUROIN	EVONIK OPERATIONS GMBH
EP3826997	PROCESS AND INTERMEDIATES FOR THE PREPARATION OF BILASTINE	FAES FARMA SA
EP3847042	AMINOSILYL-FUNCTIONALIZED CONJUGATED DIENES, THEIR PREPARATION AND THEIR USE IN THE PRODUCTION OF RUBBERS	SYNTHOS SA
EP3856733	METHOD FOR MANUFACTURING (2,2-DIMETHYL-1,3-DIOXOLAN-4-YL)METHANOL	DEASYL SA

转载本文请联系原作者获取授权，同时请注明本文来自陈立新科学网博客。

链接地址：https://wap.sciencenet.cn/blog-681765-1359962.html?mobile=1

分享到:

当前推荐数：0

推荐到博客首页

网友评论0 条评论

该博文允许注册用户评论请点击登录